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O-66 A Graphical Cellular Dashboard for Analysis of Metabolomics Data
PRESENTING AUTHOR: Suzanne Paley, SRI International, United States
CO-AUTHORS: Peter Karp                                                  
We present a visual cellular dashboard for graphical interactive analysis of metabolomics datasets.  The tool organizes metabolo-
mics data biologically, into individual metabolic pathways and groupings of related pathways.  The dashboard enables the user to 
easily assess the activation levels of different areas of metabolism, from gross areas such as carbohydrate degradation, to specific 
pathways such as proline biosynthesis.  The hierarchical organization of the dashboard is its key organizing principle.  At the highest 
level, the dashboard is organized into four panels: Biosynthesis, Degradation, Energy Metabolism, and Other. Each panel consists of a 
series of graphs, such as for amino acid biosynthesis and cofactor biosynthesis.  Each graph depicts all measurements for metabolites 
within those metabolic pathways.  The user can click on any graph to generate a new window containing an expanded panel that 
includes a graph for each component of the previous graph, e.g., clicking on the graph for amino acid biosynthesis produces individ-
ual graphs showing metabolite levels within every amino acid biosynthetic pathway.  Clicking on one of those amino acid graphs drills 
down further to produce a graph showing the levels of each individual metabolite within the pathway.  From here, users can also 
view the pathway diagram overlaid with metabolite data.  This tool is available at the BioCyc website, http://biocyc.org.
O-72 Assessing Proficiency in Mass Spectrometric Lipid Measurement and Annotation using a NIST International Lipidomics Interlaboratory Comparison Exercise
PRESENTING AUTHOR: Candice Ulmer, National Institute of Standards and Technology (NIST), United States
CO-AUTHORS: Christina Jones, Alan Heckert, Jeremy Koelmel, John Bowden                                             
Advances in mass spectrometric techniques have increased the number of lipid species detected. Measuring lipid profile shifts has 
promising potential for personalized medicine and biomarker discovery applications. However, there is limited harmonization in the 
lipidomics community regarding sample handling/preparation, data processing, and lipid identification strategies. Our lipidomics 
interlaboratory study was designed to (1) highlight challenges and sources of variance in the lipidomics workflow, (2) provide lipid 
concentrations and associated uncertainty ranges derived from various matrices, diverse methodologies, and institutions to serve 
as benchmark values for quality assurance in lipid measurement, and (3) develop software to standardize lipid measurement. 
Domestic (n = 18) and international laboratories (n = 14), representing academia, industry and government, quantitated 1527 
unique lipid species levels in triplicate (nmol/mL) for 52 lipid classes from the following samples: SRM 1950 (Metabolites in Frozen 
Human Plasma), SRM 2378 series 1-3 (Fatty Acids in Frozen Human Serum), and an Avanti Bovine Liver Extract. Consensus means 
and corresponding uncertainty values were calculated for 330 lipids (annotated at lipid species level) in SRM 1950 and compared 
to published data by LIPID MAPS. Z-scores were used to assess proficiency in quantitation by laboratory and by the individual lipid 
species. The following laboratory-provided meta-data was scrutinized alongside lipid measurement for each material: laboratory 
profile (targeted or global), sample extraction, sample introduction/separation, mass spectrometry instrument, and data processing 
protocols. Two resulting software, LipidQC and LipidPioneer, were also designed from observations in the interlaboratory study to 
address quality assurance and accuracy in lipid exact-mass calculations, respectively.
O-77 MAIMS: a GAIMS alternative for the deconvolution of UDP-N-acetyl-D-glucosamine 13C mass isotopologue profiles
PRESENTING AUTHOR: Dries Verdegem, Metabolomics Expertise Center - VIB / KU Leuven, Belgium
CO-AUTHORS: Hunter Moseley, Wesley Vermaelen, Abel Acosta Sanchez, Bart Ghesquière                                             
In 2011, the GAIMS algorithm for the deconvolution of the UDP-GlcNAc 13C mass isotopologue profile into the contribution of 
specifically labeled glucose, ribose, acetyl and uracil moieties upon U-13C-glucose administration was presented. O-GlcNAc signaling 
has been recognized as an important factor in the maintenance of metabolic homeostasis through its cell signaling, gene transcrip-
tion and translation actions and epigenetic reprogramming. In line with this, the precursor for O-GlcNAcylation (UDP-GlcNAc), the 
production of which relies on the activity of several metabolic pathways, has been put forward as a key nutrient sensing metabolite. 
Consequently, the outlook of unraveling the UDP-GlcNAc isotopologue profile into relative fluxes through several essential biochemical 
pathways (e.g. glycolysis, pentose phosphate pathway, TCA cycle and pyrimidine biosynthesis) using GAIMS was promising and its 
development a significant contribution to the field of Metabolic Tracer Analysis (MTA), which deals with the qualitative interpretation 
of stable isotope incorporation patterns. Unfortunately, GAIMS was presented as a proof-of-concept algorithm only and despite its 
usefulness never made available to the MTA community as a usable tool. We have therefore implemented the freely available MAIMS, 
a tool inspired by the original GAIMS algorithm and providing identical functionality. To solve the described deconvolution problem, 
which is in essence a non-convex optimization problem, MAIMS relies on Multistart metaheuristics, in which the optimal solution is 
sought by performing several local searches with random initialization. Applying MAIMS on UDP-GlcNAc measurements in prolifer-
ating endothelial cells (ECs) confirmed recently discovered metabolic preferences in these cells but also resulted in novel metabolic 
insights.
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O-88 The whole is easier than the parts: Improving molecular formula identification using Gibbs sampling on fragmentation trees
PRESENTING AUTHOR: Marcus Ludwig, Friedrich-Schiller-University Jena, Germany
CO-AUTHORS: Kai Dührkop, Louis-Felix Nothias-Scaglia, Sebastian Böcker                                               
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) is one of the predominant experimental platforms for untargeted 
metabolomics, but searching acquired tandem spectra in spectral libraries will only identify the usual suspects. SIRIUS 3.4 combines 
isotope pattern and fragmentation pattern analysis, and enables de novo identification of molecular formulas. While showing excel-
lent performance for compounds with mass below 500Da, larger compounds (potentially) containing halogens prove to be chal-
lenging due to the tremendous number of candidate molecular formulas. We introduce ZODIAC, a computational tool utilizing the 
inherent dependence between compounds to improve identification quality. Metabolites produced by organism(s) are derived from 
multiple, but limited, biogenetic pathways. As a result, metabolites in a biological sample are likely to share (structural) properties. 
Hence, correct molecular formula identifications are expected to be more similar (measured by fragmentation tree similarity) than 
incorrect ones. We derive a probabilistic model where related explanations for different compounds support each others’ plausibility. 
Using Gibbs sampling, we estimate the best molecular formula for each compound using the posterior probability. ZODIAC also allows 
to incorporate spectral library hits as “anchor” within the network of explanations, further boosting identification quality. We applied 
ZODIAC to Euphorbia dendroides LC-MS/MS data. We find that the identification rate for 48 compounds with mass above 700Da im-
proves from 43.8% when estimating each compound’s molecular formula independently using SIRIUS 3.4, to 85.4% using ZODIAC. 
By adding MS/MS anchors, performance was improved to 97.9%. Hence, Zodiac enables comprehensive molecular formula identifica-
tion, forming the basis for reliable downstream analysis, including structural elucidation.
O-127 Simultaneous Quantification of 124 Amino Metabolites in 22 Metabolic Pathways Using UH-PLC-MS/MS
PRESENTING AUTHOR: Huiru Tang, Fudan University, China
CO-AUTHORS: Jin Wang, Yulan Wang, Lihong Zhou                                               
Metabolites containing amino groups cover multiple pathways and play important roles in redox homeostasis and biosyntheses of 
proteins, nucleotides and neurotransmitters. Here, we report a new method for simultaneous quantification of 124 such metabolites 
in more than 20 metabolic pathways in a single short run. This is achieved by derivatization-assisted sensitivity enhancement (DASE) 
with 5-aminoisoquinolyl-N-hydroxysuccinimidyl carbamate (5-AIQC) followed with comprehensive analysis using ultra-high perfor-
mance liquid chromatography and electrospray ionization tandem mass spectrometry (UHPLC-MS/MS). In an one-pot manner, this 
quantification method enables simultaneous coverage of more than 20 important metabolic pathways including protein biosynthesis/
degradation, biosyntheses of catecholamines, arginine and glutathione, metabolisms of folate-associated homocysteine, taurine-hy-
potaurine et al. Compared with the reported ones, this method is capable of simultaneously quantifying thiols, disulfides and other 
oxidation-prone analytes in a single run and suitable for quantifying aromatic amino metabolites. This method is also much more 
sensitive for all tested metabolites with LODs well below 50 fmol (at sub-fmol for most tested analytes) and shows good precision for 
retention time and quantitation with inter-day and intra-day relative standard deviations (RSDs) below 15% and good recovery from 
renal cancer tissue, rat urine and plasma. The method was further applied to quantify the amino metabolites in silkworm hemolymph 
from multiple developmental stages showing its applicability in metabolomics and perhaps some clinical chemistry studies. It is ex-
pected that this method would be applicable in foodomics as well.
O-147 Automated Real-Time Quality Control of LC-MS Metabolomics Data
PRESENTING AUTHOR: Jan Stanstrup, Steno Diabetes Center Copenhagen, Denmark
CO-AUTHORS: Stinus Lindgreen                                                  
Robust results and sound conclusions can only be achieved when high quality data are available. In metabolomics this is particularly 
difficult to achieve since the large datasets necessary require long acquisition times – typically weeks to months.  Because of the 
production time, critical problems can remain hidden until initial data analysis, at which point hundreds of samples might have been 
analyzed. At this time it will be expensive and time-consuming, if at all possible, to re-analyze the samples. The common practice of 
spot-checking during the run is unreliable for identifying issues that, while non-obvious, can have detrimental effects on data consis-
tency. As metabolomics is maturing to the point where it can form the basis of clinical diagnostic platforms, a definitive requirement 
will be tight control of data quality.  To this end, we have developed an automated system that tracks quality parameters and gener-
ates dynamic online reports in real time. Common problems can be detected as the samples are being analyzed, thereby giving the 
operator the ability to identify and correct any issues immediately. The system tracks selected compounds for retention time drift and 
line broadening, loss of m/z calibration and sensitivity loss. It is also possible to concurrently monitor levels of known contaminants 
and warn the operator if contamination reaches unacceptable levels. The system is fully open source, modular, extendable and based 
on R allowing bioinformaticians to tune or extend the system to specific needs.
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O-163 Using standardised drift-tube ion mobility to enhance non-targeted assessment of the wine metabolome
PRESENTING AUTHOR: Tim Causon, University of Natural Resources and Life Sciences, Austria
CO-AUTHORS: Dragana Petrusheva, Elena Bogeva, Violeta Ivanova-Petropulos, Stephan Hann                                             
Liquid chromatography with drift-tube ion mobility spectrometry-mass spectrometry (LCxIM-MS) is emerging as a powerful addition 
to existing LC-MS workflows for addressing a diverse range of metabolomics-related questions [1,2]. Importantly, excellent preci-
sion under repeatability and reproducibility conditions of drift-tube IM separations [3] supports the development of non-targeted 
approaches for complex metabolome assessment such as wine characterisation [4]. In this work, fundamentals of this new analyt-
ical metabolomics approach are introduced and application to the analysis of 90 authentic red and white wine samples originating 
from Macedonia is presented. Following measurements, intersample alignment of metabolites using non-targeted extraction and 
three-dimensional alignment of molecular features (retention time, collision cross section, and high-resolution mass spectra) pro-
vides confidence for metabolite identity confirmation. Applying a fingerprinting metabolomics workflow allows statistical assessment 
of the influence of geographic region, variety, and age. This approach is a state-of-the-art tool to assess wine chemodiversity and is 
particularly beneficial for the discovery of wine biomarkers and establishing product authenticity based on development of fingerprint 
libraries.   References 1. Stow, S.M., Causon, T.J., Zheng, X., Kurulugama, R.T., Mairinger, T., May, J.C., Rennie, E., Baker, E., Smith, 
R.D., McLean, J.A., Hann, S., Fjeldsted, J.C. Submitted to Analytical Chemistry 2. Metz, T.O., Baker, E.S., Schymanski, E.L., Renslow, 
R.S., Thomas, D.G., Causon, T.J., Webb, I.K., Hann, S., Smith, R.D., Teeguarden, J.G. 2017. Bioanalysis, 9, 81. 3. Causon, T.J., Došen, 
M., Reznicek, G., Hann, S.  2016. LC-GC Europe, 29, 666. 4. Ortmayr, K., Causon, T., Hann, S., Koellensperger, G.  2016. Trends Anal. 
Chem., 82, 358.
O-200 MALDI Imaging of lipids and pharmaceuticals in human prostate cancer explants.
PRESENTING AUTHOR: Paul Trim, South Australian Health and Medical Research Institute (SAHMRI), Australia
CO-AUTHORS: Xander Spotbeen, Bala Prabhala, O. Johan Gustafsson, Margaret Centenera, Johan Swinnen, Lisa Butler, Marten Snel 
Defining lipid perturbations in prostate cancer may lead to a better understanding of disease pathology, prognosis and therapy 
efficacy.  A study using MALDI imaging for phospholipids and drug penetration studies using a novel tissue culture explant model of 
prostate cancer will be presented.     Our innovative tissue explant model allows for a single tissue core obtained from surgery to be 
cut into small cubes and cultured under different conditions; in this case, treatment with the current clinical agent Enzalutamide or 
vehicle (DMSO) as a negative control.  Using the same patient material allows each sample to have its own matched controls.  Anal-
ysis of the cultured tissue cores using MALDI imaging has allowed us to view the spatial distribution of several distinct phospholipid 
species within specific pathological regions of these heterogeneous tissues, enhancing the identification of tumour lipid alterations 
and metabolite signatures.  Further to this, we have verified that the pharmaceutical compound enzalutamide, when dissolved in the 
tissue culture media, completely penetrates the tissue core over a relatively short period.  The work presented is underpinned by ex-
tensive untargeted lipidomic analysis, in which lipid species identified in whole tissue homogenates have been mapped using MALDI 
Imaging.  This has provided the spatial information of individual lipid species not achievable using other techniques.  Demonstrated 
here are techniques relevant to the wider metabolomics community adding spatial information to the metabolomics workflow.
O-212 Exploring the use of ultra-high performance supercritical fluid chromatography mass spec-trometry (UHPSFC-MS) for lipidomics applications
PRESENTING AUTHOR: Joost Brandsma, University of Southampton, United Kingdom
CO-AUTHORS: John Langley, Julie Herniman, Timothy Jenkins, Tony Postle                                             
Lipids and lipid-derived metabolites play key roles in the cellular homeostasis, metabolism and signalling of all organic life. Conse-
quently, the applications of lipid analytical platforms are varied and wide-ranging: from disease biomarker discovery and phenotyp-
ing, to nutritional biochemistry, or the molecular basis of microbial ecology and its impact on global elemental cycles. The recent 
resurgence of supercritical fluid chromatography (SFC) has provided the lipidomics field with a separation technology that is not only 
orthogonal to conventional gas and liquid-based systems, but promises tangible benefits in terms of chromatographic resolution and 
analysis times. The efficacy of this technology for both targeted and untargeted lipidomics studies will be demonstrated with exam-
ples from newly-developed lipidomics assays using ultra-high performance supercritical fluid chromatography mass spectrometry 
(UHPSFC-MS). These include quantitative methods to measure: 1) all major neutral and polar membrane lipids in mammalian and 
plant/algal cells; 2) lysophosphatidic acids (LPAs) and other lysophospholipids; 3) eicosanoids; 4) cardiolipins (CLs); and 5) free fatty 
acids (FFAs), fatty acid methyl esters (FAMEs) and triglycerides (TAGs). In each of these examples UHPSFC offers a different, and in 
many cases superior, chromatographic separation to established GC or LC methods. Moreover, analysis times are short with assays 
taking between 2 and 10 minutes, depending on the target compound(s). The new generation UHPSFC systems are particularly 
well-suited to lipid analysis, providing a valuable alternative for analytes that are hard to separate by other methods, and offering 
increased sample throughput in large-scale lipid/metabolomics studies.
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O-217 Feature extraction from high-dimensional metabolomics datasets using Knowledge Discovery by Accuracy Maximization (KODAMA)
PRESENTING AUTHOR: Stefano Cacciatore, Imperial College, United Kingdom
CO-AUTHORS: Leonardo Tenori, Claudio Luchinat, Phillip Bennett, David MacIntyre                                             
Knowledge discovery and data mining are interdisciplinary areas focusing upon development of methodologies useful for extracting 
features from complex data (e.g., metabolomics) that facilitates increased knowledge of the system being studied. Here we present 
the application of our recently improved and optimised learning algorithm, KODAMA, to high dimensional data specifically focusing 
on metabolomics datasets. The core idea of the algorithm is to use only the data set as input (no a priori knowledge is needed) and 
apply an iterative procedure that permits classification with a high cross-validated predictive accuracy. The cross-validated accuracy 
can be calculated by using any supervised classifier. External class information (e.g., patient metadata) can now be integrated in 
KODAMA before performing the iterative procedure thereby supporting an additional semi-supervised approach for highlighting other-
wise hidden features of interest. KODAMA represents a valuable tool for performing feature extraction on noisy and high-dimensional 
datasets and can be used to identify metabolite features associated with the generated output and the related patient information 
that are easily interpretable for the user.
O-249 NMR Quantitates Whole Blood, Tissue and Even MS-Detected Metabolites
PRESENTING AUTHOR: Daniel Raftery, University of Washington, United States
CO-AUTHORS: Nagana Gowda, Danijel Djukovic, Haiwei Gu                                               
Conventional human blood metabolomics employs serum or plasma and provides a wealth of metabolic information. However, 
important metabolites such as coenzymes that are present in red blood cells are missed. We show here that 1H NMR can simultane-
ously quantitate 7 coenzymes and antioxidants (NAD+, NADH, NADP+, NADPH, ATP, ADP, AMP, GSH, and GSSG) in extracts of whole 
human blood, in addition to the nearly 70 metabolites that we quantify in serum/plasma, with essentially no additional effort. A new 
sample preparation method was developed for detecting these unstable species without affecting other metabolites. We similarly de-
veloped an approach to quantitate these species in 5 tissue types. Coenzyme and antioxidant levels represent a sensitive measure of 
cellular function in health and numerous diseases; the NMR method presented here offers new capabilities for deriving their concen-
trations simultaneously in numerous sample types.  Quantitative NMR data can also be applied to determine MS-detected metabo-
lite concentrations without the use of internal or external metabolite standards. Metabolite concentrations in a serum sample were 
determined using NMR and a TSP reference. MS peak integrals of these metabolites were then compared to MS peak integrals in 7 
new samples and used to determine the metabolite concentrations. Concentrations determined by NMR and NMR-guided MS agreed 
extremely well (R2&gt;0.99). However, six metabolites correlated poorly due to stability issues in their MS analysis. Expansion of the 
number of quantified metabolites without internal standards is continuing.
O-256 When the microbiome meets the metabolome: A Framework for integrative longitudinal anal-ysis
PRESENTING AUTHOR: takoua jendoubi, School of public health, Imperial College London, United Kingdom
CO-AUTHORS: Panagiotis Vorkas, Perrine Masson, Arnaud Wolfer, Erwan Werner, Jeremy Nicholson, Bernard Walther, Elaine 
Holmes, Timothy Ebbels, Robert Glen                                      
Metabonomics time-course experiments provide the opportunity to observe the evolution of metabolic profiles in response to internal 
and external stimuli. Along with other omic longitudinal profiling technologies, these techniques have great potential to complement 
the analysis of complex relations between variations across diverse omic variables and provide unique insights into the underly-
ing biology of the system. However, many statistical methods currently used to analyse short time-series omic data are i) prone to 
overfitting or ii) do not take into account the experimental design or iii) do not make full use of the multivariate information intrinsic 
to the data. The model we propose is an attempt to i) overcome overfitting by using a weakly informative Bayesian model, ii) capture 
experimental design conditions through a mixed-effects model and iii) model interdependencies between variables by augmenting 
the mixed-effects model with an ARIMAX component . We present our methodology in the context of a randomized controlled trial in 
a rat model. In this study, comprehensive metabolic phenotyping of metformin effect was performed, by monitoring the longitudinal 
metabolic variations in the plasma of healthy Wistar rats. The analysis was complemented with 16S rRNA gene sequencing in order 
to observe concurrent changes in the gut microbiome and attempt to identify potential blood biomarkers of putative changes in the 
gut microbiota. Results show that mild alterations observed within the gut microbiome are associated with a cascade of changes 
involving the host organism metabolome and gut microbiome, possibly supporting the hypothesis of an inter-level feedback loop.           
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O-264 Identifying epimetabolites by mass spectrometry-based cheminformatics
PRESENTING AUTHOR: Hiroshi Tsugawa, RIKEN, Japan
CO-AUTHORS: Zijuan Lai, Gert Wohlgemuth, Masanori Arita, Oliver Fiehn                                             
Epimetabolites are metabolites removed from canonical biochemistry pathways that can be associated with biological functions. Most 
often, these compounds have unknown chemical structures and are discovered in untargeted metabolomics by statistical associa-
tions. We here present a systematic workflow supporting three tasks for the identification of epimetabolites. (i) BinBase investigator: 
query compounds in BinBase metabolomics database for annotation records with biological metadata across 1,900 studies in over 
90,000 samples. (ii) MS-DIAL: universal chromatographic feature deconvolution with high resolution mass spectrometry analytics. (iii) 
MS-FINDER: automatic structure elucidation for GC-EI-MS and LC-ESI-MS/MS with searching against an enzyme promiscuity library, 
MINE database. Importantly, our new versions are now also capable of utilizing GC-MS data although both MS-DIAL and MS-FINDER 
were only suitable for LC-MS/MS data. The main part of this talk is to introduce our strategy for the identification of novel epimetab-
olites that were discovered in very different biological studies. Second, the MS-DIAL update is featured by comparing it against other 
open access or commercial chromatogram deconvolution methods using identical GC-MS raw data as input. Finally, the theory and 
update of MS-FINDER is introduced with the comparison against alternative software including open access or commercial programs.
O-268 Curated open-access LC-Orbitrap-MS/MS spectral library of endogenous metabolites and lipids
PRESENTING AUTHOR: Prasad Phapale, EMBL, Germany
CO-AUTHORS: Andrew Palmer, Dominik Fay, Ivan Protsyuk, Theodore Alexandrov                                             
Metabolite and lipid identification is crucial to derive biological conclusions is still a major challenge for any untargeted metabolom-
ic studies. Even High-resolution MS measurements (accuracy &lt; 1 ppm) are not sufficient for unambiguous identification in many 
cases. The gold standard for metabolite identification in metabolomics MS community is by matching fragmentation spectra (MS/MS) 
from authentic standards. The comprehensive LC-MS/MS spectral libraries are still not freely available due to several challenges. Here 
we share our ‘LC-Orbitrap-MS/MS EMBL-MCF spectral library’ from over 700 authentic metabolite standards which cover major endog-
enous biochemical pathways. We have performed LC-MS/MS analysis of over 700 authentic standards purchased from IROA, Sigma, 
Avanti and other sources. Class-specific protocols were used to analyze these compounds in both positive and negative ESI ionization 
modes. We have developed the web-browser based software Curatr, which hosts the library, facilitates the curation, and enables 
search and sharing (http://curatr.mcf.embl.de/). We have curated all relevant MS/MS spectra across chromatographic profiles from 
accurate (&lt; 10 ppm) precursors and possible adducts. Alongside fragmentation data, we record the LC-MS protocol and collision 
energies used. The curated spectra and related LC-MS metadata is freely available for download in several formats.  This is the first 
ever freely available LC-Orbitrap-MS/MS spectral library containing not only MS/MS spectra for over 700 compounds but also all meta-
data along with LC-MS protocol. The library is freely available online at our core facility website (www.embl.de/mcf) enabled by the 
Curatr web-based software. We are working on integrating the EMBL-MCF spectral library into GNPS, MassBank and MetaboLights.  
O-273
Enhanced Negative Mode Ion-less Matrices for Imaging Mass Spectrometry – Assessing 
MALDI Matrices for Metabolite Annotation and Spatial Metabolomics in Plant and Mammalian 
Systems
PRESENTING AUTHOR: Berin Boughton, University of Melbourne, Australia
CO-AUTHORS: Jeffrey Spraggins, Wesley Bryson, Richard Caprioli, Andrew Palmer, Theodore Alexandrov, Antony Bacic, Ute Roess-
ner                                         
Imaging Mass Spectrometry (IMS) is rapidly maturing as an advanced method for profiling the spatial distribution of metabolites 
in tissues. A new online data analysis platform, METASPACE, allows automated annotation of metabolites unlocking the potential 
of IMS. Matrix Assisted Laser Desorption Ionization (MALDI) is the most common IMS platform and uses chemical matrices to aid 
ionization. Current matrices used for negative ionization are limited or possess drawbacks. A suitable matrix for negative ionization 
is a non-reactive organic base, with a high pKa and high UV absorbance that does not generate low molecular weight matrix ions or 
adducts complicating interpretation. Proton Sponge, 1,8-Bis(dimethethylamino)naphthalene (DMAN) was reported by Shroff et al. 
(2009) as an Atmospheric Pressure-MALDI matrix possessing these qualities but is unsuitable for routine MALDI-MS due to sublima-
tion under high vacuum environments of most MALDI instruments. Here, we report the analogue, 1,8-Bis(1-pyrrolidinyl)naphthalene 
(BPYN) as an enhanced negative mode ion-less matrix for high mass and high spatial resolution Fourier Transform Ion Cyclotron Res-
onance (FTICR) MALDI-IMS of plant and mammalian tissues; and demonstrate the capacity to conduct positive mode ionization using 
the same matrix. To validate performance, we compared BPYN to common negative and positive ionization mode matrices on serial 
sections of rat brain. For each matrix, metabolite annotation was performed using METASPACE at False Discovery Rate of 0.2 and 
Metabolite Signal Match score cut-off of 0.1 for each matrix. We found equivalent or better performance for the analysis of fatty-ac-
ids, glycerophospholipids and gangliosides when using BPYN compared to common matrices in use.
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O-301 Automated metabolite substructure recommendation from unexplained spectra using pattern mining
PRESENTING AUTHOR: Aida Mrzic, University of Antwerp, Belgium
CO-AUTHORS: Pieter Meysman, Wout Bittremieux, Kris Laukens                                               
The identification of metabolites from mass spectral data remains the largest bottleneck in advancing metabolomics. Despite the 
existence of several reliable tools for structural elucidation of known metabolites, there is still no reliable bioinformatics tool that can 
identify previously unseen compounds. Here, we present a tool based on an automated method for substructure recommendation 
from mass spectra using pattern mining. Our approach identifies parts of unknown metabolites based on previously seen recurring 
substructures. This approach does not require any prior information regarding the metabolites to be identified, and therefore can be 
used for the partial identification of unknown unknowns. We generated substructure recommendations for the MS/MS spectra from 
58 metabolites from the previous two CASMI challenges. For all but one CASMI compound, the recommendations were significantly 
enriched with correct substructures. As this approach is best used complementary to existing metabolite identification tools, it was 
combined with the MAGMa search engine, which uses a structural database and was the winner of CASMI2014. Combining the sub-
structure recommendations with the top 50 MAGMa identifications, we improved the ranking of the correct structure for 55% of the 
compounds (in addition to 20% top ranked compounds which retained their rank), resulting in a significant increase in correct metab-
olite identifications. The substructure recommendation procedure is implemented in an online tool, where users can upload their own 
MS/MS spectra to get recommendations.
O-309 Multivariate modelling with unbiased variable selection
PRESENTING AUTHOR: Carl Brunius, Chalmers University of Technology, Sweden
CO-AUTHORS: Lin Shi, Rikard Landberg                                                
Metabolomics and other ‘omics’ technologies in general result in large, high-dimensional experimental data, which can be used e.g. 
for mechanistic investigations into pathophysiological processes or to discover biomarkers. To cope with the data structure, multi-
variate (MV) modelling is frequently used. However, the number of variables will normally far outweigh the number of observations 
and modelling thus requires reliable validation. Partial least squares analysis (PLS) and random forest (RF) are able to handle large, 
high-dimensional data with collinear variables and are widely applied for scientific MV computations. Although designed for MV 
analyses, these methods benefit from a compact data structure with non-redundant predictors in terms of decreased computation 
times, improved predictive performance, reduced likelihood of overfitting and simplified data interpretation. Variable selection is thus 
an important step to obtain parsimonious MV models. We have developed the MUVR algorithm, an approach for unbiased variable 
selection in which a nested cross-validation procedure, i.e. with an inner and outer cross-validation loop to separate data into train-
ing, validation and testing partitions to minimise overfitting, was extended to also tune the number of variables. Integrating variable 
selection with crossvalidation provides simultaneous solutions to the minimal-optimal and all-relevant problems, i.e. finding on one 
hand the minimal solution with non-redundant data and on the other all relevant features. The MUVR algorithm allows for both PLS 
and RF core modelling and supports regression, classification and multilevel analyses. The algorithm was compared, using authentic 
data, to several other variable selection techniques, both side-by-side and in combinations.
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O-346 Quantitative Lipidomics and Discovery Metabolomics Applied to Human Sebum
PRESENTING AUTHOR: Elizaveta Freinkman, Metabolon, Inc., United States
CO-AUTHORS: Richard Robinson, Kelli Goodman, Anne Evans, Luke Miller                                             
Sebum is a lipid-rich secretion that coats the surface of human skin and contributes to antimicrobial defense, water retention, pho-
toprotection, and wound healing. The human sebum lipidome is uniquely characterized by the presence of wax esters and squalene, 
as well as free fatty acids and di- and triacylglycerols. Past lipidomic studies of sebum have been limited to bulk fatty-acid measure-
ments or, more recently, to complex lipids identified only at the sum composition level and without absolute quantification across lipid 
classes. Here, we developed the first analytical method that simultaneously quantifies and resolves the molecular composition of the 
major lipid classes of human sebum. We collected sebum samples from 60 healthy volunteers and subjected them to organic solvent 
extraction followed by automated flow injection into a QTrap 5500 mass spectrometer operated in Multiple Reaction Monitoring 
mode. Starting from a broad combinatorial list of &gt;2,500 molecular species, we identified approximately 1,000 specific lipid species 
that reproducibly account for the vast majority of total signal in each lipid class, and included at least one internal standard per class. 
We went on to validate the analytical reproducibility, recovery, and linearity of the assay. In addition, we performed the first global 
metabolomic analysis of sebum on Metabolon’s established Discovery HD4 platform, revealing significant levels of ~50 metabolites 
including amino acids, nucleotide metabolites, microbial metabolites, and xenobiotics. Together, these optimized, high-throughput 
methods provide unprecedented insight into the lipidomic and metabolomic composition of human sebum.
O-352 MicrobiomeAnalyst - a web-based tool for comprehensive statistical, visual and functional analysis of microbiome data
PRESENTING AUTHOR: JIANGUO XIA, McGill University, Canada
CO-AUTHORS: Achal Dhariwal, Jasmine Chong, Salam Habib, Luis Agellon                                             
MicrobiomeAnalyst (http://www.microbiomeanalyst.ca) is a novel web-based tool that integrates the latest progress in statistics and 
visualization techniques, coupled with high-quality knowledge bases to enable comprehensive analysis of various data sets generated 
in microbiome studies. MicrobiomeAnalyst contains four modules - the Marker Data Profiling (MDP) module offers comprehensive 
support for community diversity profiling, differential abundance analysis and prediction of metabolic potentials for 16S rRNA marker 
gene data; the Shotgun Data Profiling (SDP) module supports diverse functional profiling, exploratory data analysis, as well as pow-
erful metabolic network visual analytics for metagenomics or metatranscriptomics data; the Taxon Set Enrichment Analysis (TSEA) 
module allows researchers to easily interpret taxonomic signatures through enrichment analysis against &gt;300 taxon sets manually 
curated from the literature and public databases; the Projection with Public Data (PPD) module allows users to visually explore their 
data with a public reference data for pattern discovery and biological insights. MicrobiomeAnalyst has been developed based on our 
high-performance MetaboAnalyst (http://www.metaboanalyst.ca) framework to support real-time interactive data analysis for ~100s 
of users. Finally, MicrobiomeAnalyst complements MetaboAnalyst with novel features for multi-omics data integration through biologi-
cal networks and several advanced multivariate statistics.
O-414 Metabolomics on the cloud using workflows: the PhenoMeNal approach
PRESENTING AUTHOR: Pablo Andres Moreno Cortez, EMBL-EBI The European Bioinformatics Institute, United Kingdom
CO-AUTHORS: Sijin He, Kenneth Haug, Namrata Kale, Reza Salek, Claire O’Donovan, Steffen Neumann, Ola Spjuth, Christoph Stein-
beck                                       
A bioinformatics analysis of metabolomics data can be demanding in a number of ways: due to the variety of metabolomics software 
tools, complexity of installing them on a High Performance Computing (HPC) environment, expertise needed to operate such soft-
ware, scalability issues and the intricacies of moving large data produced in the context of metabolomics from ingestion point to the 
HPC site, among others. Here we present the PhenoMeNal computational infrastructure for metabolomics, which is built to tackle 
these problems. We rely on proven workflows environments, such as Galaxy, to facilitate the use of complex metabolomics software. 
To avoid installation issues, the tools and environments that we provide are packaged in software containers (Docker), and can be 
used as well independently of our complete installation. The problem of running tools in different development and production envi-
ronments is tackled by managing our containers through a Kubernetes container orchestrator layer, which means that the higher tier 
of PhenoMeNal can also be deployed on any Kubernetes installation. Finally, we provide an automated manner of deploying all the 
infrastructure through a modern web interface on different cloud providers (i.e. Google, Amazon and OpenStack installations), where 
the user only provides his/her credentials to have a small private running cluster with all the tools available in a matter of minutes. 
Currently we deliver more than 30 metabolomics tools through our customized Galaxy workflow environment which we hope will be 
useful for the community, and we illustrate how to make more tools available on it.
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O-425 The use of ion mobility coupled with high resolution mass spectrometry to improve separa-tion and identification of lipid biomarkers in metabolic diseases
PRESENTING AUTHOR: Julian Griffin, University of Cambridge, United Kingdom
CO-AUTHORS: Christine Hinz, Sonia Liggi, Julia Denes, Antonio Murgia, Zoe Hall, Ke-di Liu, Pierluigi Caboni, Luigi Atzori, John Fjeld-
sted                                      
A major challenge of LC-MS of complex lipid mixtures is the separation/identification of isobaric compounds, which often have similar 
chromatographic properties and fragmentation data can be inconclusive. Ion mobility (IM) separates isobaric ions based on their 
mobilities through an inert gas, with mobility correlated to collisional cross sections (CCSs) of molecules, which in turn relate to struc-
ture. LC IM-MS was performed on an Agilent 6560 Q-TOF using a C18 reverse-phase method examining both total lipid extracts and 
lipid classes (free fatty acids, phospholipids (PLs), neutral lipids) following solid phase extraction. Firstly, we investigated how obesity 
remodels the composition of cell membranes in white adipose tissue, examining both diet (high fat diet; HFD) and genetic (the 
leptin deficient ob/ob mouse) induced models of obesity. Using a combination of samples and standards, and an in-house database 
of mass-to-charge (m/z) ratios, retention times, MS/MS spectra, and CCS values of phospholipid and fatty acid standards we con-
firmed previous reports that both the head group and degree of unsaturation alter CCS, with CCS values increasing with the degree 
of saturation. Multivariate statistics discriminated adipose tissue from control and ob/ob mice on a regular chow diet as well as both 
mouse genotypes on HFD. Both HFD and genetic obesity were characterised by a reduction in the diversity of PLs species detected. 
The lipidome of blood plasma from inflammatory bowel disease (IBD) patients has also been investigated, with IM identifying species 
associated with arachidonic acid metabolism altered in IBD.
O-444 Identification and discrimination of sparse networks in metabolic systems
PRESENTING AUTHOR: Lindy Rae, The University of New South Wals, Australia
CO-AUTHORS: Benjamin Rowlands, Ben Cassidy                                                
Identification and comparison of networks in metabolic data can yield valuable systems biochemistry information, allowing use of sys-
tems information to identify metabolic compartments, points of deregulation and metabolic patterns associated with disease. Here, 
we adapted methods for network identification for application to brain metabolism. We used steady-state data sets from guinea pig 
cortical brain tissue slices incubated with [1-13C]glucose and [1,2-13C]acetate. Acetate preferentially labels glial cells due to silencing 
of the metabolizing enzyme by acetylation in other brain compartments. Using substrates labelled in this fashion allows us to deter-
mine not only the fates of these labels, but also the substrate of origin, since the double or single label result in distinct labelling pat-
terns.  The resultant labelling patterns and also total metabolite pools can be subsequently measured using 1H/13C NMR spectrosco-
py. We constructed conditional independence networks where the direct strength of association between each pair of metabolites is 
estimated using partial correlation. A standard partial correlation suffers from errors induced by the larger number of interactions to 
estimate from relatively few data samples. Here, we estimated partial correlations using the MISTIC algorithm [1] which regularizes 
the calculation by imposing a strict sparsity penalty on the estimated partial correlations, setting many to zero. This, in our relatively 
simple system produced an interpretable metabolic network, providing insights into the compartmentation of acetate metabolism in 
brain.   Marjanovic, G. et al. Large scale l0 sparse inverse covariance estimation. 2016 IEEE ICASSP 
O-445 Towards accessible, standard and reproducible Metabolomics
PRESENTING AUTHOR: Reza Salek, EMBL-EBI, United Kingdom
CO-AUTHORS: MetaboLights Team, PhenoMeNal Team, Christoph Steinbeck, Claire O’Donovan                                             
Reproducing results in any science are quite challenging as a recent 2016 survey by Nature (http://www.nature.com/news/re-
ality-check-on-reproducibility-1.19961) has shown 2/3 of researchers are concerned about science reproducibility. In the field of 
metabolomics, for results to become reproducible, descriptions of an investigation in a manuscript are insufficient. To overcome 
this, and increase the chance of result reproducibility, standard frameworks for data sharing and sharing of experimental data are 
invaluable. In this presentation, developments in data standards initiatives in metabolomics, including  for NMR raw data (COSMOS 
initiative- http://www.cosmos-fp7.eu/)  developments for metabolite identification and  for data quality (both joint efforts by MSI 
and HUPO-PSI) will be discussed. It will also be shown how emerging metabolomics data sharing platforms can promote , accessible 
data sharing standards. Finally, our own experiences, as well as community efforts in creating metabolomics data analysis workflows, 
particularly in Galaxy environments which can capture study-specific experimental parameters will be presented. Such workflows 
would ideally run on a dedicated e-infrastructure platform, such as the ones developed by the PhenoMeNal consortium (http://
phenomenal-h2020.eu/home/) on a High Performance Computing (HPC) environment. Such efforts, coupled with wider community 
involvement can pave the way for a greater standard and reproducible results in data analysis, data integration and reuse of data in 
metabolomics.
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O-453 Advancing Metabolomics through Imaging Mass Spectrometry and Direct Tissue Analysis
PRESENTING AUTHOR: Richard Yost, University of Florida - Southeast Center for Integrated Metabolomics, United States
CO-AUTHORS:                                                    
Mass spectrometric imaging (MSI) provides a level of chemical and metabolomic information unmatched by any other imaging modal-
ity (including histopathology, MRI, and PET scans).  Furthermore, MSI offers the potential for rapid and direct analysis of tissue even 
when an image is not of interest. This presentation will explore innovations in MSI and direct tissue analysis, focusing on sampling 
methods (including matrix-assisted laser desorption ionization MALDI and real-time in situ microextraction using the flowprobe) along 
with strategies for increasing the speed, spatial resolution, information content, and quantitative performance of the methods.  MSI 
takes advantage of the remarkable sensitivity and selectivity of mass spectrometry (including high revolution MS and tandem mass 
spec MS/MS and MSn).  Furthermore, MSI can yield insight into hundreds of analytes in a single metabolomics analysis, without 
labeling.  Even when a chemical “image” is not of interest, MSI techniques can provide rapid and direct analysis of tissue, including 
samples too small for classic GC/MS or LC/MS metabolomic analysis. This presentation will present data for a variety of metabolomics 
applications, focusing on characterization and biomarker detection in a variety of diseases.  These studies will include the potential 
for rapid screening for skin cancer (melanoma), assessment of liver allographs for liver transplantation, and investigation of treat-
ment modalities in diseases such as Parkinson’s.
O-462 Big fat back-track: mapping desaturase activity using ozone-induced dissociation mass spec-trometry
PRESENTING AUTHOR: Stephen Blanksby, Queensland University of Technology, Australia
CO-AUTHORS: Reuben Young, Berwyck Poad, David Marshall, Martin Sadowski                                             
Mass spectrometry is unarguably the pre-eminent technology for the detection, identification and quantification of lipids in biology. 
Contemporary approaches based on electrospray ionization mass spectrometry can yield a detailed profile of the lipids present within 
a cell, tissue or organism. While changes in such a profile can be sensitively detected and used as markers of biochemical change, 
mapping these changes to known biochemical pathways can be hindered by a lack of lipid structural information. Moreover, mass 
spectrometry – even at very high resolution – can be blind to dynamic processes in lipid metabolism that are not manifested as a 
change in mass. The most striking example of this phenomenon is the profile of lipid unsaturation. While different levels of unsatu-
ration result in clear mass shifts (i.e., 2 Da for each double bond), changes in the site(s) of unsaturation result in isomeric lipids that 
have identical mass. We have developed ozone-induced dissociation (OzID) mass spectrometry specifically to visualize the unsatura-
tion profile of lipid extracts. This technology uses the reaction of ionized lipids with ozone inside the mass spectrometer to uniquely 
assign the site(s) of unsaturation in lipids and reveal the presence of isomers. Application of OzID to a series of prostate cancer cell 
lines reveals an unusual pattern of unsaturation that can be traced back to the aberrant activity of the FADS2  desaturase enzyme. 
Tracking carbon-carbon double bond positions through a wide array of lipid classes provides novel insights into enzyme-substrate 
interactions and allows direct comparison with the available transcript data.
O-473 Towards reliable lipoprotein particle predictions from NMR spectra of human blood: Interlab-oratory ring test validation of a rigorously standardized NMR protocol
PRESENTING AUTHOR: Bekzod Khakimov, Postdoc, Denmark
CO-AUTHORS: Sandra Centelles, Huub Hoefsloot, Parvaneh Ebrahimi, Mads Lind, Mette Kristensen, Niels de Roo, Doris Jacobs, John 
van Duynhoven, Claire Cannet, Fang Fang, Eberhard Humpfer, Hartmut Schäfer, Manfred Spraul, Søren Engelsen, Age Smilde                    
Lipoprotein profiling of human blood by 1H Nuclear Magnetic Resonance (NMR) spectroscopy is a rapid and promising approach to 
monitor health and disease states in medicine and nutrition. However, lack of standardization of measurement protocols has prevent-
ed the use of NMR based lipoprotein profiling in meta-studies. In this study, an extremely standardized NMR measurement protocol 
was applied in a ring test performed across three different laboratories in Europe on plasma and serum samples from 28 individu-
als. Data was evaluated in terms of (i) spectral differences, (ii) differences in LPD predictions obtained using an existing prediction 
model and (iii) agreement of predictions with cholesterol concentrations in high and low density lipoproteins (HDL and LDL) particles 
measured by standardized clinical assays. ANOVA-simultaneous component analysis (ASCA) of the ring test spectral ensemble that 
contains methylene and methyl peaks (1.4-0.6 ppm) showed that 97.99% of the variance in the data is related to subject, 1.62% to 
sample type (serum or plasma) and 0.39% to laboratory. This inter-lab variation is in fact smaller than the maximum acceptable in-
tra-lab variation on quality control samples. It is also shown that the reproducibility between laboratories is good enough for the LPD 
predictions to be exchangeable when the strict conditions for NMR acquisition are maintained. With this validated protocol resulting in 
highly reproducible prediction of lipoprotein distributions across laboratories, a step is taken towards bringing NMR more into scope 
of prognostic and diagnostic biomarkers, reducing the need for tedious methods such as ultra-centrifugation or HPLC.
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O-479 3D Molecular Cartography of the Exposome  and Metabolome of Fruits
PRESENTING AUTHOR: Louis-Felix Nothias, CNRS / UC San Diego, France
CO-AUTHORS: Alexander Aksenov, Alexey Melnik, Ivan Protsyuk, Theodore Alexandrov, David Touboul, Pieter Dorrestein                            
The “3D-Plant2Cells” project aims to investigate the impact of pesticides on common fruits metabolome and the microbiota in three 
dimensions. To achieve that objective, we first developed a mass spectrometry (MS)-based methodology for the 3D molecular car-
tography of pesticides/metabolites on a fruit surface. For that, we employed cotton swabs to sample locations of common fruits. The 
corresponding samples were then extracted and analyzed by gas or liquid phase chromatography coupled to MS in both untargeted 
and targeted modes. The MS data were mapped on a 3D model of corresponding fruit using the ‘ili web-based software (Protsyuk 
et al, 2017), allowing the visualization and sharing of pesticide/metabolite distribution on the fruit surface. Detected pesticides were 
annotated with GNPS spectral libraries and unknown features annotated with Sirius. The 3D molecular cartography offered unique ca-
pabilities for fruit exposomics and metabolomics, as the molecular complexity can be described and visually represented in an easily 
interpretable topographical molecular maps. The method also capitalizes on combination of targeted mode that offers  sensitivity with 
downstream spectral annotation capability of untargeted MS/MS. To validate the method, we investigated the performance of this 
swab-based protocol by looking at various aspects of the sampling process including (1) the sensitivity, (2) the compound recovery, 
(3) the sampling reproducibility, and (4) the influence of the matrix effects related to swab and fruit. We will present methodological 
developments regarding the validation of the method for the detection and quantification of pesticides, along with the first 3D molec-
ular model of pesticides on common fruits.
O-502 Lighting up the world of metabolomics
PRESENTING AUTHOR: Roy Goodacre, University of Manchester, United Kingdom
CO-AUTHORS: Omar Alharbi, Malama Chisanga, Heidi Fisk, Kat Hollywood, Howbeer Muhamadali, Ali Subaihi, Chloe Westley              
Many different physicochemical techniques are used for the identification and quantification of metabolites.  Whilst our group (www.
biospec.net) has developed a range of MS-based techniques for metabolomics, and used these for large-scale molecular pheno-
typing, this presentation will concentrate on our recent advances in Raman spectroscopy. Raman spectroscopy is a non-destructive 
vibrational spectroscopy technique, and as is well known to most spectroscopists Raman spectroscopy has a rich history for the 
analysis of chemical species. However, whilst this inelastic light scattering approach offers unique specificity for molecular characteri-
zation the signal is usually rather weak. Fortunately this signal can be significantly enhanced using surface enhanced Raman scatter-
ing (SERS). SERS involves coupling the analyte(s) with a metal surface (roughed at the nano-scale and hence why we tend to use 
colloids) during the Raman acquisition.  Using judicious design of experiments we have recently demonstrated excellent detection 
and quantification for a range of drugs and biomarkers using SERS.  In this presentation we shall demonstrate this for the absolute 
quantification of drugs and metabolites directly in human body fluids.  When the sample matrix is complex then prior separation is 
needed and so we shall also highlight our work in coupling liquid chromatography to Raman. Finally, as Raman has a spatial resolu-
tion of ca. 1 um it can be used for imaging of biological systems and this will be demonstrated for drug detection in eukaryotic cells 
as well as metabolic labeling of bacteria with stable isotopes as a step towards understanding microbial communities.
O-517 Novel methods for data generation and data integration in metabolomics
PRESENTING AUTHOR: Johan Trygg, Umeå University, Sweden
CO-AUTHORS:                                                    
Today, massive amounts of data experimental data is being generated by modern high-throughput ‘omics and sensor technologies 
with increasing availability and decreasing experimental costs. This overwhelming size and complexity of modern ‘omics’ and pheno-
typic data have driven systems analysis towards the adoption of multivariate analysis and network modeling methods. In addition, 
machine learning methods capability to analyze so called unstructured data (text, images, audio), accelerated by the Python and R 
open source communities has allowed us to tap into an exciting dimension of so called big data that we can start to integrate with 
existing structured data (omics, spectroscopy, chemistry, etc…). The principle, garbage in – garbage out, highlights the importance of 
good quality data. Here, Design of Experiments, DOE, provides easy to use strategies and methods to understand the influence and 
causality of all the relevant factors and parameters studied. I will share some new developments within DOE that enable the genera-
tion of high-quality and representative data in ‘omics. In particular, I will focus on generalized fractional factorial designs that allows 
generation of representative and balanced data, the optimization of data processing operations and balanced and representative 
selection of subsets from biobanks and larger cohorts. For data integration, I will describe the latest developments of OnPLS, a multi-
block analysis technology for statistical integration of complex multi-omics datasets.
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P-1 NormalizeMets: statistical tools for implementing, assessing and choosing normalization methods for metabolomics data
PRESENTING AUTHOR: Gavriel Olshansky, The University of Melbourne, Australia
CO-AUTHORS: Darren Creek, Gavriel Olshansky, Julie Simpson                                               
In the statistical analysis of metabolomics data, normalization is a crucial step, which is necessary for dealing with inevitable sources 
of unwanted variation such as those originating from multiple batches, laboratories, long runs of samples, and other confounding 
biological variation. Metabolomics normalization is often considered a grey area where there is a distinct need to develop a greater 
understanding of when, why, and how to normalize the data. We present a joint graphical user interface within Microsoft Excel and R 
software as a potential “one-stop shop” for normalizing metabolomics data. The package includes widely-used traditional and recent-
ly developed metabolomics normalization methods to (a) remove the unwanted variation component to obtain a normalized data ma-
trix that is suitable for downstream statistical analysis, and/or to (b) accommodate the unwanted variation component in a suitable 
statistical model designed to answer the research question of interest. The software allows easy comparisons to be made between 
different normalization methods using several statistical criteria, hence guiding metabolomics researchers to assess and choose a 
suitable normalization method for a given dataset and a research question. Having chosen the appropriate normalization method, the 
package can then be used to obtain end statistical outputs for (i) clustering, (ii) classification, (iii) biomarker identification adjusting 
for confounding factors and (iv) correlation analysis.
P-2 Automated Kits and Devices for Quantitative Metabolomics
PRESENTING AUTHOR: David Wishart, University of Alberta, Canada
CO-AUTHORS: Rosa Vazquez-Fresno, Arnau Serra-Cayuela, Rupasri Mandal, Debjani Bhattacharyya Chowdhury, Yiran Zhang, Itha-
yavani Iynkkaran, Ziamin Zhang, Nazanin Assempour, Mark Berjanskii, Nicolas Vozza, Seyed Jafari, Silvia Mari                                 
Automation nuclear magnetic spectroscopy (NMR) and mass spectrometry (MS) techniques remains a pressing challenge in the field 
of metabolomics. Both are powerful techniques, but limited by requirements for highly qualified personnel to operate the equipment 
and perform time-consuming spectral profiling and data analysis. In an effort to “democratize” metabolomics, The Metabolomics 
Innovation Centre (TMIC) is developing easy-to-use kits and devices that streamline metabolomic workflows, improve inter-lab repro-
ducibility, increase throughput and reduce costs. The goal is to provide everything necessary to run a metabolomic analysis, except 
instrumentation. TMIC’s NMR kit contains all the components required for 1H NMR analysis, including buffer solution, deuterated 
internal standards and detailed instructions. The kit also contains an access code for BAYESIL, a web-based, automated NMR spectral 
profiling server. BAYESIL automatically determines the concentration of NMR-detectable metabolites accurately (~95% correct identi-
fication; ~10% quantification error) in &lt; 3 minutes per sample. This NMR kit is compatible with serum, plasma, cerebrospinal fluid, 
ruminal fluid, milk and fecal water samples. TMIC’s GC-MS kit includes a derivatization reagent, internal and alkane standards (C8-
C20 and C22-C40), and detailed instructions. The kit contains an access code for GC-AutoFit, an automated, web-based tool, which 
can identify and quantify up to 120 compounds in urine, serum, plasma, CSF and milk. TMIC is also developing low-cost, portable, 
multiplexed lateral flow devices, enzyme-based colorimetric assays and electronic impedance sensing systems that are capable of 
simultaneously measuring multiple metabolites. These kits and devices will enable a wealth of new metabolomics applications in both 
research and clinical settings.
P-3 Contaminant DB: the Environmental Contaminant Database
PRESENTING AUTHOR: Naama Karu, Department of Biological Sciences, University of Alberta, Canada
CO-AUTHORS: Tanvir Sajed, Yannick Djoumbou Feunang, Zinat Sayeeda, An Chi Guo, David Arndt, David Wishart                                           
ContaminantDB is the world’s largest electronic repository containing detailed information on small molecule (&lt;1500 Da) chemical 
contaminants which can appear in water, air, soil, food, buildings etc. at unnatural levels. ContaminantDB has been designed and 
developed to facilitate exposome and environmental metabolomics research, and help with the identification of trace compounds /
contaminants in humans, animals and plants. Currently ContaminantDB has over 70,000 compounds, 20,000 of these compounds not 
found in any other chemical database. Every entry contains a validated chemical structure, a description, physico-chemical data, esti-
mated production volume, predicted or known MS/MS spectra and a detailed chemical taxonomy/ontology. Most contaminant entries 
are classified according to their environmental source, application and potential biological impact (e.g. carcinogens; endocrine-dis-
rupting). Examples for contaminant groups include high-production volume (HPV) chemicals, plasticizers, combustion byproducts, 
pesticides, pharmaceuticals, wastewater compounds and disinfection byproducts.  ContaminantDB was constructed using the same 
principles as large databases previously developed at Wishart lab: the Human Metabolome Database (HMDB), DrugBank, FoodDB, 
and the toxic exposome database (T3DB). Many compounds in ContaminantDB are interlinked to these databases as well as external 
resources. Where data is available, the concentration of the compound in specific matrices is presented, to allow meta-analysis be-
tween quantitative studies. Additionally, the database supports various browsing and searching capabilities including structure, text, 
mass spectra and NMR spectra searches. We believe ContaminantDB will be an important resource for environmental and biological 
research. Over the coming years, ContaminantDB will be continuously growing in functionality and content to meet the increasing 
demand from the scientific community.
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P-4 A Novel Labeled Metabolomics Workflow applying Isotope Ratio Outlier Analysis (IROA) and SWATH® Acquisition for Unambiguous Compound Identification
PRESENTING AUTHOR: Chris Hodgkins, SCIEX, Australia
CO-AUTHORS: Chris Beecher, Felice de Jong, Baljit Ubhi                                               
Data dependent, mass spectrometry workflows tend to be the choice for the untargeted metabolomics studies. Data independent 
techniques such as SWATH® Acquisition are different in that they allow for unbiased data collection and MSMS of every single mass 
precursor can be collected allowing for information rich datasets. However, unambiguous metabolite identification can be increasingly 
challenging due to the lack of databases, chemical noise and isobaric compounds. The SWATH analysis of the Isotope Ratio Outlier 
Analysis (IROA) labeled Internal Standard (IS) provides the first mechanism for simultaneous and unambiguous compound identi-
fication and quantitation for unbiased metabolomics analysis. Applying Variable Window SWATH® Acquisition strategy to an IROA 
Internal Standard (IS) spiked sample made it possible to unambiguously identify and accurately quantify hundreds of biochemicals in 
a single unbiased metabolomics analysis using a 6600 TripleTOF® high resolution mass spectrometer. Here, we present SWATH-IROA 
whereby uniquely-labeled IROA metabolites were captured within discrete SWATH windows, and subjected to fragmentation. IROA 
fragments and adducts were shown to have the identical labeling patterns of their precursor ions, with defined formulae.  All artefac-
tual (non-IROA) peaks from the SWATH windows were eliminated and data was quantitated based on MSMS peaks. The combination 
of IROA and SWATH allows a path in which a basic metabolomic-style system may be used for the accurate quantitation of several 
hundred compounds in a single sample without the need for a baseline separation.  Specific software was developed to automatically 
find, quantitate and identify all natural abundance peaks that corresponded to their known IROA isotopomers.  
P-5 Development of anionic metabolome analysis method using capillary ion chromatogra-phy-mass spectrometry
PRESENTING AUTHOR: Akiyoshi Hirayama, Keio University, Japan
CO-AUTHORS: Masaru Tomita, Tomoyoshi Soga                                                
[Introduction] MS-based platforms (such as GC/MS, LC-MS and CE-MS) have been frequently used in the field of metabolomics. 
Recently, ion chromatography (IC) coupled with MS has been applied in metabolomics as it was found to be an excellent platform for 
separation of charged compounds. In this study, we have demonstrated the applicability of IC-MS for anionic metabolome analysis.
[Methods] Capillary IC-MS analysis were performed using a Dionex ICS-5000+ system equipped with a Q Exactive Orbitrap MS 
system (Thermo Fisher Scientific, San Jose, CA) via a ESI probe. An Agilent 1100 series capillary HPLC pump (Agilent Technologies, 
Waldbronn, Germany) was used to deliver sheath liquid. Anionic metabolites were separated on a Dionex IonPac AS11-HC-4 µm 
(0.4 × 250 mm, 4 µm; Thermo Fisher Scientific) that was maintained at 35°C. [Preliminary results] Firstly, influence of sheath liquid 
conditions on IC-MS-based metabolome analysis were investigated, and IPA with 0.1% acetic acid was selected as optimum solution. 
Under this optimized condition, 49 anionic metabolites, including organic acids, sugar phosphates, nucleotides and coenzymes, were 
successfully separated and detected with mass spectrometer. Acceptable method validation results were obtained related to repro-
ducibility, linearity and sensitivity of the IC-MS method. Notably, the concentration detection limits of the tested compounds were 
between 1 and 10 nmol/L despite small volume injection (0.4 ?L). Currently, we are applying this platform to the anionic metabolomic 
profiling for several cancer cell lines. [Novel aspects] The developed IC-MS platform could be a powerful new tool for anionic metab-
olome analysis.
P-6 Metabolomic imaging of colorectal tumors in mice and humans
PRESENTING AUTHOR: Shuichi Shimma, Osaka University, Japan
CO-AUTHORS: Yasushi Kojima, Masahiro Aoki, Emi Takeo, Tomoyoshi Soga                                             
Conventional mass spectrometric analysis using tissue extraction precludes determining the spatial distribution of the metabo-
lites, whereas imaging mass spectrometry (IMS) is a feasible technique to visualize them. However, there are a lot of challenges in 
performing IMS successfully, especially in sample preparation, making the methodological optimizations essential. We present here 
optimized sample preparations for mouse and human intestinal tumor tissues. Tissue sections of intestinal tumors of Apc mice and 
clinical samples of colon cancer were prepared at 8 µm thickness. The obtained sections were thaw-mounted on ITO glass slides 
(Matsunami glass, Osaka, Japan). To provide tiny crystal matrix seeds, we performed a vacuum vapor deposition of 9-aminoacridine 
(9-AA) for negative ion detection and ?-cyano-4-hydroxycinnamic acid (CHCA) for positive ion detection using iMLayer (Shimadzu, 
Kyoto, Japan). After the deposition process, recrystallization was performed using 5% methanol vapor for negative ion and 100-µL 
CHCA solution spraying (8 mg/mL in 50% methanol/0.1% formic acid) with an artistic air-brush for positive ion. IMS was performed 
using iMScope (Shimadzu, Kyoto, Japan). In negative ion detection, recrystallization contributed to detect peaks derived from metab-
olites with high intensity, and enabled simultaneous metabolite detection including sugar phosphates In positive ion detection mode, 
S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) were clearly detected. Specifically, SAM was accumulated inside 
the tumor regions only, while SAH showed an even distribution in both the tumor and normal regions of the same sample tissues. 
Notably, we found that SAM provided ring-like distributions, and that the center of the rings was necrotic.
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P-7 Next generation lipid profiling of human red blood cells
PRESENTING AUTHOR: Amani Batarseh, School of Medicine, Illawarra Health and Medical Research Institute, University of Wollon-
gong, Wollongong, NSW, Australia
CO-AUTHORS: Sarah Abbott, Eva Duchoslave, Ayedh Alqarni, Stephen Blanksby, Todd Mitchell                                            
Lipids play important roles in cellular signalling in health and disease. Red blood cells (RBC) are widely studied as carriers of possi-
ble lipid biomarkers in clinical studies. For example, the RBC ?-3 index has been used as a predictor of cardiovascular disease. The 
complexity of the phospholipidome is often underestimated by conventional mass spectrometry. A comprehensive yet unambiguous 
structural identification of RBC lipids is an integral part of understanding their role in cellular functions. Recently, Pham et al. (2014) 
reported a novel top-down workflow combining collision- and ozone-induced dissociation (CID/OzID) to yield information rich spectra 
used to uniquely assign sn-substitution and carbon-carbon double bond position in phospholipids. In complex extracts however, the 
spectral interpretation was confounded by the presence of isobaric lipids resulting from direct infusion protocols. Chromatographic 
separation of lipids is one potential solution to this spectral complexity. Following extensive optimization for optimal ozone reaction 
times and sufficient data points across the chromatographic peak, a successful composite workflow combining two new CID/OzID 
experimental designs, coupled with reverse-phase liquid chromatography (RPLC) separation using a C30 column, enhanced struc-
tural characterization of RBC lipids. We present for the first time a software-plug-in for automating OzID-mass spectral annotations. 
Infusion and LC strategies were found to be complementary and when examined together, provided a richer picture of the structural 
diversity of the RBC phospholipidome with preliminary data extending the number of phosphatidylcholines from 30 to almost 100, 
and provoking interesting questions as to the functional role of this diversity.
P-8 Development of high-sensitive and high-throughput methods for chiral amino acid analysis
PRESENTING AUTHOR: Yosuke Nakano, Department of Biotechnology, Graduate School of Engineering, Osaka University,, Japan
CO-AUTHORS: Yutaka Konya, Moyu Yaniguchi, Eiichiro Fukusaki                                               
Amino acids are ubiquitous compounds of significant importance in life science due to their diverse vital functions in living organisms. 
In ?-amino acids, due to the configuration, the structure is able to form enantiomers. Generally, in order to distinguish these struc-
tures, they are commonly referred to as L- or D-amino acid. While L-amino acids obviously predominate in nature, D-amino acids 
were considered to have relatively minor functions in biological process. However, recent technological advances in separation tech-
niques have promoted studies of chiral amino acids and the distribution of free D-amino acids has been of considerable interest in 
various fields. A number of analytical methods of amino acid enantioseparation for qualification and quantification have been report-
ed. However, the previous work have never fulfilled both resolution and throughput. Recently, we have demonstrated that eighteen 
chiral proteinogenic amino acids except proline are perfectly separated by using liquid chromatography-time of flight mass spectrom-
etry (LC-TOFMS) equipped with a chiral crown ether column. This method enabled the high-throughput baseline enantioseparation 
of amino acids while maintaining excellent peak resolution. However, higher sensitivity and wider dynamic range for quantification 
would be required in some occasions. Most recently, we successfully constructed a simultaneous analytical system for the enantiosep-
aration of amino acids using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Compared to the LC-TOFMS method, 
the LC-MS/MS method demonstrated the higher sensitivity required for detection of trace D-amino acids in samples. These analytical 
methods can be applied to various fields and push D-amino acid research to a new stage.
P-9 Shotgun Lipidomics of prostate cancer cells using ESI-MS Shimadzu 8050 and simplified data analysis by SimLipid software
PRESENTING AUTHOR: Rajesh Gupta, Queensland University of Technology, Australia
CO-AUTHORS: Martin Sadowski, Sanjib Meitei, Stephen Blanksby                                               
Lipidomics is a relatively recent omics field of research which includes complex lipidome analysis. It is an emerging field in biomedical 
research as lipids play an important role in cell, tissue and organ physiology and have potential as biomarkers of disease or treatment 
success. Shotgun lipidomics involves identification and quantification of lipids by direct infusion of complex lipid samples into the 
mass spectrometer without any chromatographic separation. In this study we performed shotgun lipidomics on lipid extracts from 
prostate cancer cells by electrospray-ionisation triple quadrupole mass spectrometry (Shimadzu 8050). Triple quadrupole functionality 
was used to perform specific precursor ion (PI) and neutral loss (NL) scans for the identification and relative quantitation of Phospho-
lipids and Glycerolipids; Phosphatidylcholine (PC), Phosphatidylethanolamine (PE), and Phophatidylserine (PS) and Triacylglycerides 
(TAGs) were performed on lipid extracts from prostate cancer cells. Different instrument parameters including sample infusion rate, 
collision cell settings, quadrupole scanning rates and resolution were optimised before acquiring sample data. A complex data was 
generated requiring special software tools for the analysis. Unlike genomics and proteomics, there are not many software tools avail-
able for comprehensive data analysis. Hence, we have developed new modules of SimLipid software that enable comprehensive lip-
idome data analysis using multiplexed PI/NL scans data, remove isotopic overlapping of peaks from multiple spectra in batch mode. 
The acquired data was directly imported into SimLipid 5.60, and phospholipids and TAGs from different samples were identified and 
quantified. We will present results containing identification and relative quantification of above lipids in prostate cancer cells.
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P-10 Microflow LC-MS/MS Workflow Allows High Sensitivity for Targeted Metabolomics
PRESENTING AUTHOR: Baljit Ubhi, SCIEX, United States
CO-AUTHORS: Baljit Ubhi                                                  
Identifying metabolites from urine and plasma are essential to understanding diseases and developing novel therapeutics. Liquid 
chromatography–tandem mass spectrometry (LC-MS/MS) analysis has become an essential tool for the identification and quanti-
fication of metabolites in complex matrices. Here, we describe a robust and sensitive workflow using a M3 MicroLC coupled to a 
QTRAP® 6500+ mass spectrometer for qualitative and quantitative analysis of  polar metabolites. We have implemented a HILIC 
microflow LC-MS/MS method for profiling polar metabolites using selected reaction monitoring (SRM) and positive/negative polarity 
switching. Microflow LC-MS/MS, despite its inherent sensitivity advantage, has not been used extensively in metabolomics due to 
requiring proper sample reconstitution for optimal microLC-hydrophilic interaction. Using this method, we have identified 255 unique 
metabolites of 310 measured targets (379 Q1/Q3 transitions) with a signal to noise ratio of 10 or greater from plasma/urine, covering 
metabolites from all major metabolic pathways.  Most of the LC-MS/MS methods for targeted metabolomics use traditional analytical 
flowrates of 350-500 ul/ min and multiple LC-MS/MS or scheduled SRM acquisitions to profile such high number of metabolites as 
compared to our single 30 min workflow. This workflow could be used for relative quantification, and integrated peak areas can be 
used for quantitation and metabolic pathway analyses across different samples. The sample preparation takes ~4 h from metabolite 
extraction to peak integration and data analysis.
P-11 NON-UNIFORM DISTRIBUTION OF METABOLITES IN ROOTS AS A RESULT OF A SHORT TERM SALINITY STRESS IN DIFFERING BARLEY CULTIVARS
PRESENTING AUTHOR: Lenin Sarabia, University of Melbourne, Australia
CO-AUTHORS: Berin Boughton, Thusita Rupasinghe, Camilla Hill, Ute Roessner                                             
Soil salinity adversely affects agriculture by inhibiting plant growth and reducing yield. Barley is rated as salt-tolerant among cere-
al crops and exhibits a great variation in salt tolerance amongst its cultivars. Changes in the total root lipid and spatial metabolite 
profile were observed in salt-treated barley roots using metabolite profiling techniques. Matrix Assisted Laser Desorption Ionisation 
Mass Spectrometry Imaging (MALDI-MSI) was employed to examine plant metabolism. This project aims to analyse the differences 
in the spatial distribution metabolites in developing barley roots grown under control and saline conditions of two feed (Hindmarsh, 
Mundah) and two malting (Gairdner and Clipper) cultivars to enhance our understanding of potential salinity tolerance mechanisms.  
Barley seeds were germinated, grown on agar plates and subjected to a short term 150 mM NaCl stress. Roots were analysed using 
a Bruker SolariX XR-FT-ICR-MS and a Sciex 6600 TripleTOF-MS, for spatial and untargeted lipidomics, respectively.  The combination 
of LC-MS and MSI identified a large number of metabolites and lipids with a unique spatial distribution. MSI was capable of discrimi-
nating salt vs control treated roots, identifying major lipid changes under salinity in a spatial manner. Non-uniform spatial distribution 
of metabolites was observed among barley cultivars. Major PC lipid species and oligosaccharides were identified to change the most 
in salt-treated roots compared to control. This work helped to uncover metabolic biology that  hasn’t been possible using traditional 
metabolomics methodology.
P-13 Development of high sensitivity CE-MS metabolome analysis system using high resolusion mass spectrometer
PRESENTING AUTHOR: Kazunori Sasaki, No, Japan
CO-AUTHORS: Hitoshi Sagawa                                                  
Capillary electrophoresis mass spectrometer (CE-MS) has been widely applied in metabolomics. High resolution mass spectrometer 
(HRMS) has not been yet up to fully fledged application for CE-MS in spite of the recent advance of HRMS. Electrospray ionization 
(ESI) source with grounded nebulizer is suited for CE-MS but a number of mass spectrometer manufacturer employ ESI source with 
high voltage applied nebulizer. In this study, we developed a novel ESI source adapter that converted from high voltage applied 
nebulizer to grounded nebulizer. We performed metabolome analysis by using high sensitive CE-HRMS system that combined CE with 
HRMS using the developed ESI source adapter. We targeted primary metabolites (amino acids, peptides, nucleobases, organic acids, 
phosphate compounds and other ionic metabolites). Our developed system of CE-HRMS was able to improve 10-fold in detection 
sensitivity compared with capillary electrophoresis time of flight mass spectrometer (CE-TOFMS). Calibration curves of a number of 
primary metabolites showed three to four digits quantitative dynamic range. In body fluid sample, we demonstrated that more than 
twice the number of metabolites were detected using the developed system relative to using CE-TOFMS. The developed system is 
expected to become an effective tool for biomarker discovery.
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P-14 Untargeted stable isotope tracing (USIT) reveals rewiring of glutamate anaplerosis as a com-mon metabolic adaptation in diseases arising from mitochondrial DNA mutations
PRESENTING AUTHOR: Qiuying Chen, Weill Cornell Medical College, United States
CO-AUTHORS: Marilena D’Aurelio, Giovanni Manfredi, Steven Gross                                               
USIT is a novel in-house untargeted stable isotope tracing workflow that informs on: (1) all features that incorporate isotope; (2) the 
number of incorporated isotope atoms; (3) fractional incorporation of isotope atoms; (4) total incorporated isotope and, (5) effects of 
cell treatments on 1-4. In USIT, we first find differentially-expressed features by comparing heavy vs light-isotope treated cells, then 
use these features as targets to generate curated isotopologues expected for heavy isotope incorporation. Apparent incorporation is 
confirmed by a reciprocal shift in isotopologue spectral patterns (i.e., heavy isotopolgue increases with a reciprocal decrease in light 
isotopologue fractional abundance). Using USIT, we identified a previously unappreciated glutamine-derived ?-ketoglutarate (?KG) 
oxidative flux concomitant with cataplerotic efflux of aspartate and subsequent cytosolic conversion to lactate and alanine in human 
mitochondrial DNA (mtDNA) mutant cells harboring disease-associated partial oxidative phosphorylation defects. This novel pathway 
maintains a continuous glutamine influx into the TCA cycle via a mitochondrial glutamate/aspartate antiporter, sustains substrate-lev-
el ATP production, contributes to re-oxidization of glycolytic NADH to NAD and provides a source of cytosolic NADPH for redox 
maintenance. The current finding contrasts with the predominant reductive carboxylation of ?KG previously observed in engineered 
cell culture models that exhibit a complete loss of oxidative phosphorylation, a lethal condition never seen in patients. Notably, stim-
ulating the oxidative flux with ?KG supplementation enhanced the viability of diverse human mtDNA mutant cell lines grown under 
obligatory oxidative conditions, which are otherwise lethal. These findings establish a rationale for dietary supplementation with?KG 
in mitochondrial diseases.
P-15 Developing an open learning environment unit on metabolomics
PRESENTING AUTHOR: Ann Kwan, University of Sydney, Australia
CO-AUTHORS: Horst Schirra, David Wishart                                                
The advent in recent years of hardware and software that facilitates the automatic collection and analysis of metabolomics data has 
resulted in a proliferation of life scientists, clinical and veterinary researchers, and their students undertaking metabolomics studies. 
To support these researchers, the development of freely available resources and courses to assist with study design, data acquisition, 
processing and/or analysis is highly desirable. Given the diverse backgrounds of these researchers, from undergraduates to ex-
perts in their respective fields, the Open Learning Environment (OLE) provides a very suitable platform for delivery of metabolomics 
resources. OLE has been hailed as a flexible and highly effective approach for the provision of novel and cross-disciplinary skillsets 
to students with varying amounts of prior knowledge and from different educational backgrounds. We are currently developing an 
OLE unit with learning modules that focus on key aspects of metabolomics, from study design, data processing and analytics to 
linking the findings with molecular/cellular data. As part of this undertaking, we have recorded a lecture series on metabolomics that 
was presented by Prof David Wishart and is scheduled to be released on the ANZMAG Youtube channel in April. This lecture series 
will be complemented by a set of online tutorials and a discussion forum. We hope that this unit will provide researchers new to the 
field of metabolomics with a foundation from which they can access other resources, including contacts with fellow researchers and 
exchange of expertise.
P-16 Tissue-specific sample dilution for reliable untargeted metabolomics
PRESENTING AUTHOR: Zhanxuan Wu, Food Nutrition & Health, Food and Bio-based Products, AgResearch Limited, Palmerston 
North, New Zealand, New Zealand
CO-AUTHORS: Karl Fraser, Marlena Kruger, David Harding, Garth Cooper, Sally Poppitt                                            
Untargeted metabolite profiling studies aim to measure as many metabolites as possible. However, no single analytical technique can 
cover the full metabolome. To date, liquid chromatography-mass spectrometry (LC-MS) offers the most comprehensive metabolite 
coverage. Although much attention has been paid to optimisation of the extraction solvent for maximum metabolome coverage, one 
overlooked aspect is the analytical quality of the LC-MS measurements. Matrix effects produced by different tissue types can interfere 
with ionisation efficiency and different tissue types can have very different metabolite composition and abundance. Thus the compo-
sition and concentration of the extract may not always be compatible with the loading capacity of the separation column or the linear 
dynamic range of the mass spectrometer. In this study, we performed a bi-phasic solvent extraction and evaluated the use of differ-
ent reconstitution volumes to re-dissolve the lipid and aqueous extracts from muscle, adipose and liver tissues. We demonstrate that 
the LC-MS signals do not always scale linearly with the analyte concentrations. Our results show that the optimum concentrations of 
tissue to reconstitution solvent for liver, muscle and adipose lipid fractions were 59.5 mg/ml, 29.7 mg/ml and 5.95 mg/ml respectively 
and 64.9 mg/ml for aqueous fraction from all three tissues. This study highlights the importance of an evaporation/reconstitution 
step during the sample preparation and we recommend a serial dilution experiment to determine the optimal reconstitution volume 
for each specific sample type prior to instrumental analysis.
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P-17 Automated System for High Throughput Targeted Metabolomic Analysis
PRESENTING AUTHOR: James Apffel, Agilent Technologies, United States
CO-AUTHORS: Anna Hjelmeland, Xinning Jiang, Michael Creech, Aaron Gee, Zhe Li, Laurakay Bruhn, Anya Tsalenko, Judith Denery, 
Celeste Sandoval, Derek Abbott                                    
In the context of industrial synthetic biology, high throughput targeted metabolic analysis of the diverse chemical space of products 
and pathway intermediates enables rapid cycles of strain optimization to improve or troubleshoot pathway bottlenecks. We have 
developed a metabolomics pipeline that combines a software tool for Automated Method Prediction (AMP), a high throughput MS 
system for data acquisition and an automated data processing system. Given a specific set of metabolic targets for each sample, AMP 
selects the smallest set of analytical methods (from a predefined set of 8) based on physicochemical properties of the targets.  The 
LC-MS system is capable of processing samples at approximately 2 minute per sample and automatically switching between multiple 
methods via column and solvent selection valving. The current LC-MS method set includes 8 methods. Acquired data is analyzed and 
scored using an automated process to generate a standardized output which is transferred to a LIMS system for use in evaluating 
and informing strain optimization processes.  The system we have developed represents a significant advance for both increasing 
throughput of metabolomics measurements and reducing the amount of expert time-intensive work involved in method selection and 
data processing.  The current system was developed for accelerating microbial strain optimization for industrial chemical production 
but has potential for advancing high throughput metabolomics measurements in other contexts as well.
P-18 Automatic CCS and MS/MS Library Creation and Application for Large Scale Metabolic and Lipidomic Profiling
PRESENTING AUTHOR: mark bennett, Nonlinear Dynamics, United States
CO-AUTHORS: Jonathan Williams, David Eatough, Lee Gethings, Mark Towers, Chrisopher Hughes, Leanne Nye, Steven Lai               
Metabolomics and Lipidomics involve identification and quantification of chemical fingerprint of cellular processes within a biological 
system. Precise identification is a major challenge since polar metabolites and lipids are chemically and structurally diverse and span 
a wide mass range. Chromatographic separation does not typically resolve all components, and often lacks retention time reproduc-
ibility. The addition of ion mobility, a gas phase separation of ion, increases peak capacity, selectivity, and can potentially resolve 
isomeric/isobaric. Benefits of collision cross-section (CCS) library obtained from mobility drift times together with accurate tandem 
mass spectrometry data (MS/MS) of human metabolites/lipids, will be shown to be an additional source of reference to aid metabo-
lite and lipid identification.    ESI and MALDI-MS were used to measure ion drift-times on Synapt G2-Si and Vion time-of-flight (TOF) 
high resolution mass spectrometers. IM was used to measure CCS values in both positive and negative ESI modes in three differently 
laboratories. The preliminary data showed excellent correlation (median centering &lt; 2%). A tandem mass spectrum of each ionised 
metabolite/lipid was also acquired and added to the scientific database. A sub-set of the CCS values were verified a Vion instrument 
to show the across instrument transferability of CCS, and on a MALDI-IM-MS to demonstrate the ionization independence of CCS 
measurements.    Utility of CCS library is demonstrated using an analysis of human plasma sample.  Spiked metabolite/lipid standards 
were identified using a combination of accurate mass measurements and CCS values. The addition of CCS measurements improved 
the confidence in identification compared to traditional analytical approaches
P-19 Speaq2: Large scale NMR metabolomics data analysis made easy
PRESENTING AUTHOR: Charlie Beirnaert, ADReM research group, Department of Mathematics and Computer Science, University 
of Antwerp, Belgium
CO-AUTHORS: Pieter Meysman, Nina Hermans, Sandra Apers, Luc Pieters, Adrian Covaci, Kris Laukens                                          
Introduction Many present day metabolomics experiments rely on both LC-MS and NMR spectrometry data to fully quantify the 
available information. NMR tools often lack the automation potential of current advanced LC-MS tools as manual intervention is still 
required in certain steps. This is a consequence of the fact that most workflows rely on interval methods, such as binning/bucketting, 
to process these spectra. This approach effectively summarizes the spectra and allows easier data processing and statistics. However, 
several problems are introduced, both in pre-processing and in the subsequent analysis, that compromise the automation poten-
tial. What we did We present a new user-friendly workflow for the analysis of NMR spectra that uses wavelets to fully automate the 
process of converting raw spectra to peaks, which are then aligned and grouped into features. Since wavelets are also often used in 
peak picking for LC-MS data (to convert spectra into peaks with minimal information loss) this method advances the integration of 
LC-MS and NMR data. A crucial aspect is that this is not just another NMR data analysis tool but it can be used to improve other tools 
that rely on the binning method or tools that start with already processed spectra into peak lists. By using the wavelet based method 
the quality of these peak lists can be improved. The framework is validated by replicating the results of two papers demonstrating 
the speed, user-friendliness, minimal user interaction and improved results. Can I use it? The algorithms are made available in the 
speaq2 R-Package.
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P-21 A Sparse Partial Least Squares Algorithm Based on Sure Independence Screening Method
PRESENTING AUTHOR: Jiyang Dong, Department of Electronic Science, Xiamen University, China
CO-AUTHORS: Xiangnan Xu                                                  
Partial least squares (PLS) regression is a widely-used dimension reduction method in many areas of scientific discoveries. However, 
it has been shown that the consistency property of the PLS algorithm does not extend to cases with very large number of variables p 
and small number of samples n. To overcome the issue, sparsity can be imposed to the dimension reduction step of PLS so that the 
sparse version of PLS (SPLS) algorithm can achieve dimension reduction and variable selection simultaneously. Here, we present a 
new SPLS method called sure-independence-screening based sparse partial least squares (SIS-SPLS) algorithm. By incorporating the 
published SIS method, the current SIS-SPLS algorithm is capable of achieving a near ideal selection of all important variables. In ad-
dition, we also provide an implementation of SIS-SPLS by using extended Bayesian information criterion (BIC) . This criterion is more 
flexible as compared to tuning parameters used in published SPLS methods. The developed method was evaluated using a number of 
numerical studies which involved both simulation and real datasets. The result showed that the proposed SIS-SPLS method offered 
low mean squared prediction errors. In addition, it was found capable in selecting all important variables and excluding nearly all 
irrelevant variables in the dimension reduction procedure. The SIS-SPLS algorithm proposed in the current work may serve as an 
alternative SPLS method for the analysis of modern biological data.
P-22 A Workflow for the Assessment of the quality of Isotopologue Distribution Measurements by Mass Spectrometry
PRESENTING AUTHOR: floriant bellvert, MetaToul-MetaboHUB, France
CO-AUTHORS: Jean-Charles Portais, Maud Heuillet, Pierre Millard                                               
Fluxomics is the measurement of actual metabolic reaction rates within biological systems (intracellular or intratissular fluxes), and 
has become a powerful tool for quantifying cell physiology for various applications as metabolic engineering, biotechnology or bio-
medical research. The most relevant approach to measure fluxes in living cells or tissues is based on isotope labeling strategies (13C) 
coupled to the detailed analysis of isotope incorporation into metabolites, measured by mass spectrometry or NMR spectroscopy. The 
quality of the biological insights provided by these approaches strongly depends on the quality of the isotopic measurements. Howev-
er, despite decades of isotopic studies of metabolism based on mass spectrometry, there is still no method to evaluate the reliability 
of MS-based isotopic measurements. Here, we present a method to address this issue. In this method a biologically-produced sample 
containing metabolites with fully predictable isotopologue distributions [1] is produced and used as reference material for evaluation 
of analytical methods. This work provides a general framework for assessing the quality of MS-based isotopic measurements, as well 
as for instrument qualification. . In addition, these results have highlight a new method to determine the working range adapted to 
these measurements. This approach is currently applied to test the analytical capacity of different MS technologies for isotopic stud-
ies on the French infrastructure MetaboHUB.  [1] Millard, P; Massou, S; Portais, J-C; Letisse, F. Anal. Chem. 2014, 86, 10288-95
P-23 Improving throughput of pre-analytical sample handling for NMR-based serum metabolomics
PRESENTING AUTHOR: Anders Pedersen, Swedish NMR Centre at the University of Gothenburg, Sweden
CO-AUTHORS: Millie Rådjursöga, Daniel Malmodin, B. Göran Karlsson                                               
Mass-spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy are the two most widely used analytical techniques to 
analyze blood metabolites. The main advantage with NMR is the possibility to identify and with high precision determine the concen-
tration of individual metabolites also in complex mixtures, combined with a very high degree of reproducibility. The latter fact makes 
it attractive for use in studies of large numbers of samples, but also for long-term studies or continuous series of samples. NMR is 
less sensitive and typically 30-50 metabolites can routinely be determined in a standard targeted approach (1,2). The lab of Daniel 
Raftery recently presented an approach where a 800 MHz 5 mm cryoprobe and protein precipitation using methanol further extend-
ed the number of identifiable metabolites. We have adapted this procedure using state-of-the-art technology (Bruker SamplePro 
pipetting robots and a Bruker 800 MHz 3mm TCI cryoprobe) in a high-throughput mode which requires decreased serum amounts 
and offers increased sensitivity. Similarly, the automated butanol-methanol lipid extraction developed by Ståhlman and coworkers 
has been implemented with an Agilent Bravo robot to enable NMR studies on both lipid-extracted and methanol-precipitated material 
from a sample volume of 250 µl.
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P-24 Recursive weighted Partial Least Squares Discriminant Analysis (rPLS-DA): a new method for finding important metabolite variables in untargeted metabolomics research
PRESENTING AUTHOR: Violetta Aru, University of Copenhagen, Denmark
CO-AUTHORS: Klavs Sørensen, Bekzod Khakimov, Åsmund Rinnan, Ulrik Sundekilde, Francesco Savorani, Lars Dragsted, Søren 
Engelsen                                         
Recursive weighted Partial Least Squares Discriminant Analysis (rPLS-DA) is a novel classification tool which combines the discrimina-
tive power of PLS-DA with the innovative variable selection method provided by rPLS. In the recursive weighted version of PLS-DA, 
the selection of the discriminant variables is made by iteratively re-weighting them in a ridge regression approach using the regres-
sion coefficients calculated by the previous (n-1) PLS model. By converging to a few variables, rPLS-DA provides a direct 1:1 metabo-
lite model interpretation. However, it is based on correlation and not causality – it will just find the combination of variables that best 
separates the classes. The classification performance of rPLS-DA was tested using two large datasets from two different metabolom-
ics investigations. In the first example, the metabolite profiles of a total of 892 milk samples from Danish Holstein-Friesian (n =456) 
and Jersey (n=436) cows were measured by 1H NMR spectroscopy. PLS-DA was firstly applied with the aim of discriminating the milk 
samples according to the different genetic backgrounds. The strong overlapping of metabolite markers in the PLS-DA model severely 
hampered variables identification and model interpretation. In contrast, rPLS-DA resulted in a simpler model with fewer discriminant 
metabolites contributing the most to samples classification. In the second study, rPLS-DA was applied for investigating the meta-
bolic differences in plasma samples of individuals in a dietary intervention study, highlighting its high potential in dietary biomarkers 
discovery.  
P-25 A Comprehensive Metabolomic Approach for identifying the Enantioeospecific Response of Urea Cycle of Tobacco Cells under Salinity
PRESENTING AUTHOR: Morteza Gholami, Assistant professor at Golestan University, Iran, Iran, Islamic Republic Of
CO-AUTHORS: Laleh Yousefzadeh                                                  
Metabolite profiling provides insight into living cells metabolism and behavior. Herein, metabolism of L- and D-ornithine was inves-
tigated to ascertain the role of enantiomers on the urea cycle of tobacco cells under normal and stress conditions. A combined GC 
and LC based metabolite profiling optimized for plant cell culture, with around 100 identified metabolites, indicated a specific up-reg-
ulation of carbohydrates, polyamines and organic sulfur (S) related metabolites by D-Orn. LC-ESI/MS based profiling of the amines 
containing groups metabolites showed an inhibition of the biosynthesis of several amino acids as a result  of salinity induced damage 
in the cells.  Additionally, Arg and other urea cycle related metabolites including, proline, putrescine and citrulline showed relevant 
increases in the D-Orn treated cells. These results indicated that D-Orn, as a D-amino acid (D-AA), can effectively participate in both 
polyamines and organic S related AAs biosynthesis, e.g. cysteine and methionine, compared to its L-enantiomer counterpart. In 
parallel, GC/MS based metabolite profiling demonstrated that D-Orn promoted up-regulation monosccharides biosynthesis alleviated 
tobacco cells. Furthermore, L-Orn had remarkable effects on fatty acids and phenolics content of the cells. Finally, results presented 
herein demonstrate for the first time that selective regulation of certain metabolic pathways and subsequently cell growth enhance-
ment and stress alleviation can be potentially performed by means of stereoselection of AAs.
P-26 SWATH® Acquisition - a Unique Approach for Untargeted Metabolomics Applications
PRESENTING AUTHOR: baljit ubhi, sciex, United States
CO-AUTHORS: Joerg Dojahn, Cyrus Papan, Zuzana Demianova                                               
SWATH® acquisition, a data independent acquisition (DIA) workflow is well adopted in quantitative discovery proteomics, but not 
commonly used in discovery metabolomics. SWATH® acquisition combines the benefits of quantitation at the MS2-level of targeted 
MRM-based workflows with MS2- level based untargeted identification for metabolite identification of DDA workflows with the com-
prehensive nature of the MSMSall workflow. Because of the comprehensive, non-stochastic nature of the fragmentation in SWATH® 
acquisition, more fragmentation and thus structural information of the analytes compared to the DDA approach is achievable. Repro-
ducibility and coverage is lower for DDA approaches compared to DIA workflows. Here we describe the improvements in metabolite 
coverage using SWATH® acquisition without sacrificing quantitation. Results obtained demonstrated a significant improvement of 
metabolites identified at the MS2 level by using SWATH® with variable windows in comparison with fixed windows in all analyzed 
matrices. We compared the ID rate from SWATH® acquisition to standard DDA. Here we were able to identify almost twice as many 
metabolites from the spectral library by SWATH® acquisition using 30 variable windows than by DDA. More confident MS2 based 
identifications then lead to more quantifiable metabolites in a metabolite expression experiment, which at the end allows better 
understanding of the biology. Spiked experiments into matrix samples of heavy labeled metabolites highlighted ten times higher sen-
sitivity (signal-to-noise) using the MS2 ion to quantitate versus the traditional MS1 approach thus demonstrating the specificity nature 
of SWATH acquisition to more traditional data dependent approaches
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P-27 Analysis of Deuterium-Labeled Lipids in E. Coli Extracts with High Resolution OrbitrapTM Mass Spectrometry
PRESENTING AUTHOR: David Peake, Thermo Fisher Scientific, United States
CO-AUTHORS: Cajetan Neubauer, Tonya Pekar Second, David Peake, Andreas Huhmer                                             
Labeling experiments are often used to estimate de novo biosynthesis rates in lipids. In D2O-labeling experiments the quantification 
of absolute D abundance is complicated by 13C, which occurs naturally. Therefore, it would be beneficial if deuterium incorporation 
could be differentiated and resolved from the 13C peak. Here we present analysis of deuterium-labeled lipids, extracted from E. 
coli, by utilizing a reverse-phase chromatography coupled to an Orbitrap TM Fusion TM Lumos TM Tribrid TM mass spectrometer 
operated at a resolution of 120,000 to 500,000 (FWHM at m/z 200) for the LC-MS/MS scans. Lipid identification was performed with 
LipidSearchTM 4.1 software. The major lipid sub-classes identified, for E. coli, in negative ion mode were phosphatidylethanolamine, 
phosphatidylglycerol, and cardiolipin. The M+1 and M+2 isotopes of selected deuterium-labeled cardiolipin, phosphatidyletha-
nolamine and phosphatidylglycerol species were fragmented with HCD. HCD product ions were detected using the Orbitrap mass 
analyzer at mass resolution of 120K, 240K or 500K. Inspection of the deuterium-labeled lipid MS/MS spectra obtained at 240K or 
500K resolution gave 2H containing product ions that were resolved from the 13C product ions. For instance, MS/MS of cardiolipin 
CL(62:1) [M-H]- anions, at 500K resolution, gave labeled 14:0 glycerol-phosphate product ions that were baseline-resolved including 
13C2C15H32O6P (m/z = 365.1998), 13C1C16H31D1O6P (m/z = 365.2027) and C17H30D2O6P (m/z = 365.2057). These species 
differ by 0.0029 Da and require a resolution of 244K to be resolved.  Our data demonstrates that in deuterium-labeling experiments, 
high resolution at the MS/MS level is essential for resolving the deuterium from the 13C peak.         
P-28 Calibration-Curve-Locking database for metabolome analysis by GC/MS
PRESENTING AUTHOR: Takeshi Bamba, Kyushu University, Japan
CO-AUTHORS: Yuki Soma, Toshiyuki Yamashita, Masatomo Takahashi, Kosuke Hata, Kuniyo Sugitate, Takeshi Serino, Hiromi Mi-
yagawa, Kenichi Suzuki, Kayoko Yamada, Takatomo Kawamukai, Teruhisa Shiota, Yoshihiro Izumi                                 
Calibration-Curve-Locking Databases (CCLD) have been constructed for automatic compound search and semi-quantitative screening 
by GC/MS in fields of forensic medicine and residual pesticide measuring [1-3]. CCLDs contain the retention time, calibration curve 
and electron impact ionization mass spectrum obtained under stable apparatus condition. We constructed a novel CCLD for metabo-
lomics study field. All standard compounds and biological samples were subjected to GC-MS just after the derivatization under stable 
apparatus conditions using following strategies. 1: DFTPP tuning for reproducible and uniform mass spectrum. 2: Retention-Time 
Locking technique to fix the retention times. 3: Automation of derivatization followed by injection to GC-MS by PAL RTC (CTC Analyt-
ics AG). 4: The system performance checking by a criteria sample mix solution. One target (quantifier) ion and one or more qualifier 
ion were selected for each compound based on the results of standard substances analysis, and a calibration curve was obtained by 
plotting the peak area ratio of the target compound to the IS versus the amount of target compound. These data were registered as 
the novel CCLD using MassHunter Quantitative Analysis software (Agilent Technologies), which enables automatic compound search 
and quantification by target deconvolution and quantification algorithm. We examined the applicability of the constructed database 
to analyzing serum samples, resulting time- and labor-saving semi-qualitative screening without the need for standard substances. 
1) Kadokami, K, et al., J. Chromatogr., A 1089, 219-226 (2005). 2) Ishida, T., et al., Rapid Commun. Mass Spectrom. 21, 3129-3138 
(2007). 3) Kudo, K., et al., Leg. Med. 14, 93-100 (2012).
P-29 The Road to Metabolomics Harmonization: Development of NIST “Omics” Reference Materials and Data
PRESENTING AUTHOR: Christina Jones, National Institute of Standards and Technology, United States
CO-AUTHORS: Katrice Lippa, Daniel Bearden, Werickson Rocha, David Sheen, Yamil Simón-Manso, Tracey Schock, Benjamin Place, 
Candice Ulmer, John Bowden                                      
As the field of metabolomics rapidly advances, there has been a parallel expansion of different measurement platforms capable of 
evaluating a broad range of diverse metabolites. Accordingly, it has become vital for NIST to engage the metabolomics community in 
measurement harmonization efforts in order to confirm and validate biological discoveries. Building upon lessons learned from com-
munity implementation and utilization of the National Institute of Science and Technology (NIST) SRM 1950 – Metabolites in Frozen 
Human Plasma, NIST is currently developing new reference materials (RMs) that may serve as valuable materials to harmonize me-
tabolomics measurements. Through these endeavors, NIST will be able to provide affordable, stable, homogenous RMs on demand 
to meet the needs of the metabolomics community. The goal is for these RMs and their associated data (RMDs) to be evaluated by 
the metabolomics community via an open-ended quality assurance program/interlaboratory comparison infrastructure, which results 
in evolving, shared data assessments. Specifically, a suite of human urine and plasma RMs is currently being developed. In addition, 
we are broadening our RM efforts to include dried-blood spots, as dried-blood spots are an emerging biospecimen useful for many 
metabolomics applications. To complement these efforts, a solution-based RM for use in assessing the relative performance and 
reproducibility of non-targeted LC-MS/MS metabolomics analytical techniques is also under development. Ultimately, NIST aspires 
to provide metabolomics laboratories with RMDs complemented by their shared data assessments, relevant method information, 
essential performance metrics, and overall consensus measurement results to improve interlaboratory comparability of metabolomics 
measurements.
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P-30 Correction of errors from pre-analytical sample management
PRESENTING AUTHOR: Rikard Landberg, Chalmers University of Technology, Sweden
CO-AUTHORS: Anders Pedersen, Daniel Malmodin, Göran Karlsson, Lars Andersson, Gunnel Tybring, Carl Brunius                                          
Health-related metabolomics studies often require the use of biobanked, or otherwise stored, cohort samples. However, sample 
handling is complex and many pre-analytical variables, including collection and processing of biological samples, can alter sample 
integrity. Multiple study centers or the use of legacy samples with limited sample management metadata further adds complexity. 
Novel means to understand and take into account such variability would enable high-quality research on archived samples. We have 
investigated alterations in the plasma metabolome, measured by NMR, as a function of pre-centrifugation conditions (1-36 h pre-cen-
trifugation delay time at 4°C and 22°C) in 16 individuals. Using the obtained data, we developed a procedure to predict, model and 
correct reproducible alterations in the plasma metabolome: Pre-centrifugation temperature and delay times were predicted using 
random forest modeling and validated on independent samples. Reproducible changes in the metabolome were modeled using a 
cluster-based approach, revealing effects of delay time on energy metabolism intermediates, especially at 22°C. We also found large, 
specific variability in metabolite concentrations after 3 h delay at 4°C, predominantly of lipids. Error correction using the cluster-based 
approach resulted in significant improvement of data quality, particularly at 22°C. Our results suggest potential to decrease the 
impact of undesired, delay-induced variability and the possibility to predict pre-centrifugation conditions in archived samples before 
use in costly downstream applications. However, results need to be confirmed in multiple, large sample sets and with analytical tech-
niques offering wider metabolome coverage, such as LC-MS
P-31 Quantification of bioactive N-acylethanolamines in human plasma
PRESENTING AUTHOR: TAKAMASA ISHIKAWA, KEIO UNIVERSITY, Japan
CO-AUTHORS: AKIYOSHI HIRAYAMA, TORU TAKEBAYASHI, TOMOYOSHI SOGA, MASARU TOMITA                                             
N-acylethanolamines, an endogenous lipid mediator in various animals, is amide compound group with a chemical structure con-
densed from long chain fatty acid and ethanol amide. In this chemical group, N-arachidonoylethanolamine (anandamide) is arachi-
donic acid which was discovered as an endogenous ligand of cannabinoid receptor (CB1) and provides cannabinoid-like biological 
activities, such as analgesia and hypotensive effects. In the same class, N-palmitoylethanolamine provides anti-inflammatory and 
analgesic action, and N-oleoylethanolamine function as anti-inflammatory. Thus, N-acylethanolamines are considered as potential 
biomarkers for various diseases. Here, we developed lipid profiling methods using liquid chromatography-tandem mass spectrometry 
(LC-MS/MS) to profile these metabolites in Tsuruoka metabolomics study, a large prospective cohort study in Japan, and cataloged 
the concentration of the N-acylethanolamines metabolites. The analytes were puri?ed by solid phase extraction (SPE). Separation of 
the analytes was achieved using mobile phase A consisted of acetonitrile/methanol/water at 20:20:60 (containing 5 mM ammonium 
formate), while mobile phase B consisted of isopropanol (containing 5 mM ammonium formate) at a flow rate of 0.3 mL/min on a 
Waters ACQUITY UPLC HSS T3 column. The analytes were quantified by LC-MS/MS using multiple reaction monitoring (MRM) mode. 
Solid phase extraction was employed in a processing protocol. Deproteinated plasma by methanol were loaded at SPE column (Mono-
SpinC18, GL Sciences Inc. Tokyo, Japan) to eliminate triacylglyceride (TG) and phospholipid phosphatidylcholine (PC) in the analytes. 
Totally, 10 kinds of N-acylethanolamines, including anandamide, was quantified in approximately a thousand subjects. The profiled 
data would contribution to understanding relationship among N-acylethanolamines and some diseases.
P-32 cosmiq - COmbining Single Masses Into Quantities
PRESENTING AUTHOR: Endre Laczko, Functional Genomics Center Zurich, Switzerland
CO-AUTHORS: Endre Laczko, David Fischer                                                
cosmiq is a Bioconductor package for the preprocessing of liquid- or gas - chromatography mass spectrometry (LCMS/GCMS) data 
with a focus on metabolomics or lipidomics applications. To improve the detection of low abundant signals, cosmiq generates master 
maps of the mZ/RT space from all acquired runs before a peak detection algorithm is applied. The result is a more robust identifi-
cation and quantification of low-intensity MS signals compared to conventional approaches where peak picking is performed in each 
LCMS/GCMS file separately. The cosmiq package builds on the xcmsSet object structure and can be therefore integrated well with the 
package xcms as an alternative preprocessing step. The cosmiq algorithm consists of the following steps:    Load the mass spectro-
metric measurement  Combine spectra  Detect relevant masses  Generate and combine extracted ion chromatograms  Detect 
chromatographic peaks  Quantification of detected peaks  Output the results   The usage of the software will be demonstrated 
on a typical data set. Package Short Url: http://bioconductor.org/packages/cosmiq/
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P-33 Microbial metabolites imaging to understand spatial re-distribution and localization of me-tabolites in single and mixed-species biofilms
PRESENTING AUTHOR: Shruti Pavagadhi, National University of Singapore, Singapore
CO-AUTHORS: Adelicia Y.L.Li, Shimma Shuichi, Sanjay Swarup                                               
Most microorganisms reside in surface-bound multicellular communities, known as biofilms, working in coherence to maximize the 
availability of nutrients, defend each other from adverse environmental conditions, and launch coordinated expeditions in search 
of new territory. Most of these processes among microbial community are carefully mediated and orchestrated by production and 
mitigation of assortment of metabolites, often creating gradients in micron scales at species boundaries. Current knowledge about 
metabolites in microbial communities comes largely from sample extraction-based methods, which loses spatial information. Imaging 
mass spectrometry (IMS) of metabolites coupled with traditional approaches could possibly overcome this limitation and allow spatial 
insights at community levels. We have been developing MALDI-IMS under microscope using iMScope, wherein images of fluorescence 
protein tagged cells in biofilms directly grown on cover slips can be overlaid with those from IMS.   In the present study, methods for 
metabolites imaging of single species and mixed species biofilms of Pseudomonas aeruginosa (YFP-tagged) and Klebsiella pneumo-
niae (DS red-tagged), grown in flow-cell chambers, were optimized. They were harvested and dried before proceeding to application 
of ionization matrix consisting of 9-aminoacridine (9-AA). We optimized both, sublimation methods using iMLayer (Shimadzu, Japan) 
and re-crystallization of 9-AA. The prepared biofilm samples were analyzed using iMScope TRIO (Shimadzu, Japan) in the negative 
ion detection mode. A number of unique mass features were identified that were species-specific, intra- as well as extra- cellularly 
localized. Interestingly, some unique mixed- species-specific mass features were also identified. Our results indicate MALDI-IMS is a 
useful tool for investigating multicellular biofilms. 
P-34 IMPLEMENATION OF A NOVEL SCANNING QUADRUPOLE DIA ACQUISITION METHOD FOR DESI IMAGING
PRESENTING AUTHOR: Paul Goulding, Waters, United Kingdom
CO-AUTHORS: Mark Towers, Emrys Jones, Philippa Hart, Emmanuelle Claude, James Langridge                                            
Here we have assessed the applicability of this new method and optimisation of settings for a DESI imaging analysis. The Sonar 
method for DESI imaging consisted of two alternating functions. In both cases the quadrupole was scanned multiple times across 
the mass range with a pre set quadrupole window. In the first function (precursor function) the collision energy was fixed at 6ev, in 
the second function collision energy was applied to fragment the ions (MS/MS function). The functions  alternated between pixels  
to generate images of precursors and  of fragments in a single experiment. The precursor and MS/MS functions were subsequently 
time aligned to relate the fragments to precursors for  identification of multiple species from a single imaging run.  Proof of concept 
experiments have been performed analysing a mouse brain tissue section in negative mode scanning the quadrupole from m/z 750-
950 with a quad window of 8 Da. For the MS/MS function the collision energy was fixed at 30eV. Reviewing the data with Driftscope 
and HDImaging a number of time aligned precursors / fragments could be identified. One example was a PS(18:0_22:6), from which 
fragments of  the neutral losses of serine, the sn1 and sn2 RCOOH groups + serine were observed as well as the sn1 / sn2 RCOO- 
ions. In addition to the time aligned nature of the precursor/ fragment spectra, the spatial distribution of the precursors and frag-
ments in the imaging data could also be used to further refine the precursor fragment assignments.
P-35 NMR based metabolomics  of OCT-embedded frozen kidney samples in mouse and man through a simple and convenient pre-analytical protocol
PRESENTING AUTHOR: Justine Leenders, University of Liège, Belgium
CO-AUTHORS: Pascal De Tullio, François Jouret, Antoine Buemi, Michel Mourad                                             
Introduction. Pre-analytical processing significantly affects tissue metabolomes. Since most frozen kidney samples are stored after 
embedding, standardization of cryoprotective medium removal before metabolomics is essential. Objectives. We used rodent and 
human kidney samples to develop an easy and robust pre-analytical procedure compatible with Nuclear Magnetic Resonance (NMR)-
based metabolomics. Methods. In mice, renal ischemia was induced for 30 minutes,followed by 48-hour reperfusion (I/R, n=6). Right 
kidneys were transversally cut in 2 fragments, and snap-frozen in liquid nitrogen (LN2) or in OCT (Optimal Cutting Temperature) 
fixative. In man, double kidney biopsies were simultaneously obtained before transplantation (n=15), and snap-frozen in LN2 or 
OCT. Results. NMR spectrum of pure OCT highlighted 2 major peaks, i.e. from 3.4 to 4.2 ppm and from 1.2 to 2.2 ppm. NMR spectra 
of mouse OCT kidneys were biased at 3.7. By contrast, NMR analyses of mouse OCT kidneys iteratively rinsed in saline significantly 
discriminated sham versus I/R groups, with Q² at 0.695 (to be compared with Q² at 0.866 for LN2 sham versus I/R kidneys). Dis-
criminant metabolites were analogous in both OCT and LN2 kidneys, with a correlation coefficient of 0.83. In man, iteratively rinsing 
OCT kidneys in saline almost completely eliminated the spectral 3.7-peak, thereby making metabolomes of OCT kidneys interpretable 
and similar to LN2 samples, with a correlation coefficient of 0.73. Conclusion. NMR metabolomics using OCT-frozen kidney samples 
is valuable in mouse and man, following standardized OCT removal. This may help use residual biobanked human tissues to better 
understand renal pathophysiology.
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P-36 metaX: a flexible and comprehensive software for processing metabolomics data
PRESENTING AUTHOR: Mei Zhanlong, BGI, China
CO-AUTHORS: Wen bo, Zeng chunwei, Liu siqi                                               
Non-targeted metabolomics based on mass spectrometry enables high-throughput profiling of the metabolites in a biological sample. 
The large amount of data generated from mass spectrometry requires intensive computational processing for annotation of mass 
spectra and identification of metabolites. Computational analysis tools that are fully integrated with multiple functions and are easily 
operated by users who lack extensive knowledge in programing are needed in this research field. We herein developed an R package, 
metaX, that is capable of end-to-end metabolomics data analysis through a set of interchangeable modules. Specifically, metaX pro-
vides several functions, such as peak picking and annotation, data quality assessment, missing value imputation, data normalization, 
univariate and multivariate statistics, power analysis and sample size estimation, receiver operating characteristic analysis, biomarker 
selection, pathway annotation, correlation network analysis, and metabolite identification. In addition, metaX offers a web- based 
interface (http://metax.genomics.cn) for data quality assessment and normalization method evaluation, and it generates an HT-
ML-based report with a visualized interface. The metaX utilities were demonstrated with a published metabolomics dataset on a large 
scale. The software is available for operation as either a web-based graphical user interface (GUI) or in the form of command line 
functions. The package and the example reports are available at http://metax.genomics.cn/. The pipeline of metaX is platform-inde-
pendent and is easy to use for analysis of metabolomics data generated from mass spectrometry.
P-37 AI-based peak detection for mass chromatogram
PRESENTING AUTHOR: Mitsuhiro Kanazawa, Reifycs Inc., Japan
CO-AUTHORS: Atsushi Ogiwara                                                  
Mass spectrometry (MS), including MS combined with gas, liquid, or ion chromatography or capillary electrophoresis, is an essential 
tool for metabolomics, and it significantly reduces analytical time and effort. However, many researchers in the metabolomics field 
still aspire to further improvements that can be applied to the vast amount of MS data. Peak detection for MS chromatograms is 
processed within the MS operating software by computational algorithms with user-defined parameters, but there are no versatile 
algorithms and parameters for diverse chromatographic shapes. It is, therefore, essential to evaluate peak detection results by visual 
inspection and to correct the results manually if the detection algorithms do not work properly. This manual effort not only wastes 
time but can also introduce human error or variation in the criteria for evaluation. Researchers, therefore, require peak detection 
algorithms that rapidly provide results consistent with those determined by human experts but with minimum manual effort. In this 
research, we propose a novel approach for peak detection using machine learning technology, which is utilized in current applications 
of artificial intelligence (AI). This research also compares manual peak detection with the proposed approach and discusses the out-
look for AI-based peak detection. We expect that this approach will realize improvements in analytical precision and will reduce the 
analytical time and effort for peak detection, thereby contributing to metabolomics research.
P-38 INTEGRATED SOFTWARE FOR LIPID DATA ANALYSIS IN DIRECT INFUSION ULTRA-HIGH RESOLUTION ACCURATE MASS SPECTROMETRY BASED LIPIDOMICS WORKFLOWS
PRESENTING AUTHOR: David Peake, Thermo Fisher Scientific, United States
CO-AUTHORS: Yasuto Yokoi, Yukihiro Fukamachi, Reiko Kiyonami, Gavin Reid, Andreas Huhmer                                            
Infusion MS-based lipidomics workflows using ultra-high resolution accurate mass spectrometry (UHRAMS) coupled with selec-
tive derivatization of lipid functional groups provide a convenient solution to address isobaric and isomeric mass lipid overlap. One 
remaining bottleneck limiting wide-spread application of high-throughput untargeted lipidomics is the lack of integrated software 
tools. We describe here LipidSearch 5.0 software designed specifically for infusion lipidomics analysis.   Extraction of lipids followed 
by selective derivatization of amino phospholipids and plasmalogen ether-containing lipids was coupled with UHRAMS analysis 
using a Thermo Scientific Orbitrap Fusion Lumos mass spectrometer. “Sum-composition level” lipid identification was performed by 
LipidSearch 5.0 software.   Key data processing features include mass re-calibration, Gaussian peak fitting and Poisson modelling 
to identify and correct isotopic overlaps. First the monoisotopic peak is assigned by searching against a user-defined database in 
SMILES format, enabling individual selection of lipid categories, class/subclass, total number of carbons and double bonds, positive or 
negative ion adducts and definition of “fixed” and “variable” modifications. Then, isotopic peaks from the identified lipid are removed 
and the process is repeated for all remaining peaks.   In a few seconds 500-1000 “sum-composition level” lipid species are confi-
dently identified from crude lipid extracts. Normalized results are used for relative quantification and statistical comparison between 
groups. Positive and negative ion results are merged, providing higher confidence for lipid identification. MS/MS spectra are searched 
for product ions predicted from ions identified during MS data processing. Unique and non-unique product ions are assessed and MS/
MS results are corrected for isotopic overlap.
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P-39 Quantitative analysis of short chain fatty acids by chlorformate derivatization using GC-MS
PRESENTING AUTHOR: Kuniyo Sugitate, Agilent Technologies Japan, Ltd., Japan
CO-AUTHORS: Norihiro Sakui, Sadao Nakamura                                                
As intestinal bacteria exist in over 30,000 species in humans, they have various influences on human as a host. Recently, interest in 
research on the relationship between the intestinal bacteria and various diseases (allergic diseases, colon cancer, psychiatric disor-
ders, etc.) has been high, particularly in physiological role of short chain fatty acids (SCFAs) which are produced by the metabolism 
of intestinal bacteria. In this study, an optimized method based on GC-MS with chloroformate derivatization was developed for SCFAs. 
The advantage of this method is instantaneous reaction in water and no heating is required. We tested several kinds of alcohols to 
conduct alkylation of SCFAs using chloroformate derivatization reagent. Because the formed alkyl ester of SCFAs with long carbon 
chains come to have big molecular weight, elution in GC/MS become late and improvement of the separation is expected.1-butanol 
showed the suitable reaction for SCFAs among them. Formic acid could not be separated in GC/MS from n-hexane with 1-propanol 
even though GC condition was changed. As for 1-hexanol, low reaction rate was observed for C1-C4 against high reaction rate for 
SFCAs with number of carbon more than 5. Finally, derivatization SCFAs were performed with chloroformate after adding mixture of 
1-butanol/pyridine under basic condition. Derivatized SCFAs was extracted with n-hexane, then injected into GC-MS. The correlation 
coefficient of all SCFAs showed over 0.998 at 20-1000pg (6 point) and LODs were below 20 pg on column. We applied this method to 
measure SCFAs in fecal sample from a mouse and various SFCAs were detected.
P-40 An investigation into MALDI imaging sample preparation compared to DESI imaging for mul-timodal MSI in Pre-clinical Breast Cancer Research
PRESENTING AUTHOR: Heather Patsiouras, Waters, United Kingdom
CO-AUTHORS: Michael Batey, Jonathan Sleeman, Kirill Veselkov, Mark Towers, Philippa Hart, Emmanuelle Claude                                          
Tissue sections were analyzed firstly by MALDI MSI using a SYNAPT G2-Si mass spectrometer with a MALDI source operating with 
a solid-state diode-pumped ND:YAG laser using a repetition rate of 1 KHz. The MALDI first sample preparation used was with CHCA 
in MeCH/Water. Consecutive tissues were then analyzed by DESI MSI, using a modified Prosolia source, directly mounted onto the 
SYNAPT G2-Si. Normal breast tissue is mammary fat pad, with a high presence of triglycerides (TG). DESI control tissue datasets, 
the highest signals were generated by the triglyceride molecules directly from the tissue sections i.e. m/z 879.74 (TG(54:6))H+ 
or (TG(52:3))Na+  and 853.73 (TG(52:5))H+ or (TG(50:2))Na+. The molecular profiles for breast tumor samples change with an 
increased intensity for the detection of phosphatidylcholine (PC). This was not observed with MALDI. MALDI triglyceride molecules 
were observed in both normal or cancerous tissue under the sample preparation conditions used. The observed difference for MALDI 
between the tissue types were more subtle and related to phospholipids. For example  m/z 808.58 (PC(36:2))Na+ was less abun-
dant in the tumor whereas m/z 772.52 (PC(32:0))K+ was more intense in the tumor sample. The lack of TGs in the MALDI datasets, 
resulted in a second preparation using CHCA in MeOH/Water, clearly showing the presence of TGs in control tissue and tumor bearing 
tissue. A third MALDI sample preparation using DHB in MeOH/Water will be tested to evaluate the nature of the lipids class ionized 
and to further examine the complementary nature of MALDI and  DESI MSI.
P-41 Reduction of matrix effect in GCMS ion source and method optimizations for cohort study of disease metabolomics
PRESENTING AUTHOR: Eiichiro Fukusaki, Osaka University, Japan
CO-AUTHORS: Masahiro Furuno, Hiromi Yadori, Hiromi Saito, Kazuo Omori, Yuichi Yamamoto, Naoto Katakami, Iichiro Shimomura       
In large scale cohort studies for disease metabolomics, it is important to maintain metabolite selectivity and sensitivity at a constant 
level from the beginning to the end of the measurement. All steps that are blood sampling, blood cell separation, extraction, concen-
tration, derivatization, GC-MS analysis, peak identification might involve causes of error and fluctuations.  Among them, silylation and 
following GC-MS analysis were studied for further improvement in the present study. Instable GC-MS analysis affords bad influence 
on peak identification in the large scale cohort sample analyses. As a result it negatively affects in organization of metabolome 
matrix.  Therefore stability of GC-MS analysis system is particularly required for automated and high-throughput analysis. Preliminary 
experiment using standard plasma for metabolomics analysis (NIST SRM1950) indicated that the first priority is to remove protein 
and trigriceride from plasma.  After survey of condition, water / acetonitrile extraction was chose as the method to remove matrix 
that negatively affects. The extracted sample was subjected to GC / MS after concentration, lyophilization, and derivatization.  The 
acetonitrile extract solution of this method can be used simultaneously as a sample for measurement of free fatty acid etc. by LC / 
MS. The most significant problem on ionization derived from plasma matrix has been drastically reduced through the present study. 
In addition, sililation process was also improved to yield better reproducibity by using solid state derivatization method.
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P-42 Make Big Data Come Alive: Interactive Data Visualization in Metabolomics Research
PRESENTING AUTHOR: Marinella Temprosa, George Washington University, United States
CO-AUTHORS: Jinxi Liu                                                  
Metabolomics research has rapidly evolved in recent years. In this data-intensive field, effective and simple data visualization tools 
empower researchers to present the big data in a meaningful way that people can quickly understand and use. Compared with tra-
ditional static graphics and tables, interactive visualization takes the concept a step further by allowing self-service faceting, probing 
and drill down. We developed several interactive data visualization applications for metabolomics research using Shiny and Markdown 
by RStudio coupled with R packages ggvis and plotly. The applications present information including quality control and regression 
analysis of more than 3000 metabolites in thousands of different models.  Results are conveyed both in data tables and statistical 
graphs. Data tables contain complete information and are downloadable.  In statistical graphs, users are allowed to view pointwise 
values using mouse-over controls,  to drill down for detail through zooming, to compare and contrast the models and to display 
subsets of results by filtering on p-values, treatment groups, model adjustments, metabolites classes or even selecting an individual 
metabolite. The web-based application employed user interface (UX) design principles to achieve a simple and intuitive interface and 
can be published to allow public or secure (authenticated) access for sharing. The above features of these Shiny applications enable 
a self-service, meaningful and flexible way to review and communicate data.  Examples of the implementation of these ideas in me-
tabolomics research  for a clinical trial, the Diabetes Prevention Program Outcomes Study, and consortium-based analyses, COMETS.  
P-43
Development of a combined untargeted and targeted metabolomic approach for the absolute 
quantification of a large set of central carbohydrate metabolites and their isomers in mice 
spinal cord in a single analytical run
PRESENTING AUTHOR: Loic Mervant, MedDay Pharmaceuticals, France
CO-AUTHORS: Fanny Leroux, Benoit Colsch, Delphine Bernard, François Fenaille, Christophe Junot, Sandrine Aros                                          
Liquid Chromatography coupled to High Resolution Mass Spectrometry (LC/HRMS)-based metabolomics allows integration of targeted 
and untargeted approaches for both the quantification of a wide range of metabolites and biomarker discovery. Nevertheless, com-
pounds quantification in biological matrices remains a tremendous challenge in metabolomics because of many coexisting isomers 
and large dynamic range. Here, we investigated the capability to combine untargeted and targeted metabolomics and the relevance 
of a novel approach to distinguish and quantify isomers in biological extracts in a single analytical run. This development was per-
formed with a Q-Exactive-Plus instrument coupled to liquid chromatography (Zic-pHILIC–negative ionization mode). For compounds 
that are separated by chromatography, absolute quantification was performed by using LC/HRMS. For isomeric/isobaric compounds 
that were co-eluted, quantification was achieved using specific ions present in MS² spectra or through differences in relative abun-
dances of common fragment ions. The relevance of this method was evaluated on mice spinal cord extracts. With this technique, 
the quantification of 40 metabolites involved in central metabolism (Krebs cycle, Glycolysis, Pentoses Phosphate Pathway), including 
33 isomers, was achieved. Furthermore, we were able to accurately determine the proportion of co-eluted isomers (absolute er-
ror &lt;10%) by estimating differences among theoretical and experimental ratios between diagnostics ions from isomer mixtures. 
At last, our method enabled reliable quantification of a number of metabolites in biological media over physiological ranges while 
maintaining a large metabolic coverage capability. In conclusion, it is a powerful tool for metabolomic studies that bridges the gap 
between traditional targeted metabolite quantification and untargeted metabolomic profiling.
P-44 Evaluation of High Speed, High Resolution Data Independent Acquisition for Combined Iden-tification and Quantitative Metabolomic Flux Analysis
PRESENTING AUTHOR: Loren Olson, SCIEX, United States
CO-AUTHORS: Baljit Ubhi, Emile Plise, Nishit Sitapara, Samira Ashtiani                                             
LC/MS has become a mainstay in metabolomics research for the identification and quantitation of metabolic species. Recently there 
has been a shift from measurement of steady-state metabolite levels to measuring the kinetic flux of labeled species in the metab-
olome. Flux analysis can elucidate the regulation of complex overlapped pathways and see differences that are lost in steady-state 
measurement. Data independent acquisition (DIA) and targeted techniques show much promise to provide a complete data solution 
for flux measurements. Herein we evaluate the merits of various high resolution mass spectrometric approaches to the measurement 
of metabolic flux.  MDCK cells were cultured under sterile conditions (standards ATCC recommendations) and seeded onto 6 well 
plates. Glucose and heavy amino flux were studies were performed using 13C6 labeled materials glucose. Time points were taken at 
0,10,20,60,180 and 1440 minutes. Cell samples were analyzed by weak anion exchange chromatography coupled to a QqTOF mass 
analyzer. Positive and negative mode datasets was generated using a targeted, data dependent acquisition (DDA) and DIA tech-
niques. PCA and PLSDA was effective for identifying species that were undergoing flux. DDA, DIA and targeted MS/MS modes each 
have distinct advantages for identification and quantitative kinetic measurements. While basic flux measurement can be derived from 
the HRMS data layer, the location of heavy atom incorporation requires MS/MS data. The use of MS/MS level data on flux measure-
ment is advantageous and in some cases affords the ability to show differences in pathway contribution where ambiguity exists.
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P-45 Analysis of Urine SRMs with Comprehensive Two-Dimensional Gas Chromatography (GC×G-C)-High Resolution Time-of-Flight Mass Spectrometry
PRESENTING AUTHOR: Martin Schaut, LECO Australia, Australia
CO-AUTHORS: Joe Binkley, David Alonso, Lorne Fell, Jonathan Byer, Liz Humston-Fulmer                                            
In this study, various sample introduction techniques were used for the identification of volatile and semi-volatile compounds in two 
new standard reference materials (SRM, smoker’s and non-smoker’s urine). These reference materials are vital in the diagnosis and 
setup of standard operating procedures for metabolic profiling of urine in humans. Solid Phase Micro Extraction, Dynamic Head-
space and Liquid Injection sample introduction techniques were used to analyze the SRMs. The applied methodology also included 
a combination of complementary hard and soft ionization techniques coupled to high resolution time of flight mass spectrometry, 
deconvolution and targeted processing methods which were used for characterization of samples.   Analyses resulted in confident 
identification of a wide variety of materials (e.g., polyaromatic hydrocarbons, phthalate metabolites, phenols and pain killers) and 
metabolite derivatives.  GCxGC-TOFMS chromatograms were highly structured showing clustered classes of compounds and provided 
high quality spectra that were searched against large, well-established databases. Comparison of the sample introduction techniques 
yielded expected results; dynamic headspace and SPME having a larger volatile profile.  High resolution time-of-flight mass spectrom-
etry (HRT) resulted in additional benefits such as accurate formula determinations for fragment, molecular and adduct ions, as well 
as, increased selectivity that reduced background interferences.   Comprehensive HRT data was probed multiple times via targeted 
and/or untargeted processing methods to identify important classes of compounds.
P-46 Development of online SPE-GC-MS system with automated SPE-based derivatization method for metabolome analysis
PRESENTING AUTHOR: Ryoichi Sasano, AiSTI SCIECE co., Ltd., Japan
CO-AUTHORS: Koji Machitani, Shusuke Osaki, Masahiro Furuno, Eiichiro Fukusaki                                             
Due to complicated sample preparation procedures that include centrifugal concentration, freeze-drying and derivatization, the 
current metabolomics protocol using GC-MS, requires not only longer processing time but also advanced technical skill. In addition, 
some silylated metabolites are unstable and the time required for complete silylation varies depending on the metabolite. Therefore, 
the time gap between derivatization and actual GC-MS analysis can potentially be a source of error. In this study, automated SPE-
based derivatization method coupled with GC-MS was developed to accomplish an extremely rapid sample preparation. The derivat-
ization method using SPE-gel has a high reaction efficiency and can provide sequential sample introduction to keep the interval from 
silylation to GC-MS injection constant. Amino acids and organic acids from the extracted samples were loaded into the SPE column 
filled with a mixture of ion-exchange sorbent. After washing with acetonitrile/water, the remaining water in the sorbent was removed 
with acetonitrile. TMS derivatization was done by permeating MSTFA reagent directly into the sorbent. A needle was automatically 
connected to the SPE cartridge and inserted into the GC-MS. Then, the TMS-derivatized metabolites were eluted with n-hexane, and 
injected directly into GC-MS with LVI spiral insert. Pre-treatment, dehydration and derivatization of the sample was done in 10 min-
utes. Applying the system to metabolite standard solutions and mouse serums resulted in good reproducibility and robustness. Thus, 
online SPE-GC-MS system with automated SPE-based derivatization method enables the rapid and reliable analysis of metabolites.
P-47 High throughput mass spectrometry-based metabolomics for optimization of strain perfor-mance; accelerating the concept-to-production process in industrial synthetic biology
PRESENTING AUTHOR: Judith Denery, Amyris, United States
CO-AUTHORS: Celeste Sandoval, Thomas Scherbart, Marites Ayson, Isabel Ribeiro, Carol Tran, Derek Abbott, Alex Apffel, Anna Hjel
meland                                       
Strain optimization for microbial production of chemicals has historically centered around screening and selection for improved strains 
based on some combination of cell growth and product titer. Unfortunately, reliance on these extracellular parameters, provides 
an incomplete picture of how these products are being made or how production can be improved. Metabolomics and proteomics 
measurements, however, provide the ability to “look under the hood” of each living cell factory to inform rapid strain optimization 
through data-driven engineering approaches. Despite the obvious value of metabolomics and proteomics analysis, the impact of such 
approaches is currently limited by the low throughput, manual and time intensive nature of the work. With funding from DARPA, the 
Amyris HTP-MS metabolomics platform has been developed for the analysis of &gt;600 samples a day, thus providing a snapshot of 
metabolic machinery that covers a wide range of microbial metabolism, representing central carbon metabolism, product pathways, 
intermediates, byproducts, and membrane components. The entire platform, including sample preparation, data acquisition, and 
data analysis, has been streamlined and automated to increase throughput by over 20-fold. These high throughput mass spectrom-
etry-based metabolomics approaches provide essential data for characterizing the genotype to phenotype relationship within the 
context of the living cell factory and serve as a key driver for iterative strain improvement. A summary of these transformative me-
tabolomics capabilities and their application in helping Amyris deliver on its mission to accelerate microbial production of high value 
chemicals from milligram-to-kilogram quantities will be presented.
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P-48 PeakInvestigator® Maximizes Discovery of Robust Metabolite Features in Complex Sample Analysis with Dynamic Thresholding & Precision Centroiding
PRESENTING AUTHOR: Jeff Peterson, Veritomyx Inc., United States
CO-AUTHORS: Jeff Peterson, Luke Schneider, Adam Tenderholt                                               
In this study we compared two different centroiding methods in the analysis of three lipidomic samples (food plate homogenates 
from different diets) processed by LC/MS.  Each sample comprised of six replicate LC/MS runs generated on an Agilent 6550 at 40K 
resolution. PeakInvestigator® (PI) is a new advanced signal processing method for centroiding mass spectrometric data, which is ful-
ly automated.  The PI results were compared to standard centroiding methods (MZmine Exact Mass). Metabolomic analyses (Metabo-
Analyst) were performed independently on the centroided masslists generated by the different methods to identify statistically-signif-
icant sample-discriminating features. Every significant (p-value &lt; 0.01) chromatographic feature found in all six technical replicates 
and unique to each sample was further examined manually.  After discarding common features found in both PI and SC analysis, PI 
consistently reported higher numbers of significant sample-discriminating features. The additional features discovered with PI were 
due to a combination of locally-adaptive dynamic thresholding, statistical signal to noise discrimination, and centroiding precision 
with statistical confidence intervals for each peak, allowing more sensitive, precise and complete construction of chromatograms.  We 
conclude that PeakInvestigator® can significantly improve metabolomic analyses and make them more reproducible since there are 
no user adjusted parameters. 
P-49 A study of chemical exposure metabolites in human urine samples by novel High Performance benchtop time of flight GC/MS system.
PRESENTING AUTHOR: Ben Macleod, LECO Australia, Australia
CO-AUTHORS: David Alonso, Joe Binkley, Lorne Fell                                               
Effective profiling methods are critical for the investigation of environmental exposure. Metabolomics is particularly useful due to 
phenotype proximity and quick insight into system perturbations. A major problem continues to be incomplete sample characteriza-
tion due to compound chemical diversity, wide concentration range of metabolites and the complexity of biological matrices. Samples 
were dried, treated with urease and derivatized. A novel benchtop GC-TOFMS and associated software were used for comprehensive 
data collection and processing. Compounds were characterized using retention index values and similarity searches against large, 
well-established databases. Different group samples were quickly compared retrospectively with Target Analyte Finding processing. 
A main objective of this research investigation was the development and implementation of an effective workflow for comparison of 
urine samples. A major bottleneck, regardless of the applied technique, is quick and confident characterization of individual metab-
olites in samples. In this study, the combination of robust chromatography and the increased dynamic range and lower detection 
limits of the GC-TOFMS system resulted in rapid identification of xenobiotics (e.g., halogenated compounds, phenols) and metabolites 
including: Acids, diacids, amino acids, fatty acids, bases, monosaccharides, disaccharides, sugar phosphates, and sterols. Software 
tools were used to quickly interrogate the rich data retrospectively in a targeted manner after compounds of interest were identified.
P-50 Metabolomic and Metagenomic basis of suppressive soils against Pythium irregulare on let-tuce “baby leaf”
PRESENTING AUTHOR: Margarita Ros, CSIC-CEBAS, Spain
CO-AUTHORS: Juan Antonio Fernandez, Trent Northen, Angel Faz, Jose Antonio Pascual, Suzanne Kosina, Benjamin Bowen               
According to sustainable agriculture, suppressive soils have emerged as an alternative to reduce the use of chemical pesticides. The 
biological basis of suppressiveness has been depicted for majority of the soils, although, can be also associated with the level of 
organic matter and nature of soil. The objective of this work was to gain insight and find difference between the microbial profiling 
present in different suppressive and conductive soils (agricultural and natural), with different organic matter contents against Pythi-
um irregulare on lettuce “Baby leaf”.  Microbial profile was studied with two approaches, high throughput sequencing of bacterial and 
fungal communities and metabolomics that has emerged as a functional microbial approach that provides insights into the metabolic 
activity of microbial communities in this case related with biocontrol against host plant pathogen.
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P-51 A biocatalytic approach towards the lab scale production of analytical standard metabolites
PRESENTING AUTHOR: Bernhard Schoenenberger, Sigma-Aldrich Production GmbH, Switzerland
CO-AUTHORS: Henrike Brundiek, Roland Wohlgemuth, Markus Obkircher, Roland Meier, Bettina Siebers, Agata Wszolek, Lu Shen, 
Christopher Bräsen                                       
A biocatalytic approach towards the lab scale production of analytical standard metabolites  The demand for new endogenous me-
tabolites with a well defined quality as analytical standards in Metabolomics is still high. The accessability to many of them either by 
isolation from natural sources or by traditional synthesis is challenging or nearly impossible due to the complexity of their chemical 
structure or due to their inherent instability.  A series of hitherto difficult to obtain metabolites have been synthesised in the gram 
scale by mimicking one or more steps of the metabolic pathways and using appropriately cloned and overexpressed recombinant 
enzymes. Three examples of successful application of this approach will be presented.
P-52 Sugar Rush: New LC-MS method to quantify the plant regulator Trehalose-6-Phosphate
PRESENTING AUTHOR: CARLA ANTONIO, Instituto de Tecnologia Quimica e Biologica Antonio Xavier (ITQB NOVA), Portugal
CO-AUTHORS:                                                    
Trehalose-6-phosphate (T6P), the intermediate of trehalose biosynthesis, is an important signal metabolite in plants. It is a signal 
of sucrose status in plants and influences many metabolic and developmental processes, including responses to stress conditions. 
However, the almost undetectable levels of T6P, together with the complex plant matrix and the presence of T6P isomers such as 
sucrose-6-phosphate (S6P), makes the detection of this metabolite challenging. This work describes the development and validation 
of a new hydrophilic interaction chromatography (HILIC) method coupled to negative ion electrospray (ESI) triple quadrupole tandem 
mass spectrometry (QqQ-MS/MS), in the highly sensitive multiple reaction monitoring (MRM) mode, to quantify metabolic interme-
diates of trehalose biosynthesis, including glucose-6-phosphate (G6P), uridine 5-diphospho-glucose (UDPG), T6P (and its isomer 
S6P). The use of piperidine and methylphosphonic acid in the HILIC mobile phase significantly helped to minimize the interaction 
between the phosphate group of the analytes and the metallic surfaces of the LC-MS system, and resulted in good peak shape and 
resolution for all target sugar phosphates. The method showed good linearity, repeatability, precision and accuracy, without the need 
for pre-analytical derivatization or any type of sample clean up, other than metabolite extraction, and was applied to quantify, in the 
picomole range, the fluctuations of S6P, T6P and G6P in Medicago truncatula roots and leaves exposed to water deficit and subse-
quent water recovery. This is, to our knowledge, the first time a HILIC-ESI-QqQ-MS/MS method is reported for the quantification of 
low-abundant T6P in the complex plant matrix of M. truncatula.
P-53 A Novel Simplified, Integrated Solution for Untargeted Metabolomics
PRESENTING AUTHOR: Katie Glenn, SCIEX, Australia
CO-AUTHORS: Tim Garrett, Ranjan Perera, Baljit Ubhi                                               
Metabolomics focuses on the chemical processes central to cellular metabolism. Mass spectrometry is the tool of choice for the 
measurement of these metabolites. However, they can be increasingly challenging workflows to setup. Therefore, a robust solution 
for screening metabolites is of increased interest allowing for a more integrated and routine mass spectrometer system. A new QTOF 
System was developed for routine, robust workflows which require minimal MS expertise. The system integrates all data acquisition, 
processing and review as well as reporting into a single piece of software. A prostate cancer study was used to determine wheth-
er the untargeted metabolomics workflow using the X500R System could find key differences between the samples. In this study, 
samples from a pilot prostate cancer study was analyzed and a clear difference between healthy and disease urine samples were 
detected using this untargeted metabolomics approach, confirming the original disease classifications. The data was collected using 
information dependent acquisition (IDA) on the X500R QTOF System and processed in MarkerView™ Software 1.3 for statistical anal-
ysis. Cancer research represents a key area where metabolomics can provide new biomarkers of disease from easy to obtain biofluids 
such as urine or plasma.  An untargeted screening approach using mass spectrometry that can be adopted by a broader range of 
research labs (not only the expert labs) would enable this valuable research to be more broadly performed. Most changes were in the 
small molecule amino acids.
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P-55 Differential analysis of LC-IMS-MS data in the analysis of complex wine samples
PRESENTING AUTHOR: Sven Meyer, Bruker Daltonik GmbH, Germany
CO-AUTHORS: Peter Sander, Klaus Meyer                                                
Several samples of red wine were prepared by spinning down the solid matter. The supernatant was diluted, divided into aliquots 
and spiked with single standards and mixtures of isomeric standards. All samples were investigated with LC-IMS-MS analyses. The 
differences were calculated using two different methods. The performance of the two subtraction algorithms are first demonstrated 
on samples spiked with different isomeric compounds. Subtracting a blank wine analysis from a spiked wine analysis yielded in a 
differential result data file. All dimensions like retention time, mass to charge, mobility and intensity are considered and retained. 
The results of the different approaches were compared. Also, the general workflow of unknown ID is demonstrated on these ex-
amples, using exact mass, isotopic pattern quality (mSigma value), fragmentation pattern of MS/MS spectra and collisional cross 
section (CCS). As an example, the investigation of catechin and epicatechin will be shown. In a second part, a differential analysis of 
non-spiked wine samples was performed. The results show several peaks that were identified as differentiators between the different 
types of red wine.
P-56 Targeted Profiling – Adaption of a Standardized and Quantitative Metabolomics Assay from Triple Quadrupole MS to Orbitrap MS
PRESENTING AUTHOR: Therese Koal, BIOCRATES Life Sciences AG, Austria
CO-AUTHORS: Doreen Kirchberg, Martin Buratti, Simon Schafferer, Kristaps Klavins, Glenn Damkroeger, Madalina Oppermann, 
Anastasia Kalli, Reiko Kiyonami, David Peake, Andreas Huhmer, Therese Koal                                   
Standardized, quantitative assays have been increasingly sought-after in metabolomics, not only in targeted but also in profiling 
studies, where inter-lab and longitudinal comparability in results are of utmost importance. The AbsoluteIDQ® p180 Kit, a proven 
tool for multiplexed standardized analysis in Targeted Metabolomics has been adapted for the high resolution Orbitrap mass spec-
trometry platform, which has been the workhorse of Profiling Metabolomics. Here we demonstrate the power of quantitative analysis 
of the kit including lipids for Targeted Profiling.on the Q ExactiveTM Focus instrumentThe AbsoluteIDQ®  p180 Kit workflow contains 
two parts: LC-MS and FIA-MS analysis. The LC-MS method provides quantitative analysis of 42 targeted amino acids and biogenic 
amines. The measured concentrations on the Q ExactiveTM Focus are absolutely comparable to those achieved on the standard 
triple quad MS-based analyses. Their performance in terms of LOD, LOQ, accuracy and precision are very similar. For the FIA-MS 
analyses, approximately 360 metabolite features, covering acylcarnitines (AC), phosphatidylcholines (PC), lyso-phosphatidylcholines 
(LPC), sphingomyelins (SM), ceramides (Cer), cholesteryl esters (CE), glycerides (DG, TG) and hexoses, can be profiled and relatively 
quantified with the Q Exactive. Although the sensitivity and precision for FIA-MS analysis on the triple quadrupole MS platforms are 
slightly better, the Orbitrap technology delivers the advantage in discerning isobaric interferences. A betatest of the newly adapted 
standardized assay has been carried out in three laboratories on different Q ExactiveTM family platforms. The results show a high 
lab-to-lab comparability, which is mandatory for robust, routine applications of the Kits in metabolomics targeted profiling.
P-57 Optimization of SONAR Elevated Energy Ramps Applied to Different Molecule Classes
PRESENTING AUTHOR: David Heywood, Waters, United Kingdom
CO-AUTHORS: Chris Hughes, Lee Gethings, Jonathan Williams, Johannes Vissers, James Langridge                                            
Initial experiments were carried out to determine optimum collision energy ramps using one quadrupole mass range, for example 
m/z 400 – 900 for analysis of complex peptide mixtures and m/z 500 – 1200 for small molecule applications. These were carried out 
in a systematic manner, i.e. by altering the starting and ending collision energy values in 5 V steps. Optimum ramps, based upon 
peptide identification rates and feature identifications, showed that ramps of 14 to 40V for proteomic and 20 to 50 V (+ve) and 25 
to 55 V (-ve) for small molecules were appropriate values. However, the potential to further optimize collision energy ramps, with the 
aim of maximizing coverage, based upon precursor m/z and retention time is apparent when analyzing the identified precursors from 
the injection of 6 µg K562 cell line onto a 300 micron ID column. It is apparent there are distinct retention time regions where SO-
NAR experiments would potentially benefit from using multiple quadrupole m/z ranges and collision energies, i.e. retention order, de-
pendent.  The analysis of complex proteomics samples show that the multi-step method has the potential to increase coverage and 
subsequent quantitation by &gt; 20%. We also applied this same methodology to small molecule (lipidomics) experiments, increasing 
the feature identification rate significantly and improving the qualitative information by extraction of analyte class information based 
upon neutral loss or product ion extraction.
Advancing the Field
13th Annual Conference of the Metabolomics Society
Page 34
P-58
UTILISATION OF SIMLIPID FOR THE CHARACTERISATION OF METABOLIC SYNDROME 
RELATED LIPIDS ACQUIRED USING A NOVEL SCANNING QUADRUPOLE DIA ACQUISITION 
METHOD
PRESENTING AUTHOR: Lee Gethings, Waters, United Kingdom
CO-AUTHORS: Ningombam Meitei, Johannes Vissers, David Heywood, Jose Castro-Perez, James Langridge                                            
Plasma samples were treated with isopropanol and centrifuged for protein precipitation. The lipid containing layer was collected and 
diluted to adjust the water content prior to analysis. Label-free LC-MS data were acquired in positive and negative ion electrospray 
mode with an oa-QTof platform using a scanning quadrupole DIA acquisition workflow. Raw data were processed and compound 
database searched using SimLipid. Subsequent compound identifications were matched to features using the in-built database, which 
comprised of lipids and in-silico MS/MS characteristic ions. The results were scored based on a proprietary algorithm, which also 
allowed for isobarics being distinguished. Identifications were curated on the basis of mass accuracy (&lt;5 ppm) for both precursor 
and product ions. Unsupervised MVA of the resulting data showed clear distinction between cohorts. OPLS-DA was used to filter for 
features of significant correlation and covariance. Further correction of the data was performed for isotopic overlap prior to targeted 
quantification, , which indicated differential expression of specific lipid classes including fatty acids, phosphatidylcholines, triglycerides 
and phosphatidylserines between the three cohorts. SONAR-based analysis indicates that scanning quadrupole DIA enables over an 
order of magnitude more specificity than a static quadrupole operated with the same resolution and it was found that a quadrupole 
transmission window of approximately 10 Da provided optimum identifications.
P-59 Black list of metabolomics by in-source decay
PRESENTING AUTHOR: Yasumune NAKAYAMA, Sojo university, Japan
CO-AUTHORS: Eiichiro Fukusaki, Takeshi Bamba                                                
Non-target metabolomics is promising technology to search biomarkers, novel compounds, and so on. Resent advancement of mass 
spectrometry (MS) dramatically expand the possibility of the non-target metabolomics. Advancement of mass resolution, MS/MS 
system, and information technology improved the annotation coverage and precision of identification. However, the some problems 
are still remains. One of the problems is miss annotation of fragment ions caused by in-source decay. Labile ions are sometimes 
fragmented at ion source due to the high voltage or temperature to enhance ionization. There fragments become the noise peaks 
at data integration and hinder peak annotation. Worse, some fragments are homologous to the ions of other metabolites. Meaning, 
these fragments are miss annotated automatically by software applications regardless the accurate mass and MS/MS. Here we intro-
duce our database “blacklist of metabolomics” to avoid this miss-annotation caused by homologous fragments. The database focus 
on amino acid, amine, nucleobase, and its derivatives and 104 standard compounds were analyzed one by one using LC/ESI/q-TOF. 
The result of data dependent acquisition, 704 noise peaks were observed at the same retention time of corresponding compounds 
and 53 homologous peaks were observed. The blacklist include the in-source fragment ions homologous to the other compound and 
their precursor. When an annotated compound were in the blacklist, the peak are suspicious. And the peak cannot be trusted when 
is observed in the same retention time with corresponding precursor ion. Our database and approach help the data of non-target 
metabolomics more credential.
P-60 Tips and tricks for setting up an NMR metabolomics facility
PRESENTING AUTHOR: Lorna Wilkinson-White, Sydney University, Australia
CO-AUTHORS: Katie Powell, Anthony Dona, William Hadden, Samantha Connolly, Luciano Gonzalez, Ann Kwan                                          
The University of Sydney’s School of Life and Environmental Sciences (SOLES) has recently set up an NMR metabolomics facility. We 
have installed a liquid handling robot and a SampleJet auto-sampler which is mounted on our 600 MHz spectrometer. This SampleJet 
has a refrigerated case that allows for individual temperature control of the racks. With these facilities, we have the capacity to run 
up to 500 samples under automation. Thus far we have run cohorts of human serum, plasma and urine, as well as bovine serum. We 
have run quality assurance/quality control on our cohorts, and the majority of collected spectra show acceptable line width and line 
shape. PCA analysis of QC samples show tight groupings, indicating consistency across the data collection. We are currently working 
on several collaborative projects that include looking at metabolic changes in pancreatic cancer patients, changes to livestock metab-
olome profiles, as well as identifying metabolites that correlate with pregnancy pathologies. We will showcase some preliminary data 
from these projects, as well as some tips and tricks on the collection of NMR metabolomics data we have learnt while setting up of 
our facility.
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P-61 MStractor: An R Based Workflow for LC and GC-MS Data Mining
PRESENTING AUTHOR: Luca Nicolotti, Metabolomics Australia, The Australian Wine Research Institute, PO BOX 197, Glen osmond, 
5064, SA, Australia
CO-AUTHORS: Jeremy Hack, Natoiya Lloyd, Markus Herderich                                               
Broad availability of hyphenated MS based techniques such as GC-MS and LC-MS has dramatically increased the analytical throughput 
over the last few decades and allowed the development of advanced analytical approaches such as metabolomics and non-targeted 
analysis. The concept underpinning non-targeted approaches is to collect and catalogue the entire chemical diversity in a biological 
sample set so that each sample constituent can be considered as a potential discriminating feature for sample characterization.   The 
enhancement in metabolite detection sensitivity, combined with non-targeted strategies, has substantially increased the complex-
ity of metabolite data sets: file sizes in gigabyte per sample range are common. This in turn has led to an increased demand for 
powerful, user-adjustable software for automated data filtering and pre-processing.    In this presentation, we describe MStractor, a 
new R script for processing data originating from non-targeted profiling experiments utilizing LC-MS and GC-MS instrumentation. The 
MStractor workflow performs the following:    Feature extraction (m/z-retention-time pair) using XCMS.  Retention time 
alignment of the detected features across the samples composing the analytical set.  Recognition and annotation of isotope 
clusters, fragments and charge states using CAMERA.  Molecular feature filtering based on multiple criteria and conservative usage of 
intensity thresholds for maximum sensitivity.  Creation of a data matrix summarizing the data processing results.     Moreover, MStrac-
tor shows some unique features such as:  1.       Parameterization based on user provided inputs obtained from instrument specifica-
tions and reference measurements. 2.       Graphical tools for real-time quality monitoring and optimization of the feature extraction 
process.
P-62 Separation of Protein and Peptides Using Styrene/N-phenylacrylamide porous layer Immobi-lized Open Tubular Capillary Column
PRESENTING AUTHOR: Ashraf Ali, Inha University, Incheon South Korea, South Korea
CO-AUTHORS:                                                    
A copolymer immobilized OT-CEC column has been developed in current study for the separation of different peptides present in a 
tryptic digest of cytochrome C with enhanced separation efficiency and improved peak capacity which is better than those of the 
previous studies. Long copolymer chains were immobilized on the inner surface of the capillary via reversible addition-fragmentation 
chain transfer (RAFT) polymerization. Pretreated silica capillary column (50 µm internal diameter and 120 cm length) was chemically 
modified with 4-(Chloromethyl)phenyl isocayanate in the presence of dibutyl tin dichloride as catalyst. The terminal halogen (Cl) of 
the bound ligand (4-(Chloromethyl)phenyl isocayanate) was reacted with sodium diethyl dithiocarbamate to incorporate the initiator 
moieties. A thin polymer layer was made on the inner surface of capillary by reversible addition-fragmentation transfer polymerization 
upon the initiator moieties using a mixture of styrene, N-phenylacrylamide, and methacrylic acid. The copolymer immobilized open 
tubular capillary column was used for the separation of synthetic mixture of five peptides and tryptic digest of cytochrome C sample 
in capillary electrochromatography. Very high separation efficiency (Ca. 1440,000 plates/m) was obtained for synthetic peptides while 
(Ca. 320,000 plates/m) for some of the peptide in tryptic digest of cytochrome C under optimized elution conditions.
P-63 Automated on-line and on-time MCF Derivatisation for GCMS in a Routine Metabolomic Labo-ratory
PRESENTING AUTHOR: Erica Zarate, University of Auckland, New Zealand
CO-AUTHORS: Saras Green, Udo Rupprecht                                                
Automated on-line and on-time MCF Derivatisation for GCMS in a Routine Metabolomic Laboratory  Erica Zarate, Mass Spectrometry 
Centre, School of Biological Sciences, University of Auckland, Auckland 1010, New Zealand (e.zarate@auckland.ac.nz) Saras Green, 
Mass Spectrometry Centre, School of Biological Sciences, University of Auckland, Auckland 1010, New Zealand (e.zarate@auckland.
ac.nz) Udo Rupprecht, Lasersan Australasia Pty Ltd, PO Box 183, ROBINA, QLD 4226, Australia (udo@lasersan.com) The analysis 
of low molecular weight compounds by GCMS in Metabolomic Studies has been well documented by various authors, however most 
derivatise off-line prior to GCMS analysis. In the case of MCF (Methyl Chloroformate) derivatisation it is very time consuming, taking 
around 4 hours per batch of 24 samples to be done. Robotic autosamplers such as from CTC-PAL are available that can perform deri-
vatisation on-line/on-time followed immediately by GCMS injection, increasing reproducibility. However, these have often not allowed 
the overlap of the lengthy derivatisation procedure with the equally lengthy GCMS run time. This presentation will describe evaluation 
of a commercial software available from Gerstel GmbH, that automatically overlaps the derivatisation procedure and comparisons in 
recoveries using a dual 100ul and 10ul syringed CTC-PAL are described in a routine Metabolomic analysis laboratory. This software is 
available to work with most CTC-PAL autosamplers independent of supplier.  
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P-284 Acoustic Mist Ionization for Ultra High Throughput Mass Spectrometry
PRESENTING AUTHOR: Phillip DeLand, Labcyte, United States
CO-AUTHORS: Rich Ellson, Martin Bachman, Ian Sinclair, Jon Wingfield, Gareth Jones, Lucien Ghislain, Eric Hall, Sammy Datwani        
Due its ability to generate high quality, label-free data for positive compound identification and quantification, LC-MS has become 
an essential tool for metabolomic studies. However, as the field of metabolomics has experienced tremendous growth, so to has 
the need for analyzing larger numbers of samples. Unfortunately, LC-MS throughput has not significantly increased beyond about 
1 sample per minute. Other techniques such as automated solid-phase extraction have shown promise but still only offer analysis 
rates of slightly better than 6 samples per minute. For over a decade, acoustic energy has been used to reliably transfer liquid in 
small, precise increments from one microtiter plate (the source) to another plate (the destination). Because there is no direct contact 
with the sample, the possibility of carryover during transfer is non-existent. It is also very fast. Our collaboration with AstraZeneca 
Pharmaceuticals and Waters Corporation has led to the study of a technology which combines acoustic delivery of liquid with high 
resolution mass spectrometry. This acoustic mist ionization - mass spectrometry (AMI-MS) combination has produced label-free MS 
data at a rate of up to 3 samples per second. Although our experience so far has primarily focused on High Throughput Screening, it 
is clear that this capability could easily be extended to metabolomics. In our presentation, we will describe the fundamentals behind 
acoustic mist ionization-mass spectrometry, construction of a prototype system and data we have collected with biochemical assays. 
We will also include examples in metabolic profiling and lipidomics.
P-286 Sample-per-second shotgun lipidomics and metabolomics using acoustically-induced electro-spray ionisation
PRESENTING AUTHOR: Rich Ellson, Labcyte, United States
CO-AUTHORS: Martin Bachman, Ian Sinclair, Jon Wingfield, Daniel Addison, Kerry Hallbrook, Sonia Houghton, Matthew Burnham, 
Phillip DeLand                                       
Lipids are abundant components of cell membranes and have vital roles beyond structural support. The identity and abundance of 
lipid species vary between cell types and cellular states. As such, lipid profiles can be a great readout for cell based assays. Current 
technologies for lipid profiling (HPLC MS/MS and direct infusion ESI-MS/MS) have relatively low sample throughput. We have de-
veloped a workflow which allows rapid analysis of cellular lipid composition and simultaneous detection of intracellular metabolites 
from small amounts of cells grown in a 384-well plate.   We use the recently developed Echo-MS platform (Sinclair et al., JALA, 
2016), which combines Labcyte Echo® liquid dispenser and Waters QToF mass spectrometer. An acoustic transducer together with a 
charging cone generate a spray of charged droplets that de-solvate on transit to the MS source. The contactless nature of introduc-
ing samples prevents carryover and allows ultrafast sample analysis. We will demonstrate the ability of the Echo-MS to analyse lipids 
and metabolites directly from adherent or suspension mammalian cells at sub-second rates. Less than 1000 cells are required to 
identify and quantify the relative abundance of polar lipid species and a wide range of metabolites in both positive and negative ion 
modes and with minimal sample preparation required. We will show data of treated cells and how simultaneous analysis of lipids and 
metabolites can help dissect the effect of a compound on biochemical pathways. We will also show how in situ lipid extraction can be 
performed to improve ionisation of phospholipids and minimise ion suppression.
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O-43 An automated, quantum-chemical in silico metabolite library engine for multidimensional NMR spectroscopy
PRESENTING AUTHOR: Jamie Dunn, Pacific Northwest National Laboratory, United States
CO-AUTHORS: Yasemin Yesiltepe, Dennis Thomas, Niranjan Govind, Mark Borkum, Nancy Washton, John Cort, Thomas Metz, Ryan 
Renslow                                       
Quantum chemical calculations are currently the most accurate method available for predicting NMR chemical shifts for a wide 
range of metabolites. Because current metabolite identification methods in complex mixtures rely on chemical shift libraries, 
high-throughput quantum chemical calculations are needed to enable identification of the estimated hundreds of thousands of 
metabolites. Furthermore, consideration of conformers is required to obtain accurate chemical shifts, and accounting for hundreds of 
conformers for each metabolite is time consuming. We built a user-friendly workflow for automated NMR chemical shift calculation 
that uses an open source, high-performance computational quantum chemistry software, NWChem. Our tool employs density 
functional theory (DFT) techniques to calculate NMR chemical shifts of molecule sets, with custom options for different solvents, 
nuclei, and user-selected chemical shift reference compounds. IUPAC InChI identifiers or chemical table files are accepted as 
input. This tool can calculate NMR chemical shifts of a molecule set with a variety of DFT methods while considering hundreds of 
conformers for each molecule.  Our tool was validated with 300 molecules that had experimental NMR chemical shifts available in 
the literature. 1H and 13C chemical shifts were calculated with eight levels of DFT theory, with RMSD errors reaching 0.8 and 5 ppm, 
respectively. Furthermore, we tested our tool on conformers obtained using DFT-based ab initio molecular dynamics, demonstrating 
the ability to reduce chemical shift errors to less than 0.1 ppm (1H) and 2 ppm (13C) using Boltzmann weighting of calculations for 
hundreds of conformers.
O-57 Metabolite Profiling of Red Sea Corals
PRESENTING AUTHOR: Alejandra Ortega, KAUST, Saudi Arabia
CO-AUTHORS: Christian Voolstra                                                  
  Looking at the metabolite profile of an organism provides insights into the metabolomic state of a cell and hence also into pathways 
employed. Little is known about the metabolites produced by corals and their algal symbionts. In particular, corals from the Red Sea 
are understudied, but interesting study objects, as they live in one of the warmest and most saline environments. In this study, we 
applied gas chromatography – mass spectrometry  metabolite profiling to analyze the metabolic profile of four coral species and their 
associated symbionts: Fungia granulosa, Acropora hemprichii, Porites lutea, and Pocillopora verrucosa. We identified and quantified 
102 compounds among primary and secondary metabolites across all samples. F. granulosa and its symbiont showed a total of 
59 metabolites which were similar to the 51 displayed by P. verrucosa. P. lutea and A. hemprichii both harbored 40 compounds in 
conjunction with their respective isolated algae. Comparing across species, 28 metabolites were exclusively present in algae, while 38 
were exclusive to corals. Taken together, this study provides a first description of metabolites of Red Sea corals and their associated 
symbionts. As expected, the metabolites of coral hosts differ from their algal symbionts, but each host and algal species harbor 
a unique set of metabolites. This corroborates that host-symbiont species pairs display a fine-tuned complementary metabolism 
that provide insights into the specific nature of the symbiosis. Our analysis also revealed aquatic pollutants, which suggests that 
metabolite profiling might be used for monitoring pollution levels and assessing environmental impact.
O-62 Differences in the biological architecture between visceral and subcutaneous adipose tissue revealed by transcriptomics and metabolomics
PRESENTING AUTHOR: Nasim Bararpour, University Center of Legal Medicine, Switzerland
CO-AUTHORS: Tiziana Caputo, Federica Gilardi, Nicolas Guex, Beatrice Desvergne, Aurelien Thomas                                            
Adipose tissue (AT) is a metabolically dynamic tissue which acts as an endocrine organ notably by regulating metabolic homeostasis. 
The response to overnutrition of distinct AT depots, such as visceral AT (v-AT) and subcutaneous AT (sc-AT), is different, with the 
production of pro-inflammatory mediators, triggering chronic low-grade inflammation, mainly in v-AT. However, less is known about 
the molecular signature and gene expression induced-phenotype that differ between these two AT depots.The aim of this study is 
to decipher the differences in the biological architecture and functions between sc- and v-AT.Comparison was performed between 
v-AT and sc-AT in mice fed either by high fat or chow diet .Analysis was done by untargeted metabolomics and transcriptomics.
Univariate t-test and PAM statistics were performed to identify discriminate markers. Gene Ontology analysis (GO) and pathway 
enrichment inferred from biological network were done using ClueGo, a Cytoscape plug-in.Several markers were significantly up- or 
down-regulated between sc- and v-ATs, regardless of diet model and inflammatory phenotype of these two tissue types.Mapped 
genes disclose clear differential expression between v-AT and sc-AT revealed by PCA.Preliminary data analysis addresses some purine 
and pyrimidine metabolites that vary across the ATs likewise some steroid metabolites and amino acids.GO analysis enriched several 
interesting pathways notified by contribution of two “omics” data such as mesenchymal development pathway which may address 
ontogenetic difference between v-AT and sc-AT tissues.Integrating information driven by metabolomics and transcriptomics analysis 
assists in revealing the shared and different biological pathways between sc- and vAT and gives powerful understanding of AT 
molecular architectures.    
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O-89 Comparative analysis of phytochemicals in the leaf extracts of Pittosporum angustifolium cultivars via LC-MS based plant metabolomics.
PRESENTING AUTHOR: ANUJA PATIL, SCHOOL OF PHARMACY, UNIVERSITY OF QUEENSLAND, Australia
CO-AUTHORS: MO Parat, PN Shaw, M Fitzgerald                                               
Introduction- Pittosporum angustifolium L., formerly known as Pittosporum phillyraeoides (Cayzer, Crisp, &amp; Telford, 2000), 
has been reported for its widespread use in Aboriginal medicinal practice. Such uses of this plant have attracted scientific 
investigations into its phytochemical profile and medicinal properties (Sadgrove &amp; Jones, 2013). The range of the Aboriginal 
peoples’ usages of this bush medicine is likely extended by the significant geographic and soil variability between states and 
territories in Australia.  Methods- This study included three cultivars and two types of extracts (Juice [GGJ] and decoction [GGD] of 
Pittosporum angustifolium L. Plant metabolites were extracted and were analysed via reversed phase ultra-high performance liquid 
chromatography/high-resolution mass spectrometry with electrospray ionisation (ESI) in positive ion mode; this methodology was 
used to compare the phytochemical profiles of GGJ and GGD.  Results- A number (101) of discriminating phytochemical markers 
was identified using multivariate hierarchical clustering analysis (HCA) (Fig. 1). Among them, three new phytochemical compounds 
in this plant were identified. Despite GGD and GGJ being derived from the same samples of plant material, the concentrations of 
these compounds were significantly higher in all GGD samples (p &lt;0.0001).  Conclusion- The present study has assessed the 
phytochemical diversity between leaf extracts and the originating cultivars of Pittosporum angustifolium L., obtained from different 
locations in Australia, by analysing metabolic fingerprints using UPLC-ToF-MS-based metabolomics and chemometric approaches. 
Clear differences were observed between the two types of extracts; in addition, intra-cultivar variation was observed.
O-104 Next generation, ‘standards-free’ metabolite identification pipeline
PRESENTING AUTHOR: Ryan Renslow, Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory (PNNL), 
Richland, WA, USA, United States
CO-AUTHORS: Dennis Thomas, Jamie Nuñez, Yasemin Yesiltepe, Niranjan Govind, Xueyun Zheng, Erin Baker, Justin Teeguarden, 
Thomas Metz                                       
The capability to identify metabolites in complex clinical and environmental samples will revolutionize the search for determinants 
of disease. In comparison to near-comprehensive genetic information, much less is understood of the metabolome, largely due to 
insufficiencies in molecular identification methods. Through innovations in computational chemistry, we have developed a platform 
to overcome a significant obstacle in the field of metabolomics: the absence of methods for accurate, comprehensive identification 
of small molecules without relying on authentic chemical standards. Our approach uses a gas-phase molecular property, collision 
cross section (CCS), which can be accurately predicted and consistently measured and, thus, can be used for identification without 
the need for standards. The pipeline uses a large-scale computational-chemistry platform for calculating metabolite CCS, which 
exploits PNNL’s high-performance computational quantum chemistry software, NWChem, and results in calculated CCS values with 
errors &lt;1-2% compared to experimentally measured values – sufficient, with accurate mass information, to allow high accuracy 
identification of metabolites.  We applied our platform to analyze positional and geometric metabolite isomers and found it was 
significantly more accurate at calculating CCS values compared to other methods. This level of accuracy enabled us to distinguish cis/
trans isomers. Furthermore, we tested its high-throughput capability with metabolites in the HMDB, which provided a measure of the 
theoretical resolving power of accurate mass and CCS. Finally, we analyzed environmental samples and CCSs were calculated in silico 
for possible metabolites. Several predicted degradation products, not available as authentic chemical standards, were identified only 
by accurate mass and in silico-derived CCS.
O-106 Lipidome Remodeling at Sea: Viral Infection of a bloom forming Marine Algae Induces the Production of Highly Saturated Triacylglycerol
PRESENTING AUTHOR: Sergey Malitsky, Weizmann Institute of Science, Israel
CO-AUTHORS: Carmit Ziv, Shilo Rosenwasser, Shuning Zheng, Daniella Schatz, Ziv Porat, Shifra Ben-Dor, Aharoni Aharoni, Assaf 
Vardi                                       
Lipidomics is a subset of metabolomics which refers to the large-scale study of pathways and networks of cellular lipids in biological 
systems. We use reversed-phase chromatography to separate complex lipid molecular species which are then analyzed by high 
resolution mass spectrometry provided by qTOF. As a biological model to study global lipidome changes we used the marine 
microalga Emiliania huxleyi. This ubiquitous alga forms massive seasonal blooms in the North Atlantic Ocean that impact nutrient 
recycling and earth climate. Viral infection of this unicellular alga induces the rapid remodeling of host primary metabolism, targeted 
towards fatty acid metabolism. We applied an untargeted LC/MS-based lipidomics approach to explore the impact of viral-induced 
metabolic reprogramming on lipid composition during interaction in this unique host-pathogen system. This included the analysis 
of few hundreds lipids from 5 different lipid classes during the course of viral infection.  We show that lytic viral infection leads to 
massive remodeling of the cellular lipidome, predominantly inducing the biosynthesis of viral specific glycosphingolipids as well as 
the accumulation of highly saturated triacylglycerols (TAGs) in lipid droplets. These virus-induced lipids accumulated in the infected 
algal cell as well as in the purified virion, thus pointing to the central role of these lipids for viral assembly. Interestingly, viral-induced 
TAGs were significantly more saturated than TAGs produced under nitrogen starvation.  This study highlights TAGs as major products 
of the viral-induced metabolic reprogramming during host-virus interaction and suggests a possible biotechnological application for 
these TAGs in biofuel production.
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O-143 Identifying Marine Natural Products - Pitfalls and Progress
PRESENTING AUTHOR: Mary Garson, The University of Queensland, Australia
CO-AUTHORS:                                                    
Chemists routinely use NMR spectroscopy to determine the structures of organic compounds. Natural product researchers, 
armed with a suite of 2D NMR methods and knowledge of biosynthetic pathways, can usually deduce the planar structure of a 
complex natural product without difficulty. The more complex task of assigning the molecular shape (that is relative and absolute 
configuration) presents more of a challenge, yet no identification of a natural product is complete without this stereochemical 
information. In recent years, the use of quantum chemical calculations for the prediction of proton and carbon chemical shifts 
provides an additional tool that aids complex structure elucidation. In this talk, I will describe some recent misidentifications in the 
natural products literature, and highlight the role of advanced NMR spectroscopy in the structural revision.  
O-156 A multi-platform metabolomics approach to identify unique compounds present in Australian bush food
PRESENTING AUTHOR: Fe Calingacion, University of Queensland, Australia
CO-AUTHORS: Melissa Fitzgerald                                                  
Australia is home for immense collection of native plants offering edible species used as food and medicine. Aboriginal people have 
developed vast knowledge of use for this diverse flora, yet majority of these species have not yet been extensively examined. In 
this study, we have exploited several bush food such as myrtle, gumbi gumbi, senna acacia and native plums to understand their 
rich chemical diversity. We determined polar and semi polar metabolites that are unique for each bush food class using ultra high 
pressure liquid chromatography-mass spectrometry. For highly similar molecules, we have used ion mobility which offered additional 
dimension of separation based on the collision cross section property of the compound. Furthermore, we identified and compared the 
volatile components of lemon myrtle with other commercially available herbs using a two-dimensional gas chromatography-time of 
flight-mass spectrometry. Lemon myrtle was found to have more of the unsaturated aldehydes and furanones that are characteristic 
of desirable flavour and fragrance agents. These information will pave the way for a wider application of these native food and 
ultimately increasing their economic value.
O-157 HSQC-TOCSY NMR profiling: making informed microbial strain selection for natural product discovery
PRESENTING AUTHOR: Larissa Buedenbender, Environmental Futures Research Institute, School of Environment, Griffith 
UniversityGriffith University, Australia
CO-AUTHORS: Leesa Habener, Tanja Grkovic, Ipek Kurtböke, Sandra Duffy, Vicky Avery, Anthony Carroll                                          
Microbial natural products are an excellent source for drug leads due to their unique structural diversity and the use of laboratory-
based fermentations rather than harvesting organisms from the environment. However, re-discovery of already known natural 
products poses a great challenge; therefore, it is important to incorporate effective dereplication protocols early in natural product 
isolation efforts. We have developed a systematic approach for microbial strain prioritization for natural product discovery based on 
HSQC-TOCSY nuclear magnetic resonance profiles combined with biological activity of crude extracts. NMR data provides structural 
information of the microbial extracts and can be used to target specific functional groups of natural products. The use of HSQC-
TOCSY experiments offered increased chemical shift resolution by spreading the structural information onto two dimensions and 
thus permitted assessment of unfractionated extracts. Here, we present how this approach was used to make informed selection of 
microbial strains with unique NMR profiles and with demonstrated anti-plasmodial activity from a library of 120 ascidian-associated 
actinomycete extracts that resulted in the isolation of new natural products.
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O-190 Comprehensive LC-MS/MS metabolomic profiling of fungal culture collections – insights into the chemical space of fungal secondary metabolites
PRESENTING AUTHOR: Mark Sumarah, Agriculture and Agri-Food Canada, Canada
CO-AUTHORS: Justin Renaud, Keith Seifert, J. Miller                                               
Filamentous fungi are capable of producing an immense variety of secondary metabolites (polyketides, terpenes, nonribosomal 
peptides) including many important mycotoxins. Over the past century, Agriculture and Agri-Food Canada has built a large resource 
of 20 000+ fungal cultures (Canadian Collection of Fungal Cultures). These include Fusarium, Penicillium, Alternaria, Aspergillus, 
and many endophyte sourced species. We have developed a comprehensive non-targeted LC-MS/MS data independent acquisition 
(DIA) method using our High-Resolution Orbitrap Q-Exactive mass spectrometer and a data processing pipeline for metabolomic 
profiling. Extracts are screened against an in-house digital MassBank Spectral Library (dMBSL) database comprised of LC-MS 
and MS/MS spectra of mycotoxins and fungal secondary metabolites for rapid and confident metabolite identification. Spectra of 
all ionisable compounds are digitally archived, allowing for comparative multivariate statistical analysis (PCA and OPLS-DA) and 
retrospective data mining. Important spectral features can be easily searched using retention times, high resolution mass, and by 
product ion fragments. Each fungal extract was also screened against panels of bacterial and fungal microorganisms as part of 
our ongoing search for novel bioactive compounds. The goal of this project is to better understand the fungi that occur in Canada 
and more importantly the secondary metabolites that they produce and their potential roles in agriculture. This data is shared with 
regulators for risk assessments and development of science based policy. To date more than 1000 strains have been screened and 
the secondary metabolites of fungal endophytes and new described Penicillium and Aspergillus species have been characterized and 
published.
O-228 Metabolomics: The solution to assessing herbal medicine safety?
PRESENTING AUTHOR: Garth Maker, Murdoch University, Australia
CO-AUTHORS: Elly Crighton, Ian Musgrave, Michael Bunce, Roger Byard, Robert Trengove                                            
Herbal medicines are part of the $2 billion Australian complementary and alternative medicine industry, lightly regulated due to 
a perception of ‘low risk’. This has been challenged by the authors, who investigated the safety of traditional Chinese medicines 
(TCM), with 92% of products tested having toxic ingredients, pharmaceutical agents or heavy metals. There is a clear need for new 
approaches to assessing safety of herbal medicines, and metabolomics could provide the solution.  A fully untargeted approach (DSA-
TOF-MS) was used to screen 150 herbal medicines, identifying numerous undeclared ingredients and potentially toxic metabolites, 
including caffeine. Secondly, to examine variation in composition between formulations, 6 commercial ginseng products were 
subjected to targeted (LC-QQQ-MS) and untargeted (GC-QTOF-MS) analysis. Numerous differences were detected in ginsenoside 
composition and metabolite profiles. Several herbal medicines have been linked to liver damage, although mechanisms of toxic action 
are often not known. Human liver cells (HepG2) were exposed to a green tea extract for 20 min at 10 mg/ml. Cells were harvested 
and analysed using GC-QTOF-MS. Data was modelled and mapped to biochemical pathways. This revealed numerous changes in 
central carbon metabolism, suggesting a disruption to glycolysis that led to increased TCA cycle utilisation of amino acids and fatty 
acids.  Metabolomic analysis clearly has the potential to make a major contribution to studies of herbal medicines, both in terms of 
safety and assessing potential health risks. For improved compliance and safety within the herbal medicine industry, the use of novel 
methods needs to be explored.
O-258 CANOPUS - Comprehensive categorization of unknowns using tandem mass spectrometry
PRESENTING AUTHOR: Kai Dührkop, Friedrich-Schiller University, Jena, Germany
CO-AUTHORS: Marcus Ludwig, Juho Rousu, Sebastian Böcker                                               
Novel computational methods such as CSI:FingerID search tandem mass spectra (MS/MS) in structure databases, and assist in 
identifying compounds in untargeted metabolomic experiments and natural products discovery. However, they cannot help for 
structures not contained in any database. Here, we present CANOPUS, a tool for predicting compound categories directly from 
spectral data. This task seems somewhat simpler than structural elucidation, but comes with certain pitfalls: Can we classify when 
our MS/MS training data is far from a uniform sample of this category, or insufficient or no training data is available? And can we 
classify a compound of a true unknown that is not contained in any structure database? CANOPUS deals with these pitfalls using 
a two step approach: First, predict a molecular fingerprint from MS/MS using a kernel support vector machine; second, predict the 
compound categories from these fingerprints using a deep neural network (DNN) trained on millions of training examples. CANOPUS 
can train compound categories for which we do not have MS/MS data and it generalizes well for compounds which structures are 
unknown to the DNN. It predicts 1,143 categories from the Classyfire ChemOnt ontology, such as flavonoids, phenylpropanoids, or 
glucocorticoids. On independent MS/MS data predictions have an average accuracy of 99.2 %, half of the categories have an F1 
score (harmonic mean of precision and recall) greater than 75 %. We applied CANOPUS to several sample datasets from GNPS such 
as a marine platonic diatom sample, and automatically assign compound categories to each MS/MS spectrum.
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O-263 Deep metabolome annotation and the necessity of a thought experiment
PRESENTING AUTHOR: Gregory Genta-Jouve, University Paris Descartes, France
CO-AUTHORS: Pierre-Marie Allard, Jonathan Bisson, Mehdi Beniddir                                               
The metabolome of an organism consists in the totality of the small molecules present in an organism at a given time. Unlike 
genome, transcriptome or proteome, it represents the real time content of the a living organism at the metabolic level. In order 
to understand the most complex biological interactions between cells, tissues, organs or individuals in a specific ecosystem, it is 
fundamental to first identify all the components, i.e. all the molecules that can be encountered. Over the last decade, identification 
of small biologically generated compounds, the metabolites, has emerged as the main issue in the field of metabolomics and despite 
all the great efforts of the community during the last years only a relatively small number of compounds have been referenced in 
accessible databases, and often with only hypothetical structures. Herein we propose to discuss the philosophical aspects of the 
important question ”what is a known natural product?” in order to move forward to a new paradigm in metabolite identification: 
identifying the real from the possible. This approach based on available tools of in silico metabolisation and MS/MS spectra prediction 
and data annotation will lead to the characterisation of new natural products with a limited amount of available biological material at 
a higher discovery rate. These improvements will enable new challenges to arise and be solved in a wide range of biological systems 
encountered in domains such as chemical ecology, drug discovery and traditional medicine studies.
O-278 Turning mould into gold: An exploration of mould metabolism to commercialize useful secondary metabolites
PRESENTING AUTHOR: Kyle Van de Bittner, University of Canterbury, New Zealand
CO-AUTHORS:                                                    
           Fungi are excellent bartenders.  Millions of years of evolution have given them a chance to perfect their chemical recipes 
for potent chemical cocktails.  Examination of the metabolites in fungal chemical cocktails has given rise to some of our most useful 
antibiotics and insecticides.  However, many useful chemicals that fungi produce still remain beyond our reach because the products 
are too complex to chemically synthesize or the fungus does not naturally produce enough of the metabolite to meet our needs.              
In this presentation I will discuss how we can use heterologous expression systems in the filamentous fungi Penicillium paxilli to 
easily elicit production of scarce metabolites from other fungal species.  Focus will be turned to a class of secondary metabolites 
known as indole diterpenes as I unravel how P. paxilli can be used to identify the function of the genes that other fungi rely on to 
prepare especially unique indole diterpene metabolites.  By identifying how these metabolites are biosynthesized we can control 
the contents and quantity of the fungal cocktails to gain access to commercial quantities of useful indole diterpenes for novel 
therapeutics.
O-292 Substance class annotation for long candidate lists in metabolite identification using structural ontologies
PRESENTING AUTHOR: Sarah Scharfenberg, Leibniz Institute of Plant Biochemistry, Germany
CO-AUTHORS: Janna Hastings, Pablo Moreno, Stephan Beisken, Christoph Steinbeck, Steffen Neumann                                            
As an integral part of Systems Biology, Metabolomics aims to detect and identify the chemical compounds that drive and 
participate in biological processes. In untargeted Metabolomics various sample types with a large number of different metabolites 
are characterized. The method of choice today is mass spectrometry because of its high sensitivity and the broad coverage of 
measurable metabolites. Tandem mass spectrometry, which reveals information about the compound structure, provides useful 
hints for identification. Despite the ongoing development of spectral- and compound databases, the main bottleneck in metabolomic 
research remains the annotation and identification of metabolites. To identify a new compound, e.g., a biomarker it is necessary to 
collect a set of annotations that support a hypothesis, such as the molecular mass, identified adducts or a substance class. Based 
on a tandem MS spectrum, MetFrag reports a list of structurally related candidate compounds that are ranked according to their 
explanatory power in terms of the measured spectrum. Given such a list, BiNChE performs an overrepresentational analysis on the 
structural ontology of ChEBI and reports a list of possible substance classes that are overrepresented throughout the candidates with 
good scores. This approach was successfully applied on two Benchmark datasets of plant metabolites and environmental standard 
compounds, respectively. The performance was compared for ‘known unkown’ and ‘unkown unkown’ compounds. For a published 
dataset of C. elegans the suggested class annotations for possibly ‘unkown unkowns’ could be supported.
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O-302 Defining the dark metabolism of the malaria parasite
PRESENTING AUTHOR: Malcolm McConville, University of Melbourne, Australia
CO-AUTHORS: Simon Cobbold, Laure Dumont, Leann Tilley                                               
A majority of peaks in mass spectrometry-based profiling studies of eukaryotic cell extracts remain chemically undefined and/or are 
not connected to annotated genes or enzyme activities. Determining the extent to which this metabolic dark matter is derived from 
novel metabolic reactions/pathways represents a major challenge in the field of metabolomics. We have started to systematically 
annotate the ‘dark’ metabolome of the parasitic protozoan, Plasmodium falciparum, the major cause of human malaria. The 
stream-lined metabolism of certain developmental stages of these evolutionarily divergent parasites make them interesting systems 
for identifying metabolic processes that evolved early in eukaryotic evolution. We have developed a novel pipeline for detecting 
endogenously synthesized P. falciparum metabolites by labeling asexual blood stages with a panel of ten 13C-labeled carbon sources.  
We identified 45% of the ~800 parasite metabolites detected by GC/MS and LC/MS which were labeled with one or more 13C-carbon 
sources.  Several novel phosphorylated metabolite species were identified which are predicted to be by-products of key enzymes 
in central carbon metabolism.  Deletion of genes encoding members of the haloacid dehalogenase (HAD) family of phosphatase 
resulted in the accumulation of some of these metabolites, with dysregulation of central carbon metabolism and reduced parasite 
growth in red blood cells. These results suggest that enzyme promiscuity may contribute to the formation of novel metabolites and 
that HAD family phosphatases have evolved metabolite proof-reading functions as well as direct roles in regulating metabolic fluxes 
through degradation of phosphorylated metabolites.
O-313
Novel UHPLC-MS-SPE-NMR and UHPLC-timsTofMS/MS Tools for Higher-throughput, 
Confident Metabolite Identifications and to Address the Number One Grand Challenge of 
Metabolomics
PRESENTING AUTHOR: Lloyd Sumner, University of Missouri, United States
CO-AUTHORS: Feng Qiu, Dennis Fine, Daniel Wherritt, Zhentian Lei, Mark Schroader, Aiko Barsch, Sven Meyer                                         
Although the vast utility of metabolomics is well documented in the literature, its full scientific promise has not yet been realized 
due to multiple challenges. The number one, grand challenge of metabolomics is large-scale, confident chemical identification of 
metabolites.  To address this challenge, we have developed sophisticated spectral, computational and empirical metabolomics tools 
for the systematic and biological directed annotation of multi-species metabolomes.  This presentation will describe the creation 
of a UHPLC-MS mass spectral library, custom software entitled Plant Metabolite Annotation Toolbox (PlantMAT), sophisticated 
UHPLC-timsTOFMS/MS and UHPLC-MS-SPE-NMR instrumental ensembles that are being used for large-scale confident metabolite 
identifications.  UHPLC-QTofMS/MS metabolite profiling was performed using Medicago truncatula extracts, and data processed 
by peak deconvolution and formula prediction. Metabolite identifications were first attempted through spectral matching with 
custom libraries generated with authentic compounds.  However, authentic compounds are not available for all metabolites; and 
a large number of the detected peaks could not be identified using spectral matching.  Thus, the orthogonal data was imported 
into PlantMAT and structures for approximately 100 saponins and polyphenolic glycosides were predicted. These compounds were 
isolated, purified and concentrated by mass directed UHPLC-MS-SPE (solid-phase extraction).  The SPE isolated compounds were 
eluted and 1D and 2D NMR spectra acquired.  UHPLC-timsTofMS/MS analyses were also performed to discover potentially overlapping 
compounds and to increase our metabolomics depth of coverage for isobaric compounds not readily separated by UHPLC.  Examples 
will be provided for hydroxylated flavonoids. The results demonstrate that the cumulative platforms allows for higher-throughput and 
high confidence metabolite identifications.
O-367 Development of Software for Efficient NMR Metabolomics Screening of Natural Products
PRESENTING AUTHOR: Kimberly Colson, Bruker BioSpin, United States
CO-AUTHORS: Christian Fischer                                                  
NMR spectroscopy has significant qualities that make it an attractive tool for metabolomics and especially for natural products.  These 
qualities include high reproducibility, compound specificity and quantitation.  Traditionally, NMR has required sophisticated operators 
to operate and harvest valuable information from resulting NMR spectra.  Also traditionally, studies of natural products rely heavily 
of purification strategies to simplify NMR spectra.     Our work focuses on the development of NMR software tool for evaluation of 
natural products metabolomics spectra, on crude extracts, with an aim to automate the spectral evaluation process.  Dereplication 
and identification of key metabolites in crude extracts are accomplished in automation using various automatically defined line fitting 
algorithms.  Limit of detection calculation are utilized to establish minimal reportable quantity of key components.   Taxonomic 
classification is achieved using scaling function routines allowing for consistent or highly variable spectra. This allows customization 
for the species or material studied.     This poster will show the software development through a series of natural product examples.  
The aim is to develop an automated work flow for analysis of these spectra for operators of various skill levels including (1) 
metabolomics researchers and (2) quality control technicians.  NMR assists the researcher with accurate component identification.  
NMR analysis of natural health products may lead to improved quality, labelling and product consistency.
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O-407 Ultrahigh-resolution metabolomics for heteroatom-containing specialized metabolites
PRESENTING AUTHOR: Ryo Nakabayashi, RIKEN Center for Sustainable Resource Science, Japan
CO-AUTHORS: Ryo Nakabayashi, Kazuki Saito                                                
Heteroatom-containing specialized metabolites are often profiled with their common structural features (e.g., ultraviolet spectrum 
or product ions) in integrated metabolomics. However, because of the huge chemical variety of the metabolites, focusing on the 
common structural in targeted analysis was impractical so far. We developed ultrahigh-resolution metabolomic approaches for 
nitrogen (N)- and sulfur (S)-containing metabolites, N-omics1 and S-omics2-5, respectively. In the ultrahigh-resolution MS spectrum, 
the isotopic ions appear as the counterpart of monoisotopic ions. Exploiting differences of exact mass and signal intensity between 
monoisotopic and isotopic ions enabled us to extract target monoisotopic ions from metabolome data. N- and S-omics using the 
solariX 7.0 T, which is the Fourier transform ion cyclotron resonance-mass spectrometry (FTICR-MS) instrument, successfully assigned 
known and unknown metabolites in plants. Matrix assisted laser desorption/ionization-imaging mass spectrometry (MALDI-IMS) is 
a powerful technique to understand both the site of target metabolites accumulating and the site of expressing biosynthetic genes 
related to the target metabolites. The accumulation pattern of the assigned metabolites were visualized by MALDI-IMS using the 
FTICR-MS instrument. Collating the spatial information on metabolites and genes through these approaches and gene expression 
analysis helps to elucidate biosynthetic mechanisms.      Nakabayashi et al., Anal. Chem. (2017)  Nakabayashi et al., Anal. 
Chem. (2013)  Nakabayashi et al., J. Nat. Prod. (2015)  Nakabayashi et al., J. Nutr. (2016)  Nakabayashi &amp; Saito, Curr. 
Opin. Biotechnol. (2017)
O-520 Known knowns, known unknowns and unknown unknowns. The art of correctly determining the structure of a natural product
PRESENTING AUTHOR: Anthony Carroll, Griffith University, Australia
CO-AUTHORS:                                                    
A major bottleneck in metabolomics research remains the definitive identification of individual metabolites found in biological 
matrices.  Unfortunately the majority of these metabolites still remain unidentified and even known compounds can be misidentified. 
Most MS and NMR based metabolomics analyses use libraries of spectroscopic data generated for known compounds to match 
spectroscopic data derived from complex mixtures to identify individual compounds present in these biological matrices. Ultimately 
however, the success of spectral data matching is dependent on the true identify of a molecule being determined correctly in the first 
place. Natural Product dereplication tools are useful to avoid the rediscovery of known compounds with known biological activities 
(the known knowns). Biodiversity and chemical diversity directly correlate and since only a small proportion of total biodiversity 
has been studied there is still a vast array of NPs of unknown structure and biological activity. These compounds are the known 
unknowns. Unfortunately the many published NP structures that have been incorrectly assigned because spectroscopic data has been 
misinterpreted. These mis-assignments remain undiscovered until a total synthesis or re-interpretation of spectroscopic data reveals 
that the molecule doesn’t match with that of the originally proposed NP structure. These compounds are the unknown unknowns 
and these structural errors are can have costly implications. NP structure determination strategies have implications for metabolomics 
research and this presentation will cover techniques that have been developed to detect known NPs, identify unknown NPs and 
correct the structures of mis-assigned NPs.
P-64 Development of an LC-HRMS metabolomics method with high specificity for metabolite identification using data independent acquisition (DIA)
PRESENTING AUTHOR: Romanas Chaleckis, Gunma University Initiative for Advanced Research (GIAR), Japan
CO-AUTHORS: Shama Naz, Hector Gallart-Ayala, Stacey Reinke, Caroline Mathon, Richard Blankley, Craig Wheelock                                           
High-resolution mass spectrometry (HRMS)-based metabolomics approaches have made significant advances. However, metabolite 
identification is still a major challenge and significant bottleneck in translating metabolomics data into biological context. In the 
current study, a liquid chromatography (LC)–HRMS metabolomics method was developed using a data independent acquisition (DIA) 
approach. In order to increase the specificity in metabolite annotation, four criteria were considered: i) accurate mass (AM), ii) 
retention time (RT), iii) MS/MS spectrum, and iv) fragment/precursor ion intensity ratios. We constructed an in-house mass spectral 
library of 413 metabolites containing AMRT and MS/MS spectra information at four collision energies. The % relative standard 
deviations between ion ratios of a metabolite in an analytical standard vs. sample were used as an additional metric for establishing 
metabolite identity. A data processing method for targeted metabolite screening was then created, merging m/z, RT, MS/MS and 
ion ratio information for each of the 413 metabolites. In the data processing method, the precursor ion and fragment ion were 
considered as the quantifier and qualifier ion, respectively.  We also included a scheme to distinguish co-eluting isobaric compounds 
by selecting a specific fragment ion as the quantifier ion instead of the precursor ion. An advantage of the current DIA approach 
is the collection of full-scan data, allowing identification of metabolites not included in the database. Our data acquisition strategy 
enables a simultaneous mixture of database-dependent targeted and non-targeted metabolomics in combination with improved 
accuracy in metabolite identification, increasing the quality of the biological information acquired in a metabolomics experiment.
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P-65 LAESI-MSI as a tool to differentiate the root metabolome of native and range expanding plant species
PRESENTING AUTHOR: Purva Kulkarni, Netherlands Institute of Ecology, Netherlands
CO-AUTHORS: Rutger Wilschut, Koen Verhoeven, Paolina Garbeva, Wim Putten                                             
Our understanding of chemical diversity in biological samples has greatly improved through recent advances in mass spectrometry 
(MS). MS-based-imaging (MSI) techniques have further enhanced this by providing spatial information on the distribution of 
metabolites and their relative abundance. This technique can be applied to study different biological samples ranging from single 
cells to intact whole-body tissue sections. However, some ionization approaches employed in MSI are operated under vacuum, need 
sample preparation and use a matrix (as in MALDI). These can somehow alter the biochemical status of the sample under study.  
We employed laser assisted electrospray ionization (LAESI), to perform MSI and study the metabolomic diversity and differences in 
intact root samples of range-expanding Centaurea stoebe and native plant species Centaurea jacea. Here, we tested the hypothesis 
that successful range expansion is associated with specific plant secondary chemistry and defense compounds.  To examine this, 
LAESI-MSI was performed in positive ion mode and data was acquired in a mass range of m/z 50-1200 with a spatial resolution of 
100 ?m. The acquired data was analyzed using in-house scripts and localization patterns were studied for identified discriminatory 
mass features.  The results revealed clear differences in the metabolite profiles for the two species, in the form of distinct metabolic 
fingerprints. The results are in-line with previous studies performed using gas chromatography (GC)-MS and direct analysis in real 
time (DART)-MS. The use of ambient conditions and no sample preparation made LAESI-MSI an ideal technique for direct correlation 
of the acquired data to underlying metabolomic complexity.
P-66 Advantage of High Resolution Accurate Mass Spectrometry for Metabolite Identification in Untargeted Metabolomics Studies
PRESENTING AUTHOR: Ioanna Ntai, Thermo Fisher Scientific, United States
CO-AUTHORS: Ralf Tautenhahn, Tim Stratton, Anastasia Kalli, Amanda Souza, Andreas Huhmer                                            
High resolution accurate mass (HRAM) spectrometry has become the analytical technique of choice for untargeted metabolomics 
studies. HRAM allows accurate mass assignments, resolving near mass isobaric species from complex mixtures, thus enabling 
confident compound identification and quantitation. Here, we aimed to investigate the effect of mass resolving power on metabolite 
identifications. Human plasma (NIST SRM 1950) was analyzed at different mass spectral resolutions ranging from 15,000 to 240,000 
with a Q Exactive HF hybrid quadrupole-Orbitrap mass spectrometer operated separately in both positive and negative mode. The 
data were analyzed using Compound Discoverer 2.1 for metabolite identification. Increased resolving power was extremely useful 
in defining isotopic distribution and determining elemental composition. Feature detection improved with increasing resolution, 
yielding the best results at resolving power of 60,000-120,000.  Metabolite identification was performed with Compound Discoverer 
2.1 searching against mzCloud and Chemspider. Highly confident metabolite identifications were obtained with mzCloud, which is 
a curated high-resolution, accurate mass spectral database. Compound identifications improved with increasing resolution but at a 
lesser extent than that of feature detection. Our findings suggest that mass spectral resolution higher than 60,000 is essential for 
obtaining greater metabolome coverage.
P-67 Metabolite profiling and bioactivity evaluations for the evaluation of family specific bioactive compounds for Cornaceae, Fabaceae, and Rosaceae families
PRESENTING AUTHOR: Su Son, Konkuk University, South Korea
CO-AUTHORS:                                                    
Thirty-four species from three plant families, namely Cornaceae (7), Fabaceae (9), and Rosaceae (18) were subjected to 
metabolite profiling using gas chromatography–time-of-flight-mass spectrometry (GC–TOF–MS) and ultrahigh performance liquid 
chromatography–linear trap quadrupole-ion trap-mass spectrometry (UHPLC–LTQ-IT-MS/MS), followed by multivariate analyses to 
determine the metabolites characteristic of these families. The partial least squares discriminant analysis (PLS-DA) revealed the 
distinct clustering pattern of metabolites for each family. The pathway analysis further highlighted the relatively higher proportions 
of flavonols and ellagitannins in the Cornaceae family than in the other two families. Higher levels of phenolic acids and flavan-3-ols 
were observed among species from the Rosaceae family, while amino acids, flavones, and isoflavones were more abundant among 
the Fabaceae family members. The antioxidant activities of plant extracts were measured using ABTS, DPPH, and FRAP assays, 
and indicated that extracts from the Rosaceae family had the highest activity, followed by those from Cornaceae and Fabaceae. 
The correlation map analysis positively links the proportional concentration of metabolites with their relative antioxidant activities, 
particularly in Cornaceae and Rosaceae. This work highlights the pre-eminence of the multi-parallel approach involving metabolite 
profiling and bioactivity evaluations coupled with metabolic pathways as an efficient methodology for the evaluation of family specific 
bioactive compounds.
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P-68 An Untargeted Metabolomics Approach to Using High Resolution Mass Spectrometry for Identifying Disease Biomarkers
PRESENTING AUTHOR: Gina Tan, Thermo Fisher Scientific, United States
CO-AUTHORS: Svetlana Rezinciuc, Heather Smallwood, Andreas Hühmer                                               
Metabolomics has increasing importance in biomarker discovery as detection and quantification of metabolites offers complementary 
value to genomics and proteomics studies. Observing metabolic changes occurring alongside gene alterations or protein activity 
can provide deeper understanding of a disease occurrence. Metabolite identification and profiling in biological samples however 
are challenging due to physiochemical diversities and varying abundance levels. To address these challenges, we pursue the LC-MS 
analytical approach using high resolution mass spectrometry and comprehensive software tools. Greater identification accuracy and 
confidence can be achieved and this workflow could potentially be applied onto clinical biological samples analysis. Nasal cell pellets 
were extracted from patient nasal wash samples through washing procedures. Metabolite extraction was performed and samples 
were filtered to remove salt content. Analysis was on a Thermo Scientific™ Orbitrap Fusion™ Tribrid™ mass spectrometer in ESI 
positive polarity at 120K resolution using a fine-isotopic determination data-dependent MS2 method. A 300ul/min flowrate, 15 min 
LC gradient with a reverse-phase C18 column chromatography method was used and data processing was on Thermo Scientific™ 
Compound Discoverer 2.0 software. Compound identification was done through automated mzCloud™, Chemspider searches, and 
KEGG pathway mapping. We identified 459 compounds by using a highly curated repository during the identification process. This 
untargeted LC-MS approach was advantageous because the high resolution MS system and intuitive statistical software capabilities 
assisted the detection of metabolites. These initial results are a proof-of-concept for similar biomarker discovery studies and present 
the ability to conduct further metabolite profiling studies with targeted metabolite panels for assay studies.
P-69 Large-Scale Generation of CCS Values to Support Unambiguous Identification of Metabolites in Untargeted Metabolomics and Lipidomics
PRESENTING AUTHOR: Zhengjiang Zhu, Chinese Academy of Sciences, China
CO-AUTHORS: Zhiwei Zhou                                                  
In untargeted metabolomics, unambiguous identification of metabolites remains a major analytical challenge. The use of collision 
cross-section (CCS) values of metabolites derived from ion mobility-mass spectrometry (IM-MS) effectively increases the confidence 
of metabolite identification, but this technique suffers from the limit number of available CCS values. Recently, we developed 
a machine learning based algorithm to accurately predict metabolites’ CCS values using molecular descriptors. The prediction 
method was externally validated with a median relative error of ?3%. Using this method, we generated a large-scale predicted CCS 
database, namely, MetCCS, containing 35 203 metabolites. For each metabolite, CCS values for five ion adducts in positive and 
negative modes were predicted, accounting for 176,015 CCS values in total. MetCCS is freely available on the Internet (http://www.
metabolomicsshanghai.org/MetCCS). Common users with limited background on bioinformatics can benefit from this software and 
effectively improve the metabolite identification. Users can identify unknown metabolites using experimentally measured m/z and 
CCS values within the defined tolerance. More recently, we further applied the developed prediction method to generate the CCS 
values of lipids. About 300 CCS values for lipids were experimentally measured and used as training dataset. We optimized 49 out of 
286 molecular descriptors of each lipid for the prediction. The prediction accuracy for lipid CCS values has been largely improved with 
a median relative error of ~1%, better than the prediction of metabolite CCS values. Finally, we demonstrated that the addition of 
CCS values in untargeted metabolomics and lipidomics workflow could significantly improve the identification accuracy and selectivity.
P-70 Subcellular metabolite tagging via biochemical derivatisation with nitroreductase
PRESENTING AUTHOR: Thomas Kralj, Monash University, Australia
CO-AUTHORS: Daniel Priebbenow, Anubhav Srivastava, Ghizal Siddiqui, Rodrigo Morales, Jonathan Baell, Darren Creek                             
The application of metabolomics is helping to develop a deeper, mechanistic understanding of cellular biochemistry and the 
development of novel metabolomics methods offers more versatile and targeted methods to do so. Determination of organelle-
specific localisation of certain metabolites can offer greater insight into the metabolic function of biological systems at the subcellular 
level. However, current metabolomic techniques for the determination of subcellular metabolite localisation and quantification lack 
efficiency, specificity and are prone to contamination. In this study, a novel method was investigated for derivatising subcellular 
metabolites present in the mitochondria by using a mitochondria-targeted nitroreductase (TAT-mMDHts-NfsA-GFP) enzyme coupled 
with nitro-aromatic derivatising probes. It was demonstrated that NfsA could tag metabolites containing carboxyl or thiol groups by 
converting nitro-aromatic probes into nitrogen radicals, producing derivatised metabolites with a signature mass shift detectable 
by mass-spectrometry. While the enzyme is capable of cellular penetration, transport into the mitochondria was not achieved, 
likely due to the pore size of the mitochondrial import channel. This study illustrates the potential for novel methods of subcellular 
metabolomics via metabolite derivatisation; although, further investigation is required into more versatile nitro aromatic probes and 
methods of organellar localisation.
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P-71 Serum metabolomics reveals the treatment effect of the water extract of Polygoni Cuspidati Rhizoma et Radix in hypercholesterolemic rats
PRESENTING AUTHOR: Chi-On CHAN, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic 
University, Hong Kong
CO-AUTHORS: Tung-Ting SHAM, Sibao CHEN, Shun-Wan CHAN, Daniel Kam-Wah MOK                                             
This study aims at using untargeted metabolomics approach to examine the hypolipidemic function of the water extract of a 
traditional Chinese medicine, Polygoni Cuspidati Rhizoma et Radix (PCRR) which is known as “Huzhang” in Chinese, on high fat 
diet (HFD)-induced hypercholesterolemic Sprague-Dawley rats by Ultra-Performance Liquid Chromatography Quadrupole Time 
of Flight-Mass Spectrometry (UPLC-QTOF-MS).  The major components of PCRR water extract have been identified as polydatin, 
emodin, resveratrol, emodin 8-O-?-D-glucopyranoside and physcion O-?-D-glucopyranoside using HPLC-DAD. The HFD-fed rats 
taking the PCRR extract supplement (450 mg/kg/day, p. o.) showed significantly lower levels of serum and liver total cholesterols. 
In the partial least squares-discriminant analysis of the UPLC-MS data, the cluster of PCRR-treated group was well separated from 
those of normal control or HFD model in the score plot. This indicated that the serum metabolite profiles of the PCRR group was 
very different from the other groups. Multivariate statistics revealed that treatment of PCRR to hypercholesterolemic rats resulted in 
significantly elevated levels of circulating chenodeoxycholate, deoxycholate, their glycine-conjugated bile acids and glycocholate level 
and restored tryptophan and lysophosphatidylethanolamine 20:4 levels when compared with HFD model. These results indicated 
that the underlying cholesterol-lowering mechanism of PCRR might be associated with bile acid biosynthesis. Besides, a number of 
resveratrol-related metabolites via microbial transformation were solely identified in the serum of PCRR-treated group. We believed 
that treatment of PCRR could modulate the structure of gut microbiota during intervention.
P-72 Profiling of Wine using ultra-high resolution Flow Injection mass spectrometric Analysis and 1H-NMR Spectroscopy
PRESENTING AUTHOR: Chris Thompson, Bruker, United States
CO-AUTHORS: Matthias Witt, Nikolas Kessler, Markus Godejohann                                               
The complexity of organic compounds in food products such as wine can be analyzed by mass spectrometry. Beside GCMS and 
LCMS, wine can be analyzed on the molecular level by Flow Injection Analysis (FIA) after solid phase extraction (SPE) when 
combined with ultra-high resolution mass spectrometry. The mass spectra are a fingerprint of these complex mixtures of organic 
compounds. Therefore, wines can be differentiated very quickly on the molecular level using this mass spectrometric technique. 
Multivariate statistical analysis of FIA-MS and 1H-NMR spectroscopy resulted in similar results.  Wine samples were analyzed after 
solid phase extraction (SPE) using a Bruker solariX XR 7T mass spectrometer using ESI (-) with a resolving power of 300,000 at m/z 
400. Mass data were subjected to deisotoping and adduct collation. Statistical analysis such as PCA and HCA as well as molecular 
formula calculation based on accurate mass, isotopic fine structure and filtering based on elemental composition was carried out 
automatically in MetaboScape 3.0. Annotated features were investigated using filters for mass defects and DBE.  SPE wine extracts 
were subjected to a Bruker FoodScreenerTM (400 MHz Avance III NMR spectrometer). Automatic solvent suppression of the solvent 
resonances enabled the detection of organic constituents present in the extracts.  Wine samples were measured in replicates to 
check reproducibility of the results for the multivariate statistical analysis using Principle Component Analysis (PCA). The results of 
both multivariate statistical analyses (FIA-MS and 1H-NMR) were very similar: Bordeaux wine were separated from the red and white 
wines from Loire and Alsace.
P-73 Shaofu Zhuyu Decoction Ameliorates Obesity-mediated Hepatic Steatosis and Systemic Inflammation by Regulating Metabolic Pathways
PRESENTING AUTHOR: jeeyoun jung, KIOM, South Korea
CO-AUTHORS: Moonju Hong, Hee-Sook Park, So Min Lee, Soon-Hee Kim, Kyung-Won Lee, Nam-Joo Jeong, Myung-Sunny Kim              
The pathogenesis of hepatic steatosis is related to blood stasis syndrome (BSS) in traditional Korean medicine (TKM) and Chinese 
medicine (TCM). In this study, we evaluate the treatment effects of Shaofu Zhuyu decoction (SFZYD), one of the famous BSS 
treatment remedies, on high fat diet (HFD)-induced inflammation and hepatic steatosis. The metabolic profiles of sera obtained 
from normal chow diet (NC) group, a HFD group, and a SFZYD-treated DIO group were investigated using CE-MS spectroscopy 
coupled with multivariate statistical analysis.   Histological and biochemical examinations indicated that SFZYD treatment ameliorates 
hepatic steatosis and systemic inflammation. In score plot of partial least squared – discriminant analysis (PLS-DA) from the sera 
showed a metabolite shift in the HFD mice toward the NC group after SFZYD administration. The significantly altered metabolites 
represented that SFZYD regulated energy metabolism, the pentose phosphate pathway and aromatic amino acid metabolism. In 
addition, SFZYD treatment recovered the expression of genes related to inflammation, e.g. Ccl2, Tnf?, Il1?, Il6, Serpine1, AdipoQ in 
the liver and adipose tissue.  Furthermore, correlation network showed that metabolic alteration by SFZYD significantly related to the 
blood parameters and expression of genes, related to inflammation, lipid metabolism, and mitochondrial dysfunction.  These results 
suggest that SFZYD  may ameliorate HFD induced hepatic steatosis and inflammation by regulating the related metabolism and 
biomarkers.            
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P-74 Metabolomic heatmaps as a tool for strain prioritization in natural product research
PRESENTING AUTHOR: Florian Zubeil, Fraunhofer IME-BR, Germany
CO-AUTHORS: Michael Marner, Jens Glaeser, Armin Bauer                                               
Metabolomic heatmaps as a tool for strain prioritization in natural product research   The continuous demand for new antibiotics to 
overcome evolved resistance led to the extensive exploration of known antibiotic producing bacterial phyla, such as Actinobacteria, 
leading to high rediscovery rates. Thereby, innovative cultivation techniques and the investigation of underexplored phyla represent 
promising approaches to discover novel antibiotics.1,2 However, accessing new bio resources provide a large amount of poorly 
characterized isolates for further analysis. Next, the similarity of the individual extracts is calculated based on this peak table. 
Successive clustering and plotting is performed using a custom R script and results in heatmaps. This provides a visual way to 
investigate the cultured diversity on a metabolomic level. 3To prioritize new isolates based on their chemical profile, we implemented 
a metabolomic heatmap approach. First, the data is processed by XCMS and a peak table is created. Using this approach we could 
demonstrate that phylogenetic closely related strains cluster together based on their metabolomic similarity. This approach helps to 
focus on a larger chemical diversity for downstream processes and further analytics. Also, analytics of strains that show a very high 
metabolomic similarity can be limited to one representative.  All in all this strategy might increase chances to find new chemistry in 
underexplored biological niches that could ultimately be a new lead structure for further pharmaceutical development.
P-75 Specific Detection of Cellular Glutamine Hydrolysis in Live Cells Using HNCO Triple Resonance NMR
PRESENTING AUTHOR: Xing Jin, Seoul National University, South Korea
CO-AUTHORS: Sujin Lee, He Wen, Jin Wook Cha                                               
Glutamine plays key roles as a biosynthetic precursor or an energy source in cancers, and interest in its metabolism is rapidly 
growing. However, the proper evaluation of glutamine hydrolysis, the very first reaction in the entire glutaminolysis, has been 
difficult. Here, we report a triple resonance NMR-based assay for specific detection of glutaminase activity carrying out this reaction 
using stable-isotope labeled glutamine. Compared to conventional methods involving coupled enzyme assays, the proposed approach 
is direct because it detects the presence of the H?N?CO amide spin system. In addition, the method is unique in enabling the 
measurement of glutamine hydrolysis reaction in realtime in live cells. The approach was applied to investigating the effects of a 
glutaminase inhibitor and the inhibitory effects of glucose on glutamine metabolism in live cells. It can be easily applied to studying 
other signals that affect cellular glutamine metabolism. 
P-76 Using trapped ion mobility MS to separate isomeric sphingosines
PRESENTING AUTHOR: Joe Anacleto, Bruker, Canada
CO-AUTHORS: Dirk Wunderlich, Verena Tellström, Niels Gödecke, Oliver Räther                                             
Galactosylsphingosine and glycosylsphingosine are important components in muscle and nerve cell membranes. Both belong to 
the class of cerebrosides and consist of the same lipid residue with a different carbohydrate moiety: Galactose vs. Glucose. They 
are involved in several diseases.    Since they have the same elemental composition and differ only by the orientation of a hydroxyl 
group, they are structural isomers. They cannot be distinguished from each other in a mixture just by exact mass measurements. 
An HPLC separation is challenging as the structural difference is very small. Here we report on the use of high resolution ion mobility 
MS to unambiguously separate these two compounds.    Several adducts were investigated for their potential to separate these 
compounds with trapped ion mobility mass spectrometry. Ions generated from salts forming [M+H]+, [M+Na]+, [M+Li] were not 
useful for ion mobility separation. Interestingly, the silver adducts gave a clear difference in the 1/k0 values of the two analytes 
allowing baseline separation in a mixture. A high ion mobility resolution of &gt; 200 provided by the timsTOF could be achieved and 
is necessary for successful separation. A simulation of lower ion mobility resolutions of 60 or 100 showed that they would be not 
sufficient to resolve the two sphingosines in the mobility dimension from each other. Baseline separation requires a resolution of  
&gt;200 which was achieved for the silver adducts. Furthermore collision cross section (CCS) values were determined for the silver 
adduct ions as well as for all other ions.
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P-77 Influence of bioactive compounds of milk on intestinal cell cultures
PRESENTING AUTHOR: Julia Jensen-Kroll, Christian-Albrecht-University Kiel, Division Food Technology, Germany
CO-AUTHORS: Tobias Demetrowitsch, Ingrid Clawin-Rädecker, Martin Klempt, Silke Szymczak, Stephan Seifert, Karin Schwarz              
   Introduction:  Milk- and galacto-oligosaccharides (MOS/GOS) are natural compounds in mammalian milk. It is quite known that 
MOS/GOS have bio-functional properties like prebiotic, immune modulating, bifidogenic and anti-inflammatory effects, but the 
mechanism is unknown.  The aim of this study was to analyse the effects of MOS/GOS on the lipid- and metabolome of intestinal 
cells. In addition, specific metabolic patterns and corresponding pathways should be identified.   Material and Methods:  The 
experimental protocol was a cell treatment for 24 h with different compositions of MOS or GOS. The cell-cultivation followed a 
harvest by physical force and acidified water, cell disruption with ultrasonic on ice and finally a SIMPLEX extraction. SIMPLEX allows 
the simultaneous extraction of metabolites, proteins and lipids. The samples were analysed by shotgun ESI-FT-ICR-MS. Data 
validation was conducted by the quality control (QC) approach (Demetrowitsch et al., 2015) and were evaluated by non-targeted 
(supervised and non-supervised) and targeted approaches.  Results:  First results from the non-supervised approach provides 
a correlation between treatment and cell metabolome. The PCA-models showed tight clusters for each treatment. Significant 
regulations were found e.g. for the compounds 543.1334 [M+K] with the calculated formula C19H28N4O12 and 279.0391 [M+Na] 
with the calculated formula C11H12O5P. The targeted lipidomics approach showed significant effects between the treatments. Highly 
significant changes were analysed for e.g. phosphatidylinositol (42:3), phosphatidylcholine (22:4) and phosphoglyceride (28:5).   
P-78 Metabolic reaction network based metabolite annotation in untargeted metabolomics
PRESENTING AUTHOR: Xiaotao Shen, Chinese Academy of Sciences, China
CO-AUTHORS: Zheng-Jiang Zhu                                                  
In untargeted metabolomics, LC-MS has enabled the detection of thousands of metabolite peaks. However, the metabolite 
identification remains the major bottleneck. MS/MS spectrum matching is the most widely used method for metabolite annotation, 
but is largely limited by the number of available MS/MS spectra. Here, we developed a recursive annotation workflow which uses 
identified metabolites as seeds and integrates metabolic reaction network to annotate metabolites. Specifically, we first created an 
in-house library containing more than 800 metabolite standards with measured MS/MS spectra and retention time (RT). A metabolic 
reaction network containing 8,074 metabolites and 15,826 reaction pairs was constructed. For metabolites in the reaction network, a 
machine-learning based prediction model was developed to predict their theoretical RTs using 800 standards as the training dataset. 
Secondly, the detected metabolic peaks were matched to our in-house library for identification. Roughly 100-200 metabolites were 
identified in common biological samples. Thirdly, the identified metabolites are used as seeds to annotate other detected metabolic 
peaks without a match with our in-house library. Peaks are checked whether they are isotopes or adducts of seed metabolites. Then, 
metabolic peaks that have high intensity correlation and high structure similarity with seed metabolites are further annotated using 
the metabolic reaction network. Furthermore, the putative annotated metabolites are scored and cross-validated to determine a 
cutoff score. Finally, new annotated metabolites are used as new seeds for next round annotation. The whole dataset are annotated 
using this recursive workflow until all the peaks are annotated.   
P-79 Targeted and untargeted multivariate comparison of LCMS data from New Zealand propolis and its likely poplar sources
PRESENTING AUTHOR: Kevin Mitchell, Callaghan Innovation, New Zealand, New Zealand
CO-AUTHORS: Stephen Bloor, Rosemary Webby, Trevor Jones                                               
New Zealand propolis is known to be a poplar type propolis. Poplar trees are widely planted in the NZ rural environment for shelter 
and erosion control and many specialised hybrid varieties have been bred for this purpose and are unique to NZ. We are undertaking 
a study of the possible poplar sources in the New Zealand environment. For this comparative work, we carried out both untargeted 
data analysis using low resolution mass accuracy UPLC-MS data and a more targeted study of metabolites from a reduced sample 
set collected from a high mass accuracy UPLC-MS system.  Samples of NZ propolis were obtained from several NZ localities as well 
as several commercially produced products (pooled localities).  A range poplar leaf and bud extracts were collected from the various 
poplar cultivars under examination.  The targeted study was limited to compounds we could identify and a number of unidentified 
compounds commonly occurring in the dataset.  Raw data from both LCMS datasets were initially processed using MZMine to 
detect and integrate peaks eluting in each LCMS run, and to align chromatograms and generate grouped peak tables.  A range of 
multivariate techniques, including principal components analysis, multidimensional scaling, and neural networks etc., were applied to 
these two datasets (using R libraries) to try to identify which varieties(s) of poplar were most similar to raw propolis. The objective 
of this study is to assist plantsmen in planting bee friendly varieties of poplar and help apiary based industries to determine which 
poplar varieties produce the highest quality propolis.
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P-80 A metabolomics approach towards understanding the aetiology of Acute Bovine Liver Disease
PRESENTING AUTHOR: Elizabeth Read, DEDJTR, Australia
CO-AUTHORS: Mark Hawes, Grant Rawlin, Simone Rochfort                                               
Acute Bovine Liver Disease has been recognised for decades as a threat to cattle in the South East of Australia, mainly occurring 
in parts of Victoria and Tasmania. Its sporadic occurrence has hindered efforts to identify and control the cause even though it is 
associated with Rough dog’s tail (RDT), a grass that is usually found in ‘toxic’ paddocks as old, dry forage. Previous investigations into 
the toxicity of RDT have shown that it is non-toxic to cattle two months after the danger period for ABLD. Investigation into fungal 
species found on RDT at the time of harvesting has identified a species of Drechslera as a possible culprit. However, the toxin that 
causes ABLD and its origins are currently unconfirmed.   In order to identify a biochemical toxin fingerprint, and potentially identify 
the toxin, a metabolomics approach has been utilised to investigate the disease. Liver and urine samples have been collected from 
healthy cattle and cattle that have succumbed to the toxicity. Aqueous extracts were analysed using a Q Exactive mass spectrometer 
and a 700 MHz NMR. Initial statistical investigation showed sample clustering according to disease state. Potential biomarkers of 
disease have been found, many of which remain, as yet, chemically unidentified. Comparison with forage and fungal metabolomes 
will be discussed.  The identification of common features between the plant or fungal metabolomes with ABLD animals will allow the 
identification of exotic metabolites in the animal tissues. These common features may be candidate toxins and strategies towards 
compound identification will be discussed.
P-81 Data Independent Analysis: An appropriate tool for qualitative and quantitative metabolomics?
PRESENTING AUTHOR: Warwick Dunn, University of Birmingham, United Kingdom
CO-AUTHORS: Shan He, Ralf Weber, Thomas Lawson, Mark Viant, William Nash                                            
The structural annotation or identification of metabolites in untargeted metabolomics studies is a key process to derive biological 
knowledge. When applying UPLC-MS, chromatographic retention time/accurate mass /gas phase fragmentation data are collected to 
aid metabolite identification. The interrogation of full scan data to derive molecular formula is routinely applied [1]. The collection 
of MS/MS data to derive structural information is also applied. Data Dependent Analysis (DDA) is traditionally applied and provides 
high specificity but low coverage of metabolites with MS/MS data. Data Independent Analysis (DIA) sequentially acquires MS/MS 
data for all metabolites in multiple DIA m/z windows (typically of m/z width 25-50). This approach provides a reduced specificity but 
100% coverage of metabolites with MS/MS data. Deconvolution after data acquisition increases specificity [2]. DIA is not routinely 
applied in metabolomics.  We will describe a robust characterisation of DIA for metabolite identification and absolute quantification 
on Thermo Scientific Q Exactive instruments coupled to UPLC separations. We have assessed DIA window width, mass resolution 
and data processing software for different UPLC separations (HILIC, RP, lipidomics) and sample types (urine, plasma, mammalian 
tissue). We have shown that data is not as complex as expected which allows larger DIA windows and a higher mass resolution to be 
applied. We have also demonstrated how DIA improves the number of metabolite identifications in an untargeted study and how DIA 
can be applied for quantitation analysis.  [1] Brown, M., et al. Bioinformatics, 2011, 27(8), 1108-1112.  [2] Tsugawa, H., et al. Nature 
Methods, 2015, 2(6), 523-526.
P-82 METABOLIC REGULATORY VARIATIONS IN RATS DUE TO CHRONIC COLD STRESS: HIGH RESOLUTION 1H NMR APPROACH
PRESENTING AUTHOR: SONIA GANDHI, INSTITUTE OF NUCLEAR MEDICINE & ALLIED SCIENCES (INMAS), DRDO, India
CO-AUTHORS: SUNIL KOUNDAL, SUBASH KHUSHU                                                
Thermal conditions influence the development of living organism in a wide variety of ways triggering various adaptive responses. 
Evidence exist for the adverse effects of chronic cold stress on human health including rapid loss of homeostasis &amp; long term 
exposure might result in cardiovascular &amp; respiratory diseases like hypertension &amp; asthma, diseases relating to immune 
system, diarrhea. NMR spectroscopy in conjugation with statistical analysis such as Principal Component Analysis (PCA) can be 
successfully used as a non-invasive tool to identify biomarkers for an early biochemical changes induced due to cold exposure. 
Chronic cold exposure on rats at 4C for 14 days (8hrs each day) showed perturbations in endogenous metabolites such as as citrate, 
2-oxoglutrate, succinate, fumarate, Creatinine, creatine &amp; taurine in rat urine samples pre &amp; post exposure. These changes 
were indicative of altered energy metabolism, altered glomerular filtration rate or gut microbiota &amp; altered liver functioning. The 
present study indicates NMR based metabonomics in conjugation with statistical analysis serves as a powerful tool for non-invasive 
monitoring &amp; early predictive markers of various metabolic alterations in urine induced by prolonged cold stress. These studies 
in correlation with in vivo imaging,  biochemical parameters can form strong basis for mass screening &amp; developing strategies to 
combat cold stress.
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P-83 The study of plasma metabolite profile after administration of Harak Formula (HRF) in relation to platelet aggregation in individual healthy volunteer
PRESENTING AUTHOR: PATCHARAMON SEUBNOOCH, Mahidol University, Thailand
CO-AUTHORS: Weerawadee Chandranipapongse, Sirikul Chotewuttakorn, Titchaporn Palo, Kwanjeera Wanichthanarak, Sakda 
Khoomrung, Onusa Thamsermsang, Suksalin Booranasubkajorn, Tawee Laohapand, Pravit Akarasereenont                                      
Harak Formula (HRF) is a polyherbal formulation. It has been used in Thai traditional medicine as a remedy for fever. HRF is a 
combination of five dried roots powder of herbal plants with equal amounts. Phytochemicals probably consist of multiple active 
components that are responsible for pharmacological activities. Due to the lack of their pharmacokinetic data in human. Our study, 
therefore, applied a metabolomics-based mass spectrometry to profiling metabolites in HRF that affect platelet aggregation.  Five 
healthy volunteers (2 males and 3 females) which ages between 29-40 years were recruited into this study. All subjects have received 
a single dose of HRF at the maximum recommended dose per day (1,500 mg) according to the latest Thai National List of Herbal 
Medicinal products. Platelet aggregation was measured by aggregometer at pre-dose and 3, 6 and 24 hours after HRF administration. 
Although, variation in platelet aggregation was seen in some individuals with specific agonist.  The average percentage of platelet 
aggregation revealed no significant difference at any time points during the study. Identification of metabolic profile using LC-QTOF 
was performed in plasma at pre-dose, 0.5, 1, 1.5, 2, 3, 4, 6 and 24 hours after dose. Untargeted metabolomics revealed changes 
in metabolic profile during 1-3 hours after HRF administration. Interestingly, we suspected groups of phytochemicals that might be 
associated with alteration of platelet aggregation in the specific individual. Using integrative analysis, we found additional factors that 
affected platelet aggregation such as platelet status, sex, age and lipid profiles. 
P-84 Variation in composition of Red Brazilian Propolis: seasonality vs. location.
PRESENTING AUTHOR: Alexandra Sawaya, UNICAMP, Brazil
CO-AUTHORS: Begoña López                                                  
In tropical countries, bees collect resins for propolis throughout the year; therefore season variations in composition are to be 
expected. Red propolis from the northeast of Brazil comes from native forests near the beach and mangrove areas, and its 
composition may also be affected by the vegetation in the region where it was collected.  Studies comparing the composition of 
samples from different States (Alagoas, Paraíba, Espirito Santo and Bahia) and samples collected monthly over one year from Sergipe 
were compared by UHPLC-MS. Furthermore the concentrations of 9 components were quantified in all samples by a validated MRM 
method, by comparison to external calibration curves of isolated compounds or analytical standards. The results show a quantitative 
variation of these components throughout the year, and do not display a clear seasonal pattern, indicating that other factors (rain 
or drought) possibly affected the composition more than the time of year. The samples collected in other states of the northeast 
presented a similar qualitative composition, but with a wide variation in the concentration of individual components, even in samples 
collected within the same region.  Several factors interfere in the chemical composition of red propolis: region, climate, time of 
the year. In order to use red propolis for its nutraceutical properties, further studies to determine ranges of concentration of these 
compounds, should be undertaken.
P-85 NMR metabolomics of infected poultry treated with a Campylobacter jejuni N-glycan based vaccine
PRESENTING AUTHOR: Goncalo Gouveia, UGA-CCRC-EdisonLab, United States
CO-AUTHORS: Harald Nothaft, Arthur Edison, Christine Szymanski                                               
Poultry meat is considered to be the primary source of human Campylobacter jejuni infection, therefore there is strong interest in a 
cost-effective solution to reduce C. jejuni levels in poultry. Vaccination is a promising public health strategy. Oral administration of 
an attenuated Escherichia coli strain engineered to express the antigenic Campylobacter jejuni N-glycan on its surface was shown to 
reduce C. jejuni colonization in leghorn and broiler chickens and thus has a great potential to prevent pathogen entry into the food 
chain. However, the birds demonstrated a bimodal response to this vaccination as well as differences in their respective microbiota. 
In addition, broilers vaccinated with or without Anaerosporobacter mobilis, a novel probiotic, and with or without Lactobacillus 
reuteri, a commonly used probiotic, demonstrated that probiotic addition results in increased vaccine efficacy, vaccine compound-
induced immune responses, and weight gain. Here we describe an untargeted NMR-based metabolomics approach to complement 
and further expand on these findings. Cecal samples from five experimental groups 1) negative control, 2) infected but no vaccine 
control, 3) vaccine, 4) vaccine + L. reuteri and 5)  vaccine + A. mobilis  were analyzed by 1D 1H NMR. We identified NMR features 
correlated with C. jejuni infection that do not have clear database matches. We are applying 2D NMR, HPLC-SPE and MS to identify 
these features and further investigating the cecal metabolome for additional metabolites that significantly differ across experimental 
groups and between vaccine responders and non-responders.
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P-86 Citrus volatile and non-volatile cues as putative kairomones for Diaphorina citri
PRESENTING AUTHOR: Carmen Rossini, Facultad de Química, Universidad de la Republica, Uruguay
CO-AUTHORS: Anna Burgueño, María Amorós, Virginia Pereira Das Neves, José Buenahora, Andrés López, Guillermo Moyna              
Huanglongbing, the most destructive citrus disease worldwide, is dispersed by the Asian citrus psyllid (ACP), Diaphorina citri. During 
host plant search, ACP integrates information from shoots including visual and odor cues.  To characterize oviposition preferences  of 
ACP a greenhouse experiment using 6 citrus species was carried out. Results showed that ACP exhibits a preference for 3 species. 
Elemental analyses on shoots from the 6 species showed no significant diferences correlated to the oviposition preference. Therefore 
we have searched for markers that may point to putatitve kairomones in the volatile organic compounds (VOC) and the leaf waxes 
(LW) by GCMS and in CDCl3 and D2O extracts by NMR.   GCMS data from VOC were conventionally analyzed, and GCMS from 
LW were analyzed using MZmine2.10, defining parameters for mass detection, chromatogram building and peak deconvolution. 
Normalized chromatograms were then aligned, generating a matrix of 646x15. NMR data were processed with MestReNova 11.0 
(0.04 binning; 11-0 ppm) generating matrices of 260x12 and 247x12 for CDCl3 and D2O extracts respectively. All data sets were 
then subjected to multivariate analyses (PCA, PLS , OPLS). In the case of CDCl3 extracts, the chemical profiles of the preferred 
citrus species were more similar among them that the ones not-preferred, pointing to non-polar compounds as possible cues for 
ACP. The analyses on VOC also grouped preferred species together. This grouping could be traced to the presence of methyl-N-
methylanthranilate. Our results suggest that a combination of long-range and contact cues could be correlated with the observed 
ACP oviposition preference.
P-87 1D and 2D NMR approaches to covering the metabolome of soybean upon abiotic stress
PRESENTING AUTHOR: Isabel Coutinho, Embrapa Instrumentação, Brazil
CO-AUTHORS: Liliane Henning, Alexandre Nepomuceno, Christian Richter, Harald Schwalbe, Luiz Colnago                                            
In this work, we explored the feasibility of 1D and 2D NMR spectroscopy to identify metabolic changes in soybean leaves and roots 
subjected to water-deficient and waterlogging conditions. The putative metabolite annotation using 1H 1D and 2D NMR spectroscopy 
led to identification of 33 primary metabolites and 13 secondary metabolites in soybean leaf and root. Multivariate analysis of the 
1H NMR data from control and waterlogging soybean leaves and roots extract revealed two cluster according to primary metabolites 
alanine, citric acid, malic acid, succinic acid, GABA and secondary metabolites. Tolerant genotype does not accumulated higher 
concentration of alanine and TCA metabolites in roots under flooding conditions when compared to sensitive ones. The sensitive 
genotype accumulated more kaempferol and cafeoyl derivatives than tolerant genotype. In addition, 1D PSYCHE* and 2D NMR 
experiments were performed to improve resolution and accurate metabolite annotation. The utility of 1D PSYCHE is demonstrated in 
a study of involving comparative metabolomics of soy genotypes tolerant and sensitive to water deficit. *Foroozandeh, M., Adams, R. 
W., Meharry, N. J., Jeannerat, D., Nilsson, M., Morris, G. A. Ultrahigh-Resolution NMR Spectroscopy. Angew. Chem. Int. Ed., 53, 6990-
6992, 2014.
P-88 The Challenges of Identification - What ‘Identifies’ a Compound
PRESENTING AUTHOR: Tim Stratton, Thermo Fisher Scientific, United States
CO-AUTHORS: Robert Mistrik                                                  
The identification of compounds detected in biological sample analysis is one of the single largest challenges in metabolomics.  The 
confident identification of both previously known compounds or the elucidation of relatively or completely unknown compounds 
requires sufficient information about the compound of interest to provide a robust confidence in the assigned identification.  Several 
excellent publications have proposed structures to build scoring systems to specify differing and increasing levels of confidence or 
support for an identification.  In the context of these, we will discuss the various degrees of information that mass spectrometry 
alone can provide and the relative ‘value’ of the identifications that can be assigned based on this data.  Semi-targeted techniques, 
to confirm the identification of previously identified compounds, will be differentiated from ‘true unknown’ approaches.  In addition, 
consideration will be paid both to the ability to determine elemental composition and utilize this for various database lookup 
approaches as well as fragmentation spectral based identification through spectral matching or substructure identification.  In our 
presentation, special attention will be paid to spectral library techniques – both for the identification of previously known compounds 
through either MS/MS or MSn means, and the capability of identifying previously unknown compounds through substructure 
identification utilizing information from previously known compounds.
Building Bridges: Natural Products / Metabolite Identification
13th Annual Conference of the Metabolomics Society
Page 54
P-89 QUINOLIZIDINE-TARGETED ANALYSIS OF FABACEOUS INVASIVE PLANTS FROM WILD AND PROPAGATED ACCESSIONS
PRESENTING AUTHOR: Ericsson Coy-Barrera, MU Nueva Granada, Colombia
CO-AUTHORS: Willy Cely-Veloza, Ana Romero-Rincón                                                
Fabaceae family is a big group of flowering plants. Several of them have been introduced in various countries for diverse purposes 
but some become a problem because of biological invasions. In Colombia, two Fabaceous species were introduced from Europe 
for ornamental uses such as Ulex Europeaus and Genista monspessulana, and they have progressively dominated some native 
environments as well as altering many aspects of ecosystem functioning. Other invasive-behaved Fabaceae ones are native such as 
some Lupinus species. For invasion success, this kind of plants can produce bioactive secondary metabolites such as quinolizidine-
related compounds. Thus, as part of our research on chemoprospecting of invasive plants, several plant accessions (n&gt;60) of 
U. europeaus, L. bogotensis and G. monspessulana, from different invaded places in Bogotá plateu, were separately investigated 
through a comprehensive targeted GC-MS-based metabolomics approach from alkaloid-enriched extracts in order to observe the 
quinolizidine-based chemical variability between samples (ontogeny and environmental factors) and its implication on antifungal 
activity against F. oxysporum.  MS-mediated annotation showed the occurrence of different sparteine and lupanine-like tetracyclic 
quinolizidines. Phytomaterials also showed antifungal capacity at different levels (2&gt;IC50(µg/mL)&gt;55). OPLS-DA-derived score 
plots indicated several differences between samples but clustered according characteristic chemical constituents and/or activity. 
Supervised analysis indicated the existence of three quinolizidine-related compounds to be responsible of the antifungal activity. The 
present targeted metabolomics exploration of these invasive plants is an excellent approach for quinolizidine-based antifungal finding 
from nature as well as ontogeny and environmental indicators (Present work was financed by UMNG through Project IMP-CIAS-2293 
- Validity 2017).
P-90 Automation of sample preparation for metabolomic analysis using robotic platform
PRESENTING AUTHOR: Hans-Joachim Huebschmann, CTC Analytics, Japan
CO-AUTHORS: Yuki Soma, Toshiyuki Yamashita, Masatomo Takahashi, Kosuke Hata, Takatomo Kawamukai, Teruhisa Shiota, Kayoko 
Yamada, Kuniyo Sugitate, Takeshi Serino, Hiromi Miyagawa, Kenichi Suzuki, Yoshihiro Izumi, Takeshi Bamba                                
Metabolomic analysis is prone to variation and errors due to manual processing at different states of sample preparation (e.g. 
extraction, purification, derivatization). Reproducible sample preparation is vital for ensuring comparable and reliable results for large 
sample series. It is important to develop methods for labor and time-saving sample preparation. We developed an automated sample 
preparation method using robotic platforms, which represent a modified Bligh and Dyer method producing samples for hydrophilic 
metabolomics by GC-MS and lipidomics by SFC-MS simultaneously. The first step of modified Bligh and Dyer method, the addition 
of 1 mL cold methanol:chloroform:water solution and internal standards for both GC-MS and SFC-MS analysis, was performed 
manually. Subsequent procedures were performed by the automated protocol using a PAL RTC System. Aqueous layer and organic 
layer were collected in clean glass vials after the automated Bligh and Dyer method. The glass vials containing the aqueous layers 
were transferred to a centrifugal vacuum concentrator for drying samples manually. Then, vials were transferred to another PAL RTC 
system for the automated just-in-time derivatization and injection system for GC-MS analysis. The vials containing organic layers 
were transferred to the SFC-MS autosampler and subjected to target lipidomic analysis. The precision of the relative peak area for 
each determined compound in the result of lipidomic and metabolomic analysis using the  automated protocol was equivalent to that 
of the manual protocol by a skilled technician. The automated protocol facilitates the overnight extraction procedure and compound 
derivatization followed by on-line GC-MS analysis, resulting in significant labor-saving.
P-91 Database on Flavonoid in Korean Foods
PRESENTING AUTHOR: Hwan-hee Jang, Functional Food & Nutrition Division, National Institute of Agricultural Science, Rural 
Development Administration, South Korea
CO-AUTHORS: Heon-Woong Kim, yu-jin Hwang, Jeong Sook Choi, Jung-bong Kim                                             
Flavonoids have received attention as functional ingredients because of their beneficial effects in the prevention of human diseases 
such as cancer and cardiovascular diseases. The health benefit of flavonoids is directly related to the daily dietary intake of 
antioxidants, it is important to evaluate flavonoid sources in food and to have overall information. Therefore, we have developed a 
comprehensive database on the nature and content of flavonoids contained in the main foods consumed by the diet. In total, 268 
kinds of Agro-food samples were used for this database including cruciferous vegetables, and citrus such as grapefruits. Also, even 
though cereal crops, mushrooms and root and tuber crops such as potatoes rarely include flavonoids, 1~2 chromatograms are 
contained for each type. It included 3,205 quantitative values on a real standard substances basis and there are library containing 
1,683 flavonoids, of which 846 were directly identified and quantitated. The analysis results contained in this database were obtained 
using UPLC-DAD/QTOF-MS combined with HPLC and mass spectroscopy. For quantitative analysis, HPLC peak areas were calculated 
using two types of specification internal standard materials. Isoflavone quantitation using fluorescein was measured at a wavelength 
of 254 nm, and flavonol, flavanol and chalcone were measured at a 280 nm using galangin, and flavonol and flavone were measured 
at 350 nm. This flavonoid database can be used as the basic data for the study and application of functional food ingredients to 
contribute to food industry development, understanding of metabolic pathways, and discovery of biological activity.
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P-93 Detection and identification of opines in abalone adductor muscle: Theory meets practice
PRESENTING AUTHOR: Jeremie Lindeque, Human Metabolomics, North-West University (Potchefstroom Campus), South Africa
CO-AUTHORS: Leonie Venter, Peet Jansen van Rensburg, Du Toit Loots, Andre Vosloo                                             
Some marine invertebrates (like abalone) have the unique ability to produce opines as a means to prevent NADH accumulation 
during anaerobic conditions. Opines are produced by joining pyruvate with various amino acids at the expense of NADH. Despite 
all the information regarding this process and the presence of opines in abalone, identification of these compounds are complicated 
due to the lack of available standards and the fact that no opine MS/MS spectra and retention time information is available. In this 
study, we employed several techniques to obtain selective detection and confident identification of these compounds in abalone 
muscle. Metabolites were extracted from abalone adductor muscle, derivatised with butanolic hydrogen chloride and analysed using 
untargeted liquid chromatography quadrupole time-of flight-mass spectrometry. The theoretical masses, formulae and fragment 
patterns of butylated opines were used to detect and identify these compounds in abalone muscle. To achieve the highest level of 
confidence with our identification, we validated the predicted identities with in-house synthesised opine standards. We conclusively 
detected and identified the presence of alanopine, lysopine, strombine and tauropine as anaerobic end-products, produced following 
exposure to environmental hypoxia, in the adductor muscle of abalone.
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P-288 Investigating MSMS coverage of a wheat profiling LC-MS data set using data dependant MSMS (ddMS2) and all ion fragmentation (AIF) strategies.
PRESENTING AUTHOR: Catherine Rawlinson, Curtin University, Australia
CO-AUTHORS: Caroline Moffat, Pao Theen See, Richard Oliver
Metabolite identification has long been a bottle-neck for metabolomics analyses. Unless comparing against an internal MS library, 
putative identification of metabolites can be difficult using mass of precursor ions in LC-MS acquisitions. As instrument capabilities 
improve, more features are being detected and mass spectral data for each feature is increasing. All ion fragmentation (AIF) and 
data dependant mass spectrometry (ddMS2) are two techniques for acquiring untargeted MSMS information using the Thermo 
Q-Exactive Orbitrap. AIF is a full scan MSMS technique, in which all molecules ionised in the source are further ionised in the C-trap, 
as opposed to ddMS2 whereby MSMS events of individual ions are triggered according to method criteria. Here, we examine the 
number and quality of MSMS features acquired using ddMS2 and AIF on pooled samples to investigate the coverage of features 
generated on a full scan only sample set. Eleven wheat varieties were profiled using full scan MS on a C18 column in positive ion 
mode. Three to four varieties were pooled to create three extracts that were analysed using identical LC and MS parameters as per 
the analytical samples, with the exception of ddMS2 and AIF specific parameters collected with a collision energy (CE) of 20eV. Both 
strategies supply analysts with spectral information previously only acquired by prior knowledge of analytes of interest. ddMS2 does 
not provide complete MSMS coverage, typically triggering on the most abundant precursor ions, whereas AIF can potentially supply a 
greater depth of information but at a potential issue to spectral purity.
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O-139 Differential multi-fluid network sheds light on metabolic processes altered in end-stage renal disease
PRESENTING AUTHOR: Jonas Zierer, Helmholtz Zentrum München/King’s College London, United Kingdom
CO-AUTHORS: Kieu Trinh Do, Maik Pietzner, Clara Barrios, Thomas Kocher, Karlhans Endlich, Tim Spector, Cristina Menni, Nele 
Friedrich, Jan Krumsiek, Gabi Kastenmüller                                    
Chronic kidney disease (CKD) is an increasing public health problem, affecting 14% of the Western populations. Here, we aimed 
to identify metabolic processes that account for the widespread metabolic shift commonly observed in renal disease.  Metabolomic 
profiling was conducted on a non-targeted mass spectrometry-based platform for plasma, urine, and saliva samples collected at the 
same visit from 72 CKD patients (GANI_MED cohort) and 906 population controls (SHIP_TREND). After preprocessing and imputation 
of missing values, metabolite levels were corrected for age, sex, and BMI. Gaussian Graphical Models (GGMs) were inferred from the 
measured data to model metabolic processes within and between fluids in cases and controls separately. Differences between the 
two models were assessed by permutation testing. The multi-fluid GGMs consisted of 882 metabolites, connected by 4404 and 2509 
edges for cases and controls, respectively. 86 edges were significantly different between the models, after correction for multiple 
testing, mainly highlighting two metabolic processes: (i) xanthine catabolism, suggesting a lack of detoxification and excretion of 
xenobiotics probably due to alterations of renal filtration; (ii) steroid metabolism, which can cause complications of CKD, including 
cardiovascular disease, due to its effect on hydro-electrolyte and glycaemic control, hypertension, and the immune system.  This is 
the first study on renal disease integrating metabolomics data from three different fluids. Modelling metabolic processes across fluids 
using GGMs allowed to focus on disturbed metabolic processes rather than differences in metabolite levels between patients and 
controls. By highlighting key processes, our results illustrate the power of integrative, multivariate data analysis.
O-171 Laboratory Evolution Reveals Proximal and Distal Causation to Gene Loss
PRESENTING AUTHOR: Douglas McCloskey, Center for Biosustainability, Denmark Technical University, Denmark
CO-AUTHORS: Sibei Xu, Troy Sandberg, Elizabeth Brunk, Ying Hefner, Richard Szubin, Adam Feist, Bernhard Palsson                                         
Biology is characterized by dual causation. The immediate response (i.e., proximal causation) to genetic perturbation is studied by 
measuring an organism’s phenotypic response to a gene knockout (KO).  The adaptive response (i.e., distal causation) is studied 
by measuring changes in an organism’s physiology that are required to overcome gene loss through evolution.  The latter has been 
poorly characterized.  In this study, using Escherichia coli as a model, a novel experimental design, analytics, and bioinformatics 
revealed mechanisms and principles of how biological systems respond and adapt to gene KO.  First, the proximal response to 
gene KO was sub-optimal, requiring adaptive evolution to re-optimize function, during which the majority of measured cellular 
components returned to levels of the reference strain.  Second, the molecular phenotype of 24 parallel-evolved endpoints had unique 
and quantifiable differences that were attributable to acquired mutations.  Third, re-optimization during adaptation reflected the 
coordinated interaction of many layers of cellular function: the initial drivers behind these changes were metabolites that proximally 
affected gene expression, which were then distally adjusted through mutation.  KO-specific case studies presented suggest that dual 
causation assessment gives deep insights into the role of a gene product in organism function and survival.
O-178 Intergenerational changes in faecal microbiome and metabolome in a C57BL/6J mouse colony
PRESENTING AUTHOR: Marten Snel, South Australian Health and Medical Research Institute, Australia
CO-AUTHORS: Jocelyn Choo, Paul Trim, Lex Leong, Guy Abell, Carly Brune, Nicole Jeffries, Steve Wesselingh, Neil Dear, Geraint 
Rogers                                      
The gut microbiome plays an important role in health and wellbeing.  It affects the immune system, metabolism, etc.  It is therefore 
important to define its variability in a widely used animal model, the mouse.  The follow-on question is: if there are variations, 
do these affect the associated faecal metabolome? We investigated two different scenarios.  Firstly, a comparison of the faecal 
microbiome and metabolome of the same strain of inbred mouse populations (C57BL/6J) that were housed in two different animal 
facilities with different husbandry conditions, including housing and diet.  This mimics the typical situation faced by scientists 
replicating an experiment from the literature.  We observed significant metabolomic and microbiomic differences between the two 
colonies. Secondly, the gut microbiota is strongly influenced maternally through vertical transmission, and the progressive loss or gain 
of taxa due to alterations in environmental factors could lead to gut microbiota divergence in subsequent generations.  This potential 
generational change was studied by looking at how the microbiome and metabolome of a C57BL/6J mouse colony changed over six 
generations under identical husbandry conditions.  In this study marked divergence in both metabolome and microbiome between 
the first (founder) generation and the second generation was observed.  Interestingly, this shift, though attenuated, continued over 
the full six generations of this experiment.  It is important to note that the magnitude of changes in the faecal metabolome closely 
follow the gut microbiota variations, therefore indicating potential metabolic consequences that should be investigated following gut 
microbiota alterations.
Building Bridges: Systems Biology / Metabolic Modelling
13th Annual Conference of the Metabolomics Society
Page 58
O-282 What is the relationship between intracellular and extracellular metabolites?
PRESENTING AUTHOR: Silas Villas-Boas, University of Auckland, New Zealand
CO-AUTHORS: Farhana Pinu, Ninna Granucci, James Daniell, Jens Nielsen, Sonia Carneiro, Isabel Rocha, Ting-Li Han                                         
Microbial cells secrete many metabolites during growth, which are important intermediates of the central carbon metabolism. This 
fact has not been sufficiently taken into account by researchers when modelling the metabolism of microorganisms for metabolic 
engineering and systems biology studies. A lot is known about how microorganisms uptake metabolites, but our knowledge on how 
and why they secrete different intracellular metabolites is poor. The secretion of metabolites by microbial cells has traditionally been 
regarded as a consequence of intracellular metabolic overflow. However, we provide evidence based on time-series metabolomic 
experiments that microbial cells eliminate some metabolites in response to an environmental cue independent of metabolic overflow. 
Moreover, we provide insight on how this knowledge can benefit metabolic modelling and engineering.
O-304 Combining text mining and metabolic network algorithms to complement and interpret metabolic profiles
PRESENTING AUTHOR: Fabien Jourdan, INRA-MetaboHub, France
CO-AUTHORS: Clément Frainay, Sandrine Aros, Nicolas Weiss, Benoit Colsch, Frédéric Sedel, Dominique Thabut, Christophe Junot      
List of discriminating identified metabolites (according to the studied disease between two groups), known as “metabolic profiles”, 
are the observable outcomes of metabolic modulations. Those lists of identified compounds are of great value to better understand 
the underlying biochemical shifts induced during a disease. Nevertheless, those lists are incomplete mainly due to the nature 
of LC/MS and the ability to identify compounds. Moreover, the analysis of human biofluids only represents the modulations of 
metabolites exchanged between the tissue and its environment, overshadowing potential metabolites of interest which are involved 
in intracellular metabolic processes and not released nor uptaken by the tissue/cell. We propose an approach combining metabolic 
networks and medical text mining to propose metabolites which may expand the biological interpretation by “filling the gaps” of  
metabolic profiles. The network strategy is inspired from social network recommendation engines such as the ones used by twitter 
or media broadcasters. It allows finding upstream and downstream metabolites biochemically related to the ones in the profile. The 
text mining approach consists in automatically mining the literature to retrieve metabolites that are significantly associated with the 
perturbation under study. The approach had been successfully applied to high resolution LC/MS metabolomics data obtained on 
Cerebrospinal fluid (CSF) of patients affected by hepatic encephalopathy. The proposed methodology combined with interactions with 
analysts allowed increasing the metabolic profile size by 40%. Some of the metabolites suggested by our recommendation system 
were confirmed using standards. Other propositions were confirmed as metabolites of interests when analyzing patient clinical data.
O-315 A Systems Biology Approach to the Understanding of Asthma Severity through the Integration of Metabolomic, Transcriptomic and Epigenetic networks
PRESENTING AUTHOR: Rachel Kelly, Brigham and Women’s Hospital Harvard Medical School, United States
CO-AUTHORS: Bo Chawes, Yamini Virkud, Kevin Blighe, Juan Celedon, Scott Weiss, Jessica Lasky-Su                                          
Background: Asthma emerges from a complex interplay between genetics and environmental exposures; consequently integrative 
omics analysis may provide important insights into underlying biology.   Methods: 328 children with asthma from the ‘Genetic 
Epidemiology of Asthma in Costa Rica’ study underwent metabolomic, transcriptomic and epigenetic profiling in blood. Weighted gene 
co-expression network analysis (WGCNA) in each dataset was used to independently identify modules of co-regulated metabolites, 
gene-probes and gene-associated cpg-sites. Modules significantly associated with metrics of asthma severity were identified and their 
biology explored.  Significantly correlated metabolite-gene and gene-gene module pairs were identified and the constituent features 
submitted for integrated pathway analysis using IMPaLA.   Results: WGCNA identified eight metabolomic modules, eight gene-probe 
transcriptomic modules and ten cpg-site epigenetic modules. Six metabolomic, four transcriptomic and three epigenetic modules 
associated (p&lt;0.05) with asthma severity based on eigenvalue. The modules were enriched for asthma relevant processes, and 
between -omic module associations were identified. In particular a ‘sphingolipid metabolism’ metabolite module associated with a 
transcriptomic (p=0.05) and epigenetic (p=0.01) module both of which were enriched for immune processes and included ORMDL3; 
a sphingolipid biosynthesis regulator and validated asthma gene.   Conclusions: This study demonstrates that integrating multiple 
omic technologies in a systems biology approach provides a more informative and biologically meaningful picture of asthma severity. 
Integration of correlated omic modules expanded and refined the single omic findings, linking dysregulated immunity to asthma 
severity via ORMDL3 and sphingolipid metabolism. Therefore metabolomics can provide a mechanistic basis for the role of a number 
of asthma genes.
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O-328 Dynamic flux modelling of adipocytes stimulated by insulin using 13C-labelled metabolites
PRESENTING AUTHOR: Lake-Ee Quek, School of Mathematics and Statistics, The University of Sydney, Australia
CO-AUTHORS: Satoshi Ohno, James Krycer, Katsuyuki Yugi, Akiyoshi Hirayama, Tomoyoshi Soga, Shinya Kuroda, David James              
Humans are exceptional at storing and expending calories, and central to this switch is adipocytes responding appropriately to 
insulin. 3T3-L1 adipocytes were fed with 13C-labelled glucose, and six metabolites samples were taken across the hour as they 
transition from basal to insulin-stimulated state.  We used B-splines and flux modelling to transform the time profiles of central 
carbon metabolite abundances and 13C enrichments into flux-concentration models. The models were then interrogated by yield and 
kinetic analyses to extract key metabolic events and underlying allosteric interactions. Upon insulin stimulation, adipocytes increased 
conversion of glucose to lactate in an overflow manner, as well as increased flux through the non-oxidative pentose-phosphate 
pathway and pyruvate carboxylase.  The latter demonstrated that insulin increased the reliance on malic enzymes to generate 
NADPH. Overall, this framework leverages the use of metabolic networks to decipher non-intuitive but highly correlated metabolite 
abundance and 13C enrichment data. This work contributes toward characterising metabolic signatures of insulin resistance in 
adipocytes, using the metabolome as an integrative readout of insulin-dependent acute metabolic responses.
O-333 A novel systemic approach to patient stratification
PRESENTING AUTHOR: Maike Aurich, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg
CO-AUTHORS: Enrico Glaab, Ronan Fleming, Ines Thiele                                               
Human diseases involve alternations of the metabolic network. Hence, there is great interest in the identification of metabolites as 
prodromal, diagnostic, or progression biomarkers. However, the search for these markers proofs to be difficult, potentially because of 
the clinical heterogeneity among patients. As part of the National centre for Excellence in Research on Parkinson’s Disease (NCER-
PD) we aim to identify novel biomarker signatures for Parkinson’s disease. Clinical heterogeneity in onset, progression, and disease 
pathology among genetic and idiopathic Parkinson’s disease patients suggests the existence of disease subtypes, who could benefit 
from more targeted disease management. Within the NCER-PD project, we apply a novel systemic approach to stratify patients and 
computationally predict markers for the disease. We take into consideration targeted serum metabolomics of patients and controls, 
the network structure of the human metabolic model, and machine learning techniques. The context of the metabolic model, which is 
based on biological literature knowledge, can highlight functional relationships between altered metabolite levels that could not have 
been identified from the data alone. We investigate the emerging functional relationships to gain insights into the mechanistic basis 
of altered metabolite levels and to identify markers to improve the diagnosis of Parkinson’s disease. Taken together, we present a 
systems approach for the analysis of metabolomic data.  
O-347 An Integrative omics approach to disentangling the relationship between prenatal vitamin D exposure, 17q21 genetic variants, sphingolipid metabolism, and the development of asthma.
PRESENTING AUTHOR: Jessica Lasky-Su, Brigham and Women’s Hospital and Harvard Medical School, United States
CO-AUTHORS: Rachel Kelly, Bo Chawes, Hans Bisgaard, Augusto Litonjua, Yamini Virkud, Scott Weiss                                          
  Background: Prenatal vitamin D supplementation holds the promise for primary prevention of childhood asthma, but may have 
markedly different preventive efficacy dependent on individual genetic make-up and the primary metabolic pathways through 
which it acts is unknown.  Objective: We utilize metabolomics to disentangle the relationship between two asthma risk factors: 1)
prenatal vitamin D supplementation and 2)asthma risk variant(17q21). Methods: Children were genotyped for the functional 17q21 
SNP rs12936231 in the VDAART(N=806) and COPSAC2010(N=581) prenatal vitamin D trials.  A total of 245 plasma VDAART 
samples were used to generate metabolomics data. We  1) evaluated the effect of vitamin D on rs12936231 in relation to asthma; 
2) identified common metabolites and pathways between vitamin D and asthma; 3) determind what metabolites were causally 
associated with vitamin D, asthma, and rs12936231; and 4) replicated these findings using an independent sample. Results: We 
identified an increasing protective effect of vitamin D by decreasing number of 17q21 risk alleles(p=0.066). We subsequently 
identified 11 metabolites associated with vitamin D and asthma(p&lt;0.05), where sphingomyelin was identified as a significant 
mediator of the vitamin D induced reduced risk of asthma(p=0.04) and replicated this finding(p&lt;0.05). We then determined that 
sphingomyelin peak intensity was inversly correlated to the number of 17q21 risk alleles. Conclusions:This study shows that prenatal 
vitamin D supplementation reduces the risk of childhood asthma through alterations of the sphingolipid metabolism dependent on 
17q21 genetic variants, which provides novel mechanistic insight into the pathogenesis of this common childhood disorder and may 
pave the path for precision prevention.
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O-387 Enhancing tetanus toxin production through fermentation maps
PRESENTING AUTHOR: Esteban Marcellin, The University of Queensland, Australia
CO-AUTHORS: Camila Orellana, Nicolas Zaragoza, Cuauhtemoc Licona-Cassani, Glenn Moonen, George Moutafis, Mark Hodson, 
John Power, Lars Nielsen                                       
Bacteria produce some of the most potent biomolecules known, of which many cause serious diseases such as tetanus. For 
prevention, billions of people and countless animals are immunised with the highly effective vaccine, industrially produced by large-
scale fermentation. However, toxin production is often hampered by low yields and batch-to-batch variability. Improved productivity 
has been constrained by a lack of understanding of the molecular mechanisms controlling toxin production. Here we have developed 
a reproducible experimental framework for screening phenotypic determinants in Clostridium tetani under a process that mimics an 
industrial setting. We show that amino acid depletion induces production of the tetanus toxin. Using time-course transcriptomics 
and extracellular metabolomics to generate a ‘fermentation atlas’ that ascribe growth behaviour, nutrient consumption and gene 
expression to the fermentation phases, we found a subset of preferred amino acids. Exponential growth is characterised by the 
consumption of those amino acids followed by a slower exponential growth phase where peptides are consumed, and toxin is 
produced. The results aim at assisting in fermentation medium design towards the improvement of vaccine production yields and 
reproducibility. In conclusion, our work not only provides deep fermentation dynamics but represents the foundation for bioprocess 
design based on C. tetani physiological behaviour under industrial settings.
O-388 Integrative Omics Approach Reveals Coordinate Regulation of Metabolites Glycosylation and Stress Hormones Biosynthesis by TT8 in Arabidopsis
PRESENTING AUTHOR: Shivshankar Umashankar, National University of Singapore, Singapore
CO-AUTHORS: Amit Rai, Megha Rai, Boon Kiat Lim, Johanan Aow Shao Bing, Sanjay Swarup                                            
Plants defend themselves against various stresses by coordinating response through phytohormones and defense-related secondary 
metabolites. Glycosylation is one of the major processes that generates structurally and functionally diverse metabolites associated 
with stress response. Glycosylation involves conjugation of core structures with chemical moieties, such as sugars. While the 
enzymes involved in glycosylation are known, there are large gaps in understanding the regulation of metabolites glycosylation 
and its coordination with defense response. To identify gene and metabolite components of the glycosylation machinery, we 
integrated genomic relationships and gene expression outcomes with metabolomics to characterize TRANSPARENT TESTA 8 (TT8), 
a transcription factor previously shown to affect flavonoid glycosides. Metabolomics analysis of TT8 loss-of-function and inducible 
overexpression lines showed that TT8 coordinates glycosylation of nucleotides in addition to flavonoids, thus revealing its key 
role in regulating activated sugars. Both transcriptome and promoter network analysis revealed that TT8 regulome includes sugar 
transporters, sugar binding and sequestration proteins, carbohydrate active enzymes and stress response genes. We show that TT8 
directly binds to the promoters of key genes in brassinosteroid and jasmonic acid biosynthesis, thus regulating the hormone levels. 
This combined effect on metabolites glycosylation and stress hormones by TT8 induced overexpression improved germination rates 
of plants under multiple abiotic and biotic stresses by nearly 30%. Conversely, loss of TT8 lead to increased sensitivity to these 
stresses. This study provides direct evidence to show that two strategies in plant defense, namely, generation of metabolite diversity 
and hormone-mediated reprogramming of stress pathways are coordinately regulated by TT8.
O-395 Towards dynamic, genome-scale modeling that captures metabolite levels and regulation
PRESENTING AUTHOR: Mark Styczynski, Georgia Institute of Technology, United States
CO-AUTHORS: Robert Dromms                                                  
In theory, metabolomics data should be ideal for use in driving genome-scale metabolic modeling, yet to date it is underutilized.  
Many of the existing modeling tools make assumptions (e.g., that metabolite levels remain at steady state) that preclude direct 
integration of metabolomics data into the underlying models and that are often not even reasonable. Nonetheless, some of these 
assumptions and approaches yield attractive computational properties. Retaining these properties while allowing integration of 
metabolomics data could allow us to drastically improve the predictions of the many analysis tools that use genome-scale metabolic 
modeling.   We have designed, implemented, and characterized a modeling strategy based on a truly dynamic flux balance analysis 
(DFBA) approach to achieve these goals. This modeling strategy adds constraints describing the dynamics and regulation of 
metabolism, while (unlike existing approaches) retaining the linear programming structure of FBA. We have evaluated the strategy 
using a simplified small-scale model to characterize some basic features of its performance, and with a model of E. coli central carbon 
metabolism to demonstrate the strategy in a physiologically relevant system. We found that our modeling strategy is more robust 
to having higher noise and fewer samples (exactly the kind of data one would expect from metabolomics experiments) compared to 
models based on differential equations. The larger E. coli model presented challenges for fitting model parameters; we developed 
several methods to address this scale-up problem. Our approach represents a promising advance for applications from metabolic 
engineering to comparative evolutionary analysis.
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O-458 Deciphering the metabolic responses to polymyxin killing in Acinetobacter baumannii ATCC 19606 by developing a high-quality genome-scale metabolic model
PRESENTING AUTHOR: Yan Zhu, Monash Biomedicine Discovery Institute, Department of Microbiology, Faculty of Medicine, 
Nursing & Health Sciences, Monash University, Australia
CO-AUTHORS: Jinxin Zhao, Tony Velkov, Jiangning Song, Falk Schreiber, Jian Li                                            
Acinetobacter baumannii has been recently ranked as No. 1 on the List of Antibiotic-resistant Priority Pathogens by the World Health 
Organization (WHO). Polymyxins have revived as the last-line therapy against multidrug-resistant A. baumannii. Alarmingly, an 
increasing number of outbreaks have been reported due to the emergence of polymyxin resistance, which urges the systematic 
investigation of the mechanisms of polymyxin killing and resistance at network level. To address this, we developed a high-quality 
genome-scale metabolic model (GSMM), designated as iATCC19606, for A. baumannii ATCC 19606 based on the literature and 
genome annotation. Flux balance analysis was employed to predict the growth and metabolic phenotypes with iATCC19606 under 
various nutrient conditions. In silico single-gene deletion was performed to predict gene essentiality. The final model contains 773 
genes, 1,190 reactions and 1,131 metabolites, representing the most comprehensive reconstruction for A. baumannii to date. As a 
result, iATCC19606 well predicted the utilisation of 195 carbon and 95 nitrogen sources. Gene essentiality analysis showed 72.3% 
accuracy compared with the single-gene deletion library. Integrative analysis with our recent transcriptomics and metabolomics 
data revealed that polymyxin treatment resulted in significant perturbations in central metabolism, as well as biosynthesis of amino 
acids, nucleotides and glycerophospholipids. Overall, this is the first integrative study by combining GSMM with multi-omics data to 
elucidate the metabolic responses to polymyxins in A. baumannii. The model iATCC19606 will be employed as a powerful tool for 
in-depth investigation of antimicrobial killing and resistance, and the rational design of effective antimicrobial therapies against this 
problematic pathogen.
O-499 Model-based Engineering of Metabolism
PRESENTING AUTHOR: Radhakrishnan Mahadevan, University of Toronto, Canada
CO-AUTHORS:                                                    
Improved understanding of the organization of metabolic networks can enable the more effective control of metabolism for several 
applications ranging from metabolite overproduction to treatment of metabolic diseases. Advances in computational modeling 
techniques have allowed the development of genome-scale models of metabolism in several organisms.  These models have become 
the basis for analysing the potential of metabolic networks and to understand their organization. Using genome-scale metabolic 
models, we analyze the role of redundancy of metabolite production pathways and its implications for the robust production of the 
target metabolites. These observations shed light on the role of redundant modes of regulation and metabolic pathways for robust 
control of metabolic fluxes. In the second part, we will discuss how orthogonality of production pathways can facilitate the effective 
control of fluxes through target metabolites and their implications for the evolution of modular pathways in metabolic networks. 
The talk will highlight how these genome-scale metabolic models can be effectivley used for metabolic engineering. Finally, we will 
conclude with a discussion of the challenges and opportunities in integrating these metabolic models with large-scale metabolomics 
data.
O-518 Environmental metabolomics with data science as an indicator of ecosystem homeostasis
PRESENTING AUTHOR: Jun Kikuchi, RIKEN, Japan
CO-AUTHORS:                                                    
A natural ecosystem can be viewed as the interconnections between complex metabolic reactions and environments. Humans, a 
part of these ecosystems, and their activities strongly affect the environments. To account for human effects within ecosystems, 
understanding what benefits humans receive by facilitating the maintenance of environmental homeostasis is important. Here we 
describe recent applications of several NMR approaches to the evaluation of environmental homeostasis by metabolic profiling 
and data science. The basic NMR strategy used to evaluate homeostasis using big data collection is similar to that used in human 
health studies. Sophisticated metabolomic approaches (metabolic profiling) are widely reported in the literature. Further challenges 
include the analysis of complex macromolecular structures, and of the compositions and interactions of plant biomass, soil humic 
substances, and aqueous particulate organic matter. To support the study of these topics, we also discuss sample preparation 
techniques and solid-state NMR approaches. Because solution and solid-state NMR can produce numerical matrix data (e.g., chemical 
shifts versus intensity) with high reproducibility and inter-institution convertibility, further analysis of such data using multivariate 
analysis and machine learning approaches is often desirable. We also describe techniques for data pretreatment in solid-state NMR, 
for environmental feature extraction from heterogeneously-measured spectroscopic data, and for the extraction of submerged 
information using machine learning approaches.
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P-94 Systems biology of circadian clock synchronization in Neurospora crassa.
PRESENTING AUTHOR: Michael Judge, University of Georgia, United States
CO-AUTHORS: Ricardo Borges, Brooke Hull, Yinwen Zhang, Yueze Yang, James Griffith, Arthur Edison, Jonathan Arnold                            
The circadian clock is a widely conserved emergent property driving daily rhythms across multiple levels of biological organization, 
with oscillations emanating from core transcription-translation feedback loops which then exert control over downstream pathways. 
In turn, multiple external factors may influence the clock, allowing for re-synchronization with external cues, or compensation for 
changes in temperature and nutrient availability. We have recently found that transcriptional clock/oscillator phases in single cells 
of the clock model Neurospora crassa synchronize over time, but only if they are in the same microenvironment. We hypothesize 
an extracellular chemical communication mechanism to explain synchronization. To explore the nature of this mechanism and 
the underlying gene-metabolite network, we are using a combination of untargeted NMR metabolomics, clock activity-guided 
fractionation, and genetic knockout mutants to screen for extracellular molecules and genetic components that may allow clocks to 
interact. Identifying pathways at the intersection of these approaches will further enable targeted MS experiments and transcript 
analyses. Preliminary NMR data on nonpolar exometabolites has already revealed circadian features, suggesting interactions of this 
sort occur in Neurospora. This experiment is being repeated with more replicates, clock mutants, and broader chemical diversity. Our 
approach will also allow us to explore broader properties of the N. crassa extracellular metabolome in the future. Moreover, this work 
offers fundamental insights about the control and multilevel properties of a pervasive systems behavior in a model organism with 
biotechnological relevance.
P-95 Mammalian systems biotechnology reveals global cellular adaptations in a recombinant CHO cell line
PRESENTING AUTHOR: Hock Chuan Yeo, Bioprocessing Technology Institute, Singapore
CO-AUTHORS: Meiyappan Lakshmanan                                                  
Effective development of host cells for therapeutic protein production is largely hampered by the poor characterization of cellular 
transfection. Here, we employed a multi-omics based systems biotechnology approach to characterize the genotypic and phenotypic 
differences between a wild-type and recombinant antibody-producing Chinese hamster ovary (CHO) cell line. At the genomic level, 
we observed extensive rearrangements in specific targeted loci linked to transgene integration sites. Transcriptional re-wiring of 
DNA damage repair and cellular metabolism in the antibody-producer, via “hard-wired” changes in gene copy numbers was also 
detected. Subsequent integration of transcriptomic data with a genome-scale metabolic model showed a substantial increase in 
energy metabolism in the antibody producer. Metabolomics/lipidomics analyses further substantiated this observation, and together 
with glycomics analysis, highlighted additional characteristics of the antibody producer. These include an elevation in long-chain lipid 
species, potentially associated with protein transport and secretion requirements, and a surprising stability of N-glycosylation profiles 
between both cell lines.  
P-96 Improved Understanding of the Role of Metals in the Metabolome and Lipidome: A Multi-“omics” Association Approach.
PRESENTING AUTHOR: Richard Robinson, Metabolon Inc., United States
CO-AUTHORS: Matthew Doyle, Anne Evans, Luke Miller                                               
Metals have long been known to play an important role in human biology with as much as one third of enzymes are thought to utilize 
metals as catalysts. While the role of some metals in biological systems has been extensively studied the examination of a suite 
of metals and their interaction across a variety of metabolic pathways has only recently become feasible through instrumentation 
allowing accurate, high throughput analysis of the lipidome, metabolome and metallome.  Here we present an association study, 
and accompanying methodology, between metals measured by ICP-MS and both small molecules measured by UPLC-MS and lipids 
measured via FIA-DMS-MS/MS.  From a single plasma sample metals (Na, Mg, K, Ca, Sc, V, Cr, Fe, Mn, Co, Ni, Cu, Zn, As, Se, Mo, 
Ag, Cd) measured via ICP-MS can be compared to small molecule metabolites measured via established non-targeted UHPLC-
MS methods and complex lipids measured via FIA-DMS-MS/MS methods.  An examination of the correlation between each of the 
measured metals and each of the measured metabolites and complex lipids was then performed.  This approach provides the tool 
which allow for novel mapping of trace metals onto established biochemical pathways as well as potential elucidation for the role of 
these metals in disease.
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P-97
Characterising a core metabolic enzyme responsible for phosphine resistance and 
fundamental metabolic regulation – from classical biology to systems biology and  genome-
scale modelling
PRESENTING AUTHOR: Horst Schirra, The University of Queensland, Australia
CO-AUTHORS: Angelo Chan, Jake Hattwell, Paul Ebert                                               
Phosphine gas is used to protect global grain reserves from pest insects, which are increasingly resistant. We identified 
dihydrolipoamide dehydrogenase (DLDH) as the enzyme responsible for phosphine resistance and characterised in C. elegans the 
toxic action of phosphine and the resistance mechanisms with NMR-based metabolomics [1]. DLDH is a core metabolic enzyme, 
central to metabolic regulation, and a new class of resistance factor. DLDH participates in four key steps of core metabolism, which 
are affected differently by phosphine in mutant and wild-type animals. The position of DLDH in the metabolic network makes it a 
highly likely candidate for a central regulator of metabolism. We are studying the role of DLDH in biological/clinical processes, such 
as lifespan determination, obesity, Alzheimer’s Disease, and respiration. Metabolomic analysis indicates a role of DLDH in the cross-
talk between branched-chain amino acid and lipid metabolism. We have developed CeCon, a genome-scale metabolic model of C. 
elegans metabolism that enables further characterization of DLDH’s role in these processes. CeCon comprises 225 pathways, 1923 
reactions and 1394 metabolites. It also identifies 20793 polypeptides, including 2754 enzymes and 73 transporters. The model forms 
the basis for creating a C. elegans consensus genome-scale model. DLDH is an exceptional case in which a combination of systems 
biology methods has identified a single genetic cause of phenotypic change that can subsequently be studied with a wide range of 
methods from classical biochemistry to systems biology. [1] Schlipalius et al., Science, 2012, 338:807.
P-98 The ryegrass (Lolium perenne) metabolome: Harnessing chemical diversity and understanding biological mechanisms for forage improvement
PRESENTING AUTHOR: Arvind Subbaraj, AgResearch Ltd., New Zealand
CO-AUTHORS: Karl Fraser                                                  
We present the ryegrass (Lolium perenne) metabolome, the widest coverage of a LC/GC-MS analysis of oligosaccharides, fatty acid 
methyl esters (FAMEs), polar, semi-polar and lipophilic/non-polar metabolites, from five clonal replicates of 724 genotypes (3620 
plants), representing 118 populations from 21 countries. Perennial ryegrass is the most important forage crop which supports 
milk and meat production worldwide, and has genetic synteny with other important food crops (rice, wheat and sorghum). An 
assessment of chemical diversity and understanding biological mechanisms is therefore essential for breeding exercises aimed at 
forage improvement.  Due to its potential impact on ruminant digestion, high water soluble carbohydrate (WSC) content has been 
a longstanding breeding objective. Chemical diversity based on total WSC content was evaluated, and genotypes were classified as 
high or low sugar groups. This classification has immediate benefits in directing breeding efforts. Metabolites that were differentially 
regulated between the two groups were tentatively identified and mapped on to reference pathways. Carbon fixation, carbohydrate 
metabolism, amino acid metabolism and biosynthesis of secondary metabolites comprised the major networks that were enriched. 
The shikimate pathway was central to this regulation. Fatty acids, galactolipids, phospholipids and diglycerides were at higher levels 
in the low sugar group. This also comprises the first report of the ryegrass lipidome. Data-driven hypotheses generated by such 
large-scale metabolomics studies demand rigorous quality control parameters, and extensive statistical/chemometric evaluations. We 
present a template for large-scale, non-targeted metabolomics studies along with potential pitfalls and emerging scenarios. A time-
resolved analysis of the ryegrass metabolome has also been conducted.
P-99 Integration of NMR metabolomics, microarray analysis and transgenesis in Anopheles gambiae
PRESENTING AUTHOR: Rudi Grosman, University of Liverpool, United Kingdom
CO-AUTHORS: Mark Paine, Gareth Lycett, Lu-Yun Lian                                               
Anopheles gambiae complex include the most important vector of malaria in sub-Saharan Africa and play host to Plasmodium 
falciparum responsible for the most lethal malaria cases. Alongside treating and curing malaria, prevention plays a critical role in 
reducing the number of malaria cases. Insecticides are crucial in keeping An. gambiae population under control, however overuse 
of the insecticides has caused an increase in resistance. Recently, cuticular hydrocarbons (CHC) and metabolic processes have 
become a point of interest to study insecticide resistance and combating malaria.   CHC’s have a range of roles including as contact 
pheromones and waterproof coating,  the latter being critical for the survival of pupal and adult stages. Although there are different 
pathways that produce CHC, a common step in its synthesis is the decarbonylation process carried out by the cytochrome P450 
enzymes (CYP-P450). Two CYP-P450s (CYP4G16 and CYP4G17) have been implicated in CHC decarbonylation through previous 
Drosophila studies, microarray analyses and recombinant protein expression. To observe the metabolic changes and their relation 
to the CHC pathways, metabolic profiles of transgenic knockdown of the two CYP-P450 enzymes in pupae were studied by nuclear 
magnetic resonance metabolomics.   Multivariate statistical analysis showed significant differences in metabolite levels between pupa 
knockdowns and control. Metabolites contributing to the separation between groups have been identified as part of the CHC pathway 
or associated pathways. Of the two knockdowns, metabolite variance of KD16 is more pronounced. This result may be associated 
with its activity earlier in the life cycle of An. gambiae.
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P-100 Establishment of Normalization Protocol for Global Metabolomics in a Large-scale Study Using Mass Spectrometry
PRESENTING AUTHOR: Daisuke Saigusa, Tohoku University, Japan
CO-AUTHORS: Ikuko Motoike, Seizo Koshiba                                                
Genome, transcriptome, proteome and metabolome are the elements of constituting central dogma, and understanding of the 
phenotype of an organism. Metabolomics is a promising approach in the search for disease biomarkers because the metabolite 
concentrations of body fluids are considered as quantitative traits that can describe and define phenotypic characteristics of 
each individual, which are generated through interactions between genes and environmental influences. Although the quality of 
metabolome, both global metabolomics (G-Met) and targeted metabolomics using mass spectrometry (MS), largely depends on the 
instrumentation, potential bottlenecks still exist at data normalization, especially for a large-scale study. Therefore, we established 
a normalization method of G-Met protocol of data analysis to compensate for intra- and inter-batch differences. In our protocol, 
samples were deproteinized in a 96-well plate using an automated liquid-handling system, and conducted either using an UHPLC-
QTOF/MS equipped with a reverse-phase column (Acquity HSS T3; Waters) or a LC-FTMS equipped with a HILIC column (ZIC-
pHILIC; Sequant). Then we applied our protocol for 1,008 plasma samples, which were obtained from our cohort study “Tohoku 
Medical Megabank Project”. All data were imported “Progenesis QI” and normalized by our software “Quantbolome”. The variations 
of 19 plates were significantly reduced using our normalization method. Finally, we demonstrated the association of SNPs by means 
of genome wide association study between genomics and metabolomics, and identified novel relations in several metabolism. The 
protocol and normalization method should prove useful for the discovery and development of biomarkers for diseases in a large-scale 
study. 
P-101 Examining the Correlations between Metabolites and Beef Cattle Carcass Data
PRESENTING AUTHOR: Samantha Connolly, University of Sydney, Australia
CO-AUTHORS: Luciano Gonzales, Anthony Dona, Michael D’Occhio, Lorna Wilkinson-White, Darren Hamblin                                            
Desirable carcass traits are difficult to predict in beef cattle before the animal is slaughtered. The ability to identify animals with 
superior carcass traits via metabolomics analysis could increase production efficiencies significantly. This is particularly relevant 
for animals kept in feedlot for prolonged period of time due to its cost. The objective of this study was to search for biomarkers 
that predict specific carcass attributes in feedlot cattle. Plasma samples have been obtained from a large cohort of animals. These 
samples have been examined on a Bruker AV 600 MHz NMR spectrometer, Nuclear Overhauser Effect Spectroscopy (NOESY) data 
was collected for all samples, and phased, baseline corrected and referenced using Matlab™. Chenomx™ and previous publications 
were then used to classify the metabolites within each individual sample. The metabolites identified were then contrasted with the 
phenotypic carcass data collected post-slaughter. The correlations between individual metabolites and specific carcass attributes were 
examined and a search for biomarkers of carcass attributes in plasma samples was performed. The expected outcome of the analysis 
is to identify a specific metabolite or group of metabolites that are able to routinely predict which animals will have superior carcass 
attributes.    
P-102 Development of a metabolomics method for measuring oxygen-sensitive THF metabolites
PRESENTING AUTHOR: Renato de Souza Pinto Lemgruber, University of Queensland, Australia
CO-AUTHORS: Kaspar Valgepea, Mark Hodson, Ryan Tappel, Michael Koepke, Lars Nielsen, Esteban Marcellin                                          
Tetrahydrofolate (THF) metabolites (Methenyl-THF; Methylene-THF; Methyl-THF) are the spinal cord of autotrophic growth by the 
Wood-Ljungdahl pathway found in acetogens (1, 2). Despite their importance, no method is available to measure intracellular 
concentrations of THF intermediates; most likely because of their rapid degradation in the presence of oxygen (1). Hence, we 
developed a method for sampling anaerobic cultures to identify and quantify THF metabolites. Culture were injected into an anoxic 
serum bottle containing anoxic acetonitrile. The samples were then filtered inside the anaerobic chamber and concentrated prior to 
LC-MS analysis. LC-MS analysis was performed using a Dionex Ultimate 3000 coupled to a QTRAP operated in positive ion mode. 
Chromatographic separation was achieved using a Phenomenex Gemini-NX C18 column. Comparison of oxic versus anoxic sampling 
revealed that THFs can only be measured if sampled anoxically. THFs quantification also showed a similar decreasing trend at high 
biomass, a trend shared by acetyl-CoA, the end product of the WL pathway Although quantification of THFs is likely only reliable 
using labelled standards, the method developed here is useful for relative quantification of THFs levels across different growth 
conditions. References: 1. Ragsdale SW. 1991. Enzymology of the acetyl-CoA pathway of CO2 fixation. Crit Rev Biochem Mol Biol 
26:261–300. 2. Drake HL, Küsel K, Matthies C. 2006. Acetogenic Prokaryotes, p. 354–420. In Dworkin, M, Rosenberg, E, Schleifer, 
KH, Stackebrandt, E (eds.), Prokaryotes (Ecophysiology and Biochemistry)Second. Springer, New York.  
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P-103 An Optimized Metabolome Sampling Methods for 13C Metabolic Flux Analysis of Komagataeibacter xylinus Using Capillary Electrophoresis-Mass Spectrometry
PRESENTING AUTHOR: Dong Sik Yang, Samsung Advanced Institute of Technology, South Korea
CO-AUTHORS: Tae Yong Kim, Sujin Park, Sunghaeng Lee, Hong Soon Rhee, Jin Kyu Kang, Jin Hwan Park                                          
Komagataeibacter xylinus is one of the microorganisms synthesizing cellulose with higher mechanical strength and degree of 
crystallinity than plant-based cellulose. K. xylinus has been genetically modified or cultivated on the better environmental conditions 
to enhance the bacterial cellulose production due to their wide variety of applications such as paper product, electronics and 
biomedical devices. However, their low productivity is still bottleneck for industrial applications and the information on metabolic 
fluxes in K. xylinus during cellulose biosynthesis is minimal due to the drawback of sample preparation in metabolomics. To obtain a 
more comprehensive and better understanding of the bacterial cellulose production pathways , the optimized metabolome sampling 
methods for 13C metabolic flux analysis were developed. Major metabolome sampling methods optimized included quenching and 
metabolite extraction: buffered (acetic acid pH 5.5) 100% methanol quenching solution at -40°C and methanol/water/chloroform 
(2:0.8:2) extraction at 50°C for 30min. The optimized method provided the better quenching effect and resolution of metabolites 
involved in cellulose biosynthesis and represented an accurate snapshot of metabolic state in K. xylinus using capillary electrophoresis 
quadrupole time-of-flight (CE-QTOF) due to the absence of cellulase treatment. The optimized method was applied to 13C metabolic 
flux analysis measuring the mass isotopomer distributions of intracellular metabolites rather than the proteinogenic amino acids to 
investigate metabolic flux in K. xylinus during cellulose biosynthesis.
P-104 A 1st generation consensus reconstruction of Caenorhabditis Elegans
PRESENTING AUTHOR: Jake Hattwell, Centre for Advanced Imaging, The University of Queensland, Brisbane, Australia, Australia
CO-AUTHORS: Angelo Chan, Paul Ebert, Horst Joachim Schirra, Christoph Kaleta                                             
To characterise phosphine resistance and metabolic regulation in C. elegans our research group has constructed CeCon, a C. 
elegans genome scale model (GSM). CeCon comprises 225 pathways, 1923 reactions and 1394 metabolites. It also identifies 
20793 polypeptides, including 2754 enzymes and 73 transporters. The model is independent of two other C. elegans GSMs but 
complements them. We are now working on combining one of these models, ElegCyc, with CeCon to create a consensus GSM 
containing information from both models. Both CeCon and ElegCyc were constructed in the Pathway Tools software, facilitating easier 
combination. We have been using the COMMGEN software to merge the two models in a semiautomatic fashion, followed by the use 
of COBRA techniques to verify that flux is carried. Originally, we compared the two models in several metrics, before exporting both 
models to SBML for merging. We generated a draft consensus model for C. elegans which can carry flux. Currently we are working 
on experimentally verifying the draft consensus model by studying the response to dietary perturbation in wild type and mutant 
worms. In the future, we want to use this model to explore the role of dihydrolipoamide dehydrogenase (DLD) in energy metabolism. 
We predict that DLD is a key metabolic regulator, as it is shown to have roles in phosphine resistance, lifespan extension, obesity, 
diabetes, cancer and Alzheimer’s Disease. Finally, through the creation of this model we hope to elucidate how DLD mutations affect 
metabolic function whilst creating a powerful resource for community use.
P-105 GC-MS based metabolomics provides a new approach to elucidate the modes-of-action of fungicides
PRESENTING AUTHOR: Pengfei Liu, China Agricultural University, China
CO-AUTHORS: Zhihong Hu, xili Liu                                                
The common existence of fungicides resistance in plant pathogen requires new compounds created with different mode of action 
which make it an urgent need to set up a fast method to discriminate their MOA from the others. In this paper GC-MS based 
metabolomics was applied to provide an approach to elucidate MOA of fungicides. A sensitive strain of Botrytis cinerea was exposed 
to EC50 concentration of 16 fungicides with different MOA (?-tubulin, respiratory chain, succinate dehydrogenase, the uncoupler, 
methionine synthesis, signal transduction, sterol biosynthesis, and Multi site). The mycelia extracts from methyl alcohol and water 
were analyzed for their “metabolome and metabolic fingerprint” by using gas chromatography-mass spectrometry. The obvious 
di?erences could be found between these MS vectors pro?les of controls and cultures treated with fungicides pro?les, hence, allowing 
the classi?cation of fungicides according to their MS vectors pro?les. A model based on hierarchical cluster allowed these antifungal 
compounds to be distinguished and classified according to their modes of action. Metabolic fingerprinting thus represents a rapid, 
convenient, and information-rich method for classifying the modes of action of antifungal substances. The metabolic fingerprints 
have changed with different treatments. The biomarkers of modes of action of fungicides also were established by ANOVA analysis 
for methionine synthesis inhibitors and signal transduction inhibitors. This study provides a comprehensive database of the metabolic 
perturbations of Botrytis cinerea induced by MOA diverse inhibitors and highlights the utility of metabolomics for defining MOA, which 
will assist with the development and optimization of new fungicides.
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P-283 The uracil metabolism in the Tetanus vaccine fermentation process
PRESENTING AUTHOR: Nicolas Zaragoza, AIBN, Australia
CO-AUTHORS: Cuauhtemoc Licona-Cassani , Camila Orellana, John Power, George Moutafis, Glenn Moonen, Mark Hodson, Lars 
Nielsen, Esteban Marcellin Saldana
Clostridium tetani is an anaerobe pathogen that causes Tetanus by producing one of the most potent toxin known, the tetanus 
neurotoxin (TeNT). Extensive immunisation programs have kept the disease controlled in humans. However, despite more than half 
a century of industrial fermentation for vaccine production, the physiological behaviour controlling toxin production in bioreactors is 
not well understood. This makes production inefficient and costly, with batch-to-batch variability and irregular toxin yields. In order 
to have an insight of the intricate toxin regulation mechanisms, C. tetani was grown in bioreactors using two conditions, yielding 
different toxin yields. Using intracellular and extracellular metabolomics, we compared the bacteria metabolic responses to these 
two conditions and we complemented the approach using time course transcriptomics. We focused our analysis on amino acids, 
vitamins and nucleotides. The data allowed us to create detailed “fermentation maps” describing C. tetani nutrient consumption 
and byproducts formation, as well as key metabolites that could be regulating the toxin synthesis pathway. Ultimately, the extensive 
metabolomics dataset will contribute to a better understanding of the Tetanus vaccine fermentation process and will be used for the 
future design of a chemical defined medium to avoid the inherent variability.
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P-289 Engineering the E.coli lipidome
PRESENTING AUTHOR: Jos Brouwers, Utrecht University, Netherlands
CO-AUTHORS: AikeJeucken, J Bernd Helms
The model organism Escherichia coli is widely used for industrial production of organic building blocks. A limitation in the production 
of hydrophobic compounds by E.coli is the destabilization of its lipid membranes and subsequent loss of cell integrity. To increase 
membrane resistance, we investigated the plasticity of the E coli lipidome by manipulation of the genes involved in lipid synthesis. 
To this end, we constructed strains overexpressing one of these 74 genes and analysed their lipidomes. We found that 60 of these 
74 genes were non-essential and we also analysed knock-out strains of these genes. As determined by principal component analysis, 
most of these mutants display a lipidome that us clearly distinct from the wild type. We find a remarkable plasticity of the E. coli 
lipidome, where major lipid species may be nearly completely abolished without effect on growth rate or butanol resistance. With 
pathway analysis we identify and visualise the relative influence of lipid metabolic genes on the lipidome of E. coli. This work provides 
a powerful tool for the engineering of E. coli membranes, thus contributing to building a sustainable biobased industry.
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O-44 MS-based metabolomics reveals BDE47 associated neurometabolic changes
PRESENTING AUTHOR: JI Fenfen, Hong Kong Baptist University, Hong Kong
CO-AUTHORS: Hemi LUAN, Yingyu HUANG, Liangfeng LIU, Min LI, Zongwei CAI                                            
Polybrominated diphenyl ethers (PBDEs) are one of the major persistence organic pollutants (POPs). As the most abundant 
congener detected in human serum, BDE47 was studied to have neurodevelopmental toxicity in mice experiment by measuring 
their spontaneous behaviors.    In our study, adult C57BL/6J mice were gavaged daily with BDE47 (0, 1, 10 or 100mg/kg bw) 
for 30 consecutive days. Every group had eight mice. The collected serum and brain samples were analyzed by LC-MS using an 
orbitrap fusion mass spectrometer. MS profiling data was preprocessed by using XCMS and the resulting peaks were fitted in 
partial least squares discriminant analysis (PLS-DA) model. Our result indicated the disturbance of tryptophan and phenylalanine 
pathways. Significant decrease of phenylalanine, tyrosine, L-DOPA and dopamine (neurotransmitters) were detected by LC-MS/
MS quantification. Also metabolites of kynurenine, 3-hydroxykynurenine which was known as a neurotoxin were upregulated in the 
exposure groups. Based on the results, we suggest the mice receiving BDE47 suffered from considerable neuro-metabolic alteration 
by disturbing the tryptophan and phenylalanine metabolism.  We further evaluated the BDE47 exposure as a potential risk factor of 
Parkinson’s disease (PD) development in the alpha-synuclein overexpressed fly (Drosophila) model. Flies were exposed to BDE47 (2, 
10, 50µM) for 30 consecutive days. The regulation of key metabolites include tyrosine, dopamine and 3-hydroxykynurenine in the 
flies in the 20th exposure day were found to be consistent with the mice experiment. Our results suggest that BDE47 may worse the 
PD development by disturbing tryptophan and phenylalanine metabolic pathways.
O-69 Rice metabolomics: unravelling brown planthopper (BPH) resistance mechanism on BPH-resistant traits
PRESENTING AUTHOR: umaporn uawisetwathana, National Center for Genetic Engineering and Biotechnology, Thailand
CO-AUTHORS: Olivier Chevallier, Yun Xu, Supavadee Yatapan, Wintai Kamonsukyunyong, Theerayut Toojinda, Apichart Vanavichit, 
Roy Goodacre, Christopher Elliott, Nitsara Karoonuthaisiri                                      
Brown planthopper (BPH) is a phloem feeding insect that causes the annual disease outbreak, called hopperburn in many 
countries throughout Asia. As Thailand is one of the major rice exporters, this outbreak critically reduces the rice production yield, 
consequently affecting the global rice security. Currently, BPH resistance mechanism is still unknown causing lower progress on 
developing effective rice varieties as well as effective farming practices. Understanding the biological mechanism of the response to 
the BPH will aid in improving a selective breeding program of such desirable trait for durable resistance.  In this study, leaf extracts of 
BPH-susceptible Thai Jasmine rice (KD cultivar) and its BPH-resistant rice isogenic lines (IL7 and IL308) were investigated to decipher 
rice metabolic responses during 8 days of BPH attack. Polar metabolomes obtained by multi-platform metabolomics analyses, namely 
UPLC-QToF-MS/MS and UPLC-Orbitrap-MS/MS were fused and subsequently analyzed. Multivariate statistical model was capable 
of distinguishing the metabolic profiles between the BPH-susceptible and BPH-resistant varieties during BPH infestation. Over 100 
primary and secondary metabolites were identified and overall metabolic perturbation underlying these traits was highlighted. This 
study provides a comprehensive insight into biochemical processes of rice adaptation and/or resistance against the BPH infestation. 
The findings from this study will help scientists narrow down their further investigation of pathways putatively involved in the BPH 
resistance mechanism of the rice in order to find an effective and sustainable alternative to prevent and control the damage from the 
infestation.
O-71 An inducible system for anthocyanin accumulation in plants for application in green systems biology
PRESENTING AUTHOR: Robert Hall, Wageningen Plant Research, Netherlands
CO-AUTHORS: Nikolay Outchkourov, Rumyana Karlova, Matthijs Hölscher, Xandra Schrama, ikram Blilou, Esmer Jongedijk, Carmen 
Díez-Símoin, Aalt-Jan van Dijk, Dirk Bosch, Jules Beekwilder                                    
Plants regularly respond to multiple (a)biotic environmental stimuli by making secondary metabolites.  Regulation of the relevant 
biosynthetic pathways is part of a complex transcriptional network which ensures that biosynthetic enzymes, transporters and 
storage capacity are present at the correct time and place. To achieve this, co-regulation of various processes beyond the relevant 
biosynthetic pathway is also needed. To study such complexity, an ‘inducible system’ could prove very valuable to follow the 
coordinated induction of biosynthesis, transport and storage, in a tissue- and development-independent manner. We have developed 
such a system for studying the program of anthocyanin-biosynthesis in tomato. A transcription factor pair from Antirrhinum was 
introduced in tomato under control of a dexamethasone-inducible promoter. This system allows the induction of anthocyanin 
formation within 24h in a variety of tissues. LC-MS based metabolomics in combination with transcriptomics profiling were used 
with several tomato tissues. The data set obtained provided a comprehensive overview of the processes accompanying anthocyanin 
biosynthesis in these materials. More than 80 metabolites and 425 genes were found to be regulated by activation of the anthocyanin 
pathway, independent of the tissue tested. In addition, tissue-specific changes in gene expression and metabolite profiles were also 
observed. This approach has revealed the broad impact of inducing anthocyanin accumulation in tomato which involves e.g. other 
unrelated biochemical pathways as well as root branching, epithelial morphology, seed germination and leaf conductance.
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O-86 Mapping carbon fate during coral bleaching: the application of 13C metabolomics
PRESENTING AUTHOR: Katie Hillyer, Victoria University of Wellington, New Zealand, New Zealand
CO-AUTHORS: Daniel Dias, Adrian Lutz, Ute Roessner, Simon Davy                                             
   Coral reefs provide critical goods and services, however these systems are globally threatened. A major driver of change is 
thermal stress associated with rising seawater temperatures, leading to coral bleaching. Where functional, coral reef systems are 
highly productive, due to an efficient symbiosis between corals and dinoflagellate algae, hosted within their cells. This nutritional 
relationship is however, sensitive to small temperature changes; when crucial thresholds are exceeded, thermal stress results 
in the loss of algal symbionts (bleaching). Major gaps still exist in our understanding of change in symbiosis metabolic function 
during bleaching, however metabolomics is providing important insight into these alterations and the mechanisms of bleaching.    
We applied a stable isotope tracer (13C bicarbonate) coupled to gas chromatography-mass spectrometry, to map the fate of 
photosynthetically fixed carbon, during thermal stress and bleaching in both partners (symbiont and host) of a model cnidarian 
symbiosis (Aiptasia) and a reef-building coral (Acropora aspera).   We detected clear metabolic and cellular responses to thermal 
stress, which progressed with bleaching extent (both partners and symbioses). Primarily, increased energy store catabolism, 
production of antioxidants and compatible solutes, coupled to reductions in complex biosynthesis pathways. However, despite the 
metabolic costs of advanced symbiont photodamage, remaining symbionts in both symbioses continued to fix carbon, produce 
organic products de novo and translocate to their hosts (primarily as glucose). This on-going translocation during bleaching, suggests 
that cnidarian hosts may manipulate symbiont nutrient provision, or target non-productive symbionts for expulsion, providing 
important insight into the mechanisms of coral bleaching.
O-135 Geographic Mosaic of Metabolites in Purple Passionflower (Passiflora incarnata): Testing the Coevolutionary Hypothesis Using 1D 1H-NMR
PRESENTING AUTHOR: Nick Batora, University of Georgia, United States
CO-AUTHORS: Ricardo Borges, Charalampos Panagos, Rodney Mauricio, Arthur Edison                                             
Plants produce an outstanding diversity of metabolites and natural products.  Insights into the ecological and evolutionary forces 
that have helped generate this great diversity is still limited.  One hypothesis is that over time coevolutionary dynamics between 
plants and specialist insect herbivores led to a greater diversity of secondary metabolites.  We tested predictions based upon the 
coevolutionary hypothesis within a species using Purple Passionflower (Passiflora incarnata).  We utilized a 1D 1H-NMR based 
metabolomics approach to assess metabolic diversity among wild populations of P. incarnata growing in a common garden 
environment.  Populations selected for this study differed in the presence and abundance of specialist herbivores in their respective 
herbivore communities.  We found that populations with more specialist herbivores produced a greater diversity of metabolites.  
Additionally, we found metabolites that are affected by herbivory from the specialist Lepidoptera, Gulf Fritillary (Agraulis vanillae).  
This work provided novel metabolites to puruse in future studies that investigate plant metabolites under natural selection from 
insect herbivores.  Furthermore, this study demonstrates the tremendous opportunity metabolomics provides in the evolutionary and 
ecological study of plant metabolites and has applications in natural product discovery.  
O-148 Actylcholine regulation after single pesticide exposure in relationship to developmental neurotoxicty, behavior and cognitive studies in mice
PRESENTING AUTHOR: Pim Leonards, VU University, Netherlands
CO-AUTHORS: Henrik Viberg, Iwa Lee, Sonja Buratovic, Per Eriksson                                             
Worldwide, serious concern has arisen about the increased incidence of learning and developmental disorders in children. Various 
epidemiological studies indicated that exposure to low doses of environmental active contaminants during human development 
can have deleterious effects on cognitive development in childhood. In the current study, which was part of the EU DENAMIC 
project, the aim was to investigate the behaviour and cognitive effects of environmental contaminants in mice and to study the 
underlying molecular mechanisms of the observed effects using metabolomics. Male mice were exposed to a single dose of pesticides 
(chlorpyrifos, carbaryl, cypermethrin, endosulfan), methylmercury or PFHxS (PND10). The studies showed that all chemicals caused 
developmental neurotoxic effects, even after a single exposure which was given at a vulnerable period of brain development. The 
cognitive and behaviour tests showed that the early life exposure of the compounds can alter adult spontaneous behavior and 
cognitive function. Interesting the chemicals with different modes of action had effects on the same apical endpoint (increased 
spontaneous behaviour). Metabolomics of brain tissues (cerebral cortex and hippocampus) showed effects related to axons/neurons, 
mitochondria, purine pathways. After pesticide exposure increased levels of the neurotransmitter acetylcholine in the hippocampus 
were found, which was not related to the acetylcholinesterase activity. Acetylcholine is probably regulated to a spontaneous transfer 
of acetyl by acetylcarnitine as both carnitine and choline were not changed. Combining all studies a positive relationship was found 
between acetylcholine and acetylcarnitine in the hippocampus.
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O-149 Metabolomics analysis of community interactions: the effect of species distributions and spatial heterogeneity on metabolic response.
PRESENTING AUTHOR: Jade O’Leary, Cardiff University, United Kingdom
CO-AUTHORS: Dan Eastwood, Carsten Müller, Lynne Boddy                                               
Species interactions mediate community dynamics, but few experimental studies have assessed the metabolic processes that govern 
competitive interactions within communities. Wood decay basidiomycete fungi are model organisms for studying community dynamics 
because they are easily manipulated in laboratory microcosms, and interactions resolve themselves within a few months. A previous 
study assessed the interactions of a three-species community in novel “Rubik’s cube” 3-dimensional systems. The elimination of 
patch fragmentation gave rise to emergent properties, namely increased competitive ability, which mediated coexistence, however, 
the mechanisms responsible for this were unclear. The current study, therefore, investigated the metabolic processes involved in the 
interactions of a community of wood decay fungi in systems where a single species occupied a greater initial patch size (although 
the same total area as its competitors), compared to when all species were evenly dispersed throughout the system. Volatile organic 
compounds (VOCs) were sampled from the headspace of interactions and analysed by TD-GC-TOF-MS, and enzyme assays and NMR 
and LC-MS metabolomics were performed on extracts of those samples. The bouquet of VOCs differed markedly between system 
types, and the metabolic and enzymatic profiles of individuals changed in response to the increased competitiveness of the species 
occupying a greater initial patch size, which in the real-world is likely to be reflected by changes to decomposition and nutrient 
cycling. 
O-150 The fate of technical-grade chlordane in mice fed a high-fat diet and its roles as a candidate obesogen
PRESENTING AUTHOR: wentao zhu, China Agricultural University, China
CO-AUTHORS: Dezhen Wang, Yao Wang, Jin Yan                                               
Epidemiological studies indicate that exposure to persistent organic pollutants is positively associated with the prevalence of obesity. 
To delineate the potential role of technical-grade chlordane in obesity development, chlordane metabolism and chlordane-induced 
metabolic changes were investigated in mice fed high-fat diet (HFD) over a 6-week period. Gas chromatography electron capture 
detector analysis showed that HFD induced more accumulation of technical chlordane in the liver, muscle and adipose tissue. The 
enantioselectivities of oxychlordane in selected tissues were also influenced by HFD. 1H NMR-based liver metabolome indicated 
that technical chlordane can enhance the metabolic alterations induced by HFD. Compared with the low-fat diet (LFD) group, no 
differences were observed in the LFD+chlordane group. However, as many as 16 metabolites were significantly different between 
the HFD group and HFD+chlordane group. Moreover, compared to the LFD+chlordane group, the abundances of 24 metabolites 
significantly increased or decreased in the HFD+chlordane group. Twenty metabolites were altered in the HFD group compared to 
the LFD group. Tryptophan profiling suggested that both chlordane and HFD can disturb tryptophan catabolism. These interactions 
between technical chlordane and HFD suggest that technical chlordane is a candidate obesogen.
O-161 Challenging in Plant Metabolomics: How can we observe and interpret metabolomic data?
PRESENTING AUTHOR: Miyako Kusano, University of Tsukuba, Japan
CO-AUTHORS:                                                    
Metabolomics has become a powerful approach that has been widely adopted, especially in the context of biochemical phenotyping 
of biological systems. As plants cannot move by themselves (they can, but the movement is limited), they produce primary 
metabolites to obtain energy to keep their life and secondary metabolites to survive under the given environments. It is estimated 
that approximately 200,000 metabolites are produced in the plant kingdom. However, there is no single technique suitable for 
measurement of all metabolites because of the chemical diversity of cellular metabolites and their broad dynamic range, particularly 
as this pertains to plants. We have put our effort to develop plant metabolomic platforms to detect diverse metabolites in not only 
model plants but also in crops and vegetables. In plant science, metabolomic approaches are increasingly used for obtaining insights 
involved in genotype comparison, stress responses, nutrition assimilation and evaluation of genetically modified plants. Metabolomics 
also applied to extract hidden metabolic networks in plants. Data interpretation of metabolite profiles can give novel insights as 
physiological meaning in plants. Here I would like to share with you our research activities to uncover mechanism(s) to maintain 
metabolic status under different stress- or nutrition conditions in the model plants, Arabidopsis (Arabidopsis thaliana) and rice (Oryza 
sativa). As applied science, I would present several examples to evaluate “quality” of plants including crops, vegetables and fruits in 
terms of metabolite composition.   
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O-167 An interatomic based approach to study the influence of pyrimidine availability on the switch from free-living to biofilm growth in Salmonella
PRESENTING AUTHOR: Anna Yssel, KU Leuven, Belgium
CO-AUTHORS: Hans Steenackers                                                  
Although we often think of bacteria as free-living single celled organisms, they often live in complex multicellular communities 
that are enclosed by a self-produced matrix, called biofilms. Biofilms are problematic in the clinical, industrial and food processing 
environments. It has been estimated that biofilms are associated with 65 percent of nosocomial infections and that treatment of 
these biofilm-associated infections costs greater than $1 billion annually in the United States alone. The switch from free-living to 
biofilm associated growth is complex and tightly regulated in response to environmental and internal factors and involves the use 
of nucleotide derived signaling molecules to facilitate changes on transcriptional, translational and post-translational levels.  We 
have used various state-of-the-art techniques time-lapse studies with GFP-promotor fusions, LC-MS/MS, RNA sequencing and an 
interatomic approach to determine how pyrimidine availability influences the molecular-decision making systems of Salmonella 
enterica serovar Typhimurium that control the switch from free-living to biofilm associated growth  We found that pyrimidine 
starvation leads to biofilm inhibition and an accumulation of purine nucleotides, and surprisingly an increase c-di-GMP (a positive 
regulator of biofilm formation). Using RNA sequencing and a network based approach we were able to identify the regulatory 
mechanisms that are responsible for repressing curli production (a major component of biofilms) despite high c-di-GMP levels. 
Our results demonstrate how the availability of important resources such as nucleotides can influence how bacteria respond to 
environmental cues.
O-271 Can metabolomics approaches be used to determine the impact of pollution in estuarine environments?
PRESENTING AUTHOR: Sara Long, University of Melbourne, Australia
CO-AUTHORS: Georgia Sinclair, Allyson O’Brien, David De Souza, Konstantinos Kouremenos, Saravanan Dayalan, Ary Hoffmann, 
Malcolm McConville, Dedreia Tull, Michael Keough                                      
Biomarkers are often used in environmental monitoring and management to assess responses to pollution in resident biota. 
Biomarkers need to be sensitive to pollution at environmentally relevant concentrations and ideally respond to specific chemical 
classes so they can be used diagnostically. Current biomarkers tend to focus on single endpoints in specific taxa that theoretically 
reflect the response of whole communities, but collection and identification of specific taxa often requires taxonomic expertise and 
a high level of sample effort that is impractical. Metabolomics techniques have the potential to identify sensitive small metabolite 
biomarkers that respond in the same way across taxonomic groups to chemicals from similar classes (e.g. metals or pesticides). 
We investigated this idea using two estuarine invertebrates (a worm and a snail) exposed to two priority chemicals detected in 
estuarine environments (zinc, a heavy metal, and boscalid, a fungicide). Individuals were exposed to a sub-lethal concentration of 
each chemical for 48 hours. Whole body homogenates were extracted, and then a multi-platform metabolomics approach (GC/MS for 
polar metabolites and targeted LC/MS for amine-containing metabolites) was used to determine effects on a number of biochemical 
pathways. Worms were more sensitive than snails to both chemicals. Amino acids and sugars were the main metabolite classes 
affected by exposure, with different metabolites altered by zinc compared to boscalid. These results demonstrate the potential for 
metabolomics approaches to be used diagnostically in biomonitoring programs as they have been able to differentiate responses 
between different chemicals.
O-401 Metabolomics study of triphenyl phosphate in earthworm Perionyx excavatus: biotransformation products and toxicity
PRESENTING AUTHOR: Lei Wang, National University of Singapore, Singapore
CO-AUTHORS: Xulei Huang, Anna Karen Laserna, Sam Li                                               
Triphenyl phosphate (TPP) is widely used as flame retardant since the phase-out of polybrominated diphenyl ethers, and has been 
detected in all environmental compartments. So far, little work has been done on its biotransformation and toxicity in terrestrial 
ecosystem. We investigated the metabolism of TPP and the perturbation of the endogenous metabolome in the earthworm, 
Perionyx excavatus, after acute exposure to TPP for one and two days, as well as after chronic exposure for 28 days, using liquid 
chromatography –tandem mass spectrometry and gas chromatography –mass spectrometry. TPP underwent quick hydrolysis and 
oxidative hydroxylation after entering into earthworm body. A range of novel phase II metabolites were identified, which can be 
categorized to thiol conjugations and phosphate conjugations. Significant perturbation of the endogenous metabolome was only 
observed two days after acute exposure with up-regulation of glucose, certain amino acids and fatty acids, and down-regulation of 
maltose and certain glycerophospholipids. These results suggest that TPP does not accumulate in earthworm and may not be toxic to 
earthworm in environmentally relevant scenarios.
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O-447 A systems analysis of source-to-sink and metabolic regulatory mechanisms in tomato fruit development by narrowband-LED light treatments
PRESENTING AUTHOR: Atsushi Fukushima, RIKEN Center for Sustainable Resource Science, Japan
CO-AUTHORS: Makoto Kobayashi, Tomoko Nishizawa, Shoko Hikosaka, Eiji Goto, Kazuki Saito, Miyako Kusano                                           
Tomato (Solanum lycopersicum) is one of the most important crops. Due to the physiological importance of the storage metabolites 
(e.g., carbohydrates), understanding metabolism for translocation from source to sink organs is of interest. Here we conducted 
integrative omics analyses to elucidate metabolic impact caused by red light emitting diodes (LED) (a peak wavelength of 660 nm) 
treatment to a single leaf with different intensities during fruit development in tomato plants. To this end we designed and set up 
the special light irradiation system, called “simplified source-sink model”, which consists of a single tomato leaf and fruit truss using 
red LED lighting during development. We evaluated the fruit size under different light intensities, suggesting that tomato fruit was 
significantly increased more than 500 mmol m-2 s-1 for 2 weeks after anthesis. We investigated transcriptomic and metabolomic 
changes of leaf and fruit samples by using microarray, RNA sequencing, and gas chromatography-mass spectrometry. These analyses 
showed the metabolic shifts in carbohydrate metabolism and in several key pathways which contributed in the fruit development. 
Our findings suggest that the developed workflow provides a promising way to discover key metabolites in central metabolism that 
contribute to increase fruit size of tomatoes.
O-477 Comparative metabolomics of xylose-fermenting yeasts by UHPLC-MS/MS: effects of oxygen levels on fermentation performance
PRESENTING AUTHOR: Patrícia Abdelnur, Embrapa Agroenergy, Brazil
CO-AUTHORS: Christiane Campos, José Antônio Ribeiro, Patrícia Costa, Henrique Veras, Clenilson Rodrigues, Nádia Parachin, João 
Ricardo Almeida, Patrícia Abdelnur                                       
Xylose fermentation is a bottleneck in second generation ethanol production since few yeast species are able to convert this sugar to 
ethanol. Efforts to improve yeast fermentation performance through genetic engineering have been done, however ethanol yield and 
productivity are still low and industrial conditions. In this work, a metabolomics platform based on Ultra High Liquid Chromatography 
coupled to tandem Mass Spectrometry (UHPLC-MS/MS) was developed to quantify key metabolites from central carbon metabolism 
(glycolysis, pentose phosphate pathway, and tricarboxylic acid cycle) in yeast. Afterwards, comparative metabolic flux analysis 
was performed to identify limiting steps on xylose metabolism. Spathaspora arborariae and S. passalidarum were cultivated in 
xylose media under aerobic and oxygen-limited conditions to investigate the oxygen influence in the xylose consumption. A total of 
nineteen metabolites were quantified in each yeast sample. To our knowledge, for the first time, intracellular metabolites from S. 
arborariae and S. passalidarum were successfully quantified. Growth under aerobic and oxygen limited conditions, lead to respiratory 
and fermentative metabolism, respectively. In the last case, cofactor regeneration was hindered and resulted in xylitol secretion 
significantly, especially for S. arborariae. These results indicated that fine control of oxygen levels during fermentation is necessary 
to optimize ethanol production with naturally xylose-fermenting yeasts. The metabolomics protocol developed in here can also be 
applied to other species.
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P-106 Metabolic profiles-based alterations as an induced response on Lepidoptera-Lupinus interactions
PRESENTING AUTHOR: Sandra Vargas Medina, Nueva Granada University, Colombia
CO-AUTHORS: Ericsson Coy-Barrera                                                  
Plants respond to phytophagous insects through synthesis of structurally diverse defensive compounds to counteract herbivory-
derived effects. Secondary metabolites could be subdivided into constitutive or induced and are then considered highly dynamic 
depending on plant damage level closely related to insect feed type. However, our understanding of plant-insect defense 
mechanisms is still limited. Metabolomics provides an opportunity to study plant secondary metabolism-mediated responses on 
plant-phytophagous interactions. A qualitative UFLC-ESI-HRMS-based metabolic fingerprinting method for untargeted analysis of 
leaves of a native Andean Lupinus plant (L. bogotensis) and feces of two Lepidoptera larvae species (Pyralidae and Noctuidae) was 
developed. Analyses revealed changes in alkaloid and phenolic plant composition. Directly-affected plant material by phytophagous-
exerted mechanical damage showed the lowest ethanolic extraction yield but it globally presented greater abundance and quantity of 
alkaloids. On the other hand, unaffected leaf samples showed phenolics-enriched profiles. According to principal component analysis 
(PCA), Pyralidae larvae attack induces spartein and hydroxyisospartein production. Also, Pyralidae larvae were found to be capable 
to structurally alter the major alkaloid composition (lupanin dehydrogenation and sparteine monooxygenation/dehydrogenation), 
whereas Noctuidae larvae were able to consume defensive compounds and eliminate them through excretory system without 
transformation. On both interactions, greater expression of tetrahydroxystilbene after larvae were fed on plants can be associated to 
an herbivory-induced response according to PCA model (R2Xcum: 0.756 and 0.748, respectively) and Monte-Carlo cross validation 
(MCCV) (area under ROC curves: 0.957 and 0.924, respectively). Developed methodology is the first evidence of metabolic-mediated 
behavior against phytophagous insects from an Andean lupine.
P-107 Investigating the Porites compressa Coral Holobiont, a Complex Symbiotic System, to Understand Mechanisms of Growth Anomalies
PRESENTING AUTHOR: Tracey Schock, National Institute of Standards and Technology, United States
CO-AUTHORS: Erik Andersson, Russell Day, Joseph Stewart, Thierry Work                                             
Thriving coral ecosystems entail a complex community structure with dynamic biochemical intercommunication. The coral holobiont 
is an intimate symbiotic community comprising a coral host and associated intracellular microorganisms, bacteria and dinoflagellates. 
To date, coral research in terms of metabolomics, is restricted to a handful of manuscripts with only one study investigating effects 
from an environmental stressor. Collecting coral samples in a manner that preserves the community structure and the metabolome 
of interest is difficult and is likely a reason for the limited studies. Here, we developed stringent collection and processing protocol 
in order to investigate Porites growth anomalies (GA), a lesion characterized by localized increased skeletal growth resulting in 
an abnormal protuberant mass on a coral colony. Porites GA are widespread in the Indo-pacific and are associated with human 
population density. Paired fragments comprising lesion (GA) and healthy Porites compressa were collected from Coconut Island 
(Oahu, Hawaii) where prevalence of growth anomalies is high. Sample handling was done so as to allow assessment of specific 
layers of the coral structure (tissue, skeleton, and a mixed layer of tissue and skeleton) by a multi-faceted omic approach, initiating 
with 1H NMR-based metabolomics. Evaluating the metabolome of the disease state in conjunction with complementary ICP-mass 
spectrometry trace element and isotopic data on the skeletal anomalies will provide a novel and diverse insight into the biochemistry 
associated with the disease.  
P-108 Characterization of metabolic responses of Nicotiana attenuata during infection with Rhizophagus irregularis by non-targeted high resolution LC-QTOF profiling.
PRESENTING AUTHOR: Terence Scanlon, Bruuker, Australia
CO-AUTHORS: Sven Helling, Ming Wang, Aiko Barsch, T Baldwin, Terence Scanlon, Emmanuel Gaquere                                           
Mycorrhizal associations are ancient and phylogenetically widespread in &gt;80% of land plant species. AMF are known to 
improve the water uptake and nutritional resources of host plants. In many cases symbiosis with arbuscular mycorrhizae positively 
influences growth and enhances plant resistance against pathogens and abiotic stresses. However the effects of AMF on plant 
defense mechanisms has only been investigated in a few studies. For this purpose, we studied untargeted LC-MS/MS metabolic 
profiles of N. attenuata tissue extracts from plants growing in either autoclaved or non-autoclaved, active AMF inoculums. We 
identified 126 differentially regulated features and observed that varying levels of AMF infection were associated with changes 
in the phytometabolome. By investigating known defense compound classes, differences in 17-hydroxygeranyllinalool diterpene 
glycosides (HGL-DTGs), polyamine-hydroxy-cinnamic acid esters (phenolamides), depsides and alkaloids could be determined. 
We show that only the malonylated HGL-DTGs were decreased in plants infected with AMF. Using an in-house MS/MS database 
consisting of approximately 400 putatively identified metabolites, and by performing an MS/MS correlation search, we identified 6 
novel phenolamides which are highly increased in plants infected with AMF. These compounds are specifically characterized by losses 
of a double bond in their caffeoyl or feruloyl moieties. The described combination of ecological screenings and unbiased metabolite 
profiling allows for the identification of potential new compounds and metabolic pathways important for the interactions between 
AMF and N. attenuata
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P-109 Impacts of high carbon dioxide and nutrients to the metabolic pathway of oxalate rich plant
PRESENTING AUTHOR: Atsuko Miyagi, Saitama Univ., Japan
CO-AUTHORS: Maki Kawai-Yamada                                                  
Rumex obtusifolius (Polygonaceae), one of the most invasive weeds in all over the world, accumulates 10-30% dry weight of 
soluble oxalate in leaves. Excess intake of oxalate-rich plant is injurious for human and livestock due to mineral lacking and urinary 
syndrome such as kidney stone. On the other hand, oxalate is useful dicarboxylic acid for plants in detoxification of metal ions 
such as aluminum ion, defense against predators, a precursor of H2O2 in wounding or aging. Thus, oxalate accumulation would 
give advantages to adapt various environments for R. obtusifolius. For oxalate synthesis, three pathways are reported in plants: 
isocitrate pathway, glycolate pathway and ascorbate pathway. However, it had not been cleared which pathway contributes to oxalate 
accumulation in plants, and what kind of factors affect oxalate synthesis. To clear the effects of environmental factors on oxalate 
synthesis, we analyzed R. obtusifolius L. grown in high CO2 and nutrient solution. Metabolome analysis using CE-MS revealed that 
the treatment of high CO2 combined with Hoagland’s solution increases the plant biomass and oxalate accumulation via the isocitrate 
pathway. These results suggest that the oxalate-rich plants would explosively produce itself in the nutrient-rich field with elevated 
CO2 in the future.
P-110 A three-phase extraction method for the reproducible, comprehensive and step-wise analysis of metabolites and lipids, glycogen and proteins from a single sample
PRESENTING AUTHOR: Vinzenz Hofferek, Max Planck Institute, Germany
CO-AUTHORS: Krzysztof Bajdzienko, Ralf Pflanz, Herbert Jäckle, Patrick Giavalisco                                             
Sample amounts can be often limiting for the comprehensive analysis of animal or human tissue samples. An all-in-one three-phase 
extraction protocol, based on a single sample aliquot can help to reduce the amount of material needed in such experiment. Many 
compound specific extraction protocols are covering only limited numbers of metabolite classes, e.g. lipids or sugars. This results 
in an increase in sample aliquots needed when conducting analysis of multiple compound classes including lipids, polar metabolites 
and proteins. The all-in-one extraction method presented here overcomes the problem of multiple sample aliquots and allows for the 
identification and quantification of glycogen, lipids, metabolites and proteins from a small amount of a single sample. I employed 
and optimized a liquid-liquid extraction method using the animal model organism Drosophila melanogaster. The three-phase 
MTBE:MeOH:H2O extraction system comprises of an upper lipid-containing (MTBE) phase, a lower polar metabolites-containing 
(MeOH:H2O) phase and a solid pellet, which contains both, proteins, glycogen and insoluble polymers (in the case of Drosophila the 
chitin of the exoskeleton). To identify and quantify the individual compounds different analytical methods and instrumentations were 
employed. In a proof of concept experiment I will provide data from a small sample set using reversed phase liquid chromatographic 
(LC) mass spectrometer (MS) for the analysis of more than 300 lipid species, next to gas chromatography (GC) MS analysis of 
primary metabolites. Additionally, proteins and glycogen, from the precipitated pellets, were analyzed using nano-LC-MS and an 
enzymatic assay, respectively.
P-111 NMR-based metabolic profiling of rice (Oryza sativa L.) grown under a free-air CO2 enrichment (FACE) field experiment.
PRESENTING AUTHOR: Yasuyo SEKIYAMA, Food Research Institute, NARO, Japan
CO-AUTHORS: Toshihiro Hasegawa, Hiroshi Ono, Hidemitsu Sakai, Yasuhiro Usui, Takeshi Tokida, Hirofumi Nakamura, Jun Kikuchi       
   Global climate change is projected to have significant impacts on crop production. Previous studies show that elevated atmospheric 
CO2 concentrations (E-[CO2]) enhance photosynthesis, as well as rice growth and yield, but decrease grain appearance quality. 
The yield and quality responses differ depending on cultivars, but the underlying mechanism is poorly understood. Metabolite 
signatures measured with a field metabolomics approach may provide insight into such mechanisms. Here we report the NMR-based 
metabolic profiling of two cultivars, differing in response to E-[CO2],  grown at the Tsukuba Free-Air CO2 Enrichment (FACE) facility 
(Ibaraki, Japan) to test the effects of E-[CO2] on rice paddy under open-field conditions. A high-yielding indica cultivar, Takanri, 
and a standard japonica cultivar, Koshihikari, were grown in 2012 at ambient (383 ppm) and elevated CO2 (578 ppm), and the 
aboveground organs were sampled at panicle initiation (early July), heading (early August) and mid-grain filling (late August). The 
1H NMR spectra of metabolites soluble in a D2O-based buffer were measured and subjected to multivariate or univariate analysis. 
Principal component analysis showed class separation corresponding to the organs, cultivars, and growth stage of the plants. The 
effect of E-[CO2] on metabolite profile was greater in the leaf blade of Koshihikari at panicle initiation and of Takanari at heading. 
Details of the metabolic changes will be presented.   References   Hasegawa et al., Improving Modeling Tools to Assess Climate 
Change Effects on Crop   Response (eds Hatfield JL, Fleisher D) (2015).   Nakamura et al., Journal of Agricultural Meteorology 
(2012).   Usui et al., Global Change Biology (2016).  
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P-112 Using Metabolomics to Assess the Early Effects of Zinc and Boscalid On Estuarine Polychaete.
PRESENTING AUTHOR: Georgia Sinclair, CAPIM, School of Biosciences, The University of Melbourne, Parkville, Vic 3010, Australia
CO-AUTHORS: Allyson O’Brien, Mick Keough, Dedreia Tull, David De Souza, Saravanan Dayalan, Sara Long                                           
Early detection of chemicals that cause adverse effects on organisms in aquatic ecosystems is crucial to protect diversity and 
to maintain ecosystem functions. Metabolomic approaches have recently shown promise to develop sensitive small metabolite 
biomarkers of low chemical exposure. Zinc is a persistent heavy metal commonly detected in most urban estuary and wetland 
sediments around Australia. Boscalid is a fungicide that has been routinely detected in estuaries (both in water and sediment) as 
result of agricultural run-off around Victoria. This study was a time-course experiment aimed at determining the metabolite changes 
in Simplisetia aequisetis (an estuarine polychaete), following exposure to a sub-lethal concentration of both zinc and boscalid 
in separate water-only exposures. Individuals were collected at six different time points over a two-week period to detect and 
understand changes in metabolites over time. Metabolites were extracted from whole worms and polar metabolites were measured 
using GCMS. The major metabolite classes detected in worms after exposure to boscalid included amino acids and sugars. When 
exposed to boscalid the changes in metabolites became noticeable at 48-hours onward. Zinc and boscalid had different metabolomic 
trending variations that were observed after exposure. Further investigation of these results will be discussed regarding the 
usefulness of incorporating environmental metabolomics into biomonitoring programs, as changes in metabolites could be used as 
diagnostic indicators of contamination.  
P-113 Metabolic effect of the OsCYP96B4 gene mutation in a novel semi-dwarf rice mutant investigated by NMR-based metabolomics and RNA-seq
PRESENTING AUTHOR: Limiao Jiang, Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical 
College, Huazhong University of Science and Technology, China ?Department of Diagnostic Radiology, Yong Loo Lin School of 
Medicine, National University of Singapore, Singapore §The authors contribute equally, China
CO-AUTHORS: Rengasamy Ramamoorthy, Shivshankar Umashankar, Srinivasan Ramachandran, Sanjay Swarup, Prakash P. Kumar       
Dwarfism and semi-dwarfism are among the most valuable agronomic traits in crop breeding, which were adopted by the “Green 
Revolution”. Previously we reported a novel semi-dwarf rice mutant derived from the insertion of a single copy of Ds transposon 
into the gene OsCYP96B4. But the systems metabolic effect of the mutation is not well understood, which is important for 
understanding the gene function. Here, the differences in the metabolome and transcriptome between the semi-dwarf mutant,  
ectopic expression (ECE) and wild-type (WT) rice were investigated by NMR-based metabolomics and RNA-seq. Compared with WT, 
ECE of the OsCYP96B4 gene resulted in significant increase of ?-aminobutyrate, glutamine, and alanine, but significant decrease 
of glutamate, aromatic and branched chain amino acids, and some other amino acids. The ECE caused significant concentration 
increase of monosaccharides (glucose, fructose), but significant concentration decrease of disaccharide (sucrose); induced significant 
concentration changes of metabolites involved in nucleotide (adenosine, adenosine monophosphate, uridine) and choline metabolism 
(phosphocholine, ethanolamine). These metabolic profile alterations were accompanied with changes in the genes involved in GABA 
shunt, amino acid metabolism, shikimate-mediated secondary metabolism, glycolysis pathway, sucrose metabolism and nucleotide 
metabolism. Semi-dwarf mutant showed similar but less pronounced changes, especially in the transcriptome. The present study 
indicates that OsCYP96B4 gene mutation caused significant alteration in the GABA shunt, amino acid metabolism, shikimate-
mediated secondary metabolism, glycolysis pathway, sucrose and nucleotide metabolism. It will provide essential information for the 
OsCYP96B4 gene function analysis and will serve as reference data for the development of new semi-dwarf mutants.
P-114 Metabolic reprogramming in PGPR-primed Sorghum bicolor in response to Colletotrichum sublineolum infection.
PRESENTING AUTHOR: Ian Dubery, University of Johannesburg, South Africa
CO-AUTHORS: Fidele Tugizimana, Paul Steenkamp, Lizelle Piater, Nico Labuschagne                                             
Defence priming is a complex natural phenomenon that pre-conditions plants for enhanced defence against a wide range of 
pathogens. It thus represents a sustainable alternative / complementary strategy for protection against disease. However, a 
comprehensive functional and mechanistic understanding of various layers of priming events is still limited. Here, a non-targeted 
metabolomics approach was used to investigate metabolic changes in plant growth promoting rhizobacteria (PGPR)-primed Sorghum 
bicolor seedlings following Colletotrichum sublineolum fungal infection. At the 4-leaf growth stage, plants were treated with a PGPR 
strain, Paenibacillus alvei at 108 cfu/mL. Twenty four h following PGPR application, plants were inoculated with C. sublineolum 
(106 spores/mL). The infection was monitored over time: 1, 3, 5, 7 and 9 d.p.i.. Non-infected plants served as negative controls. 
Intracellular metabolites were extracted with 80% methanol-water and analysed by UHPLC-MS. The acquired data was analysed 
using different chemometric methods. These computed models revealed strong defence-related metabolic reprogramming observed 
in primed (compared to naïve) plants as early as 1-3 d.p.i.. Evaluation of orthogonal projection to latent structure-discriminant 
analysis (OPLS-DA) loading shared and unique structures (SUS)-plots uncovered that the differential stronger defence responses 
against the fungal infection observed in primed plants involved mostly enhanced levels of amino acids (phenylalanine, tyrosine, 
tryptophan), phytohormones (JA and SA conjugates, and zeatin), and defence-related components of the lipidome. Furthermore, 
other defence responses in both naïve and primed plants were characterised by a complex mobilisation of phenolic compounds and 
de novo biosynthesis of 3-deoxyanthocyanidin phytoalexins (apigeninidin, luteolinidin), apigenin, luteolin and related conjugates.
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P-115 Metabolomics as a tool to study allelopathic interactions between Mediterranean plant species
PRESENTING AUTHOR: Monica Scognamiglio, Max Planck Institute for Chemical Ecology, Research Group Biosynthesis/NMR, 
Germany
CO-AUTHORS: Bernd Schneider                                                  
Allelopathy plays a very important role in ecosystems. It is defined as any direct or indirect, harmful or beneficial effect of one plant 
on another through the production of chemicals released into the environment.1  The understanding of this phenomenon has been 
partially constrained, among other things, by the methods available to study the secondary metabolites involved. A new method 
based on metabolomics has been recently developed,2,3 and it is herewith applied to the study of allelochemicals from selected 
plant species of the Mediterranean region. Donor plant (Arbutus unedo, Myrtus communis, Medicago minima and Daphne gnidium) 
extracts were analysed by 1H and 2D NMR in order to define their chemical composition. They were tested for their phytotoxicity 
on a receiving plant species (Aegilops geniculata) on which morphological and metabolomics analyses were performed. Tests were 
carried out also with partially purified fractions and with the pure putative allelochemicals. The extracts of the four plant species 
showed a strong inhibitory activity on the receiving plant. NMR paired with multivariate data analysis of the receiving plant let 
to hypothesize the main metabolic pathways affected. Studies with the pure compounds confirmed in some cases the putative 
allelochemicals, while in other cases it was possible to determine the occurrence of synergistic effects. Some of the compounds were 
taken up and, in some cases, modified by the receiving plant.    References  1. Rice E. L., Allelopathy, 1984 2. D’Abrosca B. et al., 
2013. Phytochemistry 93, 27 3. Scognamiglio M. et al., 2014. Phytochemistry 106, 69
P-116 Defence-related metabolic reprogramming in Sorghum bicolor in response to Colletotrichum sublineolum infection
PRESENTING AUTHOR: Fidele Tugizimana, Department of Biochemistry, University of Johannesburg, South Africa
CO-AUTHORS: Ian Dubery, Paul Steenkamp, Arnaud Djami-Tchatchou, Lizelle Piater                                             
Metabolic alterations of sorghum cultivars responding to Colletotrichum sublineolum infection, were investigated. Plants were 
inoculated with a fungal spore suspension (106 spores/mL) at the 4-leaves growth stage. The infection was monitored over time: 0, 
3, 5, 7 and 9 d.p.i.. Non-infected plants were used as negative controls. Intracellular metabolites were extracted with 80% methanol-
water. The extracts were analysed on an UHPLC system coupled to high-definition mass spectrometry and the acquired data were 
processed and analysed. Chemometric models indicated time- and cultivar-related metabolic changes that reflect defence responses 
to the infection. Metabolic pathway and correlation-based network analyses revealed a functional metabolic web, containing defence-
related molecular cues to counterattack the pathogen’s invasion. Components of this network are altered-metabolites from a range 
of interconnected metabolic pathways including phenylalanine metabolism, phenylpropanoid/flavonoid biosynthesis, riboflavin- and 
tryptophan metabolism; with the phenylpropanoid/flavonoid pathways being the central hub of the web. One of the key features of 
this altered metabolism was the accumulation of an array of phenolic compounds, particularly the 3-deoxyanthocynidin phytoalexins, 
apigeninidin and luteolinidin (and related conjugates), that exhibit fungitoxic properties to halt pathogen proliferation. The metabolic 
results were complemented by gene expression analyses that showed upregulation of defence-related genes, PR3, PR10, PAL, 
PPO and flavonoid 3’-hydroxylase (F3’H). Unravelling key characteristics of the biochemical mechanism underlying the sorghum–C. 
sublineolum interactions provided valuable insights with potential applications in crop protection. Furthermore, the study contributes 
to ongoing efforts towards a comprehensive understanding of the regulation of plant metabolism under biotic stress. 
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P-118 Callus tissues as model systems for studying host-pathogen interactions between New Zealand kauri and Phytophthora species.
PRESENTING AUTHOR: Laura Raymond, Scion, New Zealand
CO-AUTHORS: Stefan Hill, Nari Williams                                                
The mighty kauri (Agathis australis), one of New Zealand’s most iconic indigenous tree species is currently under serious threat from 
kauri dieback, a deadly disease caused by the pathogen Phytophthora agathadicida. Phytophthora, which translates from Greek 
as “plant destroyer” have been the cause of some of the most devastating widespread global epidemics, with perhaps the most 
notorious example P. infestans the cause of the 1840’s Irish potato famine. To understand the mode of infection of Phytophthora, 
we have employed a systems biology approach covering a range of analyses from genes (transcriptomics) to pathology. As part 
of this study, metabolomics based on NMR and LC-MS has been implemented to understand chemical markers associated with the 
various infection stages. Complications can arise in analysis when dealing with real world trees that have not only Phytophthora, 
but a host of unknown other biotic and abiotic stressors impacting on the metabolome. To overcome this challenge and single out 
chemical markers for Phytophthora infection (either from the host or Phytophthora) plant callus tissue was cultured as model system 
for studying host-pathogen interactions. Kauri callus tissue was challenged with three species of Phytophthora known to infect kauri 
(P. agathidicida, P. cinnamomi, and P. multivora) and 1H NMR spectroscopy of aqueous extracted secondary metabolites was used 
to screen the validity of this approach to understand the infection process.   Preliminary 1H NMR analysis indicate that the controls 
and Phytophthora infected callus tissues have statistically distinct chemical profiles and these differences correlate with the level of 
Phytophthora infection.
P-119 LIPIDOMICS APROACH TO IDENTIFY NOVEL SALINITY RESPONSE MECHANISUMS IN BARELY ROOTS
PRESENTING AUTHOR: Thusitha Rupasinghe, Metabolomics Australia, Australia
CO-AUTHORS: Dingyi Yu, Siria Natera, Ute Roessner                                               
Barley (Hordeum vulgare L.) is an essential food and brewing crop. As a glycophyte, it suffers substantial yield loss when grown 
under saline conditions. Relatively little is currently understood of salt stress perception and responses in plant roots, which involve 
complex changes at the physiological, metabolic, molecular, transcriptional, and genetic level. We aim to develop new tools to unravel 
how plants respond to the perception of salt stress. Evidence is accumulating that lipid signaling is an integral part of the complex 
regulatory networks in the responses of plants to salinity through modifications of membrane lipids, which occur through the activity 
of phospholipases, lipid kinases and phosphatases such as phospholipase D and diacylglycerol kinase that produce different classes 
of lipid and lipid-derived messengers. In addition, abiotic stress provokes enhanced production of reactive oxygen species, resulting 
in lipid modifications producing oxidized lipid species..      Initial analyses using lipidomics revealed that roots from tolerant and 
sensitive cultivars respond differently to salt stress. To investigate the modifications of lipids leading to root responses to salinity, we 
are using a combination of multiple approaches such as targeted and untargeted lipid analyses of barley roots. We also developed 
new lipidomics approaches using high-resolution mass spectrometry technologies to monitor the level of oxidized lipid species 
produced in barely roots due to salinity. Given the lack of fundamental knowledge of the lipids involved in signaling and metabolism 
under salinity stress, our results provide insight into novel mechanisms how barley roots respond to salt stress.
P-120 ENVIRONMENTAL METABOLOMICS PROVIDES INSIGHTS INTO PHYSIOLOGICAL RESPONSES OF SOUTHERN SAND FLATHEAD IN PORT PHILLIP BAY
PRESENTING AUTHOR: Dedreia Tull, Metabolomics Australia, Bio21 Molecular Science and Biotechnology Institute, The University 
of Melbourne, Australia
CO-AUTHORS: Sara Long, David de Souza, Konstantinos Kouremenos, Jarrad Baker, Kathryn Hassell, Malcolm McConville, Vincent 
Pettigrove, Marthe Gagnon                                       
Port Phillip Bay is located on the central south coast of Victoria, Australia. It is a large urbanised marine embayment encompassing 
an area of roughly 1950 km2 with a coastline approximately 264 km; and hosts a population of over four million people on its 
catchment basin. The Bay receives waters from the Yarra River, discharges from sewage treatment plants, and petrochemical and 
agricultural inputs. It is home to a wide range of fish species, with seagrass beds used as nursery sites. The southern sand flathead 
(Platycephalus bassensis) are long-lived carnivorous ambush predators that have a sedentary, non-migratory lifestyle. They conceal 
themselves in fine sediments, are not strong swimmers and are believed to be representative of the area from where they are 
collected. Consequently they are considered a suitable bioindicator species for their local environment. The aim of this study is to 
use metabolomics to investigate responses of sand flathead to different environments in Port Phillip Bay. Two year old female fish 
were collected from five sites within the bay. Assessment of the fish for general condition showed differences between fish from 
urbanised/industrialised sites (Corio Bay, Hobsons Bay, Mordialloc) compared to fish from low population density areas (Sorrento 
and St Leonards). For the metabolomics analysis, livers were subjected to polar metabolite analysis using gas chromatography mass 
spectrometry. The PCA results showed that the samples from Sorrento separated from those of the other sites. Notably, fish from 
Sorrento and Mordialloc showed significant differences in amino acids, glycolytic and TCA intermediates.
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P-121 Bisphenol S Exposure Modulate Macrophage Phenotype as Defined by Cytokines Profiling, Metabolomics and Lipidomics analysis
PRESENTING AUTHOR: Chao Zhao, State Key Laboratory of Environmental and Biological Analysis, Hong Kong Baptist 
University;State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, 
Chinese Academy of Sciences, Hong Kong
CO-AUTHORS: Zhi Tang, Jiacheng Yan, Zongwei Cai                                               
As an important structural analogue of bisphenol A (BPA), bisphenol S (BPS) has been used as alternative to BPA in industrialized 
production. However, the immunotoxicity of BPS remains poorly understood. As a critical model in inflammatory responses, 
macrophages are used to explore the immunotoxic potential and mechanisms of BPS at environmentally relevant concentrations 
in our study. Here, we are combining molecular toxicology and mass spectrometry (MS)-based global metabolomics and lipidomics 
study together to estimate the variation of cytokines profiling and metabolism characteristic following BPS exposure. Our results 
demonstrated that BPS exposure induced pro-inflammatory phenotype by activating the immuno-related cytokines which include 
TNF-?, IL-1? and IL-6, modulating metabolic pathways which include glycolytic, glutathione (GSH), sphingomyelin (SM)-ceramide 
(Cer), glycerophospholipids (GPs) and glycerolipids (GLs). These toxicological mechanisms are providing us with a deeper 
understanding of the critical role of metabolites and lipids reprogramming in immunotoxicity of BPS.
P-122 Identifying Early Urinary Metabolic Changes with Long-Term Environmental Exposure to Cadmium by Mass-Spectrometry-Based Metabolomics.
PRESENTING AUTHOR: Gao Yanhong, Centers for Disease Control and Prevention of Guangdong Province, China, China
CO-AUTHORS: Lu Yonghai                                                  
Cadmium (Cd) is a common environmental pollutant, and urinary Cd (UCd) is generally used as a marker of exposure; however, our 
understanding on the related urinary metabolic changes caused by Cd exposure is still not clear. In this study, we applied a mass-
spectrometry-based metabolomic approach to assess the urinary metabolic changes in human with long-term environmental Cd 
exposure, aimed to identify early biomarkers to assess Cd nephrotoxicity. Urine samples from 94 female never smokers aged 44?70 
with UCd in the range of 0.20?68.67 ?g/L were analyzed by liquid chromatography quadrupole time-of-flight mass spectrometry 
(LC-Q-ToF-MS) and gas chromatography?mass spectrometry (GC?MS). It was found that metabolites related to amino acid 
metabolism ( L -glutamine, L -cystine, L -tyrosine, N-methyl- L -histidine, L -histidinol, taurine, phenylacetylglutamine, hippurate, and 
pyroglutamic acid), galactose metabolism ( D -galactose and myo-inositol), purine metabolism (xanthine, urea, and deoxyadenosine 
monophosphate), creatine pathway (creatine and creatinine), and steroid hormone biosynthesis (17-?-hydroxyprogesterone, 
tetrahydrocortisone, estrone, and corticosterone) were significantly higher among those with a UCd level higher than 5 ?g/L. 
Moreover, we noticed that the level of N-methyl- L -histidine had already started to elevate among individuals with a UCd 
concentration of ?2 ?g/L. The overall findings illustrate that metabolomics offer a useful approach for revealing metabolic changes as 
a result of Cd exposure.
P-123 Metabolomics analysis of volatile organic compounds from a tomato core collection
PRESENTING AUTHOR: Chang-Muk Lee, National Institute of Agricultural Sciences, Rural Development Administration, South 
Korea
CO-AUTHORS: Su-Yeon Kim, Jaeeun Song, Joon-Soo Sim, Bum-Soo Hahn                                             
The combination of volatile organic compound(VOC) plays an important role in the food and beverage industries. Based on the 
features of fruit weight, sweetness, peel color, and flesh color, we selected a tomato core collection constituted with 43 varieties. 
To investigate compositional differences that were involved in ripening of tomato, we analyzed VOCs by targeted-metabolomics. 
Among 43 tomato varieties, we identified 40 volatile metabolites from 27 groups of tomato fruits by comparing GC-TOF-MS profiles 
of each steam-distilled extracts. The VOCs observed in the majority of tomato varieties were trans-2-hexenal(42.4% of total VOCs) 
and hexanal(15.9%). Another abundant VOCs included ethylbenzene(6.8%), 6-methyl-5-hepten-2-one(3.6%), 1-hexanol(3.6%), 
2-phenylethanol(3.5%), and 2-isobutylthiazole(3.3%). For the characterization of cultivar-specific VOCs, the metabolite 
profiles were subjected to principal component analysis. The component clusters revealed that the 2 Solanum lycopersicum 
varieties(WIR6473 and 19990913) showed high accumulation of terpenes, including farnesylacetone and trans-geranylacetone. The 
amounts of volatile alcohols, 1-hexanol and trans-2-hexen-1-ol, was highest in S. ceresiforme(IT297128). Interestingly, 4 wild-
types demonstrated unique constituents of VOCs. S. galapagense(IT199485) contained trans-2-nonenal and heptanal, while S. 
pimpinellifolium(IT173722) maintained 1-octen-3-one, 1-heptanol, and linaool. Other wild-type varieties, S. peruvianum(IT173831) 
and S. lycopersicum(IT296530) showed high contents of 1-octen-3-ol, and nonanal, respectively. There was no clear relationship 
between VOCs and agricultural categories chosen for the construction of core collection. These results imply the possibility of VOC 
component indexing between diverse tomato core collections by GC-TOF-MS metabolomics.
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P-124 Development of a GCMS-based Metabolomics Pipeline and its Application to an Insect Model
PRESENTING AUTHOR: Joel Herring, Queensland University of Technology, Australia
CO-AUTHORS: Pawel Sadowski, Silvia Gemme, Anthony Clarke                                               
  Tephritid fruit flies are the single most important horticultural pests of the Australian, Pacific, and Asian regions, being the major 
cause of ‘grubs in fruit’ and causing 100’s of millions of dollars of crop damage annually (Fletcher 1987).  Development of novel 
tools to understand the biology of these pests better is crucial to their eventual long-term and environmentally sustainable control 
(Clarke et al. 2011). Metabolomics is emerging as a convenient and relatively cheap way to validate the data found using techniques 
such as genomics and transcriptomics. This study aims to develop a GCMS-based (trimethylsilyl (TMS) derivatised) metabolite 
profiling pipeline using a low resolution instrument, Shimadzu GCMS TQ8040 and a high resolution accurate mass platform, the 
Thermo QExactive GC Orbitrap (QEGC) and apply it to the Queensland fruit fly (Bactrocera tryoni). The data corresponding to a 
different dietary regime was analysed using TraceFinder and Skyline software tools. The high resolution mass spectra obtained from 
the QEGC provided confident compound identification (via the Golm Database) when Tracefinder software was used for compound 
deconvolution while Skyline enabled compound quantitation using extracted ion chromatogram (XIC) data. This is the first time a 
metabolite profiling approach has been applied to this destructive pest.    
P-125 Environmental Metabolic Footprinting (EMF) vs half-life: proposition of an integrative new proxy to evaluate pesticide environmental fate and impact
PRESENTING AUTHOR: Cédric BERTRAND, CRIOBE - Université de Perpignan, France
CO-AUTHORS: Marie-Virginie Salvia, Amani Ben Jrad, Rahul Suryawanshi, Chandrashekhar Patil, Delphine Raviglione                                            
Pesticides are regularly used for diverse applications and are disseminated in the environment. These substances could be harmful 
and their presence must be monitored. To date, the half-life, t1/2, was often employed in order to study the environmental fate 
of pesticides. It can indicate whether or not the compound will persist in the environment. However, this value gives restricted 
information as it does not describe all the phenomena occurring such as the formation of by-products and the effect on biodiversity. 
A new approach, the “Environmental Metabolic Footprinting” (EMF)[1][2][3], was developed in the laboratory. It brings a new 
integrative proxy, the resilience time that reflects all the previously described phenomena. One other advantage appearing using this 
approach is that it permits studying the environmental impact of complex mixtures. No tools are available yet and they are required 
as biocontrol products are considered. This approach was tested within microcosms (soil, sediment) on botanicals and microbials (Bti 
,insecticide).  [1] C. Patil et al. (2016) EMF : a novel application to study the impact of a natural and synthetic ?-triketone herbicide 
in soil. Science of the Total Environment 566-567, pp. 552-558  [2] C. Patil et al. (2015) Metabolomics approach to evaluate fate 
and impact of natural herbicides in the environment. The 11th International Conference of the Metabolomics Society, San Francisco, 
(Poster).  [3] C. Bertrand et al. (2016). Metabolomics approach to evaluate resilience of soil after treatment with natural herbicide. 
13th International Conference on Protection and Restoration of the Environment, Mykonos , Greece (Oral).
P-126 Functional analysis of Buffalo grass (Stenotaphrum secundatum) expressing a novel gene conferring glufosinate-resistance
PRESENTING AUTHOR: SIRIWAT BOONCHAISRI, School of Science,  RMIT University, Australia
CO-AUTHORS: DANIEL DIAS, TREVOR STEVENSON                                                
Buffalo grass (Stenotaphrum secundatum) is a popular turfgrass species widely used in golf courses, athletic fields and home 
lawns. A serious problem affecting the quality of this turf is the infestation with annual weeds that requires extensive effort and 
investment to control. To simplify weed management, a transgenic herbicide-resistance (HR) turfgrass together with a broad 
spectrum herbicide affords cheap and efficient weed control. Recently, a novel gene sequence isolated from Alcaligenes faecalis was 
inserted into the Buffalo grass to provide resistance to the commercially available, broad spectrum herbicide, glufosinate. Molecular 
analyses of 4 transgenic events revealed a variation in gene copy number being corresponded with expression levels of this gene. 
In a glasshouse experiment, all of our HR grasses survived the glufosinate treatment at a commercial dose (0.5% v/v) over the wild 
types. Furthermore, the HR grasses with a greater insert gene copy numbers demonstrated lower glufosinate-induced visual injuries 
than the other HR grasses. To further assess the effects of the introduced gene on the molecular and physiological phenotypes, 
GC-MS based metabolite profiling was performed. Comprehensive analyses, both molecular and metabolomics confirmed the 
negligible effects of expression of the inserted gene upon plant metabolisms. Here, detailed analyses and supporting evidence will be 
presented.
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P-127 Metabolomics reveals metabolic disturbance in adult mice after neonatal exposure to triphenyl phosphate and its metabolite
PRESENTING AUTHOR: Dezhen Wang, China Agricultural University, China
CO-AUTHORS: Wentao Zhu, Yao Wang, Jin Yan                                               
The widespread application of organophosphates flame retardants (OPFRs) provides the opportunity for human exposure, which is 
raising great concerns. However, information on these chemicals’ toxicological effects in rodents is limited. Here, we investigated 
the effect of triphenyl phosphate (TPP), one of the most widely used OPFRs, and its main metabolite diphenyl phosphate (DPP) on 
the endocrine systems and metabolic profiles after neonatal exposure from postnatal day 1 to 10 in ICR mice. Both TPP and DPP 
exposure advanced the opening of vagina, but did not induce significant uterotrophic response. In addition, low dose of TPP increase 
the body weight of male mice. Metabolic fingerprinting showed that low doses of TPP mainly disturbed lipid metabolism, while DPP 
and high doses of TPP impacted pyruvate metabolism and TCA cycles. Taken together, our observations show that TPP could affect 
endocrine systems and induced metabolic disturbances in adult mice.
P-128 Variation and Correlation Analysis of Carotenoids and Tocols in Pigmented Rice Cultivars
PRESENTING AUTHOR: Jae Kwang Kim, Incheon National University, South Korea
CO-AUTHORS: Soo-Yun Park, Sun-Hyung Lim, Sun-Hwa Ha, Jae Kwang Kim                                             
Correlations between the concentrations of various metabolites can be examined to gain information regarding metabolic 
associations. Gas-chromatography coupled with time-of-flight mass spectrometry (GC-TOFMS) and high-performance liquid 
chromatography (HPLC) were used to analyze the relationships between flavonoids, carotenoids , policosanols, sterols, and tocols 
in rice (Oryza sativa L.), including five black cultivars and two red cultivar. The metabolite profiles were subjected to data mining 
processes, including principal component analysis (PCA), Pearson’s correlation analysis, hierarchical clustering analysis (HCA) and 
batch learning-self organizing map analysis (BL-SOM). We performed PCA to evaluate the differences among cultivars. PCA could 
fully distinguish between these cultivars. HCA of these metabolites resulted in clusters derived from common or closely related 
biochemical pathways. The distance among neurons within SOMs indicates the correlation between metabolites. Our results showed 
that carotenoids were correlated positively with tocotrienols. The metabolic profiling approach could be used as an alternative 
method to predict food quality and identify metabolic links in complex biological systems.
P-129 Quantification of de novo triacylglycerol synthesis through stable isotopic labelling during nitrogen deprivation in Chlorella sp
PRESENTING AUTHOR: Sheik Nadeem Elahee Doomun, Deakin University, Australia
CO-AUTHORS: Damien Callahan, Stella Loke, Peter Beech                                               
Neutral lipids [e.g., triacylglycerol (TAG)] are high-energy storage molecules accumulated by some microalgae. The fatty acids (FAs) 
within TAGs can be converted to fatty acid methyl esters for biodiesel. It is well-documented that stress conditions can increase 
TAGs production in some microalgae. However, it was unknown how much of the newly made TAG was from newly fixed carbon 
or recycled carbon from within the cell. To determine the changes in carbon partitioning, the 13C stable isotope was added to the 
culture as bicarbonate, ensuring any newly fixed carbon would result in labelling of the FAs. To measure the FA labelling, a novel 
approach was applied using solid phase extraction to isolate the three main lipid classes followed by negative chemical ionisation gas 
chromatography mass spectrometry of pentafluorobenzl ester derivatives of the FAs. This technique allows intact FAs to be measured 
and hence the full isotopomer pattern can be determined. This novel approach enabled the amount of de novo FA production to be 
determined in the three key lipid classes. These data showed that, under nitrogen deprivation (ND), de novo FAs in TAGs were still 
being formed at three times the rate compared to nitrogen replete conditions. The de novo TAGs formed under ND were synthesised 
mostly from newly fixed carbon; however, there was some evidence that TAGs were also produced by recycling carbon from the 
pre-existing lipid pool. These data have great implications for optimising growth parameters towards maximising TAG synthesis while 
maintaining high rates of biomass production.
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P-130 The impacts of Barley yellow dwarf virus titre on the wheat metabolome under elevated CO2
PRESENTING AUTHOR: Simone Rochfort, Agriculture Research Victoria, Australia
CO-AUTHORS: Simone Vassiliadis, Kim Plummer, Kevin Powell                                               
Nuruk, a traditional Korean fermentation starter for brewing alcoholic beverages from starch, is a dough made from grains such as 
wheat, barley, or rice by various enzyme-releasing microorganisms. To investigate whether these microorganisms in Nuruk affect the 
quality of the alcoholic beverages produced, we conducted a foodomics study on three kinds of superior quality Korean traditional 
Nuruk, Omegigok, Baksuwhandongjugok, and Migok. These Nuruk were selected from 58 kinds of restored or commercial Nuruk 
through assessments of brewing properties and organoleptic characteristics. The foodomics study of each Nuruk as well as its 
alcoholic beverage products was performed through a combination of metagenomics and metabolomic approaches, involving various 
instruments such as GC-MS, CE-TOF-MS, and 1H NMR along with multivariate analyses. In addition, microbial communities were 
monitored during the fermentation process to identify correlative relationships between metabolites and microbes. Results revealed 
that the volatile metabolites of alcoholic beverages fermented using Nuruk are likely strongly affected by the microbial community 
in Nuruk, whereas the non-volatile metabolites are affected by Nuruk ingredients. In addition, even if Nuruk is contaminated 
by pathogenic microorganisms, these microbes are killed with the commencement of alcohol fermentation, and the microbial 
composition reverts to the normal, desirable Nuruk microbial composition. This metabolomic information and profile of each Korean 
traditional Nuruk will contribute to the understanding of the correlation between Nuruk and traditional alcoholic beverage quality as 
well as to the overall development of alcoholic beverages.
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P-287 In-orchard metabolomics to understand plant responses to orchard management practises
PRESENTING AUTHOR: Daryl Rowan, Plant & Food Research, New Zealand
CO-AUTHORS: Tony McGhie, Janine Cooney, Helen Boldingh, Duncan Hedderley , Annette Richardson
                                           
Kiwifruit (Actinidia) are vigorous perennial vines requiring intensive management (canopy pruning, girdling and&nbsp;elicitor 
treatments) to maximise fruit yields and provide protection from the bacterial pathogen Pseudomonas syringae pv. Actinidiae. We 
ask; can we employ in-orchard metabolomics to understand and predict plant responses to these orchard management practises? 
We have adopted a combined LC-MS based metabolomics and targeted phytohormone analysis approach. Progress, and challenges, 
encountered in moving metabolomics into the orchard are discussed.
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O-93 MS-based Flavor Profiling of Okinawan Subtropical Plant Resources
PRESENTING AUTHOR: Yonathan Asikin, Division of Biosphere Resource Science and Technology, Graduate School of Life and 
Environmental Sciences, University of Tsukuba, Japan
CO-AUTHORS: Ning Wang, Miyako Kusano, Naoto Hirose, Makoto Takeuchi, Koji Wada                                            
Volatile flavors are complex mixture of aroma compounds in various concentration and intensity levels in organisms, particularly in 
plants. They make large effects on flavor perception and food taste, therefore to food quality. Comprehensive volatile flavor analysis 
by using gas chromatography-mass spectrometry (GC-MS) with selected ion monitoring (SIM) revealed discriminant chemical markers 
in volatile flavor component of Okinawan subtropical plant resources, including Hirami lemon and pineapple. The recorded total ion 
masses were hyphenated and used as dataset for discriminating genetic and seasonal diversities of these fruits. The unsupervised 
multivariate data construction via principal component analysis extracted specific qualifier ions. These are m/z 119, 134, and 135 
corresponding to the mass spectrum of limonene and ?-terpinene and m/z 149 and 164 in that of methyl thymol as discriminant 
variables in the profiles of Hirami lemon, whilst m/z 57, 59, 74, 88, and 134 were found in the mass spectra of various esters in 
pineapple. The flavor profile constructions of these plant resources were further elucidated for their flavor distinctiveness using 
hierarchical clustering. The developed method was also applied to non-centrifugal brown sugars derived from sugarcane. The results 
revealed key discriminant ions for associated aroma compounds, including acetaldehyde (m/z 42 and 43), butanoic acid (m/z 55 
and 73), acetic acid (m/z 60), and pyrazines (m/z 94, 108, and 122). The GC-MS/SIM-based volatile flavor profiling thus provide 
discriminative ion masses in aroma compounds of the Okinawan subtropical fruits as a potential “digital markers” that may impact 
the quality of plant resources and products.
O-108 Demonstration of the utility of biomarkers for dietary intake assessment; proline betaine as an example
PRESENTING AUTHOR: Helena Gibbons, University College Dublin, Ireland
CO-AUTHORS: Charlotte Charlotte JR Michielsen Michielsen Michielsen, Milena Rundle, Gary Frost, Breige McNulty, Anne Nugent, 
Janette Walton, Albert Flynn, Michael Gibney, Lorraine Brennan                                      
There is growing interest in the development of metabolomics derived dietary biomarkers as objective measures of dietary intake. 
However, there is a dearth of studies demonstrating dose-response relationships and most importantly, use of metabolomics derived 
dietary biomarkers to estimate food intake is absent. The objective of this study was to demonstrate the use of dietary biomarkers 
in quantifying citrus intakes. NutriTech participants (n=50) consumed varying amounts of orange juice for three days over three 
consecutive weeks. Urine samples were collected and analysed on a 600-MHz Varian NMR spectrometer using the first increment 
of a NOESY pulse sequence. Calibration curves were developed to predict intakes and an independent cohort (n=565) validated 
the calibration curves. Proline betaine displayed a dose-response relationship to increasing orange juice in 24h and fasting samples 
(p&lt;0.001). In a test set, orange juice intakes predicted using calibration curves displayed excellent agreement with true intake 
(bias: 43g: 24h, -18g: fasting samples). There were significant associations between predicted orange juice intake measured in 
24h and fasting samples and true intake (r=0.710-0.919). Citrus intakes were predicted for the independent cohort with excellent 
levels of agreement with self-reported intake (bias 22g) and agreement improved following normalisation to osmolality (bias 4g). 
The development of calibration curves successfully enabled proline betaine to estimate citrus intakes in a large cross-sectional study. 
Furthermore, this was supported by demonstrating a dose-response relationship between proline betaine and orange juice intake. 
Expansion of this approach to other foods will be important for the development of objective intake measurements.
O-111 A muti-omics approach to understanding flavour-compound production in rice
PRESENTING AUTHOR: Dara Daygon, The University of Queensland, Australia
CO-AUTHORS: Sangeeta Prakash, Ben Ovenden, Peter Snell, Mariafe Calingacion, Louise Forster, Mary Garson, Susan McCouch, 
Melissa Fitzgerald                                       
Screening for rice aroma quality has, in the past, focused solely on one fragrant compound, 2-acetyl-1-pyrroline (2AP), a strategy 
which is not sufficiently robust for large-scale analysis, and is not representative of the total aroma experience of rice consumers. 
We overcame these limitations by combining descriptive sensory evaluation with trained panellists, untargeted metabolite profiling of 
volatile compounds by two dimensional gas chromatography- time-of-flight mass spectrometry (GC ´ GC-TOF-MS), and a genome-
wide association study (GWAS) using genotyping-by-sequencing. We determined the important metabolites that correlate with 
both pleasant and unpleasant aroma perception, and annotated these compounds through a combination of library matching and/
or synthesis of authentic chemical standards. We further validated the impact of these metabolites on rice aroma in a set of rice 
varieties grown across three locations in Australia. Lastly, the genetic basis of the metabolites was determined through GWAS in 
a collection of 380 rice accessions. This approach lead to: (i) the identification of compounds that significantly impact rice aroma, 
and therefore, consumer preferences; (ii) the discovery of metabolites that provide evidences to unravel the biosynthesis 2AP; (iii) 
the identification of genetic regions and candidate genes associated with the production of several compounds; (iv) recognition 
of the effects of genotype-by-environment (GxE) interaction on the accumulation of indole, a repulsive-smelling compound whose 
production is found to be triggered by stress in some rice varieties. These results provide essential information in rice varietal 
development and in the optimisation of management practices in rice farming systems.
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O-123 Detection of Novel QTLs for Metabolomic and Agronomic traits in Tea (Camellia sinensis)
PRESENTING AUTHOR: Robert Koech, University of Pretoria, South Africa
CO-AUTHORS: Pelly Malebe, Christopher Nyarukowa, Richard Mose, Samson Kamunya, Zeno Apostolides                                            
Tea (Camellia sinensis) is popular beverage globally and has been demonstrated to have wide variety of pharmacological properties 
including; antioxidant, anti-inflammatory, anticancer, antidiabetic and neuroprotective effects. These health benefits associated with 
tea intake has led to high consumption of tea products. Tea quality is a complex and subjective trait and depends on its biochemical 
components. In this study, we have developed a genetic map using metabolomics couple with DArTseq platform on a segregating 
251 F1 population derived from a reciprocal cross between two heterozygous tea cultivars (TRFK 303/577 and Gw Ejulu). The map 
consisted of 15 linkage groups that spanned 1162.80 cM with mean interval of 1.2 cM between markers. A total of 15 phenotypic 
traits were assessed in the two tea plant populations. Both interval and multiple QTL mapping revealed a total of 33 putative QTLs in 
the 15 LGs associated with tea quality at a significance genome-wide threshold of 5%. In total, six caffeine QTLs, 23 catechins QTLs, 
three theaflavins QTLs and one QTL for liquor brightness were detected. Of these 33, 13 major QTLs were identified for five traits 
in three main regions on LG01, LG03, LG11, LG12 and LG13. The population variability explained by each QTL was predominantly 
at moderate-to-high levels and ranged from 5.5% to 56.6%, with an average of 10.7%. The identification of QTLs that are linked 
to these markers at the seedling stage, and using Ultra-Performance Liquid Chromatography coupled with genetic markers would 
accelerate development of elite tea cultivars for marker-assisted selection.
O-128 A metabolomic approach to determine the influence of grape ripening, cultivar, vineyard site and vintage on wine composition
PRESENTING AUTHOR: Leigh Schmidtke, Charles Sturt University, National Wine and Grape Industry Centre, Australia
CO-AUTHORS: Alain Deloire, Campbell Meeks, Guillaume Antalick, Katja Suklje, John Blackman                                            
Understanding the interactions of environmental and vineyard management influences on grape berry composition are the mainstay 
challenges for viticulturists and winemakers worldwide.  Grape composition results from numerous interactions between cultivar 
growing conditions, water availability and the level of berry ripeness.  A temporal and spatial investigation of berry, and subsequent 
wine composition and style was undertaken for two consecutive vintages in climatically diverse regions of Australia.  Controlled 
triplicate fermentations of Shiraz and Cabernet Sauvignon grapes were undertaken.   Harvest dates were determined at defined berry 
maturities using a sugar accumulation model to target   three wine styles (Fresh, Intermediate and Mature).  Sensory descriptive 
analysis of wines enabled different styles to be readily identified.  Comprehensive profiling of grape composition, winemaking inputs, 
wine chemical and volatile composition, in addition to wine sensory scores generated nine individual data blocks for each wine.  A 
metabolomic approach (ANOVA Multiblock Orthogonal PLS) was used to elucidate the impact of experimental factors (vineyard, 
region, vintage and grape harvest stage) for each cultivar.  Loadings extracted from models with significant effects were subject to 
hierarchical cluster analysis (HCA) following rotation of model components to a consistent direction of effects levels in scores plots.  
The contribution of each data block to experimental factors, ANOVA designs and HCA assists in understanding the impact of grape 
berry ripening on Shiraz and Cabernet Sauvignon wine composition.  Whilst vintage is a significant contributing factor, differences 
arising from grape harvest stage, region and vineyard management practices on grape berry and wine compositions could be 
determined.
O-220 Tomato juice consumption alters the human plasma metabolome
PRESENTING AUTHOR: Jessica Cooperstone, The Ohio State University, United States
CO-AUTHORS: David Francis, Steven Schwartz, Janet Novotny, Earl Harrison                                             
Consuming a diet rich in tomatoes has been associated with a decreased risk for a number of different chronic diseases, including 
heart disease and cancers.  Most attention has been paid to lycopene, the red pigment in tomatoes, as being responsible for these 
effects.  However, studies where whole tomatoes are administered are often more efficacious than purified lycopene, suggesting 
other compounds from tomatoes may also play a role.  The objective of this study is to understand how tomato supplementation 
affects the global metabolome of humans to better contextualize their health benefits.  Tomatoes were grown specifically for 
this study and hot break processed to be shelf stable. Healthy non-smokers (n=35, BMIs from 18.5-30 kg/m2) consumed a low 
carotenoid diet for two weeks, and then all subjects consumed the same basal diet (designed for weight maintenance) for 4 weeks 
supplemented with 360 mL of one of three juices: high ?-carotene tomato juice (variety 97L97), high lycopene tomato juice (variety 
OH2461), or a calorie matched cucumber juice control.   Methanolic extracts of plasma were analyzed comparing metabolite 
differences in individuals on these three diets.  By employing UHPLC-QTOF-MS-based untargeted metabolomics, we were able to 
detect over 5,000 entities in plasma, and distinguish metabolite profiles based on diet using multivariate statistics and modeling 
techniques.  An understanding of both exogenous and endogenous metabolomic changes in humans consuming tomatoes can 
generate testable hypotheses to understand ways in which this fruit may be exerting protective effects.
Metabolomics in Food Research - Edibilomics
13th Annual Conference of the Metabolomics Society
Page 85
O-229 Inhibiting lipid oxidation using hydrophobic and hydrophilic natural antioxidants in an oil in water emulsion food system
PRESENTING AUTHOR: Sara Ghorbani Gorji, University of Queensland, Australia
CO-AUTHORS: Mariafe Calingacion, Heather Smyth, Melissa Fitzgerald                                               
Oxidative instability of an oil in water emulsion (O/W) reduces the shelf life of the foods that contain these. Usually synthetic 
antioxidants are added to the O/W emulsion to prevent the development of rancidity. The objective of this work was to first 
elucidate the kinetic of oxidation in an O/W emulsion system stored for 92 days at 4 °C, 25 °C and 38 °C. Secondly, keeping in 
view the increasing demand for natural antioxidants, to investigate the antioxidant efficacy of hydrophobic and hydrophilic natural 
antioxidants in an O/W emulsion system stored at 38 °C for 60 days. The samples were analysed using both comprehensive two-
dimensional gas chromatography (GC x GC) coupled with mass spectrometry (MS), and UPLC with MS and ion mobility. Descriptive 
sensory analysis of samples, combined with metabolomics provided new insights about the efficacy of both natural hydrophobic and 
hydrophilic antioxidants in an O/W emulsion system. The evolution of oxidation products was analyzed during storage, and very close 
relationships were found between the volatile compounds generated from fatty acids and the original oil composition in the fatty 
acids. This research is able to provide the food industry with natural antioxidants to use with validated capacity in the O/W emulsion. 
O-272 Milk lipidomics: what we know and what we don’t
PRESENTING AUTHOR: zhiqian Liu, Agriculture Victoria, Australia
CO-AUTHORS: Simone Rochfort, Ben Cocks                                                
Bovine milk contains 3-6% of fat, of which the dominant portion is in the form of triacylglycerols (TAG), while polar lipids including 
phospholipids and sphingolipids represent 0.5-1% of total fat. Several hundred of lipid species have been identified in bovine milk so 
far, making it the most complex material in nature in terms of lipid composition.  Significant progress has been made in the past two 
decades in the identification of quantification of lipid species thanks to the advance in analytical tools especially high-resolution mass 
spectrometer. Currently milk lipid is characterised in two ways, i.e. global fatty acid profiling by GC and lipid species composition by 
LC-MS/MS; the former provides information on the abundance of each fatty acid, whereas the latter on the abundance and fatty acid 
composition of each lipid species. Using these analytical platforms, the influence of various genetic and environmental factors (such 
as cow breed, cow diet, stage of lactation and seasons) on lipid composition has been investigated. It is clear now that milk lipid 
composition displays remarkable cow-to-cow and seasonal variation, and is also prone to influence by animal diets. Milk lipidomic 
analysis still faces a number of challenges, such as determination of fatty acid position on glycerol backbone, chromatographic 
separation of TAG positional isomers and absolute quantification at the species level.  As well as the peculiarity of milk lipid 
composition, the pros and cons of various LC separation techniques and MS methodologies for lipid structural elucidation and 
quantification will be illustrated in this presentation.
O-303 GC/MS-based metabolomics approach for the discrimination of Indonesian specialty coffee
PRESENTING AUTHOR: Sastia Putri, Department of Biotechnology, Graduate School of Engineering, Japan
CO-AUTHORS: Tomoya Irifune, Yusianto Yusianto, Eiichiro Fukusaki                                               
Coffee is one of the most consumed beverages in the world and there is an increasing global trend for consumption of high quality 
coffee, such as specialty Arabica and fine Robusta. Development of single origin coffee is one of the most important strategies 
to maintain coffee quality, grade and high cupping score. Indonesia is the second largest specialty Arabica exporter in the world 
with 150,000 tons export per year. In addition, Indonesia has over a dozen variety of specialty coffees from different geographical 
origins such as Java, Sumatera, Bali and Toraja coffee that are renowned in the global specialty coffee market. Despite its profitable 
prospect and high demand in the market, there is no reliable and standardized method for discrimination of Indonesian specialty 
coffee. In this study, non targeted GC/MS-based metabolomics approach was used to classify Indonesian high quality coffee based on 
geographical origin.  Extracts of 16 green and roasted coffee beans (Coffea arabica and Coffea canephora ) from different cultivation 
areas in Indonesia were analyzed and subjected to principal component analysis. Ten Specialty Arabica coffee from 7 cultivation 
areas and five Fine Robusta from 3 cultivation areas were used to further classify Indonesian coffee according to origin of cultivation. 
The result from this study demonstrate that the species and origins can be rapidly discriminated by evaluating the major metabolites 
of green coffee beans using GC/MS-based metabolite profiling. This is the first report to address the classification of Indonesian 
specialty coffee using metabolomics approach.
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O-377 Estimation of dietary intake; comparison of a dietary biomarker and a 4-day food diary
PRESENTING AUTHOR: Lorraine Brennan, UCD Institute of Food and Health, Ireland
CO-AUTHORS: Xiaofei Yin, Helena Gibbons                                                
To date, there is a dearth of data comparing the performance of dietary biomarkers to self-reported estimates of intake. The 
objective of this study was to compare the estimation of chicken intakes using the chicken biomarker guanidoacetate and 
chicken intakes reported in a 4-day food diary.  Previously we identified guanidoacetate as a chicken biomarker using NMR based 
metabolomics. From the urinary guanidoacetate concentrations a calibration curve was built. Urine samples collected in the 
National Adult Nutrition Survey (NANS) (n=565) were analysed by a 600-MHz Varian NMR spectrometer and guanidoacetate was 
quantified. Chicken intake for NANS participants was determined using the biomarker data. Bland and Altman analysis evaluated the 
agreement between reported intake from NANS and intake from the biomarker data. A calibration curve was developed using urinary 
guanidoacetate concentrations ranging from 1.47 to 3.66 mM. Using this calibration curve (Y=1.08e-02X+4.96e-01, Y is urinary 
guanidoacetate (mM) and X is chicken intake (g)) and NANS participants’ urinary guanidoacetate levels (concentration ranges of 
0.07 to 3.13 mM) chicken intake was calculated for the NANS participants. Bland and Altman analysis revealed that the 95% limits 
of agreement of measurement differences ranged from -125 to 64.37 g/day, and the mean bias was -30.31 g/day demonstrating 
excellent agreement between reported and calculated chicken intake.  This study demonstrates that the chicken biomarker performed 
as well as the 4-day food record in determining intake. This opens the possibility for the biomarkers to aid dietary assessment in 
future studies and marks a significant development for metabolomics derived dietary biomarkers.
O-442 A metabolomics approach to investigating red wine mouth-feel
PRESENTING AUTHOR: Emma Sherman, The New Zealand Institute for Plant & Food Research, New Zealand
CO-AUTHORS: Damian Martin, Claire Grose, Silas Villas-Bôas, David Greenwood                                             
Wine mouth-feel is defined as tactile sensations felt inside the mouth when tasting wine or after expectoration. One important 
mouth-feel sensation often used when describing wines is “body”. The term body is often used interchangeably with viscosity 
which is logical given the numerous studies that have found significant correlations between perceived and physical viscosity 
measurements. Previous studies have found a number of small molecules present at relatively low concentrations in wine also 
correlate with perceived viscosity, indicating there may be more to wine body than rheology. In this study 48 Pinot noir wines from 
two vintages and several geographic regions were subjected to sensory and chemical analysis. An expert panel of wine professionals 
assessed the body of the wines as well as a number of other sensory attributes. The non-volatile profile of the wines was analysed 
by reverse phase UPLC coupled with a Thermo Scientific Q-Exactive Orbitrap mass spectrometry system utilising polarity switching. 
Accurate mass data were acquired in centroid mode and processed using MZmine. Multivariate statistical analyses of the non-volatile 
profiles in combination with perceived body ratings, as scored by the expert panel, showed that a number of different features 
correlated with wine body and were driving the models. MSn experiments identified several candidate biomarkers in the wines that 
may contribute to perceived body. This study provides a platform to advance knowledge about how small molecules may influence 
wine mouth-feel.
O-461 Dietary whole grain modifies microbiota and enhances production of novel compounds associated with energy metabolism
PRESENTING AUTHOR: Kati Hanhineva, University of Eastern Finland, Finland
CO-AUTHORS: Olli Kärkkäinen, Jenna Pekkinen, Tomi Tuomainen, Klaudyna Borewicz, Ville Koistinen, Jukka Leppänen, Marilena 
Vitale, Maria Lankinen, Ursula Schwab, Jussi Paananen, Tuomo Laitinen, Jaana Rysä, Marko Lehtonen, Anna-Marja Aura, Natalia 
Rosa-Sibakov, Emilia Nordlund, Valerie Micard, Marjukka Kolehmainen, Kaisa Poutanen, Angela Rivellese, Gabriele Riccardi, Rosalba 
Giacco, Seppo Auriola, Antti Poso, Hannu Mykkänen, Hauke Smidt, Matti Uusitupa, Pasi Tavi, Kati Hanhineva        
Epidemiological evidence suggests that diet rich in whole grains reduces the risk of lifestyle-related chronic diseases including 
cardiovascular diseases and type 2 diabetes. Molecular mechanisms responsible for the beneficial health effects are not well known, 
however, key contributor is the phytochemical and fiber dense bran that is maintained in whole grain based dietary products. The 
bran-derived components may have biological role themselves, and also via the colonic microbiota, since the role of diet in shaping 
the composition of microbiota has become evident, which in turn is an essential contributor to our health.  Here we present a study 
with multiple metabolite profiling assays on a range of experiments involving in vitro, animal, and human based studies, and describe 
a novel group of compounds that are produced endogenously and by the colonic microbiota. We show that following the bran-
induced shift in the composition of the microbiota these compounds are elevated in metabolically active organs in mice. Likewise, 
several of these compounds were increased also in humans after whole grain rich dietary interventions. Furthermore, we suggest 
their potential bioactive role, via demonstrating their implications in energy metabolism in cultured neonatal mice cardiomyocytes. 
Taken together, these compounds are one of the possible mediators for the beneficial health effects of whole grain rich diets.
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O-464 Targeted metabolomics to provide insights into the role of trace sulfur compounds in wine aroma and quality
PRESENTING AUTHOR: Vilma Hysenaj, Metabolomics Australia, The Australian Wine Research Institute, PO BOX 147, Glen 
Osmond, 5064, Australia
CO-AUTHORS: Marlize Bekker, Markus Herderich, Paul Smith, Natoiya Lloyd                                             
Volatile sulfur containing compounds (VSCs) play a significant role in the determination of the characteristic flavours and off-flavours 
of many foods and beverages. VSCs have been largely studied in wine because of their detrimental impact on wine aroma. In wine 
VSCs such as hydrogen sulfide (H2S), methanethiol (MeSH) and ethanethiol (EtSH) contribute to unwanted so called ‘reductive 
aromas’. These compounds are responsible for imparting wine aromas such as egg, vegetable, burnt, rotten and struck flint. 
Understanding the formation and the fate of these compounds during fermentation and storage of wine is crucial as they negatively 
contribute to wine aroma and may also negatively impact wine quality. Measurement of these VSC by established GCMS methods 
can be tedious, time-consuming and often not reproducible due to the highly reactive nature of these compounds. To address these 
shortcomings we developed a fast and accurate UHPLC-MS/MS targeted derivatisation method that accurately quantifies thiols and 
disulfides in wine. This method was established to quantify the three main thiol compounds associated with ‘reductive aromas’ 
namely H2S, MeSH and EtSH, as well as thiols such as benzyl mercaptan which imparts aromas of struck flint that is an important 
component of minerality and other wine style-related characters. An additional five VSC’s associated with ‘reductive aromas’ are also 
included in this method. Here we present an accurate and robust targeted metabolomics method able to monitor a wide range of 
thiol and disulfide compounds in wine. The method development, validation and its application for wine will be discussed.     
O-497 Edibilomics
PRESENTING AUTHOR: Hanne Christine Bertram, Aarhus university, Denmark
CO-AUTHORS:                                                    
Diet contributes to shape our health. This fact receives increasing attention, and there is consequently a vast interest in developing 
efficient strategies to elucidate how the intake specific dietary components influences human health, and to unravel the underlying 
mechanisms by which they exert these effects. Metabolomics provides a useful tool for examining the endogenous response to intake 
of specific dietary components. By metabolomics analyses of a variety of samples such as blood, urine, feces and tissues, it may be 
possible to disentangle the way that a specific dietary component exerts effects on endogenous metabolism, on the activity of the 
gut microbiome and on host-gut microbiome interactions. In addition, metabolomics is also an efficient tool for examining how intake 
of specific dietary components is reflected the presence of exposure markers and thereby represents a pillar in biomarker discovery 
and biomarker establishment in nutrition research. Here examples of edibilomics: the application of metabolomics in nutrition 
research, will be presented.  
O-500 Metabolomics tools and approaches for characterising flavours, phenolics and quality markers in grapes and wine
PRESENTING AUTHOR: Markus Herderich, The Australian Wine Research Institute, Australia
CO-AUTHORS: Vilma Hysenaj, Esther Kristianto, Luca Nicolotti, Natoiya Lloyd                                             
The diverse chemical composition, unique sensory attributes and perceived quality of a wine result from combining 100s of 
metabolites of grapes, yeast and bacteria, and oak wood. So far only a relatively small proportion of secondary metabolites 
present in vines and grapes has been extensively studied; yet hundreds of molecular features can be detected in a comprehensive 
characterisation of a grapevine’s or wine’s metabolome. It remains to be established which of the many “known unknown” 
compounds may impart sensory effects in wine, are potentially suitable as quality markers, or could play a role in human nutrition 
as bioactive agents. Non-targeted metabolomics approaches therefore can provide a much greater understanding of how vines, 
yeast and bacteria, together with grape growing and winemaking practices, shape the composition and sensory properties of a wine. 
Notably, metabolomics approaches can also be applied to characterise a wine’s metabolome and the complex chemical reactions 
in wine that are influenced by changes to grape processing and winemaking, or result from oxidation of wine compounds, acid 
hydrolysis and other chemical reactions during storage, transport and wine ageing. In this presentation key aspects of experimental 
design, method development and validation, and data analysis for successful metabolomics applications in grape and wine research 
will be discussed, with focus on the analysis of volatile trace metabolites and aroma compounds, non-targeted profiling of non-
volatile polyphenols, and analysis of resveratrol metabolites in human plasma.
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P-131 Rapid Evaporative Ionization Mass Spectrometry For High-Throughput Screening In Food Analysis: The Case of Boar Taint
PRESENTING AUTHOR: Sara Stead, Waters Corp, United Kingdom
CO-AUTHORS: Renata Jandova, Kaat Verplanken, Christof Van Poucke, Lynne Vanhaecke                                             
Increasing awareness on animal welfare has led to a European Treaty announcing a voluntary ban on the surgical castration of 
piglets by 2018. An alternative to surgical castration is rearing of entire males, however, the main setback is the possible occurrence 
of boar taint, an off-odour caused by the release of androstenone (AEON), skatole (SK) and indole (IND) when the meat is heated. 
To prevent adverse consumer reactions, there is an urgent need for rapid methods allowing detection of boar taint at the slaughter 
line.     Rapid evaporative ionization mass spectrometry (REIMS) has been used as an emerging technique to develop a predictive 
model for accurate high-throughput identification of boar taint in pig adipose tissue. A first of its kind step towards achieving at-line 
classification of boar carcasses. Pig adipose tissue was sampled using the iKnife handheld sampling device, which was connected 
directly to a Q-TOF mass spectrometer equipped with REIMS source. Untargeted mass spectrometric profiling in both negative and 
positive ionisation mode of pig neck fat samples enabled the construction of a predictive model for the classification of carcasses in 
boar taint positive or negative groups. The predictive model showed high accuracy (&gt;93%) and a very low false positive and false 
negative rate (alpha and beta-error ? 5%), demonstrating the potential and applicability of this model on pig carcasses. The REIMS 
technique delivers a result within 10 seconds from sampling to result, this technique guarantees point-of-control analysis, which 
represents a major step forward in high-throughput screening of aberrant pig carcasses.
P-132 Effects of feeding frequency on the polar metabolite profile of human milk
PRESENTING AUTHOR: Karl Fraser, AgResearch, New Zealand
CO-AUTHORS: Hanna Lagstrom, Johanna Makela, Shikha Pundir, David Cameron-Smith, Nicole Roy                                            
Human milk is the primary source of nutrition for infants and is recognised as the gold standard for feeding new-born full-term 
healthy infants. It delivers the nutrition necessary to support the growth and development of term infants during the first six months 
of life, and thus is rich in normal nutrients such as carbohydrates, fats, proteins, minerals and vitamins. It also contains an array of 
biologically-active constituents, including antimicrobial substances, growth factors, cytokines, immunoglobulins and specific immune 
cells. The analysis of human milk composition is complicated by many factors, including the changing nutritional composition of 
the milk: within a single feed; during the day; in response to maternal diet; and over the course of the lactation period. Thus the 
frequency of daily lactations will likely affect the metabolic composition of the milk. We present here untargeted metabolomics 
profiling of polar metabolites in human milk using hydrophilic interaction liquid chromatography MS (HILIC-MS) performed on a 
cohort of almost 800 women participating in the STEPS (Steps to healthy development) study in South-West Finland. Interrogation 
of the resulting HILIC-MS data matrix using feeding frequency classifications of either partial (i.e. infant supplemented with formula 
feeding) or full-time feeding by orthogonal partial least squared discriminant analysis revealed considerable differences in metabolite 
concentrations. For example, the tetrasaccharide stachyose and carnitine levels were both significantly (FDR&lt;0.05) elevated in the 
partial feeding group. This demonstrates the value of metabolomics profiling to evaluate compositional differences within a highly 
complex sample matrix such as human milk.
P-133 Simpler variable selection for lipidomics using multilevel statistical tools
PRESENTING AUTHOR: Jérémy MARCHAND, CEISAM, UMR6230, France
CO-AUTHORS: Yann Guitton, Sébastien Déjean, François Bartolo, Estelle Martineau, Bruno Le Bizec, Patrick Giraudeau, Gaud 
Dervilly-Pinel                                         
Metabolomic -and by extent lipidomic- studies generate large amounts of data, which require tailored statistical methods. Multivariate 
statistical analyses, such as Principal Component Analysis (PCA) for data exploration, or Partial Least Square Discriminant Analysis 
(PLS-DA), for supervised analysis are therefore commonly used [1]. However, when the experiment design includes repeated 
measurements (for instance several measurements acquired on the same individual at different time points), too few available 
exploratory solutions enable dealing with such characteristic, which generates biological noise and hinders further interpretation. The 
so-called multilevel approaches, as included in the mixOmics R package, make an efficient use of these repeated measurements and 
after subsequent multivariate analysis, better reveal the differences between sample groups and relevant variables [2-3].  We will 
demonstrate that a two-factor multilevel approach, followed by PLS-DA, can greatly simplify the interpretation of the results from 
the statistical treatment of lipidomic data acquired with multiple analytical methods. We will present a simple and efficient solution 
for relevant variable selection. The strategy has been efficiently applied in a public health related project to highlight biomarkers of 
chemical exposure in food producing animals on two data sets respectively acquired by Mass Spectrometry and multidimensional 
Nuclear Magnetic Resonance fingerprinting. A distinct discrimination between the sample groups was obtained, allowing a simple 
selection of the relevant variables, thus highlighting potential biomarkers.
Metabolomics in Food Research - Edibilomics
13th Annual Conference of the Metabolomics Society
Page 89
P-134
Impact of carbon source and sulphur-amino acids on microbial-mediated volatile organic 
compounds released profile: Case study of a psychotropic food spoilage bacterium in a model 
system
PRESENTING AUTHOR: Mohsen Zareian, University of Otago, New Zealand
CO-AUTHORS: Patrick Silcock, Phil Bremer                                                
Proton transfer reaction mass spectrometry complemented with GC–MS was used to investigate temporal changes in volatile 
organic compounds (VOCs) released profile of the psychotropic food spoilage bacterium, Pseudomonas fluorescence. Due to the 
highly heterogeneity and complexity of food matrices and the challenging task to identify characteristic volatile markers as spoilage 
indicators, a model system was designed to investigate a typical food spoilage scenario that frequently occurs in refrigerated foods. 
Basal medium (Vogel’s) was supplemented with glucose (0 or 0.5 % w/v) and/or sulphur-amino acids i.e. cysteine (Cys, 0 or 1 mM) 
and/or methionine (Met, 0 or 1 mM). Met and Cys influenced the VOCs fingerprints produced particularly in terms of S- derivatives. 
Principal component analysis showed that the separation of compounds was based upon a combination of Met and time. Met derived 
the most variation of the compounds and the loading plot indicated that m/z 35 (H2S), m/z 95 (dimethyl disulfide), m/z 97 (dimethyl 
furans), m/z 63 (dimethyl sulfide) and m/z 49 (methanethiol) derived the most significant variation. In contrast, the fingerprint of 
the VOCs evolved from glucose and Cys revealed a different distribution pattern. Supplementation of Met to medium, containing 
glucose, derived further variation in the volatiles indicating that an additional cluster of compounds exist. Multivariate cluster analysis 
identified a distinct group of S-derivatives (m/z 63, m/z 95 and m/z 97) being clustered with the highest similarity percentage. 
Detailed information on VOCs release profile, especially of S-derivatives, can potentially be used as food spoilage indicators.
P-135 Estimating population food consumption and dietary status using wastewater based epidemiology
PRESENTING AUTHOR: Phil Choi, University of Queensland - Queensland Alliance for Environmental Health Science, Australia
CO-AUTHORS: Jake O’Brien, Ben Tscharke, Sharon Grant, Rachel Mackie, Kevin Thomas, Jochen Mueller                                          
Estimating population dietary status using wastewater based epidemiology  Wastewater is a unique repository of chemicals excreted 
by humans. Therefore, wastewater analysis can provide information regarding the chemicals consumed by humans in a given 
wastewater catchment. This approach, termed wastewater based epidemiology, has been used to estimate the consumption of drugs 
in a multitude of cities throughout the world. Here, we present our previous findings which used wastewater based epidmiology to 
show differences in alcohol consumption among different cities around the world, and during different days of the week. We also 
present food metabolites, food constituents and other nutrients which are currently under assessment to be used as biomarkers 
to estimate dietary status through wastewater analysis. Challenges involved in developing accurate models to estimate food 
consumption and nutrient intake from wastewater analysis are also discussed. Once developed, wastewater based epidemiology 
could serve as a novel method to objectively assess spatial and temporal dynamics in food consumption and dietary status at a 
population level.
P-136 Determining the geographical origin of beef using UPLC-Orbitrap-MS/MS based lipidomics
PRESENTING AUTHOR: Daniel Kam-Wah MOK, Department of Applied Biology and Chemical Technology, The Hong Kong 
Polytechnic University, Hong Kong
CO-AUTHORS: Ka-Yi MAN, Chi-On CHAN, Ka-Hing WONG, Kevin Wing-Hin KWOK                                             
Traceability of food origin is one of the most important public health issues for governmental authorities and food industry, especially 
for net food importing countries and cities. For consumers, the interest in origin of beef has increased in recent years. However, 
nutrition related tracing method of beef is absence. This study aims at using lipidomics approach to examine the geographical origin 
of beef by Ultra-Performance Liquid Chromatography coupled with electrospray ionization-Orbitrap-Mass Spectrometry (UPLC-ESI-
Orbitrap-MS).  Beef samples of total 39, including 8 samples with organic label from three different geographical origins (Australia, 
United States and Japan), were collected from the local market. In the partial least squares-discriminant analysis (PLS-DA) of the 
(–) UPLC-ESI-MS data, a clear distinction between the cluster of three different geographical origins was observed in the score 
plot. This indicated that the geographical origin is the dominant factor to affect the metabolite profiles of beef, specifically the 
phosphoethanolamine (PE) and phosphatidylserine (PS) group. In addition, the cluster of organic beef was well separated from 
conventional beef in PLS-DA of both (+) and (–) UPLC-ESI-MS data. This indicated that the metabolite profile of organic beef was 
different from the other groups. Multivariate statistics revealed that the level of diglyceride (DG) and PE group in organic beef was 
significantly higher than conventional beef, and the level of triglyceride (TG) is opposite.
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P-137 Influence of yeast and lactic acid bacterium on the constituent profile of soy sauce during fermentation
PRESENTING AUTHOR: Risa Harada, Department of Biotechnology, Graduate School of Engineering, Osaka University, Japan
CO-AUTHORS: Masanobu Yuzuki, Kotaro Ito, Kazuki Shiga, Takeshi Bamba, Eiichiro Fukusaki                                            
Soy sauce is a one of the most popular Japanese traditional seasonings. During the soy sauce production, firstly koji mold is 
inoculated into steamed soybean and roasted wheat (soy sauce koji making). Then koji is mixed in salt solution, and this mixture 
(called “moromi”) is fermented by lactic acid bacterium (LAB) and yeast. Soy sauce contains various constituents, such as amino 
acids, saccharides, organic acids and volatiles that are metabolized by these microbes. Although constituents relate to soy sauce 
quality, the investigation of the constituent profile during fermentation is difficult due to the complexity of the constituent changes. 
Therefore, we applied metabolomics to soy sauce fermentation to understand the influences of each microbe on the constituent 
profile. We investigated changes in low molecular weight hydrophilic and volatile compounds using gas chromatography/mass 
spectrometry (GC/MS)-based non-targeted metabolic profiling. In this study, we analyzed four types of soy sauces considering the 
influence of these microbes (LAB+Yeast, LAB only, Yeast only, none). Through the statistical analysis of the constituent profile, we 
found constituents such as saccharides and amino acids which characteristically change in each fermentation phase. Additionally, our 
results suggested a novel finding that LAB affected the production of several constituents such as cyclotene, furfural, furfuryl alcohol 
and methional. This is the first study on the investigation of constituent changes based on the influence of microbes during soy sauce 
fermentation using metabolomics analysis. This aspect would be useful in the future to improve soy sauce quality by elucidating 
relationship between constituents and microbes.
P-138 Dissecting the Health Benefits of Red Wine Extract of Onion by Mass Spectrometry-Based Metabolomics Approach
PRESENTING AUTHOR: Pui-Kin So, The Hong Kong Polytechnic University, Hong Kong
CO-AUTHORS:                                                    
Onion is widely used in functional food formulations because of its multiple beneficial health effects, including antioxidant, anti-
allergic, anti-obesity, anti-diabetic, anti-microbial effects, etc. On the other hand, red wine is also widely recognized to confer a wide 
range of health benefits. e.g., reducing risk factors of cardiovascular disease, anti-cancer, anti-inflammation, etc. Red wine extract of 
onion (RO) has been unofficially used to promote health and is emerged as a potential functional food formulation. RO was recently 
found to exert better cardioprotective effects than red wine because of its higher effectiveness in suppression of cholesterol level. 
So far, there was no study investigating the relationship between the chemical composition and health benefits of RO. In this study, 
we apply LC-MS to dissect the chemical-function relationship of RO by examining the chemical composition difference between RO, 
red wine (RW), onion extract (O) and mixture of RW and O (RWO). Our results showed that RO contained significantly higher level 
of antioxidant chemicals, e.g., quercetin and isorhamnetin derivatives and S-methyl cysteines, and other bioactive compounds, e.g. 
S-lactoylglutathione involving in detoxification, than RW, O, and RWO. For example, RO was found to contain up to 30 folds more 
quercetin derivatives than O and RWO, revealing that red wine could assist the extraction of bioactive components from onions 
during preparation of RO. These data provide understanding on the nutritional and functional value of RO on chemical composition 
basis and insight into further optimization of the functional formulation.
P-139 PERENNIAL RYEGRASS TOXICOSIS: EFFECTS OF THE INDOLE DITERPENOID MYCOTOXINS ON MOVEMENT AND METABOLISM IN A MOUSE MODEL
PRESENTING AUTHOR: Priyanka Reddy, School of Applied Systems Biology, La Trobe University, Bundoora, Victoria 3083, Australia, 
Australia
CO-AUTHORS: Myrna Deseo, Martin Combs, Jane Quinn, Simone Rochfort                                             
The mycotoxin lolitrem B is found in endophyte-infected perennial ryegrass (Lolium perenne) and is present in around 90% of 
ryegrass pastures in Australia and New Zealand. Ingestion causes a neurological syndrome in grazing livestock called Perennial Rye 
Grass Toxicosis (PRGT) (Cunningham, 1959; Combs et al., 2014) where clinical signs include hyperexcitability, muscle tremors, ataxia 
(“staggers”) and, in severe cases, clonic seizures and death (Combs et al., 2014). It remains unclear whether these neurological signs 
result only from the blockade of large conductance potassium channels (BK channels) by indole diterpenoid toxins, primarily lolitrem 
B (Munday-Finch SC., 1997; Imlach, 2011). Furthermore, the toxicity of biosynthetic pathway intermediates of lolitrem B is also 
largely undefined. To address these questions, lolitrem B and several intermediates were purified from infected perennial ryegrass. 
Using a time-series analysis, the effects on movement in dosed mice were quantified for lolitrem B and related compounds. Animals 
exposed to lolitrem B showed a significant increase in tremor and decreased ability to maintain stability during accelerated rotarod 
testing, while the other metabolites showed varied effects. Metabolic profiling of the mice tissues and serum were undertaken for 
animals exposed to lolitrem B at key time points. This study suggests the possible mechanism and quantity of residual lolitrem B in 
tissue samples. Characterization of clinical signs and metabolic changes associated with exposure to the family of indole diterpenoid 
toxins present in perennial ryegrass will provide useful information for generation of animal safe grass varieties for the dairy and 
meat industries.
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P-140 M?nuka honey markers: linking nectar metabolites to honey authentication
PRESENTING AUTHOR: Nigel Joyce, Plant & Food Research, New Zealand
CO-AUTHORS: John van Klink, Bruce Smallfield                                                
Poster TITLE:  M?nuka honey markers: linking nectar metabolites to honey authentication John van Klink, Bruce Smallfield and Nigel 
Joyce.   In New Zealand, m?nuka flowering supports a thriving and valuable honey industry, but is threatened by increasing supplies 
of fraudulent products. Our studies on field-sourced pure m?nuka honey confirmed several compounds that may be useful as 
biomarkers of genuine m?nuka honey including: o-methoxyacetophenone, the major headspace volatile by GC-MS, and phenyllactic 
acid, leptosperin and lepteridine by LC-MS. We have also been studying m?nuka nectar production in order to understand its 
regulation. Phytochemical analysis of nectar sampled from varying flower development stages was profiled in relation to phenotypic 
characteristics using a metabolomics approach. The expression of &gt;400 compounds over six flower development stages was 
reviewed. The concentration of dihydroxyacetone, the precursor to the main m?nuka honey bioactive (methylglyoxal), followed 
the same pattern as total sugars. The key phytochemical markers leptosperin and lepteridine also followed this pattern through 
flower development, suggesting that their biosynthesis was intimately linked to nectar production. These data provide a baseline for 
studying m?nuka honey marker compounds and plant biosynthesis.
P-141 Unravelling the hidden potential of fruit/vegetable by-products
PRESENTING AUTHOR: Ninna Granucci, University of Auckland, New Zealand
CO-AUTHORS: Philip Harris, Silas Villas-Boas                                                
New social and environmental concerns are challenging the current agri-food systems towards more sustainable practices from 
production to distribution. Therefore, the focus of this study was to build a more comprehensive picture of fruit and vegetable 
by-product composition to determine their potential for bioconversion and/or bio-refinery processes. The gross and fine chemical 
composition of three main fruit and vegetable by-products produced by New Zealand’s juice and beverage industries (apple, orange 
and carrot pomaces) were assessed using a wide range of mass spectrometry based techniques, including GC-MS, LC-MS and 
ICP-MS. We were able to analyse over 300 different chemical components present in these substrates, including sugars, amino 
and organic acids, fatty acids, pesticide residues, minerals, protein amino-acid composition, in addition to basic nutritional profile 
(e.g. total protein, fat, soluble sugars, dietary fibres, phenolics, etc.). Overall, all by-product showed high levels of dietary fibres 
formed mainly by beta-1,4-glucans, and soluble sugars (fructose and glucose). However, most substrates presented low protein and 
amino acid content. Interestingly, around 20% of the total fat content in all substrates were formed by polyunsaturated fatty acids, 
including omega-6 and omega-9 fatty acids. Potassium, calcium, and phosphorus were the most abundant minerals, with carrot 
pomace showing the highest concentrations (15, 5, and 1.5 mg/g respectively). Carrot pomace also showed the highest sodium 
levels among all substrate tested (above 3mg/g). Therefore, despite considerable difference in composition between different by-
products, our study clearly demonstrates that these usually wasted food grade substrates have great potential for bioconversion into 
high value-added products.
P-142 Foodomics reveals the roles of Korean traditional Nuruk in brewing technology
PRESENTING AUTHOR: Jang-Eun Lee, Korea Food Research Institute, South Korea
CO-AUTHORS: Jeong Hyun Yun, Jae Ho Kim                                                
Nuruk, a traditional Korean fermentation starter for brewing alcoholic beverages from starch, is a dough made from grains such as 
wheat, barley, or rice by various enzyme-releasing microorganisms. To investigate whether these microorganisms in Nuruk affect the 
quality of the alcoholic beverages produced, we conducted a foodomics study on three kinds of superior quality Korean traditional 
Nuruk, Omegigok, Baksuwhandongjugok, and Migok. These Nuruk were selected from 58 kinds of restored or commercial Nuruk 
through assessments of brewing properties and organoleptic characteristics. The foodomics study of each Nuruk as well as its 
alcoholic beverage products was performed through a combination of metagenomics and metabolomic approaches, involving various 
instruments such as GC-MS, CE-TOF-MS, and 1H NMR along with multivariate analyses. In addition, microbial communities were 
monitored during the fermentation process to identify correlative relationships between metabolites and microbes. Results revealed 
that the volatile metabolites of alcoholic beverages fermented using Nuruk are likely strongly affected by the microbial community 
in Nuruk, whereas the non-volatile metabolites are affected by Nuruk ingredients. In addition, even if Nuruk is contaminated 
by pathogenic microorganisms, these microbes are killed with the commencement of alcohol fermentation, and the microbial 
composition reverts to the normal, desirable Nuruk microbial composition. This metabolomic information and profile of each Korean 
traditional Nuruk will contribute to the understanding of the correlation between Nuruk and traditional alcoholic beverage quality as 
well as to the overall development of alcoholic beverages.
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P-143 Global Untargeted Metabolomics Approach to Reveal Metabolic Shifts during Postharvest Cold Storage of ‘Kinnow’ Mandarin
PRESENTING AUTHOR: Manpreet Saini, National Agri-Food Biotechnology Institute, Mohali, India; Panjab University. Chandigarh, 
India, India
CO-AUTHORS: Neena Caplash, Sukhvinder Singh                                                
Fruit metabolism continues at an inhibited rate during postharvest cold storage, leading to significant changes in fruit quality 
attributes generally measured as quantification of a few metabolites having nutritional and flavour importance. Mass-spectrometry 
based global untargeted metabolomics is an approach to gain comprehensive coverage and insight into the fate of thousands of 
metabolites in a biological system. To study the metabolic shifts during cold storage of ‘Kinnow’ mandarin, commercially mature fruit 
were stored at low temperature (5°C) for 8 weeks and sampling was conducted at weekly intervals. Methanolic (80%) extracts of 
juice were injected into an UHPLC-QTOF mass spectrometer operated in an independent data acquisition mode enabling generation 
of TOF-MS and MS/MS data. Mass spectral output analysis involved peak alignment, normalization against an internal standard, 
and then unsupervised and supervised multivariate analyses using Analyst™, PeakView™ and MarkerView™ software. About 8000 
features for each data set were detected in the mass range of 100-1000 m/z. Following data pre-processing, multivariate statistical 
analyses reflected significant metabolic shifts during cold storage for 8 weeks. Clustering of fruits into three major groups was 
possible: early-(0-2 weeks), mid- (3-5 weeks) and late- (6-8 weeks) stages of cold storage. Multivariate analyses coupled with 
metabolite annotation using databases such as Metlin and MassBank revealed putative identification of discriminant metabolites 
linked to different stages of cold storage of ‘Kinnow’ mandarin. In conclusion, LC-QTOF based metabolomics can be a powerful tool 
to unravel the mechanisms underlying the postharvest cold storage-induced metabolite changes ultimately leading to fruit quality.
P-144 Metabolomics approach to investigate food waste valorisation through fermentation
PRESENTING AUTHOR: Sachindra Cooray, Interdisciplinary Graduate School, Nanyang Technological University, Singapore, 
Singapore
CO-AUTHORS: Wei-Ning Chen                                                  
Brewers’ spent grain (BSG) is a nitrogen rich and fiber rich by-product generated in the beer manufacturing process, produced in 
high volumes throughout the world. Here we have investigated the use of biofermentation to add value to food waste materials, 
such as spent grain. In this study we use solid state fermentation (SSF) using GRAS state fungi for valorization of BSG to enhance 
its nutrient content. Subsequently, untargeted GC – MS based metabolomics was used to analyse the constituents at different stages 
of fermentation, followed by statistical analysis. Initially, we used various solvents to extract extracellular metabolites from spent 
grain, and found methanol to extract more metabolites, compared to water, hexane, dichloromethane and ethylacetate. Additionally, 
we investigated between alkylation and silylation for derivatization prior to GC – MS analysis, in which silylation provided better 
results. The metabolites attributing to significant changes between unfermented BSG and fermented BSG were determined using 
multivariate data analysis and searched against NIST mass spectral library for identification. We observed increased levels of amino 
acids, some fatty acids, vitamins and antioxidants in fermented BSG when compared to unfermented BSG. This data provided insight 
on the variations in the metabolites observed during fermentation, proving that biofermentation enhanced BSG’s nutrient content. 
In conclusion, this study reveals the importance of a metabolimcs study to provide information to shed light on valorization in 
fermentation. Furthermore, data from metabolomics studies can be used to find novel applications for food wastes and innovative 
processing methods for valorization of waste materials.
P-145 Characterisation of the Human breastmilk using “multi-omics” analysis.
PRESENTING AUTHOR: Mikaïl Berdi, UMR Service de Pharmacologie et d’Immunoanalyse, CEA, INRA, Université Paris-Saclay, 
F-91191 Gif-sur-Yvette, France, France
CO-AUTHORS: François Fenaille, Florence Castelli, Benoit Colsch, Christophe Junot, Blandine de Lauzon-Guillain, Karine Adel-Patient 
Human breastmilk is considered as the most complete form of nutrition for infants. Composition of breastmilk can change in response 
to many maternal factors but also to match the infant’s needs. However, the precise composition and evolution of metabolites, 
oligosaccharides and lipids is poorly documented. In the present study, we proposed the first detailed multi-omic description of 
breastmilk. We developed methods to analyse the metabolites, oligosaccharides and lipids contained in breastmilk by combining 
optimized extraction procedures and liquid chromatography coupled to high resolution mass spectrometry. All the developments and 
analytical validations have been made with a commercial pool of colostrum. Then we analyzed the global composition of breastmilk 
samples collected at days 2, 3, 4, 5 and 6 post-partum (pool of n= 13 to 124 / sampling date). Data treatment was made essentially 
using the Workflow4Metabolomic platform (http://workflow4metabolomics.org) while multivariate and univariate analyses were then 
performed to highlight relevant metabolic differences.  Using these combined approaches, we were able to detect and annotate 
more than 200 metabolites, 80 oligosaccharides and 500 lipids in breastmilk. The dynamic analyses of these compounds at different 
days of lactation evidenced differences in terms of concentrations between day 2 and day 6.   Developed and validated methods 
will be used to further study individual samples from mother-child cohorts, allowing to analyze the impact of various maternal and 
environmental factors on the composition of milk, and their impact on infant growth and health.
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P-146 RANCIDITY IN ANCIENT GRAINS; the solution from Metabolomics
PRESENTING AUTHOR: Lourdes Urban Alandete, University of Queensland, Australia
CO-AUTHORS: Dr Torsten Witt Prof. Melissa Fitzgerald                                                  
Now a days the consumption of whole grains has increased due to the health benefits associated with them. There is much already 
reported about these health benefits but not much about the issues surrounding their use in food processing. What is missing, 
is a deep understanding of how one of the most valuable components -the lipids- become degraded and how can we stop that. 
Metabolomics is the technology we need to develop a deep understanding of the important molecules and what happens to them: 
starting from the fatty acid composition, then, tracking down until reaching the volatiles level. Profiling of the volatile molecules is our 
target since the major problem the food industry is facing is the short shelf-life of whole grain products due to their susceptibility to 
rancidity. Rancidity is the organoleptic perception of specific sub-products from lipid oxidation being firstly detected by the consumers 
for their characteristic smell. Using GCxGC-MS together with other analytical instruments, we have done an intense study to find 
common volatiles that we could target as an indicator of rancidity in a variety of whole grains including ancient grains like teff, quinoa 
and buckwheat and the traditional barley and sorghum. We can relate those volatiles to the fatty acid composition and also with 
different storage conditions to provide a better knowledge of the process that leads to rancidity, and therefore new options for the 
food industry.
P-147 Chronic addition of blueberries to the diet modifies the urinary metabolite profile in humans as shown by a LC-HRMS-based metabolomic study
PRESENTING AUTHOR: Tony McGhie, The New Zealand Institute for Plant and Food Research, New Zealand
CO-AUTHORS: Sarah Cordiner, Duncan Hedderley, Carol Cheatham, Mary Ann Lila                                             
Blueberry consumption is widely known to benefit human health and is supported by numerous scientific publications. Consuming 
berry fruits enhances both cognition and motor control in animals. Blueberries contain relatively high concentrations of 
phytochemicals including anthocyanins, procyanidins, and chlorogenic acid.    Here we report the analysis of urinary metabolites 
following 6-month consumption of blueberries by elderly humans.  Our hypothesis was that chronic consumption of a dietary-relevant 
amount of blueberries has a measureable effect human metabolism.  We attempted to detect and identify human urinary metabolites 
that were 1) derived directly from blueberries and 2) endogenous human metabolites that were altered as a result of consuming 
blueberries. This study included a detailed assessment of cognitive function, not reported here.   Using RPLC-ESI-HRMS, we detected 
1946 molecular features (MF) in negative mode and 1846 MF in positive mode. Currently, statistical analysis has included principal 
component analysis and T-Test.  Twenty five metabolites were detected that either increased or decreased with p-value&lt;0.05 and 
a fold-change&gt;2.  Attempts to identify these metabolites chemically are on-going, but several have been identified as ferulic acid 
and valerolactone metabolites, which are probably derived from blueberries. Furthermore, metabolite data downloaded from the 
Human Metabolome Database was used with TASQ (Bruker Daltonics) quantitation software to detect and semi-quantify 326 known 
urinary metabolites.   We have established that a relatively small amount of blueberry added to the diet produces a measureable 
change in urinary metabolite profiles.  As yet we have not identified any endogenous human metabolite that is altered as a result of 
blueberry consumption.
P-148 Metabolic profiling study of food samples – determination of saturated fatty acids (SFAs), unsaturated fatty acids (UFAs), sterol, prenol and esters by using DI-SPME-GCMS
PRESENTING AUTHOR: Xin Du, Murdoch University, Australia
CO-AUTHORS: Yonglin Ren                                                  
The currently used GCMS based metabolites profiling methods for analysis of fatty acids in food samples have an obvious 
disadvantage, such as interfered by their derivatives in the analytical samples. Therefore, the obtained levels of fatty acids results 
are total free fatty acid derivatives. However, a technology of direct immersion solid phase microextraction technology coupled to 
a gas chromatography-mass spectrometry platform (DI-SPME-GC-MS) can significantly avoid the interference between fatty acids 
and others. This method can also offer for simultaneous determination of saturated fatty acids (SFAs), unsaturated fatty acids 
(UFAs), fatty acids esters, sterol and prenol lipid species in wheat, barley and canola. The metabolites are extracted by Methanol: 
Acetonitrile: dH2O (2:2:1 v/v) solvent and followed by DI-SPME sampling &amp; injection technology. The saturated fatty acids 
(SFAs), unsaturated fatty acids (UFAs), sterol lipids, prenol lipids and esters are extracted and analysed with high selectivity 
and sensitivity in comparison with syringe injection. It is no doubt, the DI-SPME-GC-MS  method can be a practical method  for 
monitoring saturated fatty acids (SFAs), unsaturated fatty acids (UFAs) and esters diversity between different food samples which 
include post-harvest stored grain and oil seeds. This method could be a validate method to be used for analysis levels of sterol and 
other lipid components in food sample for human daily intake.
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P-149 Mapping and Chemometric Pattern Analysis on the Basis of Flavonoid DB in Korean Agro-food Resources
PRESENTING AUTHOR: Heon-woong Kim, Functional Food & Nutrition Division, National Institute of Agricultural Science, Rural 
Development Administration, South Korea
CO-AUTHORS: Hwan-hee Jang, yu-jin Hwang, Jeong Sook Choi, Jung-bong Kim                                             
Flavonoids are the most important group in secondary plant metabolites and generally produced as defense mechanisms against 
pathogens and disease organisms. These compounds have been reported to play an important role in the preventive aspects in 
human disease. In this study, the flavonoid chemometrics and maps was constructed using 3,205 quantitative values based on the 
already established flavonoid database from a total of 268 Korean agro-food resources. The UPLC-DAD-QTOF/MS based flavonoid 
profiles can be visualized as chemometrics through alignment and standardization procedures. Furthemore, the chemometrics can 
be variously mapped through clustering by PLS-DA modeling (SIMCA-P 11.0 software). In particular, since the teas(green and black) 
and pulses(soybean, kudzu vine) contains high levels of flavanol and isoflavone, respectively, clusters were formed independently 
from other groups such as vegetables, fruits and cereals in the food group map. This whole map can be further subdivided and 
enlarged for each food group. As a new research area in metabolomics, the metabolites mapping using complicated data matrix, 
could be provided and predicted numerous results including useful informations and hypotheses about scientific phenomenon hard 
to understand in specific classes as wells as used like an actual map. In future, these research could be applicated that the metabolic 
map constructed from metabolites associated with metabolic fluids of animal and human, and found easily therapeutic drugs.
P-150 NMR metabolomics analysis of urine from elderly men fed a high protein diet
PRESENTING AUTHOR: Aahana Shrestha, Liggins Institute, University of Auckland, New Zealand
CO-AUTHORS: Amber Milan, Sarah Mitchell, Nina Zeng, Farha Ramzan, Pankaja Sharma, Scott Knowles, Cameron Mitchell, Karl 
Wagner, Patt Edwards, Linda Samuelsson, David Smith                                   
Higher protein diets have been promoted as beneficial for maintaining muscle mass in the elderly. However, the metabolic 
consequences of such diets are poorly understood. This study used 1H Nuclear Magnetic Resonance (NMR) spectroscopy to evaluate 
the urinary metabolite profiles of elderly men following a high protein diet compared to an adequate protein diet. For this study, 
30 healthy men (74.2 ± 3.6 years) were randomised to consume either a high protein (1.6 g protein/kg body weight/day) or an 
adequate protein diet (0.8 g protein/kg body weight/day) for 10 weeks. Urine samples (24-hour collection) were collected before 
and after the intervention. These were analysed for creatinine, urea, and uric acid by colorimetric assays. Untargeted metabolomics 
was performed using a 700 MHz NMR spectrometer. Metabolites were identified using 2D NMR techniques and quantified using 
Chenomx software. Data were analysed using univariate and multivariate statistics. Preliminary results are available for nitrogenous 
compounds. Total nitrogen excretion was greater after the high protein diet at 15.3 ± 0.5 g N/day vs. 7.1 ± 0.5 g N/day (interaction 
time and diet, p&lt;0.001). Urinary metabolites related to nitrogen excretion were increased after altered protein intake, suggestive 
of additional metabolomics changes that will be elucidated with the untargeted NMR results.
P-151 Authentication of two different fish oils by qualitative lipid profiling using semi-targeted approach on QTRAP platforms
PRESENTING AUTHOR: Akanksha Singh, Sciex, India
CO-AUTHORS: Niladri Chatterjee, Vishnu K V, Ajeeshkumar K K, Anandan R, K Ashok Kumar, Suseela Mathew, Baljit Ubhi, Manoj 
Pillai                                       
Globally, there is increasing consumer awareness on traceability and authenticity of fish and fisheries products. Fish oil, rich in the 
health promoting poly unsaturated fatty acids (PUFA) is in high demand in health food markets. The price and nutritional value of 
fish oils are determined by factors such as fish species used, processing method and storage. The differences in price between such 
oils may lead to mislabelling and adulteration. In this work, we demonstrate a proof of concept that qualitative shotgun lipid profiling 
using mass spectrometry can be used to differentiate between two different fish oils. Five samples each of Sardine (Sardinella 
longiceps) oil and Shark (Echinorhinus brucus) liver oil were diluted and directly infused in a quadrupole-linear ion trap SCIEX 
QTRAP® 4000 system. Data was acquired for 23 precursor ion scan and 4 neutral loss scan experiments in positive ionization mode. 
Similarly, in negative ionization mode data was acquired for 52 precursor ion scan and 5 neutral loss scan experiments. The lipid 
identification was performed using the LipidView™ Software for lipids present in the fish oil sample. Multiplexed precursor ion scan 
and neutral loss scan could identify many lipid classes based upon the precursor ion and neutral loss information. Cholesteryl ester, 
Diacyl glycerol, Triacylglycerol, Monoalkyldiacylglycerol, Phophatydyl choline and Sphingomyelin were the major lipid class identified. 
Statistical analysis including principal component analysis and student t-test done using MarkerView™ software could clearly 
distinguish between the sardine oil and shark liver oil.
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P-152
Geographical Origin Discrimination of Oolong Tea (TieGuanYin, Camellia sinensis (L.) 
O. Kuntze) Using Proton Nuclear Magnetic Resonance Spectroscopy and Near-Infrared 
Spectroscopy
PRESENTING AUTHOR: Jingjing Xu, Department of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic 
Resonance, Xiamen University, China
CO-AUTHORS: Kian-Kai Cheng, Guiping Shen, Jiyang Dong                                               
A total of 90 Oolong tea samples were collected from three different growing places in Fujian province of China. Both proton nuclear 
magnetic resonance (1H NMR) and near-infrared spectroscopy (NIR) were used to analyze the collected tea samples. With the aid of 
chemometrics methods, differential components in 1H NMR data and characteristic wavenumbers from NIR spectra were identified. 
Since NMR and NIR provide complementary information for tea samples, data fusion was carried out by combining 1H NMR and NIR 
spectra of the collected tea sample. Experimental results showed that a better discrimination accuracy of geographical origins of 
Oolong tea could be achieved by combining NMR and NIR data (86.2-95.8%), as compared to using NMR data (68.2-78.7%) or NIR 
data (80.0-89.3%) alone. The current data suggested that a combination of NMR and NIR methods could serve as an efficient way 
for geographical origins discrimination and qualitative control of Oolong tea.
P-153 Differentiation of pork meat quality using GC-TOF-MS-based metabolite profiling
PRESENTING AUTHOR: Yoshio Tamura, Central Research Institute for Feed and Livestock, National Federation of Agricultural 
Co-operative Associations, and Division of Biosphere Resource Science and Technology, Graduate School of Life and Environmental 
Sciences, University of Tsukuba, Japan
CO-AUTHORS: Kazutoshi Miyaura, Yonathan Asikin, Miyako Kusano                                               
The pork meat quality is greatly affected by many factors, including pig varieties, pork production areas, and cooking methods. Pork 
quality is conventionally verified by sensory evaluation and compositional analysis but there are remaining challenges on its result 
reproducibility and correlation between them. Therefore, comprehensive profiling on taste- and flavor-related metabolites in pork 
meat is required to clarify its potential discriminatory attributes of quality. Pork meat obtained from different origins (Japan, America, 
and Canada) was chosen as representatives to evaluate each meat quality. Raw- and roasted-forms of the meat was analyzed using 
GC-TOF-MS to detect primary metabolites. The acquisition data matrix was visualized by principal component analysis (PCA), and 
contribution of each metabolite was obtained from resulting PCA loading plot. One hundred peaks were detected wherein 60 of them 
were annotated. PCA score plot clearly indicated that the first two principal components (PC1 and PC2) were able to discriminate 
pork meat according to their origins and cooking state (raw or roasted), respectively. The metabolite profiles of Japanese pork in 
both raw- and roasted-forms were found to be distinct according to each form. On the other hand, the profiles of American and 
Canadian pork were gathered together despite their different forms. Moreover, the PCA plot revealed discriminant metabolites that 
are thought to be important to pork quality, such as sweetness-related amino acids (serine and glycine), umami-related amino acid 
(glutamic acid), and nucleic acid-related compound (inosine). Thus, GC-TOF-MS-based metabolite profiling has great potential to 
select metabolite index which discriminate pork quality.
P-154 Mapping of Greek olive oil using FT-ICR mass spectrometry flow injection analysis and multivariate data analysis
PRESENTING AUTHOR: Wiebke Timm, Bruker Daltonik, Germany
CO-AUTHORS: Theodora Nikou, Matthias Witt, Aiko Barsch, Christopher Thompson, Maria Halabalaki                                            
Olive oil consumption is a product of high economic importance, and there is an urgent need for quality and authenticity control. 
Numerous analytical methods including HPLC-UV, GC-MS, LC-MS, and NMR have already been employed. In this study, we 
used magnet resonance mass spectrometry (MRMS) using flow injection analysis (FIA) and multivariate data analysis (MDA) to 
differentiate Greek olive oils from different regions.    Multiple parameters influencing olive oil composition were investigated. 300 
samples were collected over two years covering the olive oil producing areas of Greece. The oil was dissolved and diluted in a 
CH2Cl2/MeOH + 10 mM ammonium acetate solution. For each sample, five replicates were measured on a solarix XR 7T (Bruker 
Daltonik) using a 100µl full loop FIA in electrospray ionization negative ion mode. Single MS spectra were acquired in 2.5 minutes. 
Due to the ultra-high mass resolution of MRMS, olive oil can be analyzed without chromatographic separation. Mass peaks were 
deisotoped, combined into features, and aligned across samples. The evaluation was done with PCA using MetaboScape (Bruker 
Daltonik), and with OPLS-DA in SIMCA-P (Umetrix). Tentative annotation of metabolites via database matching took into account 
accurate mass and isotopic fine structure information. Samples could be clustered according to geographical origin using OPLS-
DA methods, while olive tree variety appear less important. PCA loading plots revealed the metabolites responsible for samples 
classification, most important are Oleic and linoleic acids. Overall, the FIA MRMS metabolic profiling workflow is a fast and reliable 
approach for olive oil quality and authenticity control.  
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P-155 Effects of dietary Allium hookeri on growth performance and anti-oxidant activity in young broiler chickens
PRESENTING AUTHOR: Sung Hyen Lee, National Institute of Agricultural Sciences, South Korea
CO-AUTHORS:                                                    
The aim of this study was to evaluate the effect of dietary supplementation of Allium hookeri root on anti-oxidant activities and 
growth performance in young broiler chickens. A total of 125 male Ross-708 broiler chickens (n = 25 birds/group) were fed standard 
diets supplemented with root or fermented root of A. hookeri at two different levels (1% or 5%) for 3 weeks from hatching. Control 
birds were provided with non-supplemented basal diets. Body weights, feed conversion ratios (FCRs), heme oxygenase (HMOX), 
aflatoxin B1 aldehyde reductase (AFAR), superoxide dismutase 1 (SOD1), catalase (CAT) enzyme, and malondialdehyde (MDA) were 
measured levels were measured in 21-day-old birds. The results showed greater body weight gains at day 14 and FCRs at day 21 in 
chickens fed diets supplemented with 1% A. hookeri root, as compared to the control group (p &lt; 0.05). Up-regulated transcript 
levels of AFAR, Hmox1, and CAT were observed in the jejunum of chickens fed diets supplemented with A. hookeri. The serum levels 
SOD and CAT were significantly increased (p &lt; 0.05) in groups treated with A. hookeri, whereas MDA levels were decreased in 
groups fed diets supplemented with A. hookeri, as compared to the control group. These results indicated that an optimum level of 
dietary A. hookeri as a feed additive to young broiler chickens influences growth and improves anti-oxidant activities.
P-156 Discrimination of Origin of Soybeans by Volatile Metabolites
PRESENTING AUTHOR: Soyoung Kim, Ewha Womans University, South Korea
CO-AUTHORS: Sang Mi Lee, Sung Mee Kim, Young-Suk Kim                                               
Soybean (Glycine max) is one of the crops cultivated globally in various areas and generally consumed in many Asian countries. 
Volatile metabolites of soybeans are significantly affected by climate and soils, where they are cultivated, as well as variety. Thus, 
volatile metabolites can be one of important factors for the determination of origins of soybeans. In this study, various pretreatment 
procedures were performed prior to the extraction of volatile metabolites to prevent any chemical and biochemical changes, in 
particular, in lipoxygenase activity during sample preparation. Then, volatile metabolites were extracted using solid-phase micro 
extraction (SPME) and analyzed by gas chromatography-mass spectrometry (GC-MS). All the datasets obtained were processed by 
multivariate data analyses such as principal component analysis (PCA) and partial least square-discriminant analysis (PLS-DA) to 
determine the key volatile metabolites related to the discrimination of their origins.
P-157 Comparative Profiling for Authentication of Deep-fired Oils by Using Gas Chromatography-mass Spectrometry
PRESENTING AUTHOR: CAO Guodong, Hongkong Baptist University, Chemistry Department, Hong Kong
CO-AUTHORS: Hong Yanjun, Cai Zongwei, Ruan Dongliang                                               
A novel approach for authentication of deep fired oils by using gas chromatography mass spectrometry was developed. Untargeted 
profiling of oil samples combined with multivariate analysis was performed on the elucidation of deterioration process of edible 
oil, which suggested monoglycerides are the most contributive molecules to the discriminatory effects of fresh edible oil and deep 
fired oil. Furthermore, accumulation behavior of monoglycerides under continuous heating processes was observed. By using the 
quantitative results, the concentrations of monoglycerides in deep fired oil and gutter oil were determined. Besides, admixture 
adulteration of fresh edible oil adulterated with deep fired oil was distinguished at very low concentration (approximate 1%). This 
described method with unambiguous qualitative and quantitative information being elucidated, proposed six of monoglycerides as 
endogenous indexes for comprehensive assessment of the degradation state of cooking oil.
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P-158 Metabolic profiling of antioxidant supplement MP using plasma 1H NMR-based metabolomics in humans
PRESENTING AUTHOR: Kyu-Bong Kim, College of Pharmacy, Dankook University, South Korea
CO-AUTHORS: Hyun-Jun Jang, Ji Won Kim, Sung Ha Ryu, Yoo Jin Kim, Oran Kwon, Siwon Kim, Suhkmann Kim                                         
Aging and age-related diseases in humans are mainly caused by oxidative stress through over-production of reactive oxygen 
species (ROS). In our previous study, multi-micronutrient supplement containing antioxidant nutrients and phytochemicals (MP) 
resulted in higher antioxidative activity by increasing serum folate with resistance to DNA damage and LDL oxidation to subjects. 
In this study, plasma samples were analyzed using 1H NMR. The metabolic profiles before MP supplementation and after 8-week 
MP supplementation were clearly separated based on multivariant analyses of principal component analysis (PCA) and orthogonal 
partial least square discriminant analysis (OPLS-DA). Twenty-seven metabolites from variable importance plots were screened 
before MP supplementation and after 8-week MP supplementation. The 27 metabolites had significantly increased levels of betaine 
but significantly decreased levels of choline, serine, and threonine after MP supplementation. These results suggested that MP 
supplementation could activate folate cycle to increase resistance to DNA damages.
P-159 Effects of dietary taurine supplementation on metabolomic variation in grouper (Epinephelus coioides) intestine
PRESENTING AUTHOR: Guiping Shen, Department of Electronic Science, Xiamen University, China
CO-AUTHORS: Jiyang Dong, Jianghua Feng, Jingjing Xu                                               
In this study, 1H NMR-based metabolomics approaches in combination with multivariate pattern recognition technologies were 
applied to investigate the impact of dietary taurine on intestine metabolomic variations of grouper (Epinephelus coioides). Fish 
was fed by one of four diets containing 0.0, 0.5, 1.0 and 1.5% supplemental taurine for 84 days feeding period. A total of 25 
metabolites were found to change significantly in intestine of fish fed with different taurine-added diets. These metabolite changes 
basically involved in the varied kinds of metabolic pathways including biosynthesis of biological substances, protein digestion and 
absorption, lipid metabolism and lipolysis, carbohydrate metabolism, digestion and absorption, and ATP-binding cassette transporters 
(ABC transporters). The substantial cores of all the metabolic pathways are exerting a regulation on fish body physiological state 
and suggesting that taurine supplementation in the diet would significantly affect the intestine metabolomic, improved glucose 
utilization and amino acid uptake, promoted the protein synthesis and further accelerate the fish growth performance. Moreover, 
this taurine benefit was supplementation level sensitive, where great metabolism change and maximum fish performance were at 
1.0% supplemental taurine under this experimental condition. Our results demonstrate that the utility of NMR-based metabolomics 
method can help to find the proper content of taurine in the aquafeeds and provide new insights into taurine roles on aquaculture at 
metabolic responses.
P-160 Metabolite profiling of different parts between brown and white beech mushroom (Hypsizigus marmoreus)
PRESENTING AUTHOR: YUJIN PARK, Konkuk University, South Korea
CO-AUTHORS: Eun Sung Jung, Da Eun Lee, Jeong Gu Kim, Young Wook Lee, Choong Hwan Lee                                            
Beech mushroom (Hypsizygus marmoreus) is a well-known for its beneficial health effects such as anticancer, antiviral, and 
antihypertensive activities. Only few studies had been reported about those bio-active metabolites. In this study, comparative 
metabolite profiling of two parts (cap and strip) of brown and white beech mushrooms was performed by gas chromatography-time-
of-flight-mass spectrometry (GC-TOF-MS) and ultrahigh performance liquid chromatography-linear trap quadrupole-ion trap (UHPLC-
LTQ-IT) MS/MS with multivariate statistical analysis. The two parts were clearly separated by PC1 and two strains were separated by 
PC2 in principle component analysis (PCA) score plot. Heat map analyses revealed that levels of most amino acids and hypsiziprenols 
were high in cap than strip part in both strains. Those of metabolites also showed a high positive correlation with antioxidant activity. 
Whereas, fumaric acid, malic acid, fructose, and benzoic acid were relatively high in stipe part. Discriminated metabolites between 
brown and white strains such as valine, leucine, serine, threonine, hypsiziprenol AA family, hypsiziprenol A10, and hypsiziprenol A11 
were dominantly found in brown strain. However, the levels of ornithine, tryptophan, succinic acid, citric acid, and myo-inositol were 
relatively high in white strain than brown strain.
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P-161 Investigating the Effect of Saskatoon Berry Syrup Addition on the Antioxidant Properties and Phytochemical Content of Rooibos Tea (Aspalathus linearis)
PRESENTING AUTHOR: Dr. Michel Aliani, Department of Human Nutritional Sciences, University of Manitoba, Canada
CO-AUTHORS: Donna Ryland, Cara Isaak, Suvira Prashar, Yaw Siow, Carla Taylor, Michel Aliani                                          
Saskatoon berry syrup (SBS) contains many vitamins, minerals and functional bioactive components that contribute to its desirable 
flavor, color and antioxidant properties. Thus, the addition of SBS to rooibos tea (RT), a popular caffeine-free beverage with a unique 
taste, could enhance the healthfulness of the product. The objective of this study was to examine the effect of SBS addition (10% 
w/w) on the antioxidant properties and phytochemical content of RT fortified with vitamin D3. Six formulations (RT, RT with SBS, RT 
with SBS and vitamin D3, RT with vitamin D3, green tea (GT), and GT with SBS) were evaluated for total antioxidant capacity (TAC), 
total anthocyanins and phytochemical content by integrating an untargeted foodomics approach. Results revealed that GT with SBS 
had significantly higher (P&lt;0.05) TAC compared to other samples. No significant differences were observed between the TAC of GT, 
RT with SBS and RT with SBS and vitamin D3. RT with and without vitamin D3 had the lowest TAC and were comparable to a 10% 
diluted sample of SBS. No significant differences were observed in total anthocyanins between teas with added SBS. The addition of 
SBS contributed several polyphenols, particularly flavonoids to teas. A total of 9 and 10 phytochemicals were significantly enhanced 
in RT with SBS compared to RT alone and GT with SBS compared to GT alone, respectively, among which 6 phytochemicals were 
similar including pyrogallol. The addition of SBS could be a favorable natural additive that may provide additional health benefits 
including antioxidant properties to RT.
P-162 GC-MS based metabolomic studies of blueberry (Vaccinium spp.) and chokeberry (Aronia melanocarpa) with various geographical origins in Korea
PRESENTING AUTHOR: INSEON SIM, KONKUK UNIVERSITY, SEOUL, South Korea
CO-AUTHORS: Dong Ho Suh, Eunju Shin, Kwang Hyun Moon, Jeong Ho Lee, Dae Geun Kim, So Yeon Im, Choong Hwan Lee              
Berries have attracted attention as a health food with various effects on physiological activities. Recently, emerging knowledge is 
being gained on the mechanisms related to environmental factors that may affect chemical composition or metabolites in berries. 
We performed metabolite profiling of blueberry (Vaccinium spp.) and chokeberry (Aronia melanocarpa) derived from 7 different 
geographical origins in Korea using gas chromatography-time-of-flight-mass spectrometry and multivariate statistical analysis. 
According to principal component analysis (PCA) score plot, berries were separated not only by different species but also by 
regional groups such as latitude (35°N and 36°N region). These distribution showed a greater effect of geographical origins on the 
metabolites than the cultivar or harvest time. In accordance with pathway analysis, most amino acids levels were relatively high in 
chokeberry compared to blueberry, while blueberry contained high levels of most sugar derivatives. In both blueberry and chokeberry 
cultivated in the region of 35°N, levels of amino acids and organic acids, including valine, threonine, aspartic acid, pyroglutamic 
acid, GABA, glutamic acid, and lactic acid showed relatively higher than those of cultivated in the region of the region of 36°N. 
Whereas, content of sucrose was specifically high in berries cultivated in the region of 36°N than 35°N. In correlation analysis, 
most amino acids and organic acids showed a high positive correlation with duration of sunshine, while sugars and sugars alcohols 
showed positive correlation with rainfall. From these results, we proposed that the primary metabolism of berries was affected by 
geographical origins and climatic conditions.
P-163 Analysis of gas chromatography-mass spectrometry to identify urinary metabolites after increased intake of whole grain, vegetables, and fruits in healthy adolescents
PRESENTING AUTHOR: Mi-Ri Gwon, Kyungpook National University and Hospital, South Korea
CO-AUTHORS: Bo-Kyung Kim, Boram Ohk, Duk-Hee Lee, Yoo Kyoung Park, Hyun-Ju Kim, Sook Jin Seong, Young-Ran Yoon               
Dietary factors in plant-based diet are important for the prevention of chronic and metabolic diseases. Especially, phytonutrients 
in vegetables and fruits have been recognized as major contributors for the decreased level of oxidative stress.  In this study, 
switching the dietary behaviors of Korean healthy adolescents to high consumption of vegetables and fruits was investigated using 
blood test of the plasma and untargeted metabolic profiling of the urine. Eighteen healthy adolescents were provided for 8 weeks 
with whole grain, vegetables, and fruits as the main food source. Anthropometric measurements, blood profiles, and dietary intake 
were measured and compared before and after the plant-based diet.   After the plant-based diet, Weight and body mass index were 
significantly decreased. Also, biological antioxidant potential of the plasma was increased. The chromatogram data acquired by gas 
chromatography-mass spectrometry analysis was processed. From the orthogonal partial least squares-discriminant analysis model, 
a total of 835 metabolites that played important role in the separation between before and after the plant-based diet were selected 
according to the variable importance in projection value ?1.0. Seven endogenous metabolites were identified; glycine, hydrocinnamic 
acid, succinic acid, stearic acid, tartaric acid, trans-ferulic acid, and fumaric acid, which are known to have antioxidant potential and 
anti-tumorigenic effects, in addition, to reduce low density lipoprotein cholesterol.   Overall, this dietary metabolomics approach will 
provide a better understanding of alterations in the endogenous metabolites affected by the plant-based diet and these alterations 
were correlated with change of anthropometric parameters and blood profiles.
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P-164 Evaluation of carotenoids variations due to plant replicates for 50 pepper varieties using targeted metabolomics analysis platform
PRESENTING AUTHOR: Yongsoo Choi, KIST Gangneung Institute of natural products, Korea, Democratic People’s Republic of
CO-AUTHORS: Jin-Ho Jo, Jeong-Sook Shin                                                
Pepper (Capsicum spp.) is one of the most important fruit crop worldwide reaching more than 28 million metric tones harvested from 
the crop. Pepper is increasingly recognized as a good source of bioactive compounds that contribute many health benefits associated 
with hypertension, blood circulation, muscle pain, obesity, and age-related macular degeneration. The well-established bioactive 
compounds in pepper include capsaicinoids such as capsaicin and capsiate, and carotenoids.  Capsaicinoids are responsible for the 
strong and hot taste of the fruits, also known as pungency. Although the key enzyme leading to the production of capsaicinoids is 
capsaicin synthase, little is known about a specific gene associated with production of a few capsaicin compounds. Carotenoids are 
an important group of pigments responsible for the fruit colors. Regarding genes encoding carotenoids biosynthesis enzyme, only 
a few genes has been reported to date. Recently, genome-wide association analysis with metabolites in crops varieties reported 
numbers of genes associated with corresponding metabolites. In order to obtain meaningful and real genes for the associated 
metabolites, care must be taken regarding sampling, sample extraction, and analytical platform. Particularly, metabolite variations 
due to plant replicates are one of most important considerations before performing genome-wide association analysis for metabolite 
trait. In this study, we developed a targeted metabolomics analysis platform to evaluate variations of several carotenoids due to plant 
replicates using 50 pepper varieties.
P-165 Metabolomic approach for biological active compounds in the Korean alcoholic beverage brewed with traditional nuruk
PRESENTING AUTHOR: HyeRyun Kim, Korea Food Research Institute, South Korea
CO-AUTHORS:                                                    
Nuruk, is a Korean traditional fermentation starter. The taste and flavor of Korean alcoholic beverage are mainly determined by 
the metabolic products such as free sugars, amino acids, organic acids, and aromatic compounds which are produced during 
fermentation process of raw materials by the microorganisms present in nuruk. In this study, we brewed Korean alcoholic beverage 
using 16 different nutritional ingredient-based traditional nuruk and then investigated ACE inhibitory effects and changes in 
metabolites. The metabolites of Korean alcoholic beverage were simultaneously analyzed by liquid chromatography electrospray 
ionization quadrupole time-of-flight mass spectrometry (LC-ESI-Q-TOF-MS). Metabolites profiling of Korean alcoholic beverage were 
affected by nutritional and microbial composition of fermentation starter. As a result, the samples taken at different Korean traditional 
nuruk were clearly distinguishable in the score plot generated by combining PC1 (33.11% of the total variance) with PC2 (16.39% 
of the total variance). To investigate the metabolites related to the biological active compounds of nuruk-based Korean alcoholic 
beverage, the components related to functionality were explored through the metabolite profiling, correlation analysis, and heatmap 
analysis. Acquired a list of candidate biological active compounds for Korean alcoholic beverage and discovered bioactive compounds 
that actually exist in the nuruk-based Korean alcoholic beverage. The Korean alcoholic beverage with a high ACE inhibitory effect 
showed significantly high contents of two metabolite ingredients (p&lt;0.001). This study revealed that mass based metabolites 
profiling was useful in helping to understand the metabolite differences by nutritional and microbial composition of fermentation 
starter.
P-166 Meat and fish consumption lead to differences in plasma N-acetylaspartate and trimethylamine N-oxide concentrations in healthy men
PRESENTING AUTHOR: Hiroshi Tatano, Department of Clinical Nutrition and Food Management, Institute of Biomedical Sciences, 
Tokushima University Graduate School, Tokushima, Japan
CO-AUTHORS: hisami Yamanaka-Okumura, Daisuke Kajiura, Masashi Masuda, Akiyoshi Hirayama, Tomoyoshi Soga, Masaru Tomita, 
Yutaka Taketani                                         
Introduction/Objectives: Nutritional biomarkers are required to objectively evaluate dietary intake. However, few studies were 
clarified the biomarker for meat and fish intake. In this study, we investigated whether there were differences in the profiles of 
postprandial plasma metabolites by meat or fish intake. Methods: In a randomized crossover study, 8 healthy men alternately 
consumed one of five test meals containing 100 g of beef, pork, chicken, mackerel and salmon on a different day. Fasting and 
postprandial plasma samples were analyzed using CE-TOFMS and multivariate data analysis. Results: OPLS-DA identified 34 
metabolites that could distinguish between meat and fish intake. Among the metabolites, N-acetylaspartate, hydroxyproline and 
5-hydroxylysine concentrations were significantly higher after meat intake than fish intake, and also trimethylamine N-oxide (TMAO), 
Val, hydroxyproline, creatine, Ile, Met, Tyr and methionine sulfoxide concentrations were significantly higher after fish intake than 
meat intake. Interestingly, high N-acetylaspartate concentrations were observed only after meat intake, but there was no difference 
between before and after the consumption of fish. Similarly, high TMAO concentrations were observed only after fish intake, 
but there was no difference between before and after meat intake. Receiver-operating characteristic curve analysis showed that 
N-acetylaspartate could predict meat intake with an AUC value of 0.9634, and also TMAO could predict fish intake with an AUC value 
of 0.9342. These results suggest that N-acetylaspartate and TMAO are good candidate biomarker to evaluate meat and fish intake, 
respectively.
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P-167 Barley Seedling Extracts Inhibit RANKL-induced Differentiation, Fusion and Maturation of Osteoclasts in the Early-to-late Stages of Osteoclastogenesis
PRESENTING AUTHOR: Sik-Won Choi, Division of Crop Foundation, National Institute of Crop Science (NICS), Rural Development 
Administration (RDA), South Korea
CO-AUTHORS: Woo Duck Seo, Hyeon Jung Kang, Mi Ja Lee, Ki Do Park, Hyun Young Kim                                            
The number of patients with osteoporosis is increasing in worldwide, and a decrease in bone mass is a major risk factor for fracture. 
The prevention of bone loss is critical for improving the quality of life for patients. However, the long-term use of anti-osteoporotic 
agents is limited due to their side effects. Barley has been traditionally ingested for thousands of years as a safe, natural food with 
pharmaceutical properties, and its seedling can enhance the biological activity of the medicinal components found in food. This 
study aimed to elucidate the anti-resorptive activity of barley seedling and its mode of action. Barley seedling extracts (BSE) dose-
dependently inhibited RANKL-induced osteoclast differentiation with alteration of I?B degradation, c-Fos and NFATc1 molecules in the 
early-to-middle stages of osteoclastogenesis. In the late phase of osteoclastogenesis, BSE also prevented DC-STAMP and cathepsin 
K, which are required for cell fusion and bone resorption, such as osteoclast function. In conclusion, barley seedling from natural 
foods may provide long-term safety and be useful for the prevention or treatment of osteoclast-mediated bone metabolic diseases, 
including osteoporosis
P-285 Volatile metabolite screen for beer and wine using large volume headspace-GCMS analysis
PRESENTING AUTHOR: Esther Kristianto, The Australian Wine Research Institute, Australia
CO-AUTHORS: Luca Nicolotti, Natoiya Lloyd, Markus Herderich                                               
Volatile metabolites are important components of beer and wine, contributing to the aroma, flavour and quality of the finished 
product. Yeast-derived fermentation products, acetate- and ethyl-esters, and higher alcohols, together with monoterpenes from 
hops or grapes impart positive fruity, floral or less sought-after solvent like characters in beer and wine. The yeast strain employed 
for fermentation and the nutrient supplements used can directly affect the concentrations of these aroma compounds. In addition, 
the choice of hops is a crucial element for beer production that drives unique flavour attributes.      A combined targeted/untargeted 
metabolomics approach using large volume headspace-GCMS was developed to monitor a wide range of volatile metabolites 
in fermented beverages. The method described in this poster accurately quantifies 18 fermentation products by SIDA and 
simultaneously performs untargeted analysis of a broad range of volatiles present in the headspace of beer or wine samples. The 
metabolite profiling data can be processed using tools such as XCMS and CAMERA and the untargeted analysis typically results in the 
detection of 30-50 metabolites in the headspace. Identification of metabolites is performed using in-house libraries containing mass 
spectra and retention index values obtained from pure reference standards. 
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O-48 LC-MS-based metabolomics revealed SLC25A22 as an essential regulator in aspartate-derived amino acids and polyamines in KRAS-mutant colorectal cancer
PRESENTING AUTHOR: Xiaona LI, State Key Laboratory of Environmental and Biological Analysis, Department of Chemistry, Hong 
Kong Baptist University, China
CO-AUTHORS: Lilan Wu, Chi Chun Wong*, Zongwei Cai*                                               
Colorectal cancer (CRC) is the third most common cancer causing death worldwide. SLC25A22, which encodes the mitochondrial 
glutamate transporter, is overexpressed in CRC and is essential for the proliferation of CRC cells harboring KRAS mutations. However, 
the metabolic effect of SLC25A22 on CRC cells has not been characterized on a metabolome-wide scale. In the study, global and 
targeted metabolomics based on ultra-high performance liquid chromatography (UHPLC) coupled to mass spectrometry (MS) were 
used to evaluate effects of SLC25A22 on metabolism in KRAS-mutated CRC cells. Global metabolomic analysis of KRAS-mutant 
DLD1 cells with or without SLC25A22 knockdown identified 35 differentially regulated metabolites, which were primarily involved 
in glutaminolysis, urea cycle and polyamine metabolism. Targeted metabolomic analysis of TCA cycle intermediates, non-essential 
amino acids, and polyamines revealed that TCA cycle intermediates (except ?-ketoglutarate), aspartate (Asp)-derived asparagine, 
alanine and ornithine (Orn)-derived polyamines were all strongly down-regulated in SLC25A22 knockdown cells. Moreover, targeted 
kinetic analysis was performed with [U-13C5]-glutamine as the isotope tracer. The 13C-labeled urea cycle metabolites were not 
detected in SLC25A22 knockdown cells, suggesting the urea cycle was not triggered due to decreased levels of Orn. On the other 
hand, most 13C-labeled Orn-derived polyamines were significantly decreased in SLC25A22 knockdown cells and medium. Exogenous 
addition of polyamines could partly restore cell proliferation in SLC25A22 knockdown cells, highlighting their potential as oncogenic 
metabolites downstream of SLC25A22-mediated glutamine metabolism. Collectively, SLC25A22 promoted synthesis of asp-derived 
amino acids and polyamines in KRAS mutant CRC cells, with the latter contributing to KRAS-mutant CRC cell growth. 
O-60 A non-targeted UHPLC-HRMS metabolomics pipeline for metabolite identification; application to cardiac remote ischemic preconditioning
PRESENTING AUTHOR: Nzoughet Kouassi Judith, Université d’Angers - UFR Santé - Institut MITOVASC, CNRS 6214, INSERM 
U1083, France
CO-AUTHORS: Cinzia Bocca, Gilles Simard, Delphine Prunier-Mirebeau, Juan Manuel Chao de la Barca, Dominique Bonneau, Vincent 
Procaccio, Fabrice Prunier, Guy Lenaers, Pascal Reynier                                      
In recent years, the amount of investigations based on non-targeted metabolomics has increased, although often without thorough 
assessment of analytical strategies applied to acquire data. Following published guidelines for metabolomics experiments, we report 
a validated non-targeted metabolomics strategy with pipeline for unequivocal metabolites identification using the MSMLS™ molecule 
library. We achieved an in-house database containing accurate m/z values, retention times, isotopic patterns, full MS and MS/MS 
spectra. A UHPLC-HRMS Q-Exactive™ method was developed and experimental variations were determined within and between 
3 experimental days. The extraction efficiency as well as the accuracy, precision, repeatability, and linearity of the method were 
assessed, the method demonstrating good performances. The methodology was further blindly applied to plasma from Remote 
Ischemic Pre-Conditioning (RIPC) rats. Samples, previously analyzed by targeted metabolomics using completely different protocol, 
analytical strategy and platform, were submitted to our analytical pipeline. A combination of multivariate and univariate statistical 
analyses was employed. Selection of putative biomarkers from OPLS-DA model and S-plot was combined to jack-knife confidence 
intervals, metabolites VIP values and univariate statistics. Only variables with strong model contribution and highly statistical 
reliability were selected as discriminated metabolites. Three biomarkers identified by the previous targeted metabolomics study were 
found in the current work, in addition to three novel metabolites, emphasizing the efficiency of the current methodology and its 
ability to identify new biomarkers of clinical interest, in a single sequence. The biomarkers were identified to level 1 according to the 
Metabolomics Standard Initiative and confirmed by both RPLC and HILIC-HRMS.
O-63 Investigation of drug-induced steatosis in HepaRG cells using untargeted LC-MS metabolomics
PRESENTING AUTHOR: Matthias Cuykx, Universiteit Antwerpen - Toxicological Centre, Belgium
CO-AUTHORS: Leen Claes, Charlie Beirnaert, Robim Rodrigues, Kris Laukens, Tamara Vanhaecke, Adrian Covaci                                          
Background: Accumulation of lipids in the liver (steatosis) is a frequent Drug-Induced Liver Injury. It is the first stage of Non-Alcoholic 
Fatty Liver Disease (NAFLD) and can progress to non-alcoholic steatohepatitis, fibrosis, cirrhosis and carcinomas, resulting in liver 
failure and death. Early detection and prevention of NAFLD are crucial in toxicological research and healthcare. Here, a hepatic in 
vitro system combined with metabolomics was used to gain more information on the mechanisms of action of sodium valproate, a 
reference steatogenic drug. Experimental outline: We optimised a LC-MS based metabolomics platform and exposed HepaRG cell 
cultures to sodium valproate at two different concentrations (IC10 and a 1/10 dilution of the IC10) and two different time points (24 
h and 72 h). The intracellular metabolites were recovered in a polar and non-polar fraction using liquid-liquid extraction, both extracts 
were analysed with optimised untargeted LC-MS platforms. After quality control, the data were subjected to PCA and PLS-DA to 
select features of interest. Results: Exposure of HepaRG cultures to sub-cytotoxic levels of sodium valproate invokes a clear alteration 
in the metabolome. Significant differences were observed that relate to adaptive mechanisms which eventually progress to lipid 
accumulation and steatosis. The metabolic changes include a conversion from lower weight to higher weight lipids and alterations 
in the levels of polar organic acids. Conclusions: Using untargeted LC-MS metabolomics on HepaRG cultures, a sodium valproate-
induced intermediary adaptation of the metabolome is observed, progressing to steatosis.
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O-80 Spatially resolved profiling of Polymyxin B induced acute kidney injury
PRESENTING AUTHOR: Andreas Dannhorn, Department of Surgery and Cancer, Sir Alexander Fleming Building, Imperial College, 
London SW7 2AZ, UK, United Kingdom
CO-AUTHORS: Nicole Strittmatter, Anna Mroz, Renata Soares, Gregory Hamm, John Swales, Richard Goodwin, Zoltan Takats              
The global problem of advancing antimicrobial resistance let to a renewed interest in Polymyxin antibiotics. These antibiotics are 
commonly used as a last resort in cases of uncontrolled infection caused by gram-negative bacteria.  Polymyxin efficacy is linked 
to known neuro- and nephrotoxicity in the clinic. In the current study we applied desorption electrospray ionisation (DESI) and 
matrix assisted laser desorption ionization (MALDI) mass spectrometry imaging (MSI)  to investigate polymyxin induced changes in 
the tissue metabolome of rat kidney sections. Kidneys from animals receiving a high dose of Polymyxin B1 showed initial increased 
formation of inflammatory markers, e.g. diacylglycerols, eicosanoids, lysophosphatidylcholines. The formation of these markers was 
dose dependant (reduced after receiving a low dose of Polymyxin B1 or after a recovery period of 24 days). Consistently, kidneys 
from animals treated with Polymyxin B nonapeptide, which is known to be less nephrotoxic, showed reduced formation of the 
inflammatory markers. The localization of the markers was found to be in the renal cortex which is consistent with urinary biomarkers 
and histopathology findings locating the nephrotoxicity in the proximal tubules and to a lesser extent in the distal tubules. Applying 
multimodal MSI, we demonstrated the ability to correlate the location of a toxic compound within a tissue with the effects it caused. 
In the case of the presented study and toxicology studies in general, this correlation can be used to help understand the mechanisms 
responsible for the toxicity and help to reveal the underlying pathways.
O-82 Analysis of the metabolomic responses to high protein meals in women at increased metabolic disease risk
PRESENTING AUTHOR: Brenan Durainayagam, Liggins Institute, New Zealand
CO-AUTHORS: Cameron Mitchell, Amber Milan, Victor Miranda, Karl Fraser, Christiani Henry, Marlena Kruger, Nicole Roy, David 
Cameron-Smith                                       
Metabolic syndrome (MetS) is a cluster of risk factors for diabetes and cardiovascular disease.  Recently, metabolomics has been 
applied to elucidate the key risk factors and changes associated with the MetS phenotype. This study aimed to comprehensively 
analyse the metabolic trajectories differentiating the responses of MetS from healthy women to high protein meals that included 
either low or high glycaemic index (GI) carbohydrates. Post-menopausal women (20 MetS, 20 healthy) consumed test meals on two 
separate mornings; the meals were high protein (30g whey), containing either high or low GI carbohydrates. Blood samples were 
collected at fasting and four postprandial time points. Metabolomic analysis were performed by applying a global metabolomics 
approach (LC-MS) accompanied by a UPLC targeted approach of amino acids. Dynamic probabilistic principal component analysis 
(DPPCA) was employed for dimension reduction, conforming with the correlation structure due to repeated measures. Linear 
mixed models (LMM’s) were fitted, controlling by random-subject factors, to identify differentially regulated metabolites. A subset 
of metabolites, mainly amino acids, demonstrated significant differences over time between MetS and healthy women. A global 
metabolomic approach reveals differences in baseline metabolic profile between healthy and MetS women; furthermore, the 
postprandial trajectories of these metabolites differed. This suggests alterations in amino acid and carbohydrate associated metabolic 
networks. The identification of compounds which change in response to food will provide insights into metabolic differences between 
healthy and MetS women and will further inform nutritional strategies to reduce disease risk.
O-83 Faecal and serum metabolomics in paediatric inflammatory bowel disease.
PRESENTING AUTHOR: Vidya Velagapudi, Institute for Molecular Medicine Finland FIMM, University of Helsinki, Finland
CO-AUTHORS: Kaija-Leena Kolho, Alberto Pessia, Tytti Jaakkola, Willem de Vos                                             
BACKGROUND: Inflammatory bowel disease [IBD] is considered to result from the interplay between host and intestinal microbiota 
but its pathogenesis is incompletely understood. While IBD in adults has shown to be associated with marked changes in body fluid 
metabolomics, there are only few studies in children. Hence, this prospective study addressed the faecal and serum metabolomics in 
newly diagnosed paediatric IBD.  METHODS: Paediatric patients with IBD undergoing diagnostic endoscopies and controls also with 
endoscopy but no signs of inflammation provided blood and stool samples in a tertiary care hospital. Blood inflammatory markers 
and faecal calprotectin levels were determined. The serum and faecal metabolomics were determined using ultra-high pressure liquid 
chromatography coupled to a mass spectrometer.  RESULTS: Serum and faecal metabolite profiles in newly diagnosed paediatric 
IBD patients were different from healthy controls and categorized Crohn’s disease and ulcerative colitis [UC] patients into separate 
groups. In serum, amino acid metabolism, folate biosynthesis and signalling pathways were perturbed in Crohn’s disease; in UC 
also sphingolipid metabolic pathways were perturbed when compared to controls. In faecal samples, there was an increased level 
of several metabolites in UC in contrast to low or intermediate levels in Crohn’s disease. There was a clear correlation with the level 
of inflammation, i.e. faecal calprotectin levels and the profile of various biologically important metabolites [carnosine, ribose and, 
most significantly, choline].  CONCLUSION: Characterization of inflammatory pattern using metabolomics analysis is a promising 
tool for better understanding disease pathogenesis of paediatric IBD.  REFERENCE: J Crohn’s and Colitis (2017). 11(3):321-334. 
PMID:27609529.
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O-129 Spatial Imaging of Invasive ductal carcinoma specimens by Desorption Electrospray Ionisation Mass Spectrometry
PRESENTING AUTHOR: DIPA GURUNG, Imperial College London, United Kingdom
CO-AUTHORS: Edward John, Francesca Rosini, Anna Mroz, James McKenzie, Zoltan Takats                                            
Breast cancer is a highly heterogeneous disease and one of the most prevalent form of cancers in women worldwide. Estrogen 
receptor (ER) measurement is a routine procedure for clinical management of breast cancer. The result from the test alone is 
used to determine which patients would benefit from tamoxifen. DESI (desorption electrospray ionisation) is a novel ambient 
ionisation technique that coupled with mass spectrometry imaging (MSI) has great potential in breast cancer diagnostics. 
Therefore, breast samples from 80 patients were analysed by DESI-MSI to understand the lipidomic differences between 
histologically normal and different molecular subgroups of breast cancer. The results from the negative ion mode dataset showed 
that DESI-MSI can be effectively used for discriminating between the malignant and histologically normal glandular tissues (with 
95% accuracy), histological grades of tumour (with 72% accuracy) and ER status (70% accuracy). Lipid species belonging to 
phosphatidylethanolamine and phosphatidylinositol class were found to be in higher abundance in the ER-positive samples compared 
to ER-negative samples and morphologically normal glandular tissues. Additionally, 101 breast samples were analysed with 
REIMS (rapid evaporative ionisation mass spectrometry) and the spectral content generated was studied. Lipids belonging to the 
phosphatidylethanolamine class were found to give the highest contribution to the separation of normal and malignant tissue classes 
in REIMS and DESI-MSI dataset. As a diagnosis tool, DESI-MSI would allow cancer diagnosis to be more precise and more accurate 
compared to routinely used methodologies in histopathology laboratories as it is solely based on sample’s biochemical features.
O-134 Metabonomic Study of Schizophrenia Using High-Resolution NMR Spectroscopy
PRESENTING AUTHOR: Ute Marx, Hochschule Pforzheim, Germany
CO-AUTHORS: Marie Meinke, R. Mark Wellard, Paul Amminger, Tina Proffitt, Stephen Wood, Christos Pantelis, Patrick McGorry, 
Gregor Berger                                       
The mental disorder schizophrenia affects the way of thinking, feeling and acting and can result in a severely limited way of living 
for both the affected person and their carers. Causes and triggers of schizophrenia, a potentially multicausal disorder, resulting in 
imbalanced metabolite concentrations in the brain that can also transfer to associated body fluids, are still unclear. Therefore, we 
analysed blood plasma samples as a readily available body fluid in order to contribute to the understanding of the mechanisms 
involved in the pathogenesis and treatment of schizophrenia. In the present study we measured and analysed 130 blood plasma 
samples from subjects with first episode psychosis and a healthy control group using one and two dimensional high-resolution NMR 
spectroscopy. The patient samples were derived from new onset as well as from chronic patients, and samples before and after 
treatment with atypical antipsychotic medication (mainly quetiapine) with or without ethyl-eicosapentanoic acid augmentation were 
analysed. For data analysis statistical techniques such as principal component analysis and partial least squares analysis-discriminant 
analysis were employed to determine metabolite differences between the groups, in order to subsequently correlate them with 
associated metabolic pathways. We identified different lipid profiles between healthy and diseased people suggesting that altered 
phospholipid profiles, arising from reduced uptake or increased phospholipid breakdown, are potentially associated with the onset 
or course of the disease. Metabolite changes during treatment could also be observed. Our results add to the understanding of 
metabolite changes in the blood occurring in early onset schizophrenia.
O-146
Metabolomic application of the Intelligent Knife (iKnife):  Rapid Evaporative Ionisation 
Tandem Mass Spectrometry (REIMS/MS) for In-Vivo Metabolite and Tissue Identification in 
the Case of Breast Cancer
PRESENTING AUTHOR: Zsolt Bodai, Imperial College London, United Kingdom
CO-AUTHORS: Edward John, Emma White, April Covington, James McKenzie, Hui-Yu Ho, Julia Balog, Daniel Leff, Zoltan Takats              
The intelligent knife (iKnife) uses aerosol formed on standard electrosurgical dissection which is aspirated into a time of flight 
mass spectrometer (TOF MS) equipped with a REIMS (rapid evaporative ionisation mass spectrometry) interface to acquire tissue 
specific MS signal. Although spectral fingerprint-based identification has been demonstrated to provide excellent tissue identification 
performance [1], mass spectra contain more information: details of the metabolites within the tissue. Normal and cancerous breast 
tissue samples were analysed ex-vivo using the iKnife system. Univariate analysis revealed significant marker ions between the 
tested tissue types then these ions were selected for MS/MS analysis. MS/MS spectra and exact mass of the ions showed that spectra 
mainly contained phospholipids and triacylglycerides. Fragment ion spectra of the selected significant ions revealed the presence 
of isomeric lipids. E.g. ion at 768.6 m/z provided characteristic fragments for PC(18:1/18:2), PC(16:0/20:3), PE(20:2/18:1) and 
PE(18:0/20:3) lipids. In order to investigate which lipids are responsible for correct tissue classification, multiple MS/MS spectra were 
acquired from normal and cancerous tissues. Fragment ions showed clear separation between the tissue types even when single ion 
MS/MS spectra were examined. These identified, significant lipids were used to compare healthy and cancerous tissues for better 
understanding of lipid metabolism and its alteration. iKnife spectra could reconstruct the lipid metabolism of breast cancer and cancer 
specific metabolic pathways were found. These ex-vivo and also in-vivo pathway analyses could improve diagnosis accuracy and 
could also be target of new treatments. [1] Angew Chem Int Ed Engl, 2009. 48(44): p. 8240-2.  
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O-154 Multi-omics Analysis of Esophageal Adenocarcinoma: How Lipid Metabolism Affects Cancer Progression
PRESENTING AUTHOR: Jeffrey Molendijk, The University of Queensland Diamantina Institute, The University of Queensland, 
Brisbane, QLD, Australia, Australia
CO-AUTHORS: Thomas Stoll, Federico Torta, Markus Wenk, Thomas Hennessy, Mark Hodson, Michelle Hill                                          
The incidence of esophageal adenocarcinoma (EAC) has increased in recent years, whilst the 5-year survival rate remains low at 
~15%. EAC is associated with altered lipid metabolism, with obesity as a major risk factor. Conversely, cholesterol-lowering statin 
drugs are protective and attenuate growth and malignant potential of EAC cells. MALDI and spectroscopy studies report changes 
in the lipid profiles of EAC tissue compared to healthy squamous epithelium. Lipids affect cancer behavior by storing energy as 
well as regulating cell survival and apoptosis. However, the specific lipid metabolism pathways involved in the progression from 
the pre-cancerous condition called Barrett’s esophagus (BE) to EAC remain unclear. To study these pathways, we conducted 
mass spectrometry (MS) -based proteomics and lipidomics experiments on 7 cell lines representing non-dysplastic BE, high-grade 
dysplastic BE and EAC.  Lipid and proteins were extracted from cell pellets using a biphasic TBME/MeOH method. Proteomic profiling 
was performed on a QE+ MS (Thermo). Untargeted discovery lipidomics experiments were performed on a 1290 Infinity II/6550 
Q-TOF LC/MS system (Agilent) whilst targeted MRM experiments were performed on a 6490 Triple Quadrupole MS system. Combined 
analysis of the proteomic and lipidomic changes were performed to identify lipid metabolic pathways differentially expressed in 
EAC progression. Our results show that lipids involved in energy storage and regulation of cell survival are associated with disease 
progression. Future work will verify candidate molecules in patient samples.
O-166 Urinary metabolic profiles associated with 5-year changes in biomarkers of glucose homeostasis: an NMR spectroscopy based study
PRESENTING AUTHOR: Nele Friedrich, Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, 
Greifswald, Germany, Germany
CO-AUTHORS: Tea Skaaby, Maik Pietzner, Betina Thuesen, Matthias Nauck, Allan Linneberg                                            
As known for the last decades, type 2 diabetes mellitus (T2DM) represents one of the major health problems which will become 
more and more important due to the steadily increasing prevalence of overweight and obesity. During the last decade metabolomics 
studies were used to gain deeper insight into the pathogenesis of diabetes mellitus with promising findings. However, longitudinal 
metabolomics studies of possible subclinical states of disturbed glucose metabolism are limited. Therefore, the aim of this study 
was to analyze the associations between baseline urinary metabolites and 5-year changes in markers of glucose homeostasis using 
urine metabolites among 3986 participants of the population-based Inter99 study analyzed by 1H-NMR spectroscopy.  The analyses 
revealed that several urinary metabolites, including alanine, betaine, 1-methylnicotinamide, trimethylamine and trigonelline, were 
found to associate with detrimental longitudinal changes in biomarkers of glucose homeostasis including fasting glucose, HbA1c 
and homeostatic model assessment for insulin resistance (HOMA-IR) index. For example, higher baseline levels of urinary alanine, 
betaine, N,N-dimethylglycine, creatinine and trimethylamine were associated with an increase in HbA1c from baseline to 5-year 
follow-up. In contrast, formic acid and trigonelline levels were associated with a decrease in HbA1c over time. The identified 
metabolites point to mechanisms within betaine and coffee metabolism as well as possible effects of the microbiome. Such 
knowledge may provide clues of pathogenetic mechanisms, targets for interventions, and might improve risk stratification of the 
population based on a readily obtainable bio fluid for clinical routine.
O-168 A combined metabolomics and lipidomics approach enables the stratification of acute-on-chronic liver failure patients according to their severity
PRESENTING AUTHOR: Francois Fenaille, CEA-INRA UMR 0496, Laboratoire d’Etude du Métabolisme des Médicaments, DRF/
Institut Joliot/SPI, Université Paris Saclay, MetaboHUB, France
CO-AUTHORS: Noémie Butin, Benoit Colsch, Christophe Junot, Joan Clària, Richard Moreau, Vicente Arroyo                                           
Acute-on-Chronic Liver Failure (ACLF) is a recently recognized syndrome characterized by acute decompensation (AD) of cirrhosis, an 
organ/system failure(s) and extremely poor survival. ACLF can be triggered by a precipitating event (e.g. bacterial infection) and is 
invariably associated with exacerbated systemic inflammation. According to the European Foundation for the study of Chronic Liver 
Failure (EF-CLIF), patients with ACLF can be classified into three groups, essentially according to the number of impaired organs. 
In the present project, we investigated whether metabolomics and lipidomics can identify potential new diagnostic biomarkers of 
ACLF. In our study, a cohort of 89 serum samples from decompensated cirrhotic patients with and without ACLF were analyzed 
and compared to healthy subjects by liquid chromatography coupled to high resolution mass spectrometry (LC-HRMS). Two 
complementary methods involving both HILIC and C18 columns for metabolomics and C8 column for lipidomics were used in both 
positive and negative ionization modes. Data mining procedures using multivariate and univariate analyses were then performed to 
highlight discriminant metabolites. Our data confirmed the metabolic and lipidomic cirrhosis signatures obtained in previous studies, 
especially regarding to the levels of glycerophosphatidylcholines, amino acids and energy metabolites. Furthermore, our approach 
enabled to discriminate between decompensated cirrhotic patients with ACLF and those without ACLF, and a specific metabolite 
signature associated with the ACLF grade has been obtained. Taken together, our findings indicate that metabolomic and lipidomic 
profiling using LC-HRMS may contribute to describe the ACLF development in cirrhotic patients and provide new insights into the 
metabolomics changes detected.
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O-169 Correlation of a plasma metabolite score with duration of hypoxia: a piglet study
PRESENTING AUTHOR: Julia Kuligowski, Health Research Institute La Fe, Spain
CO-AUTHORS: Rønnaug Solberg, Ángel Sánchez-Illana, Anna Parra-Llorca, Leonid Pankratov, Guillermo Quintás, Ola D. Saugstad, 
Máximo Vento                                         
Hypoxic-ischemic encephalopathy (HIE) secondary to perinatal asphyxia is a leading cause of mortality and long-term neurologic 
co-morbidities in the term neonate. Moderate whole body hypothermia initiated within 6 hours from birth is the most successful 
intervention for treatment of moderate to severe HIE. This work strives for an early metabolic biomarker score for assessing the risk 
of developing moderate to severe HIE in order to provide an objective measure for aiding clinical decisions. From a consolidated 
piglet model for neonatal hypoxia-ischemia, plasma samples were withdrawn before and at different time points after a hypoxic 
insult. A set of three metabolites (choline, 6,8-dihydroxypurine and hypoxanthine) showing maximum correlation with hypoxia time 
was identified from an untargeted liquid chromatography coupled to tandem mass spectrometry experiment and a multivariate Partial 
Least Squares metabolite score for predicting hypoxia time was established. Its performance as a biomarker for perinatal hypoxia was 
compared to lactate which is currently considered as the gold standard. The metabolite score performed similar to lactate for plasma 
samples withdrawn before and directly after a hypoxic insult, both providing sensitivity and specificity values equal to 1. However, 
in samples collected 2 h after resuscitation, lactate levels were not suitable for identifying asphyxiated piglets, while the metabolite 
score provided enhanced predictive capacity. Results evidenced the usefulness of the metabolite score for an early assessment of the 
severity of hypoxic insults. Ongoing studies are testing its capacity for clinical diagnosis and patient stratification in multicenter trials 
involving newborns with HIE.
O-172 Ion mobility–mass spectrometry based high-throughput metabolomics facilitates metabolite biomarker discovery in colorectal cancer
PRESENTING AUTHOR: Zhiwei Zhou, Chinese Academy of Sciences, China
CO-AUTHORS: Meimei Xu, Zhengjiang Zhu                                                
Colorectal cancer (CRC) is one of the most common and lethal cancers around the world. Untargeted metabolomics has been proved 
as a powerful technology to discover metabolite biomarkers for CRC diagnosis. Here, we first developed an ion mobility–mass 
spectrometry (IM-MS) based high-throughput method for large-scale untargeted metabolomics. The analysis time for each sample is 
optimized as short as 3 minutes. We analyzed 194 tissue samples from CRC patients within 18 hours. The results showed that more 
than 90% of metabolites in quality control (QC) samples have RSDs less than 30%, proving the excellent stability and reproducibility 
of the method. For each sample, roughly 1000-1200 metabolites were detected in the 3-min analysis, and 300-400 metabolites were 
identified. Next, 80% of samples were randomly selected as training data, and the rest were used as validation data. In training data, 
cancer tissue and para-cancer tissue samples of CRC patients can be clearly differentiated using orthogonal partial least squares 
discriminant analysis (OPLS-DA). 125 dysregulated metabolites were selected with statistical tests of OPLS-DA (VIP &gt; 1), fold 
change (FC &gt; 1.3), paired t-test (p &lt; 0.05). The combination of 12 potential biomarkers out of 125 metabolites was further 
optimized using LASSO regression. The AUC value in validation data was 0.98, with sensitivity of 94.0% and specificity of 100%. 
We will further validate the biomarker in 800 plasma samples from CRC patients. In conclusion, our IM-MS based high-throughput 
metabolomics can effectively facilitate biomarker discovery, and has the great potential for large-scale metabolomics.
O-179 Urinary metabolomics-based sub-phenotyping of a large-scale multi-omics asthma cohort identified tryptophan dysregulation associated with asthma
PRESENTING AUTHOR: Stacey Reinke, Murdoch University, Australia
CO-AUTHORS: Shama Naz, Romanas Chaleckis, Héctor Gallart-Ayala, Johan Kolmert, David Broadhurst, James Schofield, Paul 
Skipp, Jeanette Bigler, Matthew Loza, Frederic Baribaud, Per Bakke, Massimo Caruso, Pascal Chanez, Stephen Fowler, Ildiko Horvath, 
Norbert Krug, Paolo Montuschi, Marek Sanak, Thomas Sandström, Dominick Shaw, Kian Chung, Ratko Djukanovi?, Florian Singer, Ana 
Souza, Ioannis Pandis, Aruna Bansal, Peter Sterk, Sven-Erik Dahlén, Craig Wheelock, U-BIOPRED Study Group _      
Aims Asthma is a heterogeneous disease with poorly defined sub-phenotypes lacking clear aetiology. Our aim was to investigate the 
utility of urinary metabolomics for identifying asthma sub-phenotypes. Methods Urine was collected from 613 participants across 15 
international sites for the European U-BIOPRED project (www.ubiopred.eu). The cohort comprised healthy controls (HC, n=108), 
mild-to-moderate asthmatics (MMA, n=87), and severe asthmatics, including non-smokers (SAns, n=310) and smokers (SAs, 
n=108). Longitudinal sampling was performed for SAns (n=225) and SAs (n=80). Untargeted metabolomic profiles were acquired 
in 17 analytical batches using LC-QTOF-MS, with HILIC chromatography, using simultaneous full scan MS and DIA at 2 collision 
energies. Pooled QC samples were injected after every 5th sample. Metabolites were identified using an in-house MS/MS library of 
413 metabolites. Batch-drift was corrected using the QC-RSC algorithm. Data were analysed using Principal Components–Canonical 
Variate Analysis (PC-CVA), Topological Data Analysis (TDA), and Hierarchical Clustering Analysis (HCA). Results 90 metabolites 
were reproducibly detected (average QC-RSD=3.3%); 43 changed significantly in asthma (FDR&lt;0.05). PC-CVA showed that HC 
and MMA differed significantly from SA (p=1.4x10-14), and SAns differed significantly from SAs (p=0.003). HCA and TDA revealed 
sub-phenotypes of SA associated with tryptophan metabolism dysregulation; blood cell transcriptomics corroborated these findings. 
Conclusions Urinary metabolomics successfully identified metabolic profiles associated with asthma severity. While observed fold-
changes were low, study power, experimental design, and strict QC measures enabled the detection of statistically robust metabolic 
alterations. Tryptophan metabolites are implicated in T-cell differentiation, cytokine activation, and oxidative stress, which may 
represent a useful strategy for sub-phenotyping asthma.
Metabolomics in Health and Medicine
13th Annual Conference of the Metabolomics Society
Page 107
O-184 Malaria parasite metabolism is supported by host derived nutrients obtained through RhopH2 mediated New Permeability Pathways
PRESENTING AUTHOR: Anubhav Srivastava, Monash Institute of Pharmaceutical Sciences, Australia
CO-AUTHORS: Natalie Counihan, Scott Chisholm, Hayley Bullen, Paul Sanders, Thorey Jonsdottir, Greta Weiss, Sreejoyee Ghosh, 
Brendan Crabb, Paul Gilson, Tania de Koning-Ward, Darren Creek                                   
Malaria is a major global health problem, with over 200 million reported cases and an estimated 429,000 deaths in 2015. Plasmodium 
parasites, which invade erythrocytes and cause malaria, drastically modify their host cells to render them permeable for exchange of 
nutrients and waste with the blood plasma via the formation of new permeability pathways (NPPs). Defining the molecular makeup 
of the NPPs is critical for identifying the best application strategies for new anti-malarial drugs and understanding the mechanisms 
by which malaria parasites can alter NPPs to develop resistance to chemotherapeutic agents.  In this study, using untargeted 
comparative metabolomics, we investigated the role of a parasite encoded protein, RhopH2 in Plasmodium-infected erythrocytes. 
We found that knockdown of RhopH2 expression leads to a depletion of essential vitamins and cofactors such as folate and thiamin 
phosphates and decreased de novo synthesis of pyrimidines. This causes a significant defect in parasite growth, replication and 
subsequent transition into the next cell cycle.  A similar metabolic and phenotypic effect was observed when wild type parasites were 
treated with a chemical inhibitor of the NPPs. For further validation, using uptake assays with different substrates, we confirmed 
that the import of metabolites known to enter Plasmodium infected erythrocytes via the NPPs is also reduced in RhopH2 knockdown 
parasites. RhopH2 was also found to interact with other proteins involved in host cell remodeling. These findings provide direct 
evidence for the contribution of RhopH2 in the formation of NPPs and highlight their importance in parasite metabolism.
O-197 BIOMARKER DISCOVERY FOR HEPATITIS C PROGRESSION USING METABOLOMICS
PRESENTING AUTHOR: Heidi Spratt, University of Texas Medical Branch, United States
CO-AUTHORS: Wendy Baker, John Petersen                                                
OBJECTIVES: Little is known about how Hepatitis C (HepC) infection progresses to Hepatocellular Carcinoma (HCC) in patients with 
advanced fibrosis. The objective of this study is to use Liquid Chromatography (LC) based Mass Spectrometry (MS) techniques to 
determine metabolites that are differentially expressed between Stage IV HepC infected individuals and individuals co-infected with 
both Stage IV HepC and HCC. We also aim to use the results from the metabolomics experiments to create a biomarker panel, using 
machine learning algorithms, for the early diagnosis of HCC. METHODS/STUDY POPULATION: LC/MS-MS metabolomics experiments 
were performed on serum samples from 30 Stage IV HepC and 30 Stage IV HepC, HCC co-infected individuals. Using statistical 
hypothesis tests, significantly different metabolites between the two groups at the 0.05 level of significance were identified. Using 
those results, machine learning algorithms were employed to create a biomarker panel which can be used to predict early stage 
HCC infection.  RESULTS: Several metabolites are significantly different between the two groups. Machine learning algorithms were 
used to identify a panel of potential biomarkers which can be used in the future to identify Stage IV HepC individuals which have 
progressed to early-stage HCC. DISCUSSION: HCC is the third most common cause of cancer deaths worldwide, yet there is no 
reliable diagnostic test for the early detection of the disease, when treatment options that improve long-term survival and patient 
outcomes are available. The discovery of a biomarker panel for the detection of early-stage HCC should provide new metabolite 
targets for diagnostic assays. 
O-203 Metabolic Reprogramming Induced by Retinoic Acid Ameliorates Desmoplasia in Pancreatic Cancer
PRESENTING AUTHOR: Amrita Cheema, Georgetown University, United States
CO-AUTHORS: Meena Rajagopal, Smrithi Menon, Tatiana Altadil                                               
Epithelial to mesenchymal transition (EMT) has been known to be integral to cancer metastasis. TGF? is a key signaling mediator that 
is involved in EMT and plays a pivotal role in increased production of extra cellular matrix (ECM) proteins that result in desmoplasia in 
PDAC. An in vitro metabolomics profiling approach was used primarily to confirm the identity of the core signaling pathways altered 
by TGF?. The unbiased view of metabolite abundance was studied to reveal the existence of unsuspected metabolic changes. A 
striking observation from metabolic phenotyping was the dysregulation of the signaling molecule, retinoic acid (RA) that was found to 
be significantly elevated in PANC1 cells treated with TGF? compared to untreated cells. We hypothesized that targeting retinoic acid 
receptor signaling, would cause rearrangement of the ECM components through metabolic reprogramming. Hence we investigated 
if retinoic acid signaling could be modulated to alleviate fibrosis in in vitro PDAC model through remodeling of the ECM components. 
The results we obtained using orthogonal methodologies shows that inhibition of retinoic acid signaling by specific retinoic acid 
receptor antagonist causes alterations in hexoseamine biosynthesis (HSB) pathway as well as extracellular matrix (ECM) remodeling. 
Targeted analysis of metabolites participating in the HSB pathway and their role in EMT mediated desmoplasia in PDAC is ongoing 
in addition to untargeted metabolomic profiling cell lines treated with retinoic acid and its receptor antagonists.  Our methodology 
underscores the power of high through put metabolomics technology for novel discoveries that further our understanding of cancer 
progression and metastasis.   
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O-222 Contaminants removal from tissue samples using DESI Ion Mobility imaging
PRESENTING AUTHOR: Vincen Wu, Imperial College London, United Kingdom
CO-AUTHORS: Jocelyn Tillner, Jeremy Nicholson, Zoltan Takats                                               
Desorption electrospray ionization (DESI) imaging is an ambient ionization technique that requires little to no sample preparation 
prior to analysis of surface analytes. DESI imaging has been demonstrated to accurately distinguish between cancer and normal 
tissue types, based on the differences in metabolic profiles. However, these studies are limited to fresh frozen, polymer-free samples, 
which are not always readily available. An alternative to these are fresh frozen samples embedded in optimal cutting temperature 
medium (OCT), which are widely available in most pathological laboratories. OCT is a common embedding medium, which consists of 
water-soluble glycols and resins and is used for sectioning fresh frozen specimens. OCT-embedded samples cause issues in positive 
ion mode DESI imaging, due to overlap in mass peaks between the metabolites from samples and polymers from OCT. Ion mobility 
mass spectrometry adds an additional dimension of separation based on the collisional cross-section (CCS) of ions. It is therefore 
able to separate isobaric peaks with different structures. As a proof of concept, both pork liver embedded in OCT and pork liver 
embedded in water were imaged with DESI, using a high resolution mass spectrometer equipped with ion mobility. The acquired 
images have demonstrated that the addition of ion mobility was able to separate overlapping OCT and lipid signals (e.g. 789.43 m/z 
and 789.46 m/z) based on their CCS values. This allowed a complete removal of interfering polymer peaks and provided comparable 
spectra for both embedding types.
O-230 Metabolomics Approach in Tohoku Medical Megabank Project Prospective Cohort Studies
PRESENTING AUTHOR: Seizo Koshiba, Tohoku University, Japan
CO-AUTHORS: Daisuke Saigusa, Ikuko Motoike, Matsuyuki Shirota, Jun Yasuda, Kengo Kinoshita, Masayuki Yamamoto                             
Tohoku Medical Megabank Organization has been conducting the Tohoku Medical Megabank (TMM) Project, which operates two 
prospective cohort studies in Japan: the TMM Community-Based Cohort Study and the TMM Birth and Three-Generation Cohort 
Study.  We have already recruited more than 150,000 participants and will start the follow-up health assessments from April 2017.  
Using the biospecimens and information collected from their participants, we have been performing genome and omics research.  
We have already determined the concentration distributions of metabolites in more than 1,000 Japanese plasma samples, using 
both mass spectrometry (MS) and NMR spectroscopy techniques.  These results have been released as a database, Japanese Multi 
Omics Reference Panel (jMorp), which is freely available in our Web site (https://jmorp.megabank.tohoku.ac.jp/).  This database is 
the first open database of Japanese standard omics information and is used as the reference data for a wide variety of medical and 
pharmacological studies.  We also investigated the correlation of these omics data with blood test values, items of questionnaires, 
and genome variants and found many kinds of correlations among them.  In order to expand our omics database, we are operating 
metabolome analysis for more than 5,000 plasma samples and will release high precision jMorp database and the results of the 
correlation analyses near future.
O-237 Molecular mechanisms of lung injury during cardiac surgery
PRESENTING AUTHOR: Raluca Maltesen, Aalborg University Hospital, Dep. of Anaesthesia and Intensive Care, Denmark
CO-AUTHORS: Katrine Buggerskov, Hanne Ravn, Reinhard Wimmer, Bodil Rasmussen                                             
Introduction: Acute lung injury is among the leading causes of morbidity and mortality in patients undergoing cardiac surgery 
with cardiopulmonary bypass (CPB). Exposure of blood to the CPB circuit and lung ischemia-reperfusion leads to lung injury with 
increased microvascular permeability, pulmonary oedema, and inflammation. Currently, the pathophysiological mechanisms are 
not completely understood.  Aim: The aims of this study are to identify intraoperative metabolic alterations, to relate them to the 
alveolar cellular immune system, and to elucidate the possible mechanisms of postoperative lung injury.  Methods: To evaluate 
cellular immune system and metabolic events in the lungs, bronchoalveolar lavage fluid (BALF) was collected from 49 surgical 
patients before and after CPB. BALF was screened for macrophages, neutrophils, lymphocytes, eosinophils (CellaVision DM96), and 
metabolites (1H Nuclear Magnetic Resonance spectroscopy). Multivariate unsupervised and paired analyses were applied to identify 
differences between samples, while Spearman correlation test was used to detect molecular associations. Statistical significance was 
defined as a p-value ?0.05. Results: Profound changes were identified in cells and metabolites at the end of CPB, indicating increased 
molecular activity in the alveoli during surgical procedure. Fold change analysis revealed changes in energy metabolites (&gt;3-
fold increased, p&lt;0.00001), amino acids (&gt;2-fold increased, p&lt;0.01), phospholipids (&gt;3-fold increased, p&lt;0.001), and 
polyamines (&gt;24-fold increased, p&lt;0.00001). Metabolites were linked to activated metabolism in BALF cells, but also to vascular 
permeability, pulmonary oedema, proteolytic activity, and oxidative stress.  Conclusion: We provide a comprehensive pulmonary 
profile of immunologic and metabolic events occurring during CPB and identify possible pathophysiological mechanisms to lung injury.
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O-239 A robust analytical pipeline for high throughput molecular phenotyping of populations
PRESENTING AUTHOR: Beatriz Jiménez, MRC-NIHR National Phenome Centre. Computational Systems Medicine. Imperial College 
London, United Kingdom
CO-AUTHORS: Torben Kimhofer, Rose Tolson, Nikita Harvey, Matthew Lewis, Jake Pearce, Elaine Holmes, Jeremy Nicholson               
The global growth of molecular epidemiology has necessitated a step change in molecular profiling technologies for delivering high 
throughput spectral data defining population phenotypes. The MRC-NIHR National Phenome Centre (NPC) is one of the first centres 
dedicated to large-scale metabolic profiling and was opened in Imperial College. A key objective of the NPC is to establish and 
validate analytical methods for large sample cohorts. We have developed and optimised high quality and robust NMR-based profiling 
approaches for large-scale metabolic phenotyping and applied it to approximately 8000 urine samples from 7 independent studies 
analysed across 4 years to assess potential confounding variation associated with experimental quality, sample stability and biological 
variation (e.g. gender and age). Within each study, two different quality control (QC) samples (one internal to the study and an inter-
study comparator) were included allowing both intra and inter-study variability to be defined. The coefficient of variation of the urine 
metabolic profile of the QC samples within a single study was below 0.1 for more than 90% of the metabolites. However inter-study 
analysis showed that while some metabolites such as creatinine or hippuric acid or even histidine present a very low coefficient of 
variance (CV&lt;0.1) others like citrate, dimethylamine, or acetate present higher variation (CV~0.5). Using QC samples to define 
confidence limits for spectral stability we applied our optimised analytical pipeline to characterise variation attributed to gender and 
age and to define “normal” reference ranges for representative metabolites involved in endogenous metabolic pathways and gut 
microbial metabolism.  
O-241 The effects of changing the liquid/solid content of an isoenergetic test meal on gastric emptying and the blood lipidome
PRESENTING AUTHOR: Xuefei Li, Department of Biochemistry, University of Cambridge, United Kingdom
CO-AUTHORS: Evelina Charidemou, Elise Orford, Sara Wassell, Mathew Harvey, Michelle Venables, Julian Griffin                                           
Gastric emptying (GE) is a term describing the process by which food leaves the stomach. This study investigates whether the 
liquid, carbohydrate rich, component of a mixed meal delays GE of the solid portion and induces changes in the plasma lipidome. 
Four of eight healthy male participants have been recruited to date in this randomised, 5-way crossover study. On each study visit, 
fasted participants received one of the five isoenergetic mixed meals (2MJ) labelled with [1-13C] octanoic acid. The meals included: 
Standard (with or without bread), high fat, high carbohydrate and high protein. Breath and plasma samples were collected at set 
intervals for 6 hours. Breath samples were analysed by Isotope Ratio Mass Spectrometry (IRMS). Plasma samples were examined 
by LC-MS based lipidomics. The GE parameters including half emptying time (Thalf, the time taken for 50% of the total 13C label 
excreted to appear in the breath) and lag time (Tlag, the time of maximum excretion rate of label in the breath) were analysed 
using WinBugs. There was no difference found in isotope recovery or Thalf between the meals, while Tlag was meal dependent (c2, 
Friedman=10.4, p=0.034). However, there was no significant difference in Tlag, Thalf(in) and Tlag(in) between meals under pairwise 
comparison with post-hoc Bonferroni correction. The lipid data were analysed using OPLS-DA. Three different groups were classified 
with the high carbohydrate meal separated most from the others (R2=0.61, Q2=0.74). This ongoing study demonstrates the use of 
stable isotope technology to follow physiological changes while profiling changes in lipidome.
O-244 Rapid characterisation of the vaginal metabolome during pregnancy using desorption electrospray ionization (DESI) MS medical swab analysis
PRESENTING AUTHOR: Pamela Pruski, Imperial College London, United Kingdom
CO-AUTHORS: Holly Lewis, Goncalo Correia, Alvaro Perdones-Montero, Paolo Inglese, Lindsay Kindinger, Elaine Holmes, Phillip 
Bennett, Zoltan Takats, David MacIntryre                                      
Sequencing based characterisation of vaginal bacterial communities (VBCs) have limited clinical application due to time and cost 
constraints and the failure to capture host-microbiota interactions. We recently developed a novel approach for rapid characterisation 
of mucosal metabolic profiles directly from medical swabs (Pruski et al. 2017) using desorption electrospray ionization mass 
spectrometry (DESI-MS). This method permits rapid assessment of VBC-related metabolic changes associated with bacterial 
vaginosis, a common condition characterised by reduced levels of commensal Lactobacillus species and overgrowth of anaerobic 
bacteria. In this study, we use DESI-MS medical swab analysis to characterise the vaginal metabolome in a cohort of 63 women 
longitudinally sampled (n=248 swabs) throughout healthy pregnancy. Relationships between maternal factors (gestational age, BMI, 
vaginal pH) and metabolite changes occurring across gestational age were assessed.  DESI-MS profiles were compared to reversed 
phase LC-MS profiles and were then correlated with paired vaginal microbiota profiles (by Bacterial 16S rRNA gene sequencing) to 
identify discriminative features predictive of VBC composition. The significant features (including SCFA, polyamines and lipids) were 
compared with metabolite profiles obtained from purified cultures. A Random Forest classifier with cross validation was applied 
to assess the prediction accuracy of a healthy vaginal community (Lactobacillus dominated) and a dysbiotic state (Lactobacillus 
depleted) achieving overall &gt; 80% accuracy using DESI MS. These results indicate that DESI MS analysis of medical swabs fulfills 
the criteria for a routine diagnostic procedure and may permit identification of vaginal dysbiosis in pregnancy and early stratification 
of women at risk of infection-related pathologies during pregnancy). 
Metabolomics in Health and Medicine
13th Annual Conference of the Metabolomics Society
Page 111
O-245 Aiding diagnosis of rare disease: applications of mass spectrometry-based metabolomics in the Undiagnosed Diseases Network
PRESENTING AUTHOR: Tom Metz, Pacific Northwest National Laboratory, United States
CO-AUTHORS: Jennifer Kyle, Kelly Stratton, Erika Zink, Young-Mo Kim, Jean-Philippe Gourdine, Heino Heyman, Melissa Haendel, 
Bobbie-Jo Webb-Robertson, Katrina Waters, David Koeller                                    
In the U.S., 6% of the general population suffers from a rare disorder that has evaded diagnosis. The goals of the NIH Undiagnosed 
Diseases Network (UDN) include improving the level of diagnosis and care for patients and facilitating research into the etiology 
of undiagnosed diseases. As the UDN Metabolomics Core, we are performing MS-based metabolomics and lipidomics analyses of 
plasma, cerebrospinal fluid (CSF) and urine from patients and first degree relatives, as well as disease models in organisms such 
as Drosophila and zebrafish. These data are being compared against similar metabolic profiles from healthy individuals and in 
integrative analyses together with results from patient gene sequencing. To allow for proper statistical analyses of UDN patient data, 
we generated reference datasets from analyses of plasma, CSF, and urine from &gt;391 individuals with no known metabolic disease 
and representative of the demographics of the UDN, all driven by power analyses of historical data. To date, we have performed 
&gt;1500 untargeted metabolomics and lipidomics analyses of plasma, CSF, and urine samples, resulting in reference datasets 
containing &gt;300 identified and unidentified metabolites and &gt;500 identified lipids as a community resource. A total of 145 
samples (83 plasma, 57 urine, and 5 CSF) from 83 UDN patients and first degree relatives have been analyzed, and the resulting 
data compared to the appropriate reference datasets in order to identify outlier metabolites and lipids.  This data is being used to 
identify the metabolic pathways that have been affected by the underlying disease processes.
O-279 DMGV is a Novel Marker of Liver Fat and Predicts Future Development of Type 2 Diabetes
PRESENTING AUTHOR: John O’Sullivan, Heart Research Institute, Australia
CO-AUTHORS: Jordan Morningstar, Qiong Yang, Baohui Zheng, Sarah Jeanfavre, Justin Scott, Celine Fernandez, Hui Zheng, 
Ramachandran Vasan, Michelle Long, Olle Melander, Thomas Wang, Caroline Fox, Randall Peterson, Clary Clish, Kathleen Corey, 
Robert Gerszten                           
Background: Unbiased “non-targeted” metabolite profiling techniques hold considerable promise for biomarker and pathway 
discovery, though there have been few successful applications to human disease. We aimed to uncover novel biomarkers of non-
alcoholic fatty liver disease (NAFLD) and cardiometabolic disease using non-targeted metabolomic profiling in well-phenotyped 
human cohorts.    Methods: Non-targeted metabolite profiling was performed using hydrophilic interaction chromatography on a 
UHPLC Q-Exactive hybrid orbitrap LC/MS system.    Results: The non-targeted platform was applied first to plasma of a discovery 
cohort of 1066  participants, of whom 470 had CT-defined fatty liver disease. An unknown metabolite with a mass/charge ratio of 
202.1185 had the strongest association with CT-defined liver fat, which was quantified using the liver-to-phantom ratio (P=1.16E-10, 
adjusting for age, sex, smoking, alcohol consumption, HDL and triglyceride concentration, HOMA-IR, hypertension, and BMI). 
Following structural elucidation by LC-MS and the synthesis of a chemical standard, we confirmed the peak identity as ?-keto-?-
(NGNG-dimethylguanidino)-valeric acid (DMGV). DMGV was significantly associated with non-alcoholic steatohepatitis (NASH), in 
a cohort of 36 patients with biopsy-proven NASH and 36 age, sex, and BMI-matched controls (OR=1.96, P=0.011, conditionally 
adjusted for age, sex, and BMI). Further, DMGV was predictive of future type 2 diabetes mellitus (T2D) in 196 cases of incident 
diabetes and 126 controls in the Malmo Diet and Cancer Study (OR=1.56, P=8.6E-4, adjusting for age, sex, glucose, and BMI; mean 
follow-up period of 12.8 years).    Conclusions: DMGV is a novel marker of NAFLD and NASH, and is a predictor of future T2D.
O-281 Metabolomic analysis of the effects of a ten week high protein diet in older men
PRESENTING AUTHOR: Amber Milan, Liggins Institute, University of Auckland, New Zealand
CO-AUTHORS: Brenan Durainayagam, Utpal Prodhan, Sarah Mitchell, Nina Zeng, Farha Ramzan, Pankaja Sharma, Scott Knowles, 
Cameron Mitchell, Anders Sjödin, Karl-Heinz Wagner, Nicole Roy, Karl Fraser, David Cameron-Smith                                
Epidemiological evidence suggests that a higher protein diet may be beneficial for optimal health, particularly for the elderly. 
However, the impact of the current protein recommended dietary allowance (RDA; 0.8 g/kg body weight per day) versus a higher 
protein intake on metabolomic profiles in the elderly has not been established. To investigate this, we prepared isocaloric omnivorous 
diets containing either the RDA or twice the RDA (2RDA) of protein. These were allocated to two groups of 15 healthy free living 
men (74 ± 4 years) and fed for 10 weeks. Blood samples were collected in the overnight fasted state prior to and immediately 
following the 10 week intervention. Non-targeted analysis of polar metabolites in blood plasma was performed by LC-MS (HILIC 
chromatography coupled to an Exactive™ mass spectrometer). Despite that the diets were designed to balance energy needs, body 
mass decreased in the men consuming the RDA, but was maintained in the 2RDA group (-2.0 ± 2.4 kg, p&lt;0.01 vs. -0.1 ± 2.2 kg, 
p&gt;0.05). Metabolite profiles were altered by dietary intervention in both groups. There were increases in glutamine (p&lt;0.001) 
and asparagine (p&lt;0.05), and reductions in glutamic acid (p&lt;0.001) and hydroxyproline (p&lt;0.005). Alanine and glycine plasma 
concentrations increased after the RDA diet but decreased after the 2RDA diet (group × time interaction p&lt;0.05 each). Ten weeks 
of controlled dietary intervention elicited marked alterations in circulating metabolite profiles, with analysis on-going to identify the 
major biochemical pathways influenced by an increased protein intake.
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O-289 Plasma metabolites associated with type 2 diabetes in a Swedish population - a nested case-control study
PRESENTING AUTHOR: LIN SHI, Department of Molecular Science, Swedish University of Agricultural Sciences, Sweden
CO-AUTHORS: Carl Brunius, Marko Lehtonen, Seppo Auriola, Ingvar A. Bergdahl, Olov Rolandsson, Kati Hanhineva, Rikard Landberg 
The discovery of early metabolic alterations of type 2 diabetes (T2D) may provide novel insight into the pathophysiology of T2D 
and improve disease prediction. We established a nested case-control study within the Västerbotten Intervention Programme 
cohort to discover plasma metabolites associated with risk of developing T2D. Using untargeted LCMS metabolomics, we analyzed 
plasma samples from 503 case-control pairs at baseline (median time of 7 years prior to T2D diagnosis) and investigated change of 
metabolites over time in 10-year follow up samples from 187 case-control pairs.  A total of 46 discriminative metabolites between 
cases and controls at baseline were unbiasedly selected using a comprehensive data-analysis pipeline adapted for large-scale 
metabolomics. After adjusting for BMI, fasting glucose and lifestyle factors, diglycerides, a bile acid, branched-chain amino acids 
(BCAA) and their catabolic metabolites were associated with increased risk of T2D, whereas phosphocholines (PCs), N-Acetylglycine, 
and 2-hydroxyethanesulfonate were associated with decreased risk. These metabolites correlated strongly with insulin resistance 
and/or beta cell dysfunction, suggesting specific roles in disease pathophysiology.  Moreover, PCs containing odd-chain fatty acids, 
BCAAs and the bile acid had high long-term reproducibility among healthy controls, and their changes over time reflected disease 
progression in cases. Furthermore, optimal utilization of predictive metabolites and traditional risk factors significantly improved T2D 
risk prediction, as assessed by area under the receiver operating characteristic curve, discrimination improvement index, and net 
reclassification index. The results underscored the ability of single measurements of predictive metabolites to reveal pathophysiology 
and to improve risk prediction several years before onset of T2D.
O-300 LIPIDOMICS REVEALS CEREBROSPINAL-FLUID SIGNATURES OF ALS
PRESENTING AUTHOR: BOCCA CINZIA, INSERMU930, France
CO-AUTHORS: CHARLOTTE VEYRAT DUREBEX, CINZIA BOCCA, FRANCK PATIN, PATRICK VOURCH, JUDITH Kouassi Nzoughet, Guy 
Laeners, Christian Andres, Gille Simard, Philippe Corcia, Pascal Reynier                                    
Objective The objectives of this study were to investigate the cerebrospinal fluid (CSF) lipidomic signature of ALS patients to evaluate 
the diagnostic and predictive values of the profile and to identify pathophysiologic biomarkers. Methods We performed an untargeted 
lipidomic analysis in 40 ALS patients compared to 45 controls. We robustly determined 122 lipids by liquid chromatography 
coupled to high-resolution mass spectrometry. Parameters of disease progression were collected at baseline and again one year 
later (ALSFRS-r, FVC, BMI°, as well as survival. Lipidome profiles were then subjected to powerful statistical modelling to compare 
ALS and controls and to model the rate of progression. Results ALS displayed a highly significant specific CSF lipidomic signature 
involving phosphatidylcholines, sphingomyelins and triglycerides. Phosphatidylcholine PC(36:4), higher in ALS (p=0.0003) was the 
strongest biomarker. Analysis of lipids in the brain cortex of ALS mice confirmed the role of some discriminant lipids such as PC. 
We also obtained an excellent model (accuracy of 79%) for predicting the variation of the ALSFRS-r score from baseline lipidome. 
Significant predictions of clinical evolution were found to be correlated to sphingomyelins and triglycerides with long-chain fatty 
acids. Interpretation Our study, which shows extensive lipid remodelling in the CSF of ALS patients, provides new biomarkers of the 
disease and its evolution. Importantly, the lipidomic signature found in ALS patients consistent with ALS mice findings, highlighted 
phosphatidylcholines, that merit to be further explored.  
O-314 Enrichment of Secondary Bile Acids associated with Food Allergy in Healthy Infant Cohort
PRESENTING AUTHOR: Yamini Virkud, Massachusetts General Hospital, United States
CO-AUTHORS: Rachel Kelly, Augusto Litonjua, Scott Weiss, Jessica Lasky-Su                                             
Rationale:  Food allergy is a life threatening condition, and while metabolomic analyses have been used in murine models of food 
allergy, metabolomics studies of food allergy in humans remain limited.  Methods: We examined plasma metabolomics from a 
cross-sectional study of infants recruited for the VDAART (N=213) prenatal vitamin D trials. We compared the 32 children with self-
reported food allergy to those without (n=181).  We employed logistic regression to identify the top metabolites associated with food 
allergy in the infant cohort, and replicated these in a cohort of Costa Rican asthmatic children with self-reported food allergy (N=243, 
38 with self-reported food allergy).  We also conducted receiver operator curve (ROC) analysis (adjusting for gender, race, and 
age) to determine the utility of our top hits in predicting food allergy.  Results: We identified 24 metabolites (p&lt;0.05) associated 
with food allergy.  Secondary bile acids represented 4 of the top 8 metabolites, including ursodeoxycholate (OR:4.51, 95%CI:2.0-
11.7, p=0.0009), glycoursodeoxycholate (OR:2.70, 95%CI:1.29-6.11, p=0.012), isoursodeoxycholate (OR:2.32, 95%CI:1.19-4.80, 
p=0.018), and glycodeoxycholate (OR:1.70, 95%CI:1.10-2.7, p=0.019). We also found an association with deoxycholate and food 
allergy in our Costa Rican cohort (p=0.0095). ROC analysis using the top 24 metabolites yielded an area under the curve (AUC) of 
0.86 (p=1.9x10-8), and using the 4 deoxycholates yielded an AUC of 0.76 (p=0.00098). Conclusions: These results suggest that 
there exist metabolite profiles of pediatric food allergy that may prove useful as biomarkers.  In particular, the strong association of 
secondary bile acids suggests a possible role for these metabolites in the pathophysiology of food allergy.
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O-319 An integrated approach combining metabolomics, lipidomics and glycomics on plasma to highlight metabolism dysregulation in hepatic encephalopathy
PRESENTING AUTHOR: Pierre BARBIER SAINT HILAIRE, CEA, SPI, Laboratoire d’Etude du Métabolisme des Médicaments, 
MetaboHUB-IdF, Université  Paris Saclay, 91191 Gif-sur-Yvette cedex, France, France
CO-AUTHORS: Benoit COLSCH, François FENAILLE, Nicolas WEISS, Dominique THABUT, Christophe JUNOT                                            
Hepatic encephalopathy (HE) is a neurological complication observed in patients with liver disease, mainly cirrhosis. About 50% of 
cirrhotic patients will develop HE with symptoms ranging from mild cognitive impairment to coma. Pathophysiological mechanisms 
remain poorly understood despite a possible role of hyperammonemia. This limits the discovery of new preventive and therapeutic 
strategies. In this context, untargeted metabolomics can be useful to understand the dysfunction of metabolic pathways in HE 
patients. A previous study performed on cerebrospinal fluid highlights the dysregulation of energy metabolism1. To complete this 
work, we focus on plasma and perform a “multi-omics” study including metabolomics, lipidomics and glycomics.   Metabolomics and 
lipidomics experiments were performed using liquid chromatography coupled to high resolution mass spectrometry. N-glycan analysis 
was performed using a MALDI-ToF/ToF instrument. Plasma samples were collected from 12 cirrhotic patients with HE, 13 cirrhotic 
patients without HE and 9 healthy controls.   In addition to the 122 metabolites found in CSF, 190 other metabolites were identified 
in plasma. In lipidomics, more than 900 lipids were annotated while around 50 N-glycans were detected. Modifications in metabolite 
concentrations between the cirrhotic and control groups were observed. Moreover, this study highlights the specific modifications 
in HE samples compared to cirrhotic ones. In lipidomics, the main impacted families are glycerophosphocholines, sphingomyelins 
and cholesteryl esters with lower concentrations in HE plasma. Metabolomics supports these observations (e.g. diminution of 
sphingosine-1-phosphate). Glycomics results are currently being analyzed. The combination of the different techniques will provide 
new complementary insights into HE metabolism dysregulation.   1: J Hepatol.,2016,65:1120
O-324 Metabolic reprogramming of macrophages exposed to Pseudomonas aeruginosa biofilm
PRESENTING AUTHOR: Valerie Copie, Montana State University, United States
CO-AUTHORS: Amanda Fuchs, Mary Cloud Ammons                                                
Currently, the annual economic cost of chronic wounds exceeds $1 billion in the United States, and the incidence of non-healing 
human wounds is expected to dramatically increase in the next several years due to emerging Type 2 diabetes epidemics. 
Several common characteristics typical of chronic wounds include tissue colonization by persistent antibiotic-resistant pathogenic 
microbial biofilms, excessive inflammation, and failure of human cells to resolve the wound. Pseudomonas aeruginosa is one of 
the predominant opportunistic pathogens that colonizes greater than 50% of all chronic wounds in the U.S, and is a serious health 
threat.To better understand the molecular processes by which P. aeruginosa biofilms interfere with human macrophage immune 
responses, we have undertaken nuclear magnetic resonance-based metabolomics studies of activated and resting macrophages. 
The studies aim to probe the metabolic reprogramming of these immune cells as result of exposure to secreted molecules produced 
by P. aeruginosa biofilms, using an in vitro host-pathogen co-culture model. Herein, we present our most recent NMR-based 
metabolomics results demonstrating the presence of a significant metabolic shift between different macrophage phenotypes. This 
metabolic phenotyping is correlated with fluorescence-activated cell sorting (FACS) analysis which has been employed to characterize 
the relationship between metabolic profiles and macrophage immunomodulation (i.e. macrophage polarization into pro- or anti-
inflammatory M1 or M2 subpopulations, respectively), resulting from macrophage exposure to secreted molecules from co-culture P. 
aeruginosa biofilms. The overall research goals are to generate foundational knowledge for the design of new, metabolism-based, 
therapeutic interventions to treat biofilm-infected human chronic wounds.
O-341
The metabolomic analysis of sequential hair segments reflected the metabolic changes of 
normal, small-for-gestational-age, and gestational diabetes mellitus affected pregnancies 
across the trimesters.
PRESENTING AUTHOR: Ting-Li Han, Liggins Institute, The University of Auckland, Auckland, New Zealand, New Zealand
CO-AUTHORS: Thibaut Delplancke, Hua Zhang, Philip Baker                                               
Background: Metabolomics is an increasingly popular analytical approach for the prediction, diagnosis, and prognosis of pregnancy 
outcomes. Biological specimens such as blood and urine provide a transient biochemical profile. In contrast, hair is a stable 
specimen which can provide a long-term metabolite profile containing information from both endogenous compounds and 
exogenous compounds. We hypothesised that the metabolomic analysis of hair segments could be used to study the longitudinal 
metabolite profile of normal pregnancies and pregnancies complicated by gestational diabetes mellitus (GDM) or resulting in a 
small-for-gestational-age infant (SGA).  Methods: Hair samples were collected from 170 women in Auckland, New Zealand at 34-36 
weeks’ gestation. The hair was segmented based on trimester and each segment was analysed using both gas chromatography-
mass spectrometry and liquid chromatography-mass spectrometry. Repeated measures ANVOA, logistic regression (adjusting for 
BMI, maternal age and ethnicity), and a Pathway Activity Profiling R package were applied to determine which hair metabolites/
metabolic pathways differed significantly across trimesters as well as between normal and adverse pregnancy outcomes.  Results: 
The hair metabolome and metabolic pathways identified were significantly different between trimesters. The majority of metabolites 
associated with SGA were saturated fatty acids such as myristate and margarate, observed in hair from the second trimester. 
Metabolites associated with GDM were involved in the central carbon metabolism, and were observed in hair from the third trimester. 
Conclusion: Our results demonstrated that hair segments could be used to reflect the longitudinal changes of the metabolite profile 
as well as to differentiate pregnancy complications from healthy pregnancies.
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O-342 Pre-pregnancy maternal obesity can result in metabolic dysregulation and memory impairment in male offspring
PRESENTING AUTHOR: Xiaobo Zhou, First Affiliated Hospital of Chongqing Medical University, China
CO-AUTHORS: Zhu Chen, Xiaobo Zhou, Ting-Li Han, Philip Baker, Hua Zhang                                            
Background: Obesity is a worldwide epidemic which is associated with ranges of health problems. There is increasing evidence that 
offspring health during childhood and later adult life is affected by maternal obesity. We hypothesized that the offspring of mice 
from an obese mother, when following a high-fat diet (HFD) after weaning, would exhibit metabolic dysregulation and memory 
impairment. Methods: In our pilot study a LepRdb/+ mouse model (n=37) was used to model pre-pregnancy maternal obesity, 
and the c57bl/6 wildtype (n=36) was used as a control group. Offspring were fed either a HFD or a low-fat control diet (LFD) after 
weaning (between 8-10 weeks). The Morris water maze was performed between 28-30 weeks. Metabolomic profiles of serum, liver, 
ovary, testis, kidney, and brown adipose tissue from each group collected at the age of 30-32 weeks, were analyzed using Gas 
Chromatography-Mass Spectrometry. Results: The offspring metabolomic profiles from the serum and organs (with exception of the 
kidney) were significantly different between the HFD-group and LFD-group. Maternal obesity only influenced the metabolomic profiles 
of serum, ovary, testis, and male brown adipose tissue in their offspring, when compared to the control group. The memory of male 
offspring from obese maternal mice was significantly impaired, while no significant differences were observed in female offspring. 
Conclusion: Our findings suggest that offspring from obese maternal mice that consume a HFD after weaning have significantly 
altered metabolomic profiles, and memory was significantly impaired in male offspring. Further research is needed to validate the 
results of our pilot study.
O-350 Insufficient Sleep Alters Plasma Metabolites Linked to Insulin Resistance and Diabetes Risk
PRESENTING AUTHOR: Christopher Depner, University of Colorado Boulder, United States
CO-AUTHORS: Rachel Markwald, Charmion Cruickshank-Quinn, Kevin Quinn, Nichole Reisdorph, Kenneth Wright                                            
Introduction: Many people in modern society sleep less than the recommended 7h/night and insufficient sleep is associated with 
increased diabetes risk. We previously reported a 5-day simulated work-week of insufficient sleep decreased insulin sensitivity. To 
identify potential biochemical mechanisms underlying such metabolic dysregulation, we investigated the plasma metabolome before 
and during insufficient sleep. Methods: We conducted a randomized cross-over clinical laboratory study where 16 healthy subjects 
aged 22.4±4.8y (mean±SD) completed 3 baseline days (9h sleep opportunity/night) followed by 5 day insufficient (5h/night), 
and adequate (9h/night) sleep conditions. At baseline, food intake was designed to meet energy requirements, whereas during 
insufficient and adequate sleep, food intake was ad-libitum. Subjects completed oral glucose tolerance tests at baseline and during 
adequate and insufficient sleep conditions for assessment of insulin sensitivity. We analyzed plasma by untargeted LC/MS every 4h 
across the final 24h of baseline, insufficient, and adequate sleep. Results: ANOVA (false discovery rate &lt; 0.2) and random forest 
analyses were used to identify the top metabolites differentiating insufficient and adequate sleep. In total, 241 metabolites (~5%) 
changed between conditions including glycerophospholipids, sphingolipids, diacylglycerols, triacylglycerols, and acylcarnitines. 
Specifically, acylcarnitines C10:1 and C10:2 were decreased, and short-chain triglyceride species (TAG-42:0, TAG-46:1, TAG-48:2) 
were elevated during insufficient sleep. Conclusion: We found insufficient sleep broadly affects the human plasma metabolome. 
Changes in plasma acylcarnitines and elevated short-chain triglycerides during insufficient sleep are consistent with altered fatty 
acid oxidation. Thus, our findings suggest insufficient sleep alters fatty acid oxidation and contributes to reduced insulin sensitivity, 
elevating diabetes risk.
O-356 How Blood Removal Affects Exercise Performance and the Plasma Metabolome
PRESENTING AUTHOR: Nathan Lawler, Centre for Integrative Metabolomics & Computational Biology, School of Science, Edith 
Cowan University, Australia
CO-AUTHORS: David Broadhurst, Joel Gummer, Chris Abbiss, Timothy Fairchild, Garth Maker, Robert Trengove, Jeremiah Peiffer             
Purpose: Blood removal has both haematological and non-haematological affects resulting in alterations to aerobic and anaerobic 
metabolism and overall exercise performance. This study examined the longitudinal effects (42 days) of whole blood removal on 
aerobic performance, and the plasma metabolome, in a “trained” and “non-trained” cohort. Methods: At baseline and 7 additional 
time points up to and including 42 days, 470 mL of whole blood were removed from 8 trained male cyclists, and 7 healthy untrained 
males. At all time points, plasma samples were collected and stored at -80°C and aerobic performance was assessed using an 
incremental cycling test (VO2max) and 4-minute self-paced cycling time trials. Plasma samples were analysed using LC-TOFMS 
(ESI +/-) employing C18 chromatography. Pooled QC samples were injected after every 5th sample. Data were processed using 
XCMS and analytical drift was corrected using the QC-RSC algorithm. Data were analysed using Repeated Measures ANOVA, 
Principal Components – Canonical Variate Analysis (PC-CVA) and Hierarchical Clustering Analysis (HCA). Results: VO2max decreased 
by 6±12%, 2±6%, 1±2% at 24 h, 7 d, and 21 d, respectively. 147 peaks changed significantly (p&lt;0.001) with time, but no 
differences were observed between study groups. PC-CVA and HCA corroborated these findings. HCA clustered metabolites into 8 
different trajectories. Conclusion: Many dysregulated metabolites mapped closely to the expected return to homeostasis; however, a 
number of metabolites appear to remain perturbed beyond the return of aerobic performance. These findings provide insight into the 
biological understanding for the effects of blood manipulation in trained and healthy individuals.
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O-366 Exploring dormant genital tuberculosis associated infertility - 1H NMR based serum lipidomics approach
PRESENTING AUTHOR: Koel Chaudhury, School of Medical Science and Technology, Indian Institute of Technology Kharagpur, 
India
CO-AUTHORS: Elavarasan Subramani, Mamata Joshi, Chaitali Datta Ray, Baidyanath Chakravarty                                             
Genital tuberculosis (GTB) is an important clinical problem causing infertility in women and is an underdiagnosed type of extra-
pulmonary tuberculosis. As an intracellular pathogen, Mycobacterium tuberculosis strongly influences the metabolism of host cells, 
potentially inducing dysregulation in lipid metabolites. This motivated us to explore the significantly altered lipid molecules that 
may enhance our understanding of the underlying host-pathogen interaction.Unexplained infertile women having at least 3 IVF 
failure with (n=26) and without dormant GTB (n=26) were recruited for this study. Serum samples were collected on day 7–10 
post-ovulation from all subjects at the Institute of Reproductive Medicine, Kolkata, India. 700 MHz proton NMR spectra of serum 
lipid fractions were recorded for both the groups. Multivariate and univariate analyses were applied to all spectra. Lipids including 
C26H3 and C27H3 free/esterified cholesterol, C19H3 free and C19H3 esterified cholesterol and CH2CO 22:6 fatty acids were found to 
significantly down-regulated in serum of women with dormant GTB compared with controls. Further, significant upregulation of serum 
free fatty acid residues such as CH2CO FA, CHCH2(CH2)n FA and(CH2)n FA and triglycerides in dormant GTB patients was found as 
compared to controls. This study reports, for the first time, a clear lipidomic differentiation between women with dormant GTB and 
controls during window of implantation. The dysregulated lipids observed in the present study are indicative of poor endometrial 
receptivity in these women. These findings may be explored further by clinicians for better therapeutic management of patients with 
GTB related infertility.
O-381 Integrated omics profiling of NGLY1 deficiency disease
PRESENTING AUTHOR: Songjie Chen, Stanford University, United States
CO-AUTHORS: Guangwen Wang, Christine Yeh, Sharon Pitteri, David Marciano, Michael Snyder                                            
  Patients of rare diseases not only suffer severe pathology, but also insufficiently diagnosed and cured due to the insufficient 
pathological information and variations of symptoms. Metabolomic profiling of patients’ biofluids provides broad information of 
the affected metabolic pathways, however, individual metabolome exhibits extensive variation due to genetic background and 
environmental factors. We generated induced pluripotent stem cells (iPSCs) from patients of a rare disease, NGLY1 deficiency, 
and corrected pathogenic mutations by CRISPR to provide superior controls for the characterization of disease relevant molecular 
phenotype. We further applied metabolomic profiling integrated with proteomics analysis of iPSCs and patients’ plasma to capture 
the disease related molecular phenotype. The integrated personalized omics profiling of cell models generated from NGLY1 deficiency 
patient are expected to discover the metabolites and proteins involved in NGLY1 deficiency affected pathways. An on-dish platform 
generated from the cell models and captured molecular phenotypes will be further applied for the screening of potential therapies. 
Such an integrated personalized approach developed in this project will have translational impact on the research of diverse rare 
diseases.   
O-384 Multi-omics analysis reveals the biochemical changes associated with artemisinin-resistant malaria parasites
PRESENTING AUTHOR: Darren Creek, Monash University, Australia
CO-AUTHORS: Ghizal Siddiqui, Adrian Russell, Anubhav Srivastava                                               
Malaria is a major global health concern, responsible for over 200 million cases and 429 000 deaths annually. Artemisinin combination 
therapies are the first-line treatment for malaria, and few effective alternatives exist. Alarmingly, the emergence and spread of 
artemisinin resistance in South-East Asia threatens our ability to treat malaria, and the mechanism of this resistance is poorly 
understood. Artemisinin resistance has been associated with mutations in the PfKelch13 gene of the malaria parasite. However, the 
function of PfKelch13, and the mechanism of resistance remain unknown. The aim of this study was to reveal the biochemical impact 
of common PfKelch13 mutations using metabolomics, peptidomics and proteomics analysis. Two field-derived parasite strains bearing 
PfKelch13 mutations associated with artemisinin resistance (Cam3.IIR539T and Cam3.IIC580Y), and an isogenic PfKelch13 wild-type 
control (Cam3.IIRev), were cultured in vitro and metabolites, peptides and proteins were extracted in parallel for analysis. Proteomics 
analysis with dimethyl labelling and nanoLC-MS revealed the abundance of PfKelch13 itself to be lower in the mutant lines. 
Metabolomics analysis using a HILIC-Orbitrap LC-MS platform revealed few significant overall differences in metabolite levels, with 
significant accumulation of glutathione and gamma-glutamylcysteine observed in the PfKelch13-mutant strains. Peptidomics analysis, 
using reversed-phase nanoLC-MS, demonstrated a depletion of haemoglobin- derived peptides, suggesting decreased haemoglobin 
digestion by the mutant parasites. Artemisinins are thought to be activated by haemoglobin-derived iron to produce free radicals that 
are responsible for their antiparasitic activity. This study suggests that PfKelch13-mutant parasites may overcome this effect by a 
combination of reduced haemoglobin digestion and enhanced glutathione production.
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O-436 Comprehensive High-Throughput Targeted Lipidomics
PRESENTING AUTHOR: kevin huynh, Baker Heart and Diabetes Institute, Australia
CO-AUTHORS: Christopher Barlow, Natalie Mellett, Jacquelyn Weir, Peter Meikle                                             
Background: Comprehensive lipidomics has allowed for unprecedented characterisation of the lipidome within biological systems. 
However, structural isomers (particularly phospholipid isomers) represent an ongoing challenge. Here we report on an improved 
targeted lipidomic methodology utilising UHPLC ESI-MS/MS with improved isomeric separation of lipid species, allowing for offline 
characterisation of structural isomers while maintaining high sensitivity and throughput. Method: Lipid species were extracted from 
10µL of plasma with a single phase chloroform/methanol extraction. Extracts were examined by UHPLC ESI-MS/MS using an IPA/
ACN/H2O solvent system and a non-linear gradient on a ZORBAX eclipse plus C18 column (2.1x100mm 1.8µm, rapid resolution 
high definition, Agilent) coupled with an Agilent 6490 triple quadrupole mass spectrometer. Characterisation of phospholipid species 
was performed using CID in negative ionisation mode and lithium adduct fragmentation in positive ionisation mode. Double bond 
positional isomers were characterised using synthesized standards. The method was used to examine a cohort of 347 plasma 
samples to assess assay performance and identify associations between lipid species and anthropometric measures (age and 
gender). Results: We identified over 600 lipid species including sphingomyelins with different sphingoid bases (d16:1, d18:0, d18:1, 
d18:2) and phospholipid isomers with different fatty acid compositions (i.e. 18:1/18:1 vs 18:0/18:2) or fatty acid isomers (i.e. 22:5 
n3/n6). The lipidomic analysis identified sphingoid base specific associations with gender and long chain acyl carnitine with age. 
Conclusion: Our current lipidomic methodology enables the profiling of over 600 lipid species in 15 min from 10µL plasma and is 
suitable for high through-put analysis of large clinical cohorts.
O-449 Using U-13C glucose to determine the impairments in glucose metabolism in both acute and chronic epilepsy mouse models
PRESENTING AUTHOR: Tanya McDonald, School of Biomedical Science, University of Queensland, Australia
CO-AUTHORS: Mark Hodson, Karin Borges                                                
There is growing evidence suggesting that metabolic disturbances contribute the development and progression of seizures. Here we 
aimed to elucidate which pathways in brain glucose metabolism are impaired in both the chronic “epileptic” stage of the pilocarpine-
status epilepticus model and in the acute flurothyl model of epilepsy by tracing [U-13C]-glucose metabolism.  Three weeks after 
pilocarpine-induced status epilepticus, mice were injected with [U-13C]-glucose (558mg/kg, i.p) and sacrificed 15 minutes later. In 
another cohort of animals, [U-13C]-glucose was administered either before or after mice experienced a 5 minute flurothyl-induced 
seizure. The percent enrichment of carbon-13 was measured in metabolites of the hippocampal formation using LCMS/MS and 
GCMS, and enzyme activities were measured via spectroscopy. Mice that develop status epilepticus had a reduction in the percent 
13C enrichment in most TCA cycle intermediates (17-35%, p&lt;0.05), coupled with 33% and 55% loss in the activities of pyruvate 
dehydrogenase and 2-oxoglutarate dehydrogenase, respectively (p&lt;0.05 for both). Similarly, in the post-seizure stage of the 
flurothyl model the incorporation of 13C in the TCA metabolites was also reduced (46-93%, p&lt;0.05), along with a 56% loss in 
pyruvate dehydrogenase activity. This loss of activity coincided with a 1.9-fold increase in phosphorylation of pyruvate dehydrogenase 
at ser232. Together this suggests that in epilepsy, impairments in pyruvate dehydrogenase activity reduce glucose entry into the TCA 
cycle. As the TCA cycle is critical for the production of ATP, which is essential to the recovery of ion and neurotransmitter balance, we 
have identified a promising target for anticonvulsant therapies.
O-466 Plasma metabolite profiles allow diagnosis and disease course monitoring of primary progressive multiple sclerosis
PRESENTING AUTHOR: Daniel Stoessel, Metabolomic Discoveries/ University of Potsdam, Germany
CO-AUTHORS: Nicolas Schauer, Ole Pless, Manuel Friese                                               
Multiple sclerosis is considered to be an inflammatory and degenerative disease of the central nervous system (CNS). It shows high 
heterogeneity with regard to its pathology and clinical progression. Primary progressive multiple sclerosis (PPMS) is distinguished 
from relapsing-remitting multiple sclerosis (RRMS), by showing lower inflammatory activity with continuous neurodegeneration 
and rarely relapses. Here, we applied untargeted high-resolution metabolomics to identify plasma metabolites profiles that 
potentially allow diagnosis of PPMS and its differentiation from RRMS and healthy controls (HC). Moreover, we sought markers that 
significantly change during disease progression and could serve as surrogate markers of neurodegeneration over time. In an initial 
exploratory phase, plasma samples were analysed by untargeted metabolomics from a two independent sex- and age-matched 
PPMS and HC cohorts. Partial least square discriminant analysis (PLS-DA) yielded predictive models for robust within-cohort and 
residual cross-cohort classification along with as set of 20 informative metabolite markers which indicated significant alterations 
in glycerophospholipid metabolism in PPMS. Moreover, this metabolite signature showed to be PPMS-specific when compared 
against a sex- and age-matched cohort of another 10 HC and 10 RRMS patients. Finally, we investigated these metabolites in a 
longitudinal cohort of PPMS patients over 24 months (n = 15). Notably, the results indicate that the glycerophospholipid (PC(O-
16:0/4:0)) significantly decreased during the observation period of PPMS (24 months). In summary, our study revealed PPMS specific 
metabolites, which show potential for non-invasive diagnosis and disease course monitoring of PPMS, and might serve as biomarkers 
for treatment efficacy in clinical trials of PPMS.
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O-474 Systemic Impact of Roux-en-Y Gastric Bypass Surgery
PRESENTING AUTHOR: JIA LI, Imperial College London, United Kingdom
CO-AUTHORS: Hutan Ashrafian, Florian Seyfried, Zhanxuan Wu, Qianxin Wu, Thanos Athanasiou, Elaine Holmes, Nigel Gooderham, 
Jeremy Nicholson, Julian Marchesi                                      
Obesity is a major health and socioeconomic problem worldwide. The most sustainable and effective treatment for morbid obesity is 
bariatric surgery such as Roux-en-Y gastric bypass (RYGB). Recent studies have shown that RYGB surgery induced systemic changes 
in gut hormones, energy metabolism, host-microbial co-metabolism and gut microbial composition in both human and rat models. 
We have applied multiple methods including metabolic, microbial and microRNA profiling to investigate systemic responses of the 
body to RYGB surgery. Through various in vivo and in vitro models, we have observed a microbial shift towards higher concentrations 
of Proteobacteria and lower concentrations of Firmicutes and Bacteroidetes in rodents after RYGB surgery. Decreased faecal tyrosine 
and increased putrescine suggested increased protein putrefaction. Increased urinary 4-cresyl compounds and decreased urinary 
TCA cycle intermediates indicate extensive disturbances in host-gut microbial crosstalk and host energy metabolism. Statistically 
significant changes of metabolites induced by RYGB were also observed in different sections of the intestinal tissues. These changes 
include amino acids, short chain fatty acids, choline-containing compounds and lipids, collectively suggesting that RYGB-induced 
metabolic changes may be associated with oxidative stress and membrane lipid metabolism. We also observed 14 significantly altered 
circulating miRNAs, suggesting modulation of signalling pathways including G protein signalling, neurodegeneration, inflammation, 
and growth and apoptosis responses. Our studies showed that RYGB surgery induced changes in both local and global metabolic 
activities. These findings aid our understanding of the metabolic phenotype of bariatric procedures and can facilitate development of 
alternative treatments for obesity-related diseases.
O-478 METABOLOMICS ANALYSIS DISTINGUISHES BETWEEN STAGES OF RENAL CELL CARCINOMA: A VALIDATION STUDY.
PRESENTING AUTHOR: Oluyemi Falegan, University of Calgary, Canada
CO-AUTHORS: Andries Zijlstra, Hans Vogel, Eric Hyndman                                               
Renal cell carcinoma (RCC) is a heterogeneous disease and remains asymptomatic until late in the disease. RCC specific biomarkers 
that may be exploited clinically for diagnostic and prognostic purposes are therefore essential. We have previously shown that 
metabolomics and multivariate statistical analysis differentiate benign from malignant renal neoplasms. We sought to reproduce and 
validate our previous findings using a larger external cohort. Preoperative fasting urine samples were collected from patients with 
clinical renal masses and assessed with 1H NMR based metabolomics and multivariate statistical analysis. Alterations in the levels of 
carnitine, o-acetylcarnitine, gluconate, choline, tartrate, glycine, pyridoxine and methanol, and tricarboxylic acid cycle intermediates 
among other metabolites were detected in RCC relative to benign controls. Orthogonal Partial Least Square Discriminant Analysis 
plots discriminated between benign masses and pT1 (R2 = 0.44, Q2 = 0.37; AUC= 0.90), benign and pT2 (R2 = 0.52, Q2 = 0.36; 
AUC= 0.92), benign and pT3 (R2 = 0.331, Q2 = 0.233; AUC= 0.88) and benign and pT4 (R2 = 0.78, Q2 = 0.61; AUC= 0.90). The 
validity of all models was confirmed by negative permutations Q2 intercepts and CV-Anova p-values lower that 0.05. Our previous 
findings were largely reproduced in this validation cohort, NMR analysis of urine samples differentiated between benign lesions 
and stage 1, 2,3 and 4 malignant renal masses. Taken together these studies suggest that urine metabolomics may be useful in 
differentiating benign renal tumors from RCC and ultimately for staging and diagnosis of renal cell carcinoma.
O-511 Strategies for TCMs Q-Marker discovery based on Chinmedomics
PRESENTING AUTHOR: Xijun Wang, Heilongjiang University of Chinese Medicine, China
CO-AUTHORS:                                                    
TCMs Q-Marker is the parameters for evaluating the quality of TCMs, it must be contained in crude herbal drug, decoction pieces and 
Chinese patent medicine, it should be related with the clinical efficacy of TCMs and changed according to the compatibility of Chinese 
medical formula. It is difficult to discover the Q-marker from the thousands and tens of thousands of compound in single crude drug, 
moreover the combination of herbal medicines in formula, therefore a new strategy is in need. Chinmedomics is the integration of 
Serum pharmacochemistry of TCM with metabolomics to elucidate the scientific value of TCM, i.e, to discover the biomarker of TCM 
syndrome, to evaluate the efficacy of TCM formula, to analyze and identify the constituents in vivo originated from TCMs under the 
acting condition, and to mine the constituents in vivo which highly correlated with regulating of biomarkers of syndrome. By applying 
Chinmedomics strategy to discover the constituents related with the clinical efficacy of TCMs, used those constituents as Q-marker 
will express the inner quality of TCM.
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O-519 Does HIV/AIDS metabonomics disclose a general response to disease?
PRESENTING AUTHOR: Debra Meyer, University of Johannesburg, South Africa
CO-AUTHORS: Aurelia Williams, Lungile Sitole                                                
Untargeted metabonomics using NMR, HRMAS-NMR, UPLC, IR-  and Raman spectroscopic analysis of biofluids from HIV/AIDS 
patients revealed a similar metabolic fingerprint. Targeted GC-MS metabonomics analysis of HIV/AIDS-affected organic acids 
showed overlap with metabolites identified in the untargeted investigations. Associated with the latter study, cytokinomics revealed 
HIV-induced modifications of the immune response which coincided with organic acid metabolic data. In addition, oxidants and 
antioxidants were identified in both targeted and untargeted analyses, which is perhaps not surprising given the extensive evidence 
supporting HIV-induced oxidative stress as a general outcome of infection. Standard biochemistry was used to validate the 
metabonomic identification of glutathione following Raman spectroscopic analysis of HIV/AIDS biofluids. All the mostly untargeted 
investigations (HRMAS-NMR quantified 12 metabolites through HR-QUEST) referred to above did not present a specific metabolite 
or groups of metabolites that could be exclusively linked to HIV/AIDS, but the main pathways affected by the retroviral infection 
was confirmed. Chemometric tools to sort through the data abound, and there is also still the continuous addition of more statistical 
approaches, in this case, multinomial logistic regression, for successful sample classification. Quantification of more metabolites, 
targeted analysis of specific groups of metabolites (extractions directed at amino acids, lipid oxidation products or to detect sugars 
specifically, in each case using specific internal standards for referencing) and/or pooling data from different techniques to eliminate 
masking effects that overlapping metabolites cause, may support or refute a conclusion supported by current data that HIV/AIDS 
metabolomics discloses a general response to disease.
P-168 Metabolomic Identification of Diagnostic Biomarkers for Malignant Melanoma
PRESENTING AUTHOR: Amy Somerset, Beaumont Health, United States
CO-AUTHORS: Andrew Bayci, Zachery Hothem, Onur Turkoglu, Richard Keidan, Rupasri Mandal, Stewart Graham, David Wishart, 
Thomas Bjorndahl, Ray Bahado-Singh, Beomsoo Han                                    
Previous metabolomics-based studies that distinguished melanoma from benign nevus relied on excision of lesions. There are 
no serum metabolomic biomarkers used for screening, staging, or optimizing treatment. Our objective was to utilize targeted 
metabolomic platforms to identify biomarkers for guiding diagnosis, staging workup, and surgical approach to melanoma patients.     
Twenty-six patients with stage III or IV melanoma and 46 controls were included.  Serum samples were analyzed using nuclear 
magnetic resonance spectroscopy and liquid chromatography coupled with mass spectrometry. Data were analyzed using partial 
least squares-discriminant analysis. Stepwise logistic regression analyses were used to develop diagnostic algorithms in the training 
set (60%) and subsequently validated using an independent test set (40%). Areas under the ROC curves (AUC), sensitivity and 
specificity for diagnosis of melanoma were calculated. Topographical pathway analyses were performed to investigate metabolic 
dysregulations in melanoma patients.   Targeted metabolomics significantly distinguished melanoma cases from controls (permutation 
test p-value=0.002). Five metabolites including PC aa C40:3, DL-carnitine, octanoyl-L-carnitine, ethanol, and methylmalonyl-L-
carnitine were identified as optimal diagnostic biomarkers in the training group. The predictive algorithm was validated in the 
independent test group and achieved an AUC (95% CI) = 0.822 (0.665-0.979), sensitivity 70% and specificity 77%. Arginine 
and proline metabolism, tryptophan metabolism, glutamine and glutamate metabolism, glutathione metabolism and arginine and 
ornithine metabolism were significantly perturbed in melanoma patients (p&lt;0.05).   Targeted metabolomic analysis demonstrated 
significant differences in metabolic profiles of melanoma patients as compared to controls, representing exciting potential to develop 
serum-based risk stratification, predict prognosis, and direct systemic therapy and surgical management.
P-169 Untargeted serum metabolite profiling of colorectal cancer using GC-Orbitrap technology
PRESENTING AUTHOR: Amanda Souza, Thermo Fisher Scientific, United States
CO-AUTHORS: Nicolas Di Giovanni, Cristian Cojocariu, Paul Silcock, Marie-Alice Meuwis, Edouard Louis, Jean-François Focant              
Globally affecting more than one million new persons each year, and killing more than 700,000, colorectal cancer is the second 
leading cause of cancer-related deaths in women and the third in men. Nevertheless, diagnosis is still largely based on invasive 
tissue sampling, while gaps remain in the understanding of its pathogenesis, with complex combinations between lifestyle, genetics, 
epigenetics, chronic inflammation (IBD) and microbiota. Untargeted metabolomics is one way to address these issues. Through 
metabolite profiling, it provides a picture of the outcome of the disease. To do so, significant variations between pathological and 
healthy phenotypes have to be found, and the responsible metabolites must be confidently identified. In this study, the ability of 
the Q Exactive GC-MS Orbitrap system to detect and identify metabolites related to colorectal cancer in an untargeted manner was 
assessed. The workflow uses the advantages of high peak capacity and chromatographic resolution of gas chromatography with the 
high resolution and sub-ppm mass accuracy of the Orbitrap mass spectrometer. The samples analyzed belonged to two populations 
linked to colorectal adenocarcinoma (active and remission, 12 samples each) along with two controls cohorts of the same size 
specifically matched for possible biases (gender, age, BMI, smoking status etc.), and pooled QC samples. Analytical raw data files 
were automatically processed through two software platforms specifically designed for the Orbitrap technology (TraceFinder™ and 
Compound Discoverer™). Compound identification was made using existing commercial libraries as well as an in-house developed 
high resolution Orbitrap metabolomics library.
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P-170 Plasma metabonomics in patients receiving lung protective therapies during cardiopulmonary bypass: a comparative randomised controlled trial
PRESENTING AUTHOR: Raluca Maltesen, Aalborg University Hospital, Dep. of Anaesthesia and Intensive Care, Denmark
CO-AUTHORS: Katrine Buggeskov, Hanne Ravn, Reinhard Wimmer, Munsoor Hanifa, Bodil Rasmussen                                            
Introduction Lung injury following cardiac surgery with cardiopulmonary bypass (CPB) remains a challenge for physicians, with 
considerable associated morbidity and mortality. We recently described the metabolic response to standard CPB and the possible 
mechanisms of postoperative lung injury, however, there are no randomized controlled trials describing metabolic responses to lung 
protective therapies during CPB. Aim To validate previously identified alterations occurring during standard CPB and to examine how 
two protective pulmonary treatments influence plasma metabolite networks.  Methods Nearly 800 plasma samples were collected 
from 90 patients randomised to standard CPB, or receiving either a pulmonary perfusion with oxygenated blood, or a hypothermic 
solution (histidine-tryptophan-ketoglutarate, HTK). Samples collected at six time points before (baseline) and after CPB were 
analysed by nuclear magnetic resonance spectroscopy and multivariate statistics.  Results Similar metabolic perturbations occurred 
after CPB, validating our previous results. Increased levels of anaerobic metabolites, and decreased phospholipids, fatty acids, 
ketones, and several amino acids were detected in all patients, regardless of randomisation group. Patients receiving oxygenated 
blood had more profound changes in metabolites related to glycolysis, tyrosine, and arginine metabolism, while HTK patients 
demonstrated differences in glutamine-glutamate, glycine, alanine, creatine-creatinine, and purine metabolism, compared to the 
standard treatment group. Conclusion This study validates previous findings and shows metabonomics’ potential in cardiac surgery 
and pharmacotherapy trials. While several metabolic differences were identified between groups, the identified networks need to be 
related to the inflammatory mechanisms known to elicit CPB-induced lung injury.
P-171 Metabolomics and qualitative flux analysis informed on the biology of response of AML to IACS-010759, a potent and selective OXPHOS inhibitor
PRESENTING AUTHOR: Pietro Morlacchi, Agilent Technologies, United States
CO-AUTHORS: Jennifer Molina, Daniel Cuthberston                                                
Acute myeloid leukemia (AML) is a highly aggressive and burdensome disease characterized by a high mortality rate among adults 
aged &gt;65 years. Novel and more effective therapeutic interventions are therefore needed to improve the clinical outcome for this 
patient population. Our group has developed and characterized IACS-10759, a novel, potent and selective inhibitor of complex I of 
the mitochondrial electron transport chain leading to robust decrease in cell viability and increase in apoptosis across AML preclinical 
models and primary patient samples. We implemented mass spectrometry-based metabolomics and qualitative flux analysis to 
explore the mechanism of metabolic response of AML to IACS-010759 treatment. Targeted metabolomics revealed a drug-induced 
metabolic imbalance consisting of variations in amino acid and nucleotide production including ATP. Stable-isotope tracing revealed 
significant metabolic alteration consisting of a metabolic switch that resulted into an increased glycolytic rate leading to abnormal 
accumulation of lactate and alanine. This indicated the inability of AML to process pyruvate through the TCA cycle and thereby 
produce reducing power, notably NADH, for ATP production in the electron transport chain. Altogether these metabolic variations 
might account for the observed loss of cell viability and, in some cases, increased apoptosis. As a result of the robust response in 
multiple cell lines, primary patient samples, and efficacy in PDX models, IACS-010759 has been advanced through IND enabling 
studies and was approved by the FDA to start a Phase I clinical trial in AML patients which is currently undergoing at MD Anderson 
Cancer Center.
P-172 High Throughput Lipid Identification and Quantification Using a Directed HRAM LC-MS-MS approach on a Modified Quadrupole-Orbitrap Mass Spectrometer
PRESENTING AUTHOR: Reiko Kiyonami, Thermo Fisher Scientific, United States
CO-AUTHORS: David Peak, Andreas Huhmer                                                
Lipids play a key role in cell, tissue and organ physiology. In order to understand the biological function of lipids and identify unique 
lipid biomarkers for early disease detection, a robust and reproducible analytical method which enables large scale lipid identification 
and quantification over major lipid classes is required. Here we present that hundreds to thousands of individual lipids can be 
identified and quantified from any biological complex samples using a HRAM LC-MS-MS approach which implements a very large pre-
defined lipid precursor ion inclusion list for directed MS-MS data acquisition on a modified quadrupole-Orbitrap mass spectrometer. 
Lipid extracts from different type of samples (human plasma, bovine liver, bovine heart) were used. An isotopic labeled lipid mixture 
with known concentration was spiked into each sample before LC-MS-MS run. A C30 column was used for lipid separation and a 
modified designed quadrupole Orbitrap mass spectrometer was used for lipid detection. For data acquisition, a HRAM full MS scan 
was followed by up to 30 HRAM MS-MS scans which would be triggered only when the detected precursor ions from survey MS scan 
match the lipid inclusion list. The lipid identification and simultaneous quantitation were performed using LipidSearch software. The 
absolute amount for each identified lipid species was estimated using the isotope-labeled lipid standard which belongs to the same 
lipid class as the identified lipid species. Excellent analytical precision was observed using this method and the CV was less than 15% 
for internal standards and most of the lipid species quantified.
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P-173 Mass Spectrometry Glycosaminoglycan Analysis for Mucopolysaccharidoses: a Reliable and Non-Invasive Tool for Detection, Diagnosis and Follow Up of Patients
PRESENTING AUTHOR: Christiane Auray-Blais, Université de Sherbrooke, Canada
CO-AUTHORS: Pamela Lavoie                                                  
Mucopolysaccharidoses (MPS) are lysosomal storage disorders leading to glycosaminoglycan (GAG) accumulation. Our project 
aimed to: 1) analyze a wider spectrum of urinary GAGs to improve the detection, diagnosis and monitoring of patients affected with 
various types of MPSs (MPS I, II, III, IV, VI, VII); 2) develop/validate a quantitative multiplex mass spectrometry (MS) method for 
the urinary analysis of dermatan sulfate, heparan sulfate, keratan sulfate, and chondroitin sulfate disaccharides; 3) compare this 
MS method with a spectrophotometric method used in many clinical laboratories. A methanolysis reaction was performed by adding 
methanol-HCl·3N to a dried urine sample, followed by heating at  for one hour, and nitrogen evaporation. The residue was dissolved 
in 200 mL of a solution containing synthesized in-house deuterated internal standards, followed by injection onto the Acquity I-Class/
Xevo TQ-S MS/MS system (Waters Corp.) in positive electrospray. Intraday precision assays were good (RSDs ? 7.6%), as well as 
accuracy results with biases from -12.0% to 8.4%. Interday precision and accuracy assays showed RSDs ? 8.7 % and biases from 
-12.8% to 14.2%. This 7-min method offers high resolution/specificity to differentiate different types of MPS patients. In comparison 
to the MS/MS method, the spectrophotometric assay showed that 30% of MPS patients from our cohort had normal results and 13% 
had borderline results, thus confirming its unreliability. This efficient UPLC-MS/MS method allows the absolute quantification of four 
GAGs for six MPS types. A GAG profile was established for diagnostic purposes, monitoring and follow up of patients, and evaluation 
of treatment efficacy.  
P-174 Genetic and metabolomic analyses of the de novo L-cysteine biosynthetic pathway in the enteric protozoan parasite Entamoeba histolytica
PRESENTING AUTHOR: GHULAM JEELANI, Department of Biomedical Chemistry, Graduate School of Medicine, University of Tokyo, 
Japan
CO-AUTHORS: Mihoko Mori, Kazuro Shiomi, Tomoyoshi Soga, Tomoyoshi Nozaki                                             
Cysteine biosynthetic pathway is of fundamental importance for the growth, survival, antioxidative stress defense and pathogenicity 
of many pathogens such as Entamoeba histolytica, Trichomonas vaginalis, Leishmania major and Salmonella typhimurium. The 
enteric protozoan parasite E. histolytica is completely devoid of glutathione and its metabolism, and cysteine is the principal 
low molecular weight thiol. The de novo cysteine biosynthetic pathway in E. histolytica involves two key enzymes, serine 
acetyltransferase (SAT) and cysteine synthase (CS), which is absent in mammals therefore, considered as promising targets for 
inhibiting the growth of this parasite. E. histolytica apparently possesses three SAT (EhSAT1-3) and three CS (EhCS1-3) isozymes. 
In order to fully understand the role of this pathway we have created ameba cell line in which expression of the genes involved in 
cysteine biosynthesis pathway is completely knocked down. Using metabolomics approach we found that this pathway is involved 
in S-methylcysteine synthesis. CS and SAT3 knockdown parasites showed impaired growth when cultured in cysteine lacking media 
while SAT1/2 doesn`t, suggesting importance of these enzymes in parasite biology and therefore could be exploited as drugs target 
against this pathogen. Further to discover inhibitors against the EhCS the compounds of Kitasato Natural products library were 
screened against two recombinant CS isozymes: EhCS1 and EhCS3. Nine compounds inhibited EhCS1 and EhCS3 with the IC50 
values of 0.31-490 microM. Since CS is also present in other protozoan, the newly identified CS inhibitors in this study can also be 
exploited to develop drugs against other neglected parasitic diseases.
P-175 Complementary metabolic profiling reveals new insights into fatty liver disease and associated comorbidities among healthy individuals
PRESENTING AUTHOR: Maik Pietzner, Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, 
Germany
CO-AUTHORS: Gabi Kastenmüller, Anna Artati, Jerzy Adamski, Markus Lerch, Jens-Peter Kühn, Matthias Nauck, Nele Friedrich              
Triglyceride accumulation in the liver, so-called fatty liver disease (FLD) represents a risk factor for metabolic diseases like type 2 
diabetes (T2DM) or cardiovascular diseases (CVD). Despite the recognition of impaired insulin signaling the molecular mechanisms 
involved are still poorly understood. We combined MS and NMR techniques to comprehensively characterize plasma and urine 
samples from 762 non-diabetic participants of a population-based sample. Liver fat content (LFC) was assessed using quantitative 
chemical shift encoded MRI. Associations between LFC as well as markers of hepatic damage and the metabolome were assessed 
by multivariable linear regression analyses controlling for several confounders. An integrated multi-fluid metabolite analysis was 
facilitated by the use of Gaussian graphical modelling (GGM). A predictive molecular signature of FLD was established using the 
LASSO embedded in a two-stage cross-validation procedure. As expected alterations in lipoprotein (atherogenic profile) and fatty 
acid metabolism were pronounced and strongly interrelated, whereby associations to free fatty acids were unique to liver enzyme 
activities. GGM analyses revealed an enriched cluster of metabolites uniquely associated with LFC, comprising branch-chained 
and aromatic amino acids. Even associations to urine metabolites were almost unique to LFC. In particular, a part of this urine 
signature improved the predictive performance for FLD moderately in comparison to classical factors. The application of untargeted 
metabolomics revealed a metabolic fingerprint of LFC which mimics molecular profiles associated with the progression of T2DM and 
CVD. Moreover, the comprehensive metabolic profiling applied here allowed for systemic understanding of previously separately 
presented molecular events associated with liver disease.
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P-176 How diets modulate the metabolome: lessons from MyNewGut
PRESENTING AUTHOR: Giulia Mancano, Food & Nutritional Sciences, University of Reading, PO Box 226, Reading RG6 6AP, UK, 
United Kingdom
CO-AUTHORS: Ahmed Hassan, Martin Beaumont, Joanna Boberska, Louise Kjølbæk, Peter Holzer, François Blachier, Lesli Larsen, 
Sandrine Claus                                       
In 2013 the MyNewGut consortium brought together 30 partners to provide practical solutions to reduce the obesity epidemic that 
affects numerous countries. Here we will present the results of three studies that aimed to evaluate the metabolic impact of common 
diets in humans and animal models using a NMR-based metabolomics approach. 1) The impact of high fat diet on brain metabolism 
was studied in mice. The metabolic profile of the hypothalamus, hippocampus, striatum and prefrontal cortex regions revealed that 
high-fat diet might be responsible for a metabolic shift. Specifically, an increase of energy metabolism with higher levels of lactate 
and creatine phosphate in the prefrontal cortex were detected. 2) In a randomised cross-over human study, AXOS (arabinoxylan-
oligosaccharides) prebiotic or high PUFA (polyunsaturated fat acid) diet was given to obese/overweight subjects with metabolic 
syndrome to asses the effect of diet on energy balance and metabolic biomarkers. Preliminary results confirmed that PUFA tended to 
reduce plasma triglyceride levels but this was susceptible to high inter-individual variability. 3) A human intervention studying high 
protein diet, which is generally perceived by the public as healthy, showed changes in individual metabolomic profiles associated 
with the disfavoured decrease of butyrate, a metabolite known to improve gut health. These data demonstrate that diet composition 
has far reaching metabolic consequences that can vary hugely from one individual to another due to individual phenotypes. These 
data complement the increasing awareness of the unsuitability of the one-size-fits-all diet recommendation and encourage a future 
personalised approach to nutrition guidelines.
P-177 Metabolic phenotyping to assess the system-wide impact of pediatric critical illness on gut health
PRESENTING AUTHOR: Anisha Wijeyesekera, University of Reading, United Kingdom
CO-AUTHORS: Sarah Thurston, Adilson Sabino, Sara Zaher, Debbie White, Jenna Ridout, Elaine Holmes, Nazima Pathan                            
Gut dysfunction has been shown to occur frequently in intensive care patients. In critical illness, damage to the intestinal mucosa 
can occur, compromising the epithelial barrier which functions to separate gut microbes and toxic products from the host system. 
When bacterial antigens translocate from the intestinal lumen into the bloodstream or lymphatic system, sepsis or multi-organ failure 
can result. Studies in critically ill adults have shown that the loss of normal intestinal microbial species and a reduction in beneficial 
bacterial co-metabolites such as butyrate (a short chain fatty acid and key energy source for colonocytes), is associated with disease 
severity and outcome. We applied a combined 1H-Nuclear Magnetic Resonance Spectroscopy and Mass Spectrometry approach 
coupled to multivariate statistical analysis, to capture the system-wide impact of critical illness, in a cohort of pediatric intensive care 
patients. Results reveal differences in metabolic phenotypes between patients compared to age-matched controls, including markers 
of gut health (microbial co-metabolites and short chain fatty acids), branched chain fatty acids, lactate and several amino acids. 
Since urine and stool phenotypes carry information on microbial co-metabolites as well as chemical signals relating to metabolic end 
products, the acquired spectroscopic data provides functional assessment of the microbiota as well as aiding in understanding the 
system-level molecular pathways that are altered in critical illness. The ultimate goal of this research is to identify pathways by which 
to target early nutritional intervention to treat gut dysfunction and improve gut health, and thereby improve short and long-term 
outcomes of pediatric critical illness.
P-178 Robust and High Throughput Lipid Profiling of dry blood spot samples using Automated FIA MSMSAll technique
PRESENTING AUTHOR: Dipankar Malakar, Sciex, India
CO-AUTHORS: Kuldeep Ravivanshi, Narinder Sahni, Akanksha Singh, Manoj Pillai, Baljit Ubhi                                            
Lipidomics is opening new ways to clinical research though it is in a nascent stage. One of the major challenges in the study of lipids 
and other biological molecules is the analysis time. We have developed a high throughput and robust method on TripleTOF® 5600 
system using Dried Blood Spot (DBS) samples during clinical research, so as to simplify overall procedure and shorten the assay time. 
Majority of the literature so far is based on using either plasma or serum considered as gold-standard matrix but both these media 
require a phlebotomist, functional laboratory and storage at very low temperatures - 40oC to -70oC. Advantage of using DBS over 
the plasma/serum makes it ideal for screening studies. 90 dried blood spot samples were used for the analysis. The lipid extracts 
were analyzed using Shimadzu LC XR system coupled to the TripleTOF® 5600 system. Samples were analysed using the Infusion MS/
MSALL workflow for complete lipidome coverage. The MS/MSALL workflow experiments performed the data independent acquisition 
and consisted of a TOF MS scan followed by a sequential acquisition of 1001 MS/MS spectra acquired at a step size of 1 Da. The lipid 
identification was performed by the LipidView™ software. Batch processing for lipid identification was performed for all the replicates 
samples. In this shotgun approach we had been successfully able to get coverage of about 1031 lipids in all detected classes. Lipid 
classes like DAG, NAPE, PC, CE, PE, TAG were found to be abundantly in the DBS samples.
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P-179 Metabolic phenotyping of formalin-fixed, paraffin-embedded colorectal cancer tissue samples by DESI-MSI
PRESENTING AUTHOR: Anna Mroz, Imperial College London, United Kingdom
CO-AUTHORS: Renata Soares, Luisa Doria, James McKenzie, Francesca Rosini, Zoltan Takats                                            
Desorption electrospray ionisation mass spectrometry imaging (DESI-MSI) is a powerful technique which creates ion images from 
mass spectra collected for tissue samples. These images are then used to show the spatial distribution of biochemical information 
over the sample area and can contribute to diagnosis of various diseases. This approach has been successfully employed in 
fresh frozen tissue samples, however since formalin-fixed, paraffin-embedded (FFPE) clinical tissue samples are the standard for 
histopathological analysis, much effort has been spent on optimising and standardizing FFPE protocols for DESI-MSI. In this particular 
study tissue microarrays (TMAs) were used. TMA contains many small representative tissue samples from hundreds of different cases 
assembled on a single glass slide, and therefore allows high-throughput analysis of multiple specimens at the same time. 10µm thick 
tissue sections were cut from a TMA block composed of samples from 18 patients (malignant tumour, cancer and normal adjacent 
tissue cores). The tissue sections were analysed in negative ionization mode by DESI-MSI, stained with H&amp;E, annotated and 
then aligned with ion images for regions of interest. Metabolic information remaining in the tissue cores after standard histological 
FFPE processing allowed the discrimination between different tissue types in multiple samples (overall accuracy over 95%). m/z 
peaks were assigned to tissue types (e.g. m/z 599.3 tumour, m/z 314.1 and m/z 350.1 both cancer and normal adjacent tissue) and 
their identification was confirmed using LC-MS. This approach could help to reveal novel set of species and therefore contribute to 
the understanding of metabolism.
P-180 Targeted and Non-targeted Quantitative Metabolomics Using a Multi-platform Approach
PRESENTING AUTHOR: Jennifer Reid, University of Alberta, Canada
CO-AUTHORS: Rupasri Mandal, Jiamin Zhang, Yiran Zhang, Rosa Vazquez-Fresno, Arnau Serra-Cayuela, Naama Karu, Edison Dong, 
Rambod Daneshfar, James Harynuk, Liang Li, Philip Britz-Mckibbin, Michael Overduin, Christoph Borchers, David Wishart                              
TMIC (The Metabolomics Innovation Centre) is Canada’s national metabolomics laboratory specializing in quantitative metabolomics 
assays for human, animal, plant and microbial samples. TMIC provides low-cost services to academia and industry, develops/
maintains freely available metabolomics databases and web servers (HMDB, DrugBank, T3DB, CFM-ID, FooDB, MetaboAnalyst) and 
develops innovative assays. TMIC provides: 1) software and databases for data interpretation and analysis; 2) platform-specific, 
fully quantitative metabolomic assays; 3) untargeted, semi-quantitative metabolomic assays; 4) pathway-specific assays; 5) class-
specific assays; 6) customized assays (based on client requests); 7) the Human Metabolome Library (a chemical library consisting 
of &gt;1130 metabolites); 8) metabolomic profiling kits; 9) bioinformatics and statistical support; and 10) specialized services 
(programming, experimental design) to support a wide range of metabolomics applications and projects. TMIC’s technologies are 
based on NMR and mass spectrometry. TMIC is constantly working towards developing, acquiring, testing and implementing new, 
quantitative metabolomic technologies. Most recently, TMIC has developed and adapted several quantitative assays to expand the 
list of detectable metabolites to include catecholamines, steroids, oxylipins, one-carbon metabolites, organic acids and volatiles. In 
addition, TMIC has incorporated two additional Canadian laboratories (TMIC nodes) adding new capabilities and resources to TMIC’s 
network. TMIC has also developed a series of quantitative metabolomics kits consisting of reagents, protocols and/or software that 
can simultaneously, inexpensively and quantitatively measure a large number of metabolites in human biofluids. TMIC’s new assays 
and technologies along with a brief description of their applications in human health, agriculture, nutrition and other fields are 
presented in this poster.
P-181 A comprehensive metabolomic profiling of blister fluid from paediatric burn patients
PRESENTING AUTHOR: Tuo Zang, a. Tissue Repair and Translational Physiology Program, Institute of Health and Biomedical 
Innovation, Queensland University of Technology, Kelvin Grove, Australia. b. School of Biomedical Sciences, Faculty of Health, 
Queensland University of Technology, Brisbane, Australia. c. Wound Management Innovation Co-operative Research Centre, 
Brisbane, Australia., Australia
CO-AUTHORS: Mark Wellard, Daniel Broszczak, Leila Cuttle, Tony Parker                                             
  Burn injury is a common and highly traumatic event in paediatric populations. At present, the diagnosis of burn injury severity is 
largely dependent on the clinician’s experience. A better understanding of burn injury biochemistry would facilitate the development 
of quantitative measures to aid diagnosis. Burn blister fluid (BF) is a viable source of biomolecules that reflect relevant systemic 
responses and the local microenvironment.   Metabolomics is a powerful technique for the discovery of novel biomarkers and 
elucidation of biochemical pathways to assist with clinical diagnosis. Nuclear magnetic resonance (NMR) spectroscopy (Bruker 
600MHz) data were utilised for multi-parametric metabolic quantification analysis of BF from paediatric burn patients in our 
investigation. One hundred and one BF samples with different clinical variables, such as burn depth, burn size, and time to re-
epithelialisation, were recruited. The fluid samples were collected by syringe during routine blister de-roofing procedures. The 
measurement parameters and sample buffer were optimised based on the NMR serum protocols. Proton NMR spectra were 
phased, baseline corrected, and referenced to sodium formate using TopSpin software (Bruker). Spectra were bucketed (AMIX 
software, Bruker) and the buckets profiled using an R package, BATMAN, to perform Bayesian deconvolution and quantification of 
metabolites. All of the 757 metabolites from the database build in BATMAN were quantitatively profiled. The statistical analysis of the 
metabolomics of burn BF was completed through MetaboAnalyst. Significant metabolites between different burn depth and time to 
re-epithelialisation were discovered. In addition, pathways related to burn injury and wound healing were revealed.
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P-182 Molecular Transducers of Physical Activity Consortium (MoTrPAC): Creating a Comprehensive Map of Molecular Changes in Response to Physical Activity
PRESENTING AUTHOR: Padma Maruvada, National Institute of Diabetes, and Digestive and Kidney Diseases, United States
CO-AUTHORS: Maren Laughlin, Ashley Xia                                                
The NIH Common Fund established the Molecular Transducers of Physical Activity Consortium (MoTrPAC) in 2016 by issuing 19 
grants to 37 Principal Investigators from 23 institutions. Aim 1: MoTrPAC will assemble a comprehensive map of the molecular 
changes that occur in response to exercise and provide insights into how they are altered by age, sex, body composition, and fitness 
level. Aim 2: To fulfill its overall objective of facilitating investigator-initiated studies and catalyzing the field of physical activity 
research, MoTrPAC will develop a user-friendly database, accessible to researchers for pursuing research on the benefits of physical 
activity. Approach: MoTrPAC Clinical Center investigators will recruit approximately 3,000 healthy subjects across the lifespan for an 
exercise study carried out at twelve sites across the United States. A variety of specimens namely blood, muscle and adipose tissues 
will be collected from study participants. In addition, research teams at three Preclinical Animal Study Sites will use a rat model to 
complement the clinical work. Samples will be analyzed by eight MoTrPAC Chemical Analysis Sites using extensive –omics analyses. 
In parallel with these efforts, the Bioinformatics Center will provide analytic tools for integrating and interrogating all of the MoTrPAC 
data into a searchable, publicly available database. This large project will be supported by a Consortium Coordinating Center 
and overseen by a Steering Committee, including the NIH. Our presentation will provide an overview of the MoTrPAC conosritum 
and approaches to develop a map of molecular signals in response to physical activity in humans.  https://commonfund.nih.gov/
MolecularTransducers/overview
P-183 Optimisation and investigation of seminal plasma for non-invasive prostate cancer diagnosis and monitoring: a NMR-based metabolomics study
PRESENTING AUTHOR: Matthew Roberts, Centre for Advanced Imaging, The University of Queensland, Australia
CO-AUTHORS: Renee Richards, Clement Chow, Marion Buck, John Yaxley, Martin Lavin, Robert Gardiner, Horst Schirra                            
Background: Non-invasive biomarkers are required to improve prostate cancer  (PCa) care. NMR-based seminal plasma metabolomics 
may be a suitable platform. Sample collection is complicated by enzymatic (prostatic acid phosphatase; PAP) influence on metabolite 
levels. Methods: 151 seminal plasma samples from men “at risk” of prostate cancer were analysed using 1H-NMR spectroscopy. 
Buffer (Add-to-Subtract) and endogenous enzyme metabolite adjustment was performed prior to metabolite profiling with 
multivariate statistical analysis (principal components analysis, partial least squares) and targeted quantitation. In an independent 
cohort, PAP was inhibited using tartrate and the subsequent effects on the kinetics of phosphorylcholine to choline hydrolysis were 
determined. Results: Metabolites in seminal plasma best distinguished low- and intermediate-risk prostate cancer from benign 
samples. High grade samples were dominated by lipids/lipoproteins with less metabolite contributions overall. Previously described 
metabolites were not validated for prostate cancer prediction. Tartrate in increasing concentrations and/or refrigerated sample 
storage (279 K) reduced apparent rate constants, indicating greatly reduced reaction rates. Metabolite profile multivariate analysis 
showed that tartrate addition stabilises phosphorylcholine and choline concentrations while maintaining personal differences in 
metabolite profiles. Conclusion: Seminal plasma metabolomics in vitro may assist clinicians to more accurately diagnose or monitor 
either low or intermediate grade prostate cancer. Less clinical benefit may be observed for high-risk patients. Sample collection has 
been optimized and should be implanted in seminal fluid metabolomics studies. Further investigation in active surveillance cohorts, 
and/or in combination with in vivo magnetic resonance spectroscopic imaging may further optimize localized prostate cancer 
outcomes.
P-184 Untargeted metabolite profiling of maternal urine, serum, and hair successfully identified biomarkers of dietary patterns related to GDM development
PRESENTING AUTHOR: Xuyang Chen, Department of Obstetrics and Gynaecology, The First Affiliated Hospital of Chongqing 
Medical University, China
CO-AUTHORS: Ting-li Han, Jamie Seymour, Yinyin Xia, Philip Baker, Hua Zhang                                            
Background: Gestational diabetes mellitus (GDM) is glucose intolerance that is first recognised during pregnancy. Maternal diet may 
play an important role in the development of GDM. Although food frequency questionnaires (FFQ) are often used to characterise 
dietary patterns, these self-reported assessments are subject to recall and social desirability biases. Therefore, the aim of this study 
was to combine dietary pattern and metabolomic data to validate the associations between dietary intake and GDM from a metabolic 
perspective. Method: A total of 50 GDM cases and 50 controls were recruited at 26–28 weeks of gestation. Dietary intake was 
assessed using a 96-item FFQ. Clinical characteristics were obtained from medical records. The urine, serum, and hair metabolomes 
were analysed using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry. Results: Two maternal 
dietary patterns were significantly different between the GDM and control groups: High Glycemic Index (HGI) pattern and Low 
Glycemic Index (LGI) pattern. The HGI pattern was associated with an increased likelihood of GDM (OR: 2.13; 95% CI: 1.16, 3.29) 
and LGI pattern was associated with a decreased likelihood of GDM (OR: 0.56; 95% CI: 0.33, 0.94). A set of 28 and 70 metabolites 
differentiated GDM cases from controls using GC-MS and LC-MS, respectively. Of the 98 significant metabolites, 10 were significantly 
associated with the HGI pattern, and 17 were significantly associated with the LGI pattern. Conclusions: Metabolomics adds 
significant value to dietary investigations as it can assist with the elucidation of metabolic mechanisms underpinning the associations 
between the maternal diet and GDM development.
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P-185 Metabolic profiling of polychlorinated biphenyls(PCBs) and organochlorine pesticides(OCPs) exposure in human plasma
PRESENTING AUTHOR: Seoyoung Jang, Korea Basic Science Institute, South Korea
CO-AUTHORS: Geum-Sook Hwang                                                  
Polychlorinated biphenyls(PCBs) and organochlorine pesticides(OCPs) are persistent organic pollutants (POPs) known as 
environmental toxins. Accumulation of POPs has adverse effects on both environment and human. However, the association 
between POPs and human metabolism are unknown. To observe the effect by accumulation of POPs in humans, we investigated the 
associations between POPs levels and concentrations of metabolite detected in human plasma samples. In this study, concentrations 
of total 33 POPs including 16 PCBs and 17 OCPs were analyzed from plasma samples of 300 participates without occupational 
exposure to POPs. PCB118, 138, 153, 180, and 187 contribute to 85% to total PCBs, and dominant OCPs were HCB, ?-HCH, p,p’-
DDT, p,p’-DDE, trans-nonachlor, and cis-nonachlor. The sum of the signed ranks of five PCBs and six OCPs, respectively, were used 
in regression analysis. Then, we conducted plasma metabolomic profiling using 1H-NMR spectroscopy. 22 metabolites were qualified 
and quantified from human plasma samples. We found that PCBs were significantly correlated with creatine, glucose, mannose, 
citrate, and phenylalanine. On the other hands, OCPs were associated with creatine, mannose, lactate, and phenylalanine. This study 
has shown that the NMR-based metabolic approach can be useful tool to understand the alteration of human metabolism and to 
identify potential biomarkers for estimating exposure effect of environmental toxins like POPs.
P-186 Lipidomic Study of Environmental Exposure: Effects of Perfluoroalkyl Substances and Phthalates on Children
PRESENTING AUTHOR: Wei-Chen Tseng, Institute of Environmental Health, College of Public Health, National Taiwan University, 
Taiwan
CO-AUTHORS: Zhi-Yi Du, Guang-Wen Lien, Wan-Yu Lin, Pau-Chung Chen, Ching-Yu Lin                                            
Perfluoroalkyl substances (PFASs) and phthalates are two groups of chemicals which are commonly used in man-made products, 
therefore can be detected in human generally. Recent epidemiologic surveys which focus on PFASs and phthalates still cannot 
provide strong association between the exposure and the adverse health effects and suggest possible mechanisms. Numerous animal 
studies showed that these chemicals disrupt the endocrine system and might influence the regulation of lipid metabolism and fatty 
acid storage. Since lipids are possible target molecules of PFASs and phthalates, the purpose of this study is to identify changes of 
critical lipids caused by those chemical exposure and to understand possible biological impacts. 290 Taiwanese children exposed to 
environmental PFASs and phthalates were included. 13 PFASs and 12 phthalate metabolites were analyzed in their biofluids by HPLC-
MS/MS. Two major lipid groups, phosphatidylcholine and sphingomyelin, in serum samples were analyzed by UPLC-MS/MS followed 
by multivariate statistical analysis to examine the differences of serum lipdome in children exposed to different levels of PFASs and 
phthalates. The results showed children exposed to different levels of perfluoro-n-tridecanoic acid, perfluoro-n-decanoic acid and 
di(2-ethylhexyl) phthalate had distinct lipidomes. Futhermore, the lipidomes of children’s serum were associated with genders, body 
mass indexes and residential regions. Lipids associated with PFAS and phthalate exposures and other factors were identified and 
linked with possible mechanisms and adverse effects. This study demonstrated MS-based lipidomic approaches are powerful tool to 
realize lipid perturbation caused by background levels of PFASs and phthalates and to suggest possible adverse health effects..
P-187 Metabolomics application in discovery of novel mechanisms during insulin stimulated glucose uptake
PRESENTING AUTHOR: Karolina Sulek, Novo Nordisk Foundation Centre for Basic Metabolic Research, Faculty of Health and 
Medical Sciences, University of Copenhagen, Denmark
CO-AUTHORS: Solvejg Hansen, Bente Kiens, Jonas Treebak                                               
It is well known that insulin increases glucose uptake. However, the underlying mechanisms have not been fully clarified. We 
speculate that the analysis of plasma metabolome during insulin stimulation can uncover novel pathway involved in glucose levels 
regulation. As part of the Copenhagen Women Study lean, healthy females (n=9; BMI&lt;25kg/m2) were recruited for the study. 
The volunteers arrived in the morning after an over-night fast. After resting in the supine position for 1 hour, a hyperinsulinemic 
euglycemic clamp was initiated (insulin infusion rate 1mU/kg/min) and performed for 2 hours. Before the clamp and during the 
steady state of glucose infusion (80 min) EDTA plasma samples were collected. Insulin levels at the baseline were 5.8±1.8 µU/mL. 
After 80 min of insulin infusion the levels averaged 80.8±7.8 µU/mL. Following methanol extraction, plasma metabolites were profiled 
using UHPLC (Dionex Ultimate 3000, Thermo Scientific) with a Luna Polar C18 column (1.6 µm, 2.1x100 mm, Phenomenex). LC was 
coupled with QToF mass spectrometer (Impact II, Bruker Daltonics) operating in electrospray ionization. XCMS and CAMERA were 
used for metabolic features extraction and annotation, resulting in approximately 20,000 buckets in positive and negative mode 
combined. MetaboAnalyst was used for statistical analysis. PCA score plot showed a clear separation between baseline and clamp. 
Plasma metabolome was significantly altered during insulin infusion affecting not only glucose, but hundreds of metabolites when 
compared to the baseline (p&lt;0.05, FDR&lt;0.1). Further MSMS analysis is required to identify the significantly shifted metabolites 
and relevant pathways for insulin-stimulated glucose uptake.
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P-188 Lipid metabolism of ovarian cancer – novel perspectives for diagnostics and therapy by DESI-MSI
PRESENTING AUTHOR: Maria Luisa Doria, Imperial College London, United Kingdom
CO-AUTHORS: James McKenzie, Anna Mroz, David Phelps, Francesca Rosini, Sadaf Ghaem-Maghami, Zoltan Takats                                           
Ovarian cancer is the most fatal female reproductive cancer worldwide and there is an increasing demand for the development of 
ovarian cancer diagnostics with improved performance. Lipids are a class of metabolites with great potential to characterize and 
uncover changes in cancer lipid metabolism, which is still poorly understood. Different techniques were therefore combined to better 
understand lipidomic variations in epithelial ovarian carcinoma (EOC). The lipidomic profile and spatial information of over 100 EOC 
samples were obtained by DESI-MSI (desorption electrospray mass spectrometry imaging), validated by LC-MS and correlated with 
immunohistochemistry results of different enzymes related to lipid metabolism (phospholipid and fatty acid pathways). From the vast 
number of the hallmarks of cancer already studied, it has been shown that lipids play a crucial role in most of them. For example, our 
results show an increase of the phosphatidic acid class (PA) as well as its products from the CDP-DAG pathway (Kennedy pathway); 
phosphatidylinositol (PI) and phosphatidylglycerol (PG). From the immunohistochemistry performed in the enzymes around this 
pathway, PLD showed a substantial increase in its expression, interestingly linked to mTOR expression, which is essential for cancer 
survival. Further changes were observed and validated with LC-MS in the different phospholipid classes and its fatty acid chain length 
composition. Overall, DESI-MSI was an excellent technique to identify the lipidomic profile and changes in ovarian cancer, with robust 
correlation by our immunohistochemistry results, showing the potential of DESI-MSI to complement histopathology at a diagnosis 
and potentially therapy level.
P-189 Tandem Mass Spectrometry Analysis of Gb3 Isoforms and Analogues in Different NOD/SCID Fabry Mice Tissues
PRESENTING AUTHOR: Michel Boutin, Université de Sherbrooke, Canada
CO-AUTHORS: Philippe Provençal, Jeffrey Medin, Christiane Auray-Blais                                               
Fabry disease is an X-linked lysosomal storage disorder caused by a deficiency in alpha-galactosidase A activity, leading to storage 
of glycosphingolipids, such as globotriaosylceramide (Gb3), in tissues and biological fluids. It is characterized by cardiac, renal and 
neurological involvement. Recent metabolomic studies performed in our laboratory revealed 22 different Gb3 isoforms and analogues 
as Fabry disease biomarkers. The objective of this study was to evaluate the levels of these biomarkers in different organs (kidney, 
brain, liver, heart, lung, small intestine, spleen), and in urine and plasma from nonobese diabetic (NOD)/severe combined immune 
deficiency (SCID)/Fabry mice (9 males and 9 females) and from NOD/SCID control mice (3 males and 2 females). These strains allow 
for a matched genetic background and a reduction in systemic lymphocytes. Tissue samples were homogenized in methanol using 
a bead mill. Tissue homogenates, urine and plasma were purified by extraction with tert-butyl methyl ether. The organic phase was 
separated by ultra-performance liquid chromatography (Acquity I-Class, Waters) and analyzed by tandem mass spectrometry (Xevo 
TQ-S, Waters) using the multiple reaction monitoring mode in positive electrospray.  As expected, biomarker levels were higher for 
Fabry mice compared to controls. Surprisingly, total Gb3 levels were significantly higher in the spleen and small intestine tissues 
compared to kidney and heart tissues, the latter organs being involved in Fabry patients’ premature death/morbidity. The method 
developed and validated for this study will be used to evaluate the clearance of Gb3 isoforms and analogues in the first gene therapy 
clinical trial for Fabry patients.    
P-190 Elucidation of the mechanisms of rice bran supplementation on the suppression of colitis development
PRESENTING AUTHOR: Kazuki Tanaka, Keio University, Japan
CO-AUTHORS: Wanping Aw, Masaru Tomita, Shinji Fukuda                                               
Oryza sativa, rice bran (RB) has reported colitis suppression effects, but the underlying mechanisms are not yet understood. We 
aimed to elucidate the molecular mechanisms of RB dietary intervention on a 2.0% dextran sulfate sodium (DSS)-induced colitis 
C57BL/6J mice model. Body weight loss, elevated disease activity index, reduced colon length and colon histopathology were 
improved in RB-fed mice. While many studies have shown that gut microbiota is altered by DSS administration, these studies 
only report a few time points in their analysis. In this study, we took a novel approach by investigating fecal microbiota and fecal 
metabolites via comprehensive microbiome (Miseq Illumina, Inc.) and metabolome (capillary electrophoresis with electrospray 
ionization time-of-flight mass spectrometry (CE-TOFMS), Agilent, Inc. and gas chromatography mass spectrometry (GC-MS), Agilent, 
Inc.) approaches from before to 10 days after DSS administration every single day to elucidate the intestinal dynamics, and identified 
the RB-related gut environmental alterations in DSS-induced colitis mice. 26 microbial families, especially Alcaligenaceae and 
Lactobacillaceae showed significant increases and Enterobacteriaceae and Erysipelotrichaceae were significantly decreased in RB-fed 
mice. 60 metabolites, especially glutarate, 4-pyridoxate, N1-acetylspermidine, 5-hydroxy-indoleacetate and short-chain fatty acids 
were significantly increased in RB-fed mice. Metabolite set enrichment analysis revealed that Vitamin B6 metabolism, tryptophan 
metabolism and ubiquinone biosynthesis were significantly increased in RB-fed mice. These results suggest that RB-related 
alterations of gut environment have the potential to prevent colitis through maintaining a robust gut environment. Our multi-omic 
approach and findings provide an important tool in developing new nutritional therapeutic applications of RB in colitis prevention.
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P-191 Dysregulated Lipid Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD)
PRESENTING AUTHOR: James Broadbent, SCIEX, Australia
CO-AUTHORS: Timothy Garrett, Kenneth Cusi, Baljit Ubhi                                               
Nonalcoholic fatty liver disease (NAFLD) is an umbrella term for a range of liver conditions affecting people who drink little to no 
alcohol. Main characteristics of nonalcoholic fatty liver disease is too much fat stored in liver cells. Nonalcoholic steatohepatitis, a 
potentially serious form of the disease, is marked by liver inflammation, which may progress to scarring and irreversible damage. 
This damage is similar to the damage caused by heavy alcohol use. At its most severe, nonalcoholic steatohepatitis can progress to 
cirrhosis and liver failure. However, if caught early the fatty liver and fatty liver to NASH process can be reversed. The Lipidyzer™ 
platform was used to evaluate two stages of NAFLD, to evaluate any dysregulation in complex lipid metabolism. Quantitative 
profiling of over 1100 lipid species from 13 different lipid classes was performed providing extensive lipid coverage. Quantitative 
lipidomics was used to profile the changes in complex lipid metabolism that occur across the stages of NAFLD, using human plasma 
samples from 3 known disease groups. The platform quantitated 851 lipid molecular species covering ceramides, cholesterol esters, 
lyosphosphopholipids, phospholipids, neutral lipids (TG and DG), and free fatty acids across the sample set analyzed with good 
reproducibility. There were a number of lipid species that had statistically significant changes from control as the disease progressed 
from simple steatohepatitis to steatohepatitis. The top 10 up-regulated and down-regulated lipid molecular species mainly consisted 
of cholesteryl esters and triacylglycerides.
P-193 Characterization of aberrant lipid metabolism in human esophageal cancer by lipidomic profiling
PRESENTING AUTHOR: Yanjun Hong, Hong Kong Baptist University, Hong Kong
CO-AUTHORS: Zhiyi Yang, Zhongjian Chen, Xiaojiao Yi, Zhenyu Guo, Wenhao Ji, Zongwei Cai                                          
Esophageal cancer (EC) is the sixth leading cause of cancer-related mortality and the eighth most common cancer worldwide. 
Metabolic reprogramming, including lipid metabolism dysregulation, has been acknowledged as one of the hallmarks of cancer cells. 
Previous studies have shown the perturbations of several lipids in EC patients. However, due to limitations in technology, only a few 
lipid species were analyzed in those studies. Lipidomic profiling, which enables characterization of lipid structures and compositions, 
has been widely applied in cancer research to study tumorigenesis and identify potential lipid biomarkers. In this study, to further 
characterize the aberrant lipid metabolism in EC, liquid chromatography—tandem mass spectrometry (LC-MS/MS) based lipidomics 
were performed on paired tumor and adjacent normal tissues from 85 EC patients. Distinct alterations of global lipid metabolism 
were indicated in EC tumor tissues based on the partial least-square discriminative analysis (PLS-DA) model (R2Y=0.797 and 
Q2Y=0.751 in positive mode; R2Y=0.702 and Q2Y=0.673 in negative mode). Over 100 potential lipid biomarkers were found to 
be perturbed in EC tumor tissues, with phosphatidylcholines (PCs) and phosphatidylethanolamines (PEs) being mostly elevated. 
Upregulated phospholipid biosynthesis was found in EC tumor tissues, indicating the requirements of continuous lipid biosynthesis for 
proliferation by cancer cells. Furthermore, the abundances of medium-chain triglycerides (TGs) were decreased, suggesting immune-
suppression effects in EC. Collectively, our results unravel the major lipid metabolic aberrations in EC tumor tissues for the first time, 
and imply the potential of lipid biomarkers for EC diagnosis.
P-195 Environmental pollutant BDE 47 enhances adipocyte differentiation via an elevation of oxidative stress
PRESENTING AUTHOR: Chunxue YANG, State Key Laboratory of Environmental and Biological Analysis, Department of Chemistry, 
Hong Kong Baptist University, Hong Kong
CO-AUTHORS: Chi-Ming WONG, Juntong WEI, C.K. CHUNG, Zongwei CAI                                             
Recently, obesity is dramatically increased globally and the conventional causes cannot fully explain its rising prevalence. 
Emerging evidence suggests the contribution of persistent organic pollutants (POPs) to the prevalence of obesity. Clinical studies 
demonstrated the association of 2,2’,4,4’-tetra-brominated biphenyl ether (BDE 47) with obesity but the mechanism is still unclear. 
We examined the effect of BDE 47 exposure during 3T3-L1 preadipocyte differentiation and explored the metabolic alterations 
via metabolomics study using liquid chromatography coupled with mass spectrometry (LC-MS). Results indicated that BDE 47 
increased both adipocytes differentiation with high lipid accumulation and high levels of reactive oxygen species (ROS). BDE 47 
also induced mitochondrial ROS via significantly promoting mitochondrial respiration in adipocytes along with the improvement of 
glycolysis. Application of mitochondrial antioxidant or xanthine oxidase inhibitor suppressed BDE 47-induced ROS generation and lipid 
accumulation. Metabolomics profiling demonstrated BDE 47 induced similar metabolic profile as the positive control (Rosiglitazone). 
BDE 47 significantly altered purine metabolism and glutathione metabolism which was related to the increase of oxidative stress. 
BDE 47 also activated the conversion from xanthine to uric acid via xanthine oxidase to elevate the ROS production during adipocyte 
differentiation. In conclusion, the environmental pollutant, BDE 47, is capable of enhancing 3T3-L1 preadipocytes differentiation via 
altering the purine metabolism to induce oxidative stress.
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P-196 Metabolomic signature in the plasma of patients with OPA1-related dominant optic atrophy reveals alteration of purine metabolism
PRESENTING AUTHOR: Cinzia Bocca, Institut MITOVASC, CNRS 6015, INSERM U1083, Université d’Angers, Angers, France, France
CO-AUTHORS: Judith Kouassi Nzoughet, Stéphanie Leruez, Patrizia Amati-Bonneau, Charlotte Veyrat-Durebex, Juan Manuel Chao 
de la Barca, Selma Kane, Stéphanie Chupin, Dan Miléa, Dominique Bonneau, Vincent Procaccio, Gilles Simard, Guy Lenaers, Pascal 
Reynier                                
Dominant optic atrophy (DOA, MIM#165500), affecting the retinal ganglion cells and their axons forming the optic nerve, is 
associated in most cases with Optic Atrophy 1 gene (OPA1) pathogenic variants. OPA1 is a dynamin GTPase involved in mitochondrial 
inner membrane processing, with a defect of mitochondrial fusion and cristae organization as a consequence of mutations. A non-
targeted metabolomics approach was applied to determine whether metabolic signature exists in DOA patients’ plasma. Twenty-
five patients with several pathogenic variants and twenty controls plasma samples were analyzed by ultra-high-pressure liquid 
chromatography coupled with high resolution mass spectrometry (UHPLC-HRMS), according to our validated method that allows 
the non-targeted exploration of 500 polar metabolites. Using this method, our results revealed a robust and significant metabolic 
signature in patients’ plasma compared to controls. This study highlights a major impairment of the purine metabolism that may 
be related either to mitochondrial dysfunction or to the modified GTPase activity of OPA1. In addition, the altered concentrations 
of metabolites, deriving from the glycerol-phospholipids pathway to name one, were evidenced in patients. In conclusion, our 
metabolomics analysis, by screening a large set of molecules, provides for the first time a human OPA1 signature that not 
only contributes to further understand the pathology with new relevant features, but also offers new directions for therapeutic 
approaches. Overall this study shows that metabolomics is a powerful approach to explore mitochondrial and ocular diseases in 
plasma.
P-198 Environmental cadmium exposure induces urinary metabolite profile alterations in general Chinese pregnant women
PRESENTING AUTHOR: Han Li, Huazhong University of Science & Technology, China
CO-AUTHORS: Yang Peng                                                  
Cadmium, as a typical heavy metal, has become a major environmental threat to human health. It is already known that high-level 
cadmium exposure has adverse effects on human health. However, understanding regarding the health effects of low-level cadmium 
exposure on pregnant women remains unclear. The aim of this study is to investigate the urinary metabolic changes of pregnant 
women exposed to low-dose cadmium, and to identify effective biomarkers. Urine samples of 246 pregnant women were collected 
in the first trimester of pregnancy and were divided into three groups based on the tertile distribution of urinary cadmium levels 
which were determined using inductively coupled plasma mass spectrometry (ICP-MS). The alterations in the metabolite profile 
were measured by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-QToF-
MS). Cadmium-related metabolic biomarkers were investigated by comparing the samples of the first and third tertiles of cadmium 
exposure classifications using a partial least-squares discriminant model (PLS-DA). Eight potential biomarkers were identified, 
including L-cystine, L-tyrosine, dityrosine, cysteineglutathione disulfide, 16DHEA-S, prolylhydroxyproline, histamine and uric acid. 
The results showed that environmental cadmium exposure, even at low levels, could cause metabolite alterations in pregnant 
women which might be associated with adverse health outcomes. The findings may be valuable for the cadmium risk assessment for 
pregnant women.
P-199 MS-Probes and Stable Isotope Coding for Targeted Analysis of Short Chain Fatty Acids in Biological Fluids
PRESENTING AUTHOR: Janine Cooney, Plant & Food Research Ltd, New Zealand
CO-AUTHORS: Tania Trower                                                  
Growing evidence suggests a link between enteric bacteria and the central and enteric nervous systems - the gut-brain axis. 
Dysbiosis of the gut microflora influences these interactions and plays an important role in the pathophysiology of functional 
gastrointestinal and nervous system disorders1.  Modulation of the balance of gut microbes through dietary intervention, particularly 
the use of probiotics and fibre, can affect production of short chain fatty acids (SCFAs), the end-products of microbial fermentation. 
SCFAs positively influence host metabolism by promoting energy homeostasis, regulating immune responses and epithelial cell 
growth, and promoting the functioning of the central and peripheral nervous systems2.  To facilitate understanding of the complex 
interplay between diet, host-gut microbiota and human health, quantitative analysis of SCFAs in faecal samples is often used to 
monitor the efficacy of gut-health interventions. Because of the volatility of SCFAs, LCMS analysis is preferred over GCMS; however, 
accurate quantitation is hampered by the lack of commercially available internal standards (IS) to compensate for matrix effects 
prevalent in biological samples. Han and colleagues recently reported an MS-probe and stable isotope coding method for the accurate 
quantitation of SCFAs in human faeces3. This method uses 12C/13C6-3-nitrophenylhydrazine to convert SCFAs quantitatively to their 
3-nitrophenylhydrazones, to increase their analysis sensitivity. Isotope label coding is enabled using 13C6-3NPH to create an IS for 
each SCFA.  We have extended this methodology for analysis of SCFAs in other types of biological samples, including digesta and 
plasma, and will demonstrate applications in human studies and animal trials.  
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P-200 Explaining the Rye Factor by Metabolomics and Fluxomics
PRESENTING AUTHOR: Johnny Östman, Swedish University of Agricultural Sciences, Department of Molecular Sciences, Sweden
CO-AUTHORS: Elisabeth Müllner, Jan Eriksson, Ali Moazzami                                               
Rye bread has been shown to produce a lower insulin response than wheat bread, even though their produced glucose responses are 
the same. This effect is called the “Rye Factor” and efforts have been made to understand its underlying mechanism. Our group has 
previously performed plasma NMR and LC-MS metabolomics in several bread intervention studies in order to illuminate the nature of 
the rye factor. Based on the previous metabolomics studies, we formed a hypothesis for the mechanism of the rye factor based on 
the differences in the rate of absorption of available carbohydrate. The hypothesis was tested using stable isotope flux analysis. Ten 
males were recruited for a crossover study in which rye/wheat breads were eaten under infusion of isotopically labeled glucose and 
blood samples were analyzed by targeted LC-MS metabolomics, from which the flux of glucose from the intestine to the blood was 
calculated.   The rate of exogenous glucose appearance was found to be significantly higher after ingestion of refined wheat bread 
compared to wholemeal rye bread during the initial 15 minutes, but the plasma glucose concentrations did not differ between the 
different breads at any postprandial time point. Additionally, the total postprandial transport of glucose, expressed as the area under 
the curve (AUC) for rate of glucose appearance, was significantly higher after ingestion of wheat bread. The higher flux of glucose 
triggers a higher production of insulin in order to prevent hyperglycemia. These findings can elucidate the nature of the rye factor.  
P-201 Automatic nuclear magnetic resonance spectroscopy (NMR) urinary analysis: a new approach for selective screening of inborn errors of metabolism (IEM)
PRESENTING AUTHOR: Claire Cannet, Bruker BioSpin GmbH, Germany
CO-AUTHORS: Lars Beedgen, Friedrich K. Trefz, Jürgen G. Okun, Claus-Dieter Langhans, Hartmut Schaefer, Manfred Spraul, 
Dorothea Haas, Stefan Kölker, Georg F. Hoffmann                                      
Background Selective screening of IEM is mainly performed by GC/MS, HPLC/MS, IEC and other methods. Work up of samples and 
methods necessary to make a diagnosis are time consuming and not all methods are applied in a sample with unspecific symptoms 
like “autism” or mental disability. After technology and automation in NMR analysis have greatly improved, we applied NMR as first 
line method in selective screening of IEM using ERNDIM proficiency testing for proof of principle. Methods To 900ul urine 10% buffer 
was added and analyzed with a Bruker IVDr System at 600 MHz. Spontaneous urine samples of 420 healthy children were used as 
reference. 16 urine samples of the ERNDIM proficiency testing program were analysed using a panel of 150 metabolites tested in 
the reference group. Results In 15 out of 16 the correct diagnose could be made:2 normal findings,6 Organo-,3 Aminoacidopathias,a 
MCAD- and Dihydropyriminidase-deficiency,a Sialidosis I and an Odontohypophosphatasia.A Glut I low excretor could also correctly 
be diagnosed. A patient with aromatic acid decarboxylase deficiency could not be diagnosed (as it was the case in 17 out of 20 
laboratories. This became an “education sample”).
P-202 Novel peroxidation products of adrenic, arachidonic, and docosahexaenoic acids in asphyxiated newborn’s plasma
PRESENTING AUTHOR: Angel Sanchez-Illana, Neonatal Research Group, Spain
CO-AUTHORS: Sudhin Thayyil, Paolo Montaldo, Dorothea Jenkins, Guillermo Quintás, Camille Oger, Jean-Marie Galano, Claire Vigor, 
Thierry Durand, Máximo Vento, Julia Kuligowski                                    
During hypoxic ischemic insult, oxidative stress appears to play a crucial role in the biochemical processes that trigger neuronal 
damage. Lipid peroxidation products are the most widely accepted compounds as indicative of lipid damage by oxidative stress. 
In this work we present a validated liquid chromatography mass spectrometry determination of 30 isoprostanoids in newborn 
plasma samples covering a broad range of those oxygenated metabolites of Polyunsaturated Fatty Acids (PUFAs). The method was 
developed taking into account the specific requirements for its use in neonatology (i.e. limited sample volumes, straightforward 
sample processing, and high analytical throughput). The method was validated following stringent FDA guidelines and was applied 
to the analysis of 150 plasma samples collected from neonates with ischemic hypoxic encephalopathy. Data obtained from the 
quantitative analysis of isoprostanoids was critically compared to that provided by a previously developed approach aiming at the 
semi-quantitative detection of total parameters of oxygenated metabolites derived lipid peroxidation biomarkers.
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P-203 Metabolic profiling reveals colonization-induced host-gut microbial interaction
PRESENTING AUTHOR: Zdenek Spacil, Masaryk University, Faculty of Science, Czech Republic
CO-AUTHORS: Tereza Pavlova, Veronika Vidova, Julie Bienertova-Vasku, Jana Klanova                                             
The colonization by microbiota (an ensemble of all symbiotic or pathogenic microorganisms that share human body space) has a 
major impact on the human host as it has been associated with numerous health outcomes. However, mechanisms underlying the 
interaction of microbe-derived metabolites with host signaling and metabolic pathways remain to be elucidated. As microbiota seems 
to have several important influences on physiological processes in human, particularly on energy metabolism and immunomodulation 
in the host, significant changes can be expected in metabolic profile with respect to diverse microbial colonization. Mass 
spectrometry-based metabolic profiling by selected reaction monitoring (SRM) assays was performed in biofluids to detect markers of 
microbial colonization, immune homeostasis and energy metabolism status. We have built SRM libraries to investigate primarily the 
microbial influence on tryptophan metabolism in urine samples (n=54) and amniotic fluid (n=58). As the result we have discovered 
previously unreported microbiota?associated metabolites, which are suitable markers of colonization and contribute novel insight 
into the host-microbiota metabolism. In parallel, we have developed methods to assess circulating endogenous markers of energy 
metabolism (i.e. TCA cycle, pyruvate, propionate, butyrate or fatty acid metabolism) and immune response to investigate either 
beneficial or harmful effects of microbial colonization on the host. This study is pioneering the transition from a descriptive to a 
mechanistic understanding of the human microbiota, which is critical not just for fully appreciating the impact of these organisms on 
host health, but also for harnessing this knowledge to treat disease. This work was supported by the GACR (#17-24592Y).
P-204 Evaluation of metabolic changes in lungs of tuberculosis-infected mice using new high resolution GC/Q-TOF
PRESENTING AUTHOR: Sofia Nieto, Agilent, United States
CO-AUTHORS: Mª Fernanda Rey-Stolle, Vineel Reddy, Adrie Steyn, Nathan Eno, Coral Barbas                                            
Tuberculosis (TB) is one of the major global health problems, with an estimated death of 1.5 million individuals annually. Using 
metabolomics, new TB biomarkers can be identified to make progress in our understanding of the disease as well as to improve the 
diagnostics. In this study, we used a mouse model of Mtb infection to determine the metabolic profile of uninfected and infected 
lung tissues. Mice were infected with 5x104 CFU of Mycobacterium tuberculosis (Mtb) H37Rv via the intratracheal route. The dried 
extracts were derivatized by O-methoximation followed by trimethylsilylation. GC/MS analysis was performed using an Agilent 7890B 
GC system coupled to a novel high resolution 7250 GC/Q-TOF equipped with EI source allowing low-energy ionization. The individual 
analytical fingerprints were obtained using the SureMass feature detection algorithm of Agilent MassHunter Unknowns Analysis. 
Statistical analysis was performed in Mass Profiler Professional (MPP). To identify new pathophysiological pathways involved in 
infection as well as biomarkers of TB, the untargeted metabolomics study was performed using uninfected and infected lung at 9 
weeks following infection. After initial compound annotation, low-energy EI data were used to confirm the molecular ions and identify 
molecular formulas of putatively identified compounds and unknowns, respectively. Using the Fold Change analysis in MPP, alteration 
in amino acids and nucleobases profiles have been observed. In addition, a change in the profile of itaconic acid, a compound that 
likely plays a role in macrophage-based immune response, has also been detected.
P-205 Analytical performance of high-resolution accurate mass (HR-AM)  quantification: A scale-up study of polar metabolites quantifiacation in glioblastoma cell cultures
PRESENTING AUTHOR: Dharmeshkumar Parmar, CSIR-National Chemical Laboratory, Pune, India
CO-AUTHORS: Avinash Ghanate, Rupa Christinal, Dr. Anu Raghunathan, Dr. Venkateswarlu Panchagnula            
Liquid chromatography-high resolution mass spectrometry enables comprehensive and simultaneous qualitative / quantitative 
measurement of metabolites using accurate-mass (HR-AM) extracted ion chromatograms. However, variations in outcomes as the 
analytical process is scaled up have not been adequately reported. Herein, we evaluated the analytical performance of LC-HRMS for 
a representative metabolomic consumption and release (CORE) investigation that involved 988 analytical runs spread over 15-days. 
The test samples comprised of methanolic extracts from two glioblastoma cell sub-types grown in vitro with drug treatment. Specific 
calibration ranges and sample dilution factors were designed subsequent to qualitative full-scan mode screening of 34 metabolites 
that majorly included amino acids, glycolysis and tricarboxylic acid cycle intermediates. R2 ~0.94-0.99 was reproducibly obtained 
with the calibration curves for 31 metabolites establishing linearity across the respective concentration ranges. Accuracy, recoveries 
and inter-day precision was  established using standard and matrix-matched spiked quality control samples. Recoveries for these QCs 
were found within 80-120%. Inter-day precision was determined using 26 replicates QC injections at regular intervals throughout the 
course of study.  Recovery values with ?25% RSD for of 31 metabolites demonstrated reasonable inter-day precision and robustness 
of the method indicating it’s fitness for the purpose. The outcome demonstrated, HR-AM quantification by LC-HRMS is an accurate 
and reliable approach that can be scaled-up for metabolomics studies involving significantly large sample runs over extended period 
of time. Additionally, using this method, differential CORE profiles indicating altered metabolism in two sub-types were identified and 
further highlighted using unsupervised principal component analysis (PCA). 
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P-206 Tissue metabolomic profiling reveals dysregulated metabolism in human esophageal cancer
PRESENTING AUTHOR: Zhiyi Yang, Hong Kong Baptist University, Hong Kong
CO-AUTHORS: Zhongjian Chen, Xiaojiao Yi, Zhenyu Guo, Wenhao Ji, Yanjun Hong, Zongwei Cai                                          
Esophageal squamous-cell carcinoma (ESCC) is among the leading causes of cancer mortality worldwide. Previous research 
on human plasma metabolomics has revealed perturbations of several phospholipid species in ESCC patients. In this study, to 
further characterize the metabolomic signatures in ESCC, paired tumor and adjacent normal tissues from 85 ESCC patients were 
investigated by liquid chromatography—tandem mass spectrometry (LC-MS/MS)-based metabolomic profiling. Tumor tissues were 
clearly separated from the normal tissues based on the partial least-square discriminative analysis (PLS-DA) model (R2Y=0.880 and 
Q2Y=0.815 in positive mode). Over 40 biomarkers were identified to be significantly perturbed in tumor tissues. Major elevated 
metabolic pathways were beta-alanine metabolism, alanine, aspartate and glutamate metabolism, kynurenine metabolism and 
glycerophospholipid metabolism, which reveal the immunosuppressive nature of ESCC. Tissues from Stage III and Stage I patients 
also exhibited significant difference, which can provide evidence for cancer staging and diagnosis for ESCC. This study gives direct 
evidences of metabolism dysregulation in ESCC patients, and suggests the diagnostic potential of biomarkers in ESCC.
P-207 Protective effect of Centella asiatica extract (ECa233) in rotenone-induced liver injury rats as revealed by metabolomics analysis
PRESENTING AUTHOR: Rossarin Tansawat, Chulalongkorn University, Thailand
CO-AUTHORS: Thidarat Intararuchikul, Narudol Teerapattarakan, Ratchanee Rodsiri, Mayuree Tantisira, Oliver Fiehn, Gert 
Wohlgemuth                                          
Liver diseases cause serious public health problems worldwide. Several studies of hepatoprotective activities from natural plant 
extracts have been reported during recent years. The aim of this study was to examine protective effect of the standard extract 
of Centella asiatica (ECa233) in rotenone-induced liver injury rats using a GC-MS based metabolomic approach. ECa233 contains 
&gt;80% triterpenoids with a ratio of madecassoside to asiaticoside of 1.5(±0.5):1. Rats were randomly divided into three groups 
(with six rats/group): sham negative control, rotenone positive control, and the ECa233 test group. Rats in the ECa233 group 
received 10 mg/kg ECa233 orally for 20 days, followed by 2.5 mg/kg intraperitoneal rotenone injection to induce toxicity before being 
sacrificed. Metabolomic analysis showed that supplementation of ECa233 protected rat liver against rotenone toxicity. Pipecolinic acid 
was one of the most important metabolites; its level was decreased in the rotenone group as compared to control. Supplementation 
with ECa233 before administration of rotenone raised pipecolinic acid to levels intermediate between controls and rotenone alone. 
Antioxidant tests revealed that ECa233 inhibited lipid peroxidation and increased catalase activities in liver tissue. The outcomes 
of this study provide further novel evidence in support of using Centella asiatica as a value-added component in new dietary 
supplements or medicines for liver disorders in the future.
P-208 METABOLITES AND LIPIDS PROFILING AND IMAGING IN DIFFERENT TYPES OF HISTOLOGICAL PREPARATION OF THYROID CANCER TISSUE SECTIONS
PRESENTING AUTHOR: Anna Wojakowska, Center for Translational Research and Molecular Biology of Cancer, Poland
CO-AUTHORS: Anna Wojakowska, ?ukasz Marczak, Laura Cole, Mycola Chekan, Malcolm Clench, Piotr Widlak, Monika Pietrowska       
The distinction of different thyroid cancer types has important implication for clinical management. Classification based on 
histopathological features can be supported by molecular biomarkers, including metabolomic and lipidomic signatures, identified 
with the use of high-throughput mass spectrometry techniques. Formalin fixation and paraffin embedding is a standard procedure 
for preservation of tissue samples and constitute highly valuable source of clinical material for retrospective molecular studies. In 
this work we used GC/MS based molecular profiling of FFPE thyroid tissue for identification of metabolites characteristic for different 
thyroid cancer types. Moreover we performed imaging and profiling of lipids present in malignant and non-cancerous formalin fixed 
thyroid tissue.   GC/MS-based molecular profiling from archival FFPE tissues was used to identify metabolites characteristic for 
different types of thyroid cancer. We revealed several metabolic signatures discriminating cancerous from normal tissue, as well as 
malignant thyroid cancers from benign follicular adenoma. Hence, the GC/MS-based metabolome profiling of FFPE thyroid specimens 
could be potentially used as an auxiliary diagnostic tool to support classification of thyroid cancers. High resolution MALDI-MSI 
technique was used for imaging of lipids in fresh frozen and formalin fixed thyroid tissue samples. Several phosphatidylcholine, 
sphingomyelin and phosphatidic acid species were detected as corresponding [M + H]+, [M + Na]+ and [M + K]+ ions. This results 
proved the viability of MALDI-MSI in search for lipid biomarkers directly in formalin fixed clinical material. This work was supported by 
the National Science Centre grants (No UMO-2013/08/S/NZ2/00868 and UMO-2012/07/B/NZ4/01450) and European Cooperation in 
Science and Technology (ECOST-STSM-BM1104-011014-046331).  
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P-209
Plant sesquiterpene lactone derivative overcomes acquired vemurafenib resistance and 
reduces cutaneous side effect of vemurafenib in mice through modulating oxylipin dynamics 
and beyond
PRESENTING AUTHOR: Lie-Fen Shyur, Agricultural Biotechnology Research Center, Academia Sinica, Taiwan
CO-AUTHORS: Meng-Ting Chang, Jia-Hua Feng, Kyoko Nakagawa-Goto, Kuo-Hsiung Lee                                             
Vemurafenib, a chemotherapeutic drug targeting BRAFV600E mutant melanoma, commonly causes cutaneous squamous cell 
carcinoma or keratoacanthomas side-effect in patients. We demonstrated that DETD-35 derived from a plant sesquiterpene lactone 
deoxyelephantopin can effectively reduce tumor growth in acquired vemurafenib resistance (A375-R) xenograft models, where 
vemurafenib showed no anti-tumor activity. We also observed that vemurafenib administration to DMBA/TPA-irritated mice (named 
DTV) promoted a much earlier onset of cutaneous papillomas formation in mice. Of note, DETD-35 treatment effectively reduced skin 
papillomas formation and numbers/sizes in DTV mice. Oxylipins are a group of lipid mediators playing critical roles in inflammation 
and cancerous diseases. LC-MS-based oxylipin metabolome study shows that vemurafenib affected the oxylipin profile and dynamics 
in DMBA/TPA-irritated mice. Of note, linoleic acid derived oxylipin metabolites, such as EpOMe(s) or DHOME(s) were elevated in 
DTV mice which can be significantly attenuated by DETD-35 treatment. The LOX/CYP450 enzymes responsible for those oxylipins 
production were found over-expressed in skin neutrophils/macrophages. Mechanistic study shows that DETD-35 inhibited the 
paradoxical activation of MAP kinases by vemurafenib in mouse skin or in HRAS mutant melanoma cells; furthermore, DETD-35 could 
also inhibit cell proliferation of HRAS mutant keratinocytes, which are observed abundantly in DMBA/TPA-irritated mouse skins. This 
study suggests that DETD-35 can be a novel adjuvant agent for vemurafenib in treatment of BRAFV600E mutant melanoma and 
reducing the drug side effect.
P-210 Biological and functional analysis of Coenzyme A biosynthetic pathway in enteric protozoan parasite Entamoeba histolytica
PRESENTING AUTHOR: Arif Nurkanto, Department of parasitology, National Institute of Infectious Diseases, Japan
CO-AUTHORS: Ghulam Jeelani, Tomoyoshi Nozaki                                                
Entamoeba histolytica is an anaerobic parasitic protozoan causes amoebic dysentery. Metronidazole has been a drug of choice 
against amebiasis for decades despite its known side effects and low efficacy against asymptomatic cyst carriers. Therefore, 
identification and characterization of specific targets is needed to design new therapeutics for improved treatment against amebiasis. 
Coenzyme A (CoA) is an essential cofactor in many living organisms as an acyl group carrier and carbonyl activating group in 
numerous reactions central to cellular metabolism. The biosynthesis of CoA from pantothenic acid is an essential universal pathway in 
prokaryotes and eukaryotes. E. histolytica also rely on the uptake of exogenous pantothenate. Using comparative genomics, we have 
identified genes involved in biosynthesis of CoA from pantothenate in E. histolytica: Pantothenate kinase (EC 2.7.1.33), bifunctional 
phosphopantothenate-cysteine ligase/decarboxylase (EC 6.3.2.5/ EC 4.1.1.36), pantetheine phosphate adenylyltransferase (EC 
2.7.7.3) and dephospho CoA kinase (EC.2.7.1.24). In order to further characterize the importance of this pathway, we have utilized 
the epigenetic gene silencing strategy. Using this strategy, we were able to repress pantothenate kinase (PanK), dephospho CoA 
kinase 1 (DPCK1) and dephospho CoA kinase 2 (DPCK2). Repression of individual above genes showed severe growth defect, 
significantly decreased in CoA concentration suggesting the essentiality of this pathway in this parasite. To better understand the 
role of unidentified metabolic system and/or change in metabolic capacity after silencing of PanK and DPCK gene, we performed 
metabolomic analysis of the above knock down strains. Significance of metabolomic changes after knocking down above CoA 
pathway genes will be discussed.
P-211 Effect of tomato interventions on the plasma lipid profile of men pre-prostatectomy
PRESENTING AUTHOR: Morgan Cichon, The Ohio State University, United States
CO-AUTHORS: Ken Riedl, David Francis, Steven Clinton                                               
Diets rich in tomatoes have been associated with a decreased risk of chronic diseases, including prostate cancer. However, the 
mechanism behind this observed protective effect remains unclear. Given the lipid-like structure of lycopene, one of the bioactive 
components of tomatoes, we are interested in the effect of tomatoes on the human lipid profile, which has not yet been evaluated 
in detail. Here we investigated the effects of red and tangerine tomato juices on the plasma lipid profile as a way of better 
understanding a mechanism of action. In addition to the traditional red tomato, a unique tangerine tomato variety was selected 
due to its different phytochemical profile, in particular, differing carotenoid composition and content. In this study, men (n=45) 
with prostate cancer scheduled for a prostatectomy consumed red tomato juice, tangerine tomato juice, or a low lycopene diet for 
3-4 weeks prior to surgery. Baseline and post-intervention plasma samples were analyzed using a differential ion mobility mass 
spectrometry-based lipidomics platform covering 13 classes of blood lipids (approximately 12,000 lipid species). The fully quantitative 
data was statistically analyzed to determine classes and species of lipids altered in response to the red and tangerine tomato juice 
interventions. Results suggest significant decreases in phospholipid and lysophospholipid classes with tomato intake. There also 
appear to be a number of specific triacylglycerides that decrease in plasma following the tomato interventions. We continue to mine 
the data to confirm lipid differences and determine if these effects vary based on tomato variety.
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P-212 Understanding asthma-COPD overlap syndrome: Exhaled breath condensate analysis using (1H) NMR based metabolomics approach
PRESENTING AUTHOR: Nilanjana Ghosh, School of Medical Science and Technology, Indian Institute of Technology Kharagpur, 
India
CO-AUTHORS: Elavarasan Subramani, Priyanka Choudhury, Saumya Samanta, Mamata Joshi, Rintu Banerjee, Parthasarathi 
Bhattacharyya, Koel Chaudhury                                         
Asthma and chronic obstructive pulmonary disease (COPD) are two common obstructive lung diseases which have been extensively 
investigated. However, asthma-COPD overlap syndrome (ACOS), where patients exhibit features of both asthma and COPD, remains 
a weakly defined clinical entity. No specific biomarker exists to differentiate ACOS from asthma or COPD. Metabolomics of exhaled 
breath condensate (EBC) has emerged as a popular non-invasive tool to help understand underlying pathophysiologies of various 
respiratory diseases. This is the first study where we hypothesize that metabolomic analysis of EBC will help classify ACOS better and 
ascertain whether this overlap syndrome has its own unique pathophysiology. EBC samples were collected from patients with asthma 
(n=23), COPD (n=26), ACOS (n=31) and healthy controls (n=27). Proton NMR spectra of EBC samples were acquired using 800 MHz 
Bruker Avance III spectrometer equipped with a CryoProbe. Following pre-processing of the spectra, both multivariate and univariate 
analysis was applied. On comparing asthma, COPD, ACOS and controls, an optimum classification of ACOS was obtained with the 
OPLS-DA model. Finally, receiver operating characteristic curve could identify with highest accuracy the metabolites responsible 
for distinguishing ACOS. Metabolites including lactate, pyruvate, propionate, ethanol and fatty acid were found to be significantly 
dysregulated in ACOS patients. In conclusion, the distinct metabolic signatures of ACOS are strongly suggestive of the disease having 
a distinct clinical identity, as compared to asthma and COPD. These findings pave way for validation studies which can help unravel 
this complex overlap syndrome better.
P-213 Serum lipid profiling reveals the effect of dietary Chrysanthemum morifolium Ramat leaf extracts on high-fat diet induced obesity in a mice model
PRESENTING AUTHOR: Jong Cheol Shon, Kyungpook National University, South Korea
CO-AUTHORS: Won Cheol Kim, Kwang-Hyeon Liu                                                
The Chrysanthemum morifolium Ramat has been known to have a various pharmacological effects such as anti-obesity and anti-
diabetes. Lipidomic biomarkers responsible for the pharmacological effects on leaf of Chrysanthemum morifolium Ramat extracts 
(CME) were investigated in serum of mice fed high-fat diets (HFD). In brief, the serum of mice fed a normal diet (ND), a HFD, a 
HFD plus CME 1.5% diet (CLL), and a HFD plus luteolin 0.003% diet (LU) for 16 weeks were analyzed using liquid chromatography-
tandem mass spectrometry (LC-MS/MS) combined with multivariate analysis. The ND, HFD, CLL, and LU groups were clearly 
discriminated upon partial least-squares discriminant analysis (PLS-DA) score plot, and the major metabolites contributing to such 
discrimination were triacylglycerols (TAGs), cholesteryl esters (CEs), phosphatidylcholines (PCs), ceramides (CERs), sphingomyelins 
(SMs), and lysophosphatidylcholines (LPCs). The levels of PCs, LPCs, SMs, and CERs were increased in HFD groups compared to ND 
groups and these lipids were recovered after administration of CME 1.5% or luteolin 0.003% extracts. The mRNA expression levels 
of ceramide synthase 6, sphingomyelin synthase 1, and choline phosphotransferase in CLL groups were also recovered to the levels 
of ND groups. In conclusion, these lipid-markers might be used to evaluate the anti-obesity effect of CME in mice. This study was 
supported by the Bio-Synergy Research Project (Grants NRF-2014M3A9C4066459) of the Ministry of Science, ICT &amp; Future 
Planning through the National Research Foundation of Korea (NRF).
P-214 Metabolomic Analysis of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibition on PC3 Cancer Cell Line
PRESENTING AUTHOR: Xuejiao Yin, National University of Singapore, AB Sciex Pte. Ltd, Singapore
CO-AUTHORS:                                                    
Nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme that catalyzes the first step in the biosynthesis of NAD 
from nicotinamide. Recent studies have demonstrated that NAMPT-mediated NAD biosynthesis in cancer cells plays a crucial role in 
several physiological processes. The down-regulation of NAMPT suppresses tumor cell growth in vitro and in vivo and sensitizes cells 
to oxidative stress and DNA-damaging agents. FK866, found to be bound to the nicotinamide binding pocket of NAMPT, specifically 
inhibits NAMPT in the cell and exhibits anti-tumor activity in preclinical tumor models. Thus, FK866 appears to be an ideal tool 
molecule for assessing the physiological function of NAMPT in the cell. GMX1778 is another important pillar in the elevation of 
NAMPT inhibitors to potential therapeutic agents. In the current study, further studies will be performed to assess the global effects 
of NAMPT inhibition by FK866, GMX1778 and their synergistic effects on cancer metabolism by using global mass spectrometry–
based metabolic profiling. We demonstrated that metabolites associated with glycolysis, pentose phosphate pathways and TCA 
cycle are affected in the same fashion under the inhibition of FK866 and GMX1778. Betaine, phosphotidylcholine, diadyglycerol, 
phosphoethanolamine, phosphatidylinositol, phosphotidylglycerol, ceramide and sphingomyelin (SM) were observed to be up-
regulated, which suggests there is cell-specific response of lipid metabolism to NAMPT inhibition with FK866 and GXM1778. NAMPT 
inhibition significantly modifies purine metabolism and pyrimidine metabolism under FK866 treatment, but not under GMX1778 
treatment. The difference in metabolic changes under FK866 and GXM1778 might due to difference in structure and binding to 
NAMPT.
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P-215 Integration of 1H NMR dereplication algorithm and MS/MS Molecular Networking for the identification of bioactive secondary metabolites
PRESENTING AUTHOR: Ian Castro Gamboa, IQ-UNESP-BRAZIL, Brazil
CO-AUTHORS: Denise Selegato, Alan Pilon, Rafael Freire                                               
Dereplication is of fundamental importance in current bioprospecting programs, emerging as a rapid way of identifying known 
compounds in mixtures, accelerating the selection and identification of biologically promising compounds. New methodologies have 
been developed, using multivariate analysis and pattern recognition algorithms, such as MS/MS Molecular Networking and Principal 
Component Analysis (PCA). The main goal of this work was to analyze the metabolic profiles of Fusarium solani and F. oxysporum 
isolated from Senna spectabilis’s rhizosphere, aiming to dereplicate important and bioactive metabolites. We have integrated two 
different methodologies applied to 1H-NMR-based metabolomics and tandem mass spectrometry. By applying the first strategy, it was 
possible to identify and mathematically separate 1H-NMR peaks responsible for F. solani and F. oxysporum metabolic differentiation, 
identifying three known molecules fusaric acid, produced majorly by F. oxysporum, a mycotoxin with high commercial value, and two 
enniatins: HA23 and beauvericin, produced by F. solani and F. oxysporum, respectively. Complementarily, by target analyzing of all 
metabolites identified above using Molecular Networking, we were able to identify eight other analogues six enniatins, three of them 
known molecules and firstly described for F. oxysporum: beauvericin F, beauvericin D and beauvericin G2; and three firstly reported 
depsipeptides as well as three picolinic acid analogues.
P-216
Untargeted metabolomic analysis of porcine serum and oral fluid following intramuscular 
administration of a porcine reproductive and respiratory syndrome virus (PRRSV) modified-
live virus (MLV) vaccine
PRESENTING AUTHOR: Dr. David Borts, Iowa State University, United States
CO-AUTHORS: David Borts, Jeffery Zimmerman, Yuly Henao Diaz, Luis Giménez-Lirola, Ting-Yu Cheng                                            
First identified in 1991, porcine reproductive and respiratory syndrome virus (PRRSV) remains an economically important cause of 
reproductive failure in breeding stock and respiratory illness and death in young pigs.  Understanding the pathogenesis of PRRSV 
and devising methods for controlling its effects remain active fields of study.  In this experiment, an untargeted metabolomics 
approach was used to detect small molecule biomarkers associated with the replication of PRRSV MLV vaccine.  Serum and oral fluid 
samples from 12 pigs collected prior to and following vaccination were analyzed.  Samples were extracted by protein precipitation 
and analyzed using ultra-high-pressure liquid chromatography (UHPLC) coupled with high resolution orbitrap mass spectrometry.  
Multivariate statistical analyses revealed well-separated clusters between the pre-vaccination and post-vaccination groups in both 
serum and oral fluid specimens.  Variable importance in projection (VIP) plots were used to rank metabolites for their ability to 
discriminate between these two groups.  Receiver-operator characteristic (ROC) curves were calculated to determine the quality of 
biomarker sets.  The resulting ROC curves suggested that the putative biomarkers identified in this study might form the basis of an 
effective diagnostic test for detecting PRRSV replication.  Additional work will focus on metabolite identification, identification of small 
molecule biomarkers of PRRSV infection, and on potential diagnostic applications, e.g., discrimination between PRRSV vaccinated vs 
wild-type infected animals and detection of persistently infected animals.
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P-218 Phenotyping analysis of a 5-compound herbal mixture on macrophage cell line using metabolomics analysis
PRESENTING AUTHOR: Katsuya Ohbuchi, Tsumura & Co., Japan
CO-AUTHORS: Chika Shimobori, Akinori Nishi, Takashi Matsumoto, Nagisa Komokata, Hirotaka Kushida, Masahiro Yamamoto              
Combination drug like traditional herbal medicine (THM) is expected to overcome limitations of single agents through their synergistic 
or additive effects produced by various compounds. However, the modes of action (MoA) of THM remain unclear due to the complex 
nature of THM. To clarify the MoA of THM, it is essential to understand which component could be involved in the pharmacological 
action and what could happen in the body, tissues, and cells by administration of THM. In this study, we selected the bioavailable 
compounds from the components in maoto, which is a Japanese traditional medicine and widely used for the febrile symptoms 
induced by viral infection, and evaluated the influence of a selected 5-compound mixture (MIX5) on macrophage cell line using wide-
targeted metabolomics analysis. We used RAW264.7 stimulated with poly I:C (PIC), a viral mimic, to evaluate the effects of MIX5 
containing ephedrine, prunasin, cinnamic acid, glycyrrhetinic acid, and isoliquiritigenin, which could be detected in the systemic blood 
after oral administration of maoto in rat and human study. MIX5 suppressed interleukins and prostaglandin D2 production induced by 
PIC. Metabolomics analysis revealed that PIC induced metabolic reprogramming following activation of macrophage. MIX5 increased 
anti-inflammatory mediators such as omega-3 fatty acid metabolites without affecting metabolic reprogramming induced by PIC. 
Additionally, the effect of MIX5 on the lipid mediators was quite different from aspirin, one of the representative cyclooxygenase 
inhibitors. These results suggest that MIX5 exerts unique anti-inflammatory activity, the MoA of which is different from those of 
conventional anti-inflammatory drugs like NSAIDs.
P-219 Salmonella typhimurium Infection Reduces Schistosoma japonicum Worm Burden in Mice
PRESENTING AUTHOR: Yulan Wang, Wuhan Institute of Physics and Mathematics, China
CO-AUTHORS: Xiaoyang Zhu, Huiru Tang                                                
Coinfection of microorganisms is a common phenomenon in humans and animals. In order to further our understanding of the 
progress of coinfection and the possible interaction between different pathogens, we have built a coinfection mouse model with 
Schistosoma japonicum and Salmonella typhimurium, and used this model to investigate the systemic metabolic and immune 
responses using NMR-based metabonomics and immunological techniques. Our results show that Salmonella typhimurium 
(ATCC14028) infection reduces adult schistosomal worms and eggs, relieves symptoms of schistosomiasis and also abates the 
mortality of mice infected by Schistosoma japonicum. In addition, Salmonella typhimurium infection counteracts the metabolic 
disturbances associated with schistosomiasis. Furthermore, immune analyses also indicate that shift of the immune response to 
different pathogens is a result of indirect interactions between Schistosoma japonicum and Salmonella typhimurium within the host. 
Salmonella typhimurium infection can ameliorate Schistosoma japonicum-caused schistosomiasis in BALB/c mice, which is most likely 
due to inverse immune polarization. Our work provides an insight into coinfection between Schistosoma japonicum and Salmonella 
typhimurium, and may further contribute to the development of new tools for controlling Schistosoma japonicum-associated diseases.
P-220 Metabolomic analysis of Haemonchus contortus infection in sheep
PRESENTING AUTHOR: Denni Currin-Ross, University of Queensland, Australia
CO-AUTHORS: Horst Schirra, Gene Wijffels                                                
The helminth Haemonchus contortus or “The Barber’s Pole” worm has been previously shown to be highly pathogenic to small 
ruminants such as sheep and goats causing anaemia, oedema, diarrhoea and even death if left untreated. This parasite, which uses 
sheep as a host system to feed and multiply, causes substantial economic losses worldwide. Furthermore, due to the exclusive and 
overuse of drug therapy (anthelmintics) H. contortus has become highly and multi-drug resistant. Therefore, new and sustainable 
control strategies have become highly sought after. In this project we investigated the changes in metabolite concentrations in two 
lines of sheep selected for resistance or susceptibility during the H. contortus host-infection stage. The data was initially analysed 
univariately before 2D and 3D multivariate clustering and trajectory plotting was undertaken. Metabolites of similar trajectories were 
grouped by means of Effect Projections (EP) and Hierarchal Cluster Analysis (HCA). Individual metabolites were analysed based on 
the data from the 1-, 2- and 3D trajectory plots. These analyses provide insights into the metabolic responses in the resistant and 
susceptible hosts during the course of a H. contortus infection.
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P-221 COnsortium for METabolomics Studies (COMETS): Developing Resources to Accelerate Scientific Discovery
PRESENTING AUTHOR: Ann Hsing, Stanford Cancer Institute, United States
CO-AUTHORS: Ann Hsing, Demetrius Albanes, Clara Barrios Barrera, Eric Boerwinkle, Juan Casas, Clary Clish, Heather Eliassen, 
Robert Gerszten, Christian Gieger, Marc Gunter, Sei Harada, Tamara Harris, David Herrington, Mattias Johannson, Bruce Kristal, 
Claudia Langenberg, Jessica Lasky-Su, Debbie Lawlor, Charles Matthews, Cristina Menni, Steven Moore, Matej Oresic, Eric Orwoll, 
Alexandre Pereira, Kathryn Rexrode, Svati Shah, Xiao-ou Shu, Pothur Srinivas, Victoria Stevens, Rachael Stolzenger-Solomon, 
Marinella Temprosa, Joanna Tzoulakim, Cornelia Ulrich, Krista Zanetti, HuaZhao
Metabolomics is an emerging approach used for epidemiologic and clinical studies, which has the potential to improve disease risk 
assessment, screening, diagnosis, prognosis and predictive response to therapy, as well as provide disease mechanistic insight. 
In recent years, there have been an increasing number of epidemiologic studies that use metabolomics to explore metabolite 
associations with a wide array of disease-related traits and outcomes. It is timely to establish mechanisms for leveraging existing 
resources and data for novel biomarker discovery using metabolomics approaches. To this end, the National Institutes of Health 
COnsortium of METabolomics Studies (COMETS) was established in 2014 (http://epi.grants.cancer.gov/comets/), and currently 
includes 39 prospective cohorts and 2 consortia from the United States, Europe, Asia and South America. The COMETS mission is 
to promote collaborations among prospective cohort studies that have measured metabolites and followed participants for a range 
of health outcomes. COMETS aims to facilitate an open exchange of ideas, knowledge, and results to accelerate a shared goal of 
identifying metabolomic profiles associated with disease phenotypes (e.g. heart disease, diabetes, and cancer). Here we describe 
the COMETS structure and progress of the consortium to advance the use and impact of metabolite profiling in population-based 
research. Briefly, we will highlight efforts in gathering metabolomics data from different studies and analytical platforms to enable 
pooled analyses. This includes the development of COMETS Analytics, which is a secure, user-friendly, web-based analytical platform 
that promotes reproducibility and data autonomy by harmonization of metabolite identifiers across consortiums and methods.
P-222 Programmed cell death driven by up-regulation of phospholipids in cancer cells: A potential anticancer compound from Bornean Dysidea sp.
PRESENTING AUTHOR: Yoong Soon Yong, Biotechnology Research Institute, Universiti Malaysia Sabah, Malaysia
CO-AUTHORS: Ping Chin Lee, Hsin-Chang Chen, Yee Soon Ling                                               
Marine sponges’ rich in pharmacologically-active chemicals, have been demonstrated to exhibit anticancer properties for decades. 
Classical natural product chemistry is evolving to modern-day metabolomics as a result of the advent analytical platforms and 
sensitive instrumentation. Vast number of compounds had been discovered from these organisms to overcome drug resistance while 
reducing side effects. High-throughput metabolomics enables researchers to identify the metabolites where overall comparison 
between the treated subjects and control could be done. Throughout such analysis, the underlying dysregulated metabolites pathway 
could be mapped to understand the overall effects. Current study, we exposed cell line SK-Hep1 (human hepatic adenocarcinoma) 
with compound isolated from Bornean Dysidea sp.. High-throughput lipidomics revealed that the cell underwent programmed cell 
death after treated with 6.5 µg/mL of isolated compound. XCMS revealed a total of 58-lipids were significantly (p-value &lt;0.05) 
perturbed. Among them are diacylglycerols and phospholipids, including phosphtatidylethanolamines (PE), phosphtatidylserines (PS), 
phosphtatidic acids (PA), and phosphtatidylinositols (PI). Upregulation of these lipids were reported to have strong correlation with 
programmed cell death (apoptosis). Cyto-histologic observation using propidium iodide and hoechst co-staining method suggested 
the cells underwent apoptosis. Additionally, it is interesting that ubiquinone derivatives, including 3-demethylubiquinol-10 (reduced 
form of Coenzyme Q10) and 6-methoxy-3-methyl-2-all-trans-decaprenyl-1,4-benzoquinol were upregulated suggesting that the 
cell mitochondrial undergoing substantial oxidative stress which eventually leading to cell death. However, the exact cell death 
mechanism is pending to be illustrated. To conclude, we discovered a promising anticancer compound from Bornean Dysidea sp.. 
Furthermore, in vivo study is necessary to evaluate the cytotoxicity of the compound.
P-223 Elevated plasma metabolites reveal actively regulated sphingomyelin-ceramide metabolic pathway in obesity
PRESENTING AUTHOR: Ping Chin Lee, Universiti Malaysia Sabah, Malaysia
CO-AUTHORS: Eric Tzyy Jiann Chong, Yee Soon Ling                                                
Obesity is associated with increased risk of several chronic diseases, including stroke, heart attack, type 2 diabetes and cancer. 
Globally, more than 600 million individuals are obese. This study aims to investigate the plasma metabolite differences between 
obese and lean individuals. Non-polar plasma metabolites were extracted from 50 obese (BMI ? 30) and 50 lean (BMI &lt; 25) 
individuals using liquid-liquid extraction method, and profiled using liquid chromatography followed by Orbitrap mass spectrometry 
technologies. The untargeted metabolite datasets were analyzed through multivariate approaches and matched to the LIPID MAPS® 
Database. Our study revealed that 11 lipid species were significantly elevated in obese than in the lean individuals, and most of these 
lipid species are major components in the sphingomyelin-ceramide metabolic pathway. This study suggests that the sphingomyelin-
ceramide metabolic pathway is actively regulated in obese individuals; the finding is useful in pathway inhibitor discoveries for future 
obesity prevention and management.      
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P-224 Development of biomarkers for the protein restriction using Slc6a19 knock out mice
PRESENTING AUTHOR: Kiran Javed, Australian National University, Australia
CO-AUTHORS:                                                    
Mutation in BoAT1 (Slc6a19) lead to an autosomal recessive disorder known as Hartnup disorder that is mainly characterized by 
reduced absorption of amino acids in the intestine and renal aminoaciduria. The characterization of Slc6a19 knock out mouse model 
has revealed signs of protein restriction such as elevated levels of FGF21, but also higher levels of GLP-1 due to increase in amino 
acid load in the intestine. The combination of both effects improve glycaemic control and makes this transporter a potential target for 
the treatment of type 2 diabetes. Our lab is currently screening for chemical compounds that can block this transporter effectively. 
To evaluate the efficacy of these compounds, there is a need to develop biomarkers that can easily detect the successful inhibition 
of BoAT1 in mice and to detect protein restriction in general. To find biomarkers that can detect the inhibition of BoAT1 in intestine 
and correlate with protein restriction and malabsorption, a non-targeted metabolomics approach was designed to identify metabolites 
in urine, fecal and breath samples. A particularly interesting group of metabolites are fermentation products of amino acids that 
may show proportionality to protein load. The microflora of the intestine ferments amino acids into short chain fatty acids and other 
metabolites. In urine samples, a significant increase in neutral amino acids and some metabolites of bacterial origin was seen in the 
knock out mice. This shows the potential of qualitative metabolomics to identify biomarkers for protein restriction and malabsorption. 
P-225 Wine, Health and Metabolomics: Consumption of dealcoholised wine with resveratrol, changes the human plasma profile
PRESENTING AUTHOR: Natoiya Lloyd, Metabolomics Australia, The Australian Wine Research Institute, PO Box 197, Glen Osmond 
SA 5064, Australia
CO-AUTHORS: Joana Fernandes, Finlay Macrae, Virginia Bird, Creina Stockley, Markus Herderich                                            
Resveratrol has been linked to positive impacts on human health following its consumption and so it is one of the most highly 
studied bioactive phenolic compounds. Of specific interest is its presence in wine which is a main dietary source of resveratrol 
and its contribution to the potential benefits of moderate wine consumption. Research has demonstrated that the bioavailability 
of resveratrol, in humans, is relatively low.1 Some studies have reported the formation of known resveratrol conjugates such as 
resveratrol mono glucuronides and sulfates, but not all biochemical changes that resveratrol undergoes during metabolism are 
clear.    For this study, metabolite changes that occur in human plasma following the consumption of resveratrol in dealcoholized 
wine were monitored using an untargeted metabolomics approach using reverse phase HPLC-HRMS (ESI negative mode). 
Bioinformatics tools including XCMS and CAMERA were used for the extraction of over a thousand molecular features. The data was 
explored using multivariate statistical methods and identification of metabolites was carried out using in-house spectral libraries 
and in-house reference standards. For characterisation of unknown metabolites, additional MS/MS experiments were performed 
for further structural information.   The focus of the presentation will be on the metabolomics tools used to monitor resveratrol 
derived metabolites. In addition, the observed compositional changes that have been observed in human plasma as a result of the 
consumption of resveratrol will be outlined.       Walle, T. et al. (2004) Drug Metabolism and Disposition, 32, 1377–82.
P-226 Salivary metabolomics for various cancer detection
PRESENTING AUTHOR: Masahiro Sugimoto, Tokyo Medical University, Japan
CO-AUTHORS:                                                    
Salivary tests facilitate frequent use since its non-invasive sample collection, which would enhance the opportunity of various 
diseases at early stage. Salivary metabolomics have shown its potential to detect various cancers, including oral, breast, and 
pancreatic cancers. However, sample collections should be carefully designed to reduce unexpected bias, and rigorous validations is 
necessary to manifest the biological link between the cancer-specific metabolic aberrance in tumor and salivary metabolite markers. 
Here, we identified metabolomic salivary markers for oral cancer detections. We utilized capillary electrophoresis time-of-flight mass 
spectrometry to quantify hundreds of metabolites in tumor and matched healthy tissues obtained from the patients with oral cancers. 
We also collected saliva samples from these patients and healthy controls. Totally, 17 metabolites showed consistently elevated in 
oral cancer saliva and tumor tissues in oral cancer patients. Of these, the combination of two metabolites showed high discrimination 
ability of oral cancer from healthy controls using saliva. We also collected salivary samples three times from oral cancer patients with 
different duration between saliva collection and the last diets. We evaluated which metabolites are sensitive or robust against the 
timing of sample collection. The identified markers showed a clinical feasible as non-invasive oral cancer screening.
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P-227 An untargeted metabolomics approach to identify new pathways involved in Aspirin effects
PRESENTING AUTHOR: linda turnu, Centro Cardiologico Monzino IRCCS, Italy
CO-AUTHORS: Chiara Manega, Benedetta Porro, Alessandro Di Minno, Sonia Eligini, Donatella Caruso, Elena Tremoli, Viviana 
Cavalca                                         
Aspirin is one of the most commonly antiplatelet drug employed for cardiovascular disease. Although its clinical efficacy has been 
well documented, a substantial inter-individual variability in drug response exists, resulting in some cases in persistent platelet 
reactivity and even in atherothrombotic events. The mechanisms at the basis of this relevant variability remain poorly understood. 
Pharmacometabolomics, allowing to investigate the changes in the metabolome induced by Aspirin, can aid to establish the 
modified pathways and to elucidate the determinants of drug responsiveness. In this study we defined an urinary metabolic profile 
of healthy subjects (n=7) before and after 7 days of low–dose Aspirin treatment, through a liquid chromatography – time of flight 
mass spectrometry platform, in positive and negative ionization mode. Many metabolites showed a statistical significant difference 
(p&lt;0.05) after Aspirin assumption (35 in positive ionization mode and 44 in negative ionization mode). Pathway analysis, 
performed on identified metabolites, reveals how histidine and purine metabolisms are greatly affected by drug exposure; in 
particular, several metabolites showed lower levels after pharmacological treatment. Interestingly, some of the metabolites of these 
pathways are involved in platelet aggregation and systemic inflammatory response. Furthermore, we observed the decrease of four 
different short-chain acylcarnitines, suggesting an increase in ?-oxidation mitochondrial process. The results presented in this report 
reveal relevant pathways altered by Aspirin treatment, which may provide important information to understand the multiple effects 
that contribute to drug response.
P-228 NMR-based Metabolomic Profiling of Blood Plasma at The Taiwan Biobank: Comparison between Normoglycemic And Prediabetic Subjects
PRESENTING AUTHOR: Chung-ke Chang, Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taiwan
CO-AUTHORS: Chen-Yang Shen                                                  
The Taiwan Biobank (TWB) operates the recruitment, monitoring and data generation of a general population cohort with no history 
of cancer and is one of the premier scientific infrastructure projects in Taiwan. We compared the metabolic profile of carefully 
selected blood plasma specimens from normoglycemic and prediabetic participants in the TWB using NMR-based quantitative 
profiling. By linking the metabolomic data with information obtained from biochemical tests and questionnaires, we observed two 
interesting trends: (1) In some populations, ?-hydroxybutyrate levels were correlated to exercise status, which in turn was associated 
with plasma glucose levels. (2) Subjects with relatively high blood plasma ethanol/methanol levels were less likely to be prediabetic. 
The first trend confirmed a number of findings reported in the literature, whilst the second one was unexpected and may provide 
clues into the mechanism of the prediabetic condition. We also tested a number of random samples at different magnetic fields, and 
found that quantitative profiling of filtered blood plasma was generally reproducible, raising the possibility of using cheaper lower-
field spectrometers for multi-site replication and data comparison. Our results suggest that biobanking of NMR-based metabolomic 
spectra coupled with quantitative profiling may provide a robust and reproducible database for research and data dissemination.
P-229 Metabolomics Analysis of Tuberculosis Drug Activity Using Q-TOF LC/MS
PRESENTING AUTHOR: Yuqin Dai, Agilent Technologies, United States
CO-AUTHORS: Travis Hartman, Steven Fischer, Kyu Rhee                                               
Pyrazinamide (PZA) is a frontline drug used in the treatment of tuberculosis. Unfortunately, widespread use has resulted in growing 
rates of PZA resistance, while knowledge of PZA’s mechanism of action remains unresolved.  Existing knowledge indicates that PZA 
is a prodrug that undergoes conversion to pyrazinoic acid (POA), the pyrazine analog of nicotinic acid, by the NAD salvage pathway-
specific enzyme nicotinamidase (PncA).  Knowledge of the downstream biochemical consequences of POA production however 
remains incomplete. NAD biosynthesis and NAD-dependent reactions are two potentially direct, but understudied, biochemical targets 
of PZA.  The reasons for this are both biological and experimental in nature but due, in part, to limitations of existing analytical 
methodologies that have hindered broad and sensitive detection of cellular metabolites.      Here we present a high performance 
Q-TOF LC/MS method that enabled the biologically unbiased study of the impact of PZA on the Mycobacterium tuberculosis 
metabolome. This method with its excellent retention time reproducibility, compound separation and Q-TOF mass accuracy was 
outstanding for metabolomics profiling experiments.  Batch feature extraction and multivariate statistical analysis was used to 
discover activity-specific metabolic changes that may help explain PZA’s unique therapeutic activity.
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P-230 Development of simultaneous screening method of ten cytochrome P450 enzyme activity in human liver microsomes using P450 substrate cocktails and LC-MS/MS
PRESENTING AUTHOR: Heo Jaekyung, Kyungpook National University, South Korea
CO-AUTHORS: Hyeon Kyung Ji, Jae Kyung Heo, Won Cheol Kim, Jong Cheol Shon, Kwang-Hyeon Liu                                            
The early detection of potential drug interactions is an important issue of drug discovery that has led to the development of 
screening methods for potential drug interactions. In this study, we developed a validated screening method for potential drug 
interactions of inhibitory drugs for ten human P450 enzymes (CYP1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, 2J2 and 3A) using 
two P450-isoform probe substrate cocktails and tandem mass spectrometry. The two P450 substrate cocktails were developed 
to minimized mutual drug interactions among P450 probe substrates. In the incubation study of these cocktails, the reaction 
mixtures were pooled and simultaneously analyzed using LC-MS/MS. The method was validated by comparing the responses for 
the metabolites in incubations of each single substrate to those in incubations with the two substrate cocktails. The change in each 
P450 enzyme activity was less than 20% in each cocktail set compared to the individual incubation. The method was also validated 
by comparing the inhibition data obtained from the incubation of each individual probe substrate alone with data from the cockail 
method. The IC50 value of each inhibitor in the cocktail agreed well with that of the individual probe drugs. As a screening method 
for potential interactions of the inhibition of these ten P450 isoforms, this method will be useful in the drug discovery process and for 
the mechanistic understanding of drug interactions.
P-231 Comprehensive quantitative metabolomic profiling to investigate metabolic alterations in invasive ductal carcinoma of the breast
PRESENTING AUTHOR: TUSHAR MORE, NATIONAL CENTER FOR CELL SCIENCE (NCCS), PUNE(MH),INDIA, India
CO-AUTHORS: SRIKANTH RAPOLE                                                  
Invasive ductal carcinoma (IDC) is one of the most common type of breast cancer with the prevalence of approximately 80%. 
Identifying metabolic alterations associated with IDC will be helpful in understanding molecular events involved in IDC progression. 
This study aims to identify IDC specific metabolic alterations and discriminating IDC subjects from benign and controls based on 
these metabolic alterations. Metabolic profiles of serum (75 IDC, 33 benign and 33 healthy controls) and tissue (25 IDC, 25 benign 
and 25 normal) samples were acquired using targeted liquid chromatography-multiple reaction monitoring/mass spectrometry 
(LC-MRM/MS) and untargeted gas chromatography-mass spectrometry (GC-MS). Univariate and multivariate statistical analysis 
were performed in order to identify statistically significant metabolites involved in IDC. Comparative analysis of IDC against control 
subjects revealed significant (p-value&lt;0.05) alteration of 54 metabolites in serum and 65 metabolites in tissue. It is notable that 
some metabolic alterations in serum including amino acids, nucleotides are correlated with tissue. Further, comparison between 
three groups depicted that some of the metabolic alterations are distinctive to IDC. Interestingly, some metabolic alterations in IDC 
were comparable to benign subjects and revealed a pattern of increment or decrement from benign to IDC samples suggesting their 
possible role in benign to malignant transformation. Pathway analysis of significant metabolites associated with IDC samples majorly 
showed involvement in pyrimidine metabolism, alanine, aspartate and glutamate metabolism, purine metabolism, D-glutamine and 
D-glutamate metabolism, fatty acid biosynthesis, glutathione metabolism. This study identified IDC associated metabolites which can 
be helpful in understanding IDC disease progression and therapeutic solutions.
P-232 Plasma metabolomics in postmenopausal Chinese-Singaporean women with low and normal bone mineral density
PRESENTING AUTHOR: Diana Cabrera, Agresearch, New Zealand
CO-AUTHORS: Marlena Kruger, Frances Wolber, Nicole Roy, Christiani Henry, Karl Fraser                                            
The application of metabolomics may lead to the discovery of novel biomarkers with the potential to predict bone loss. In the 
present study, we applied untargeted metabolomics in combination with multivariate analysis to identify molecular changes in the 
blood of postmenopausal Singaporean women with low and normal bone mineral density (BMD). Plasma samples from 97 women 
were analysed with positive ionisation mode by using hydrophilic interaction liquid chromatography mass spectrometry (HILIC-MS). 
Serum C-telopeptide of Type I collagen (CTx-1) was measured by using a sensitive and specific enzyme linked immunosorbent 
assay (ELISA). In addition, dual energy X-ray absorptiometry (DXA, Discovery A, Hologic, WI, USA) was used to measure bone 
mineral density (BMD) of the femoral neck. Overall 127 metabolites were detected via HILIC-MS of plasma samples; however, 
multivariate analysis were not able to distinguish differences between BMD and the metabolome of postmenopausal Singaporean 
women. Hypoxanthine and threonine levels were significantly different between low and normal BMD groups (P &lt; 0.05). Alanine, 
arginine, cysteine, creatine, creatinine, histidine, homoserine, kynurenine, glutamine lysine, phenylalanine, proline, tryptophan and 
4-aminophenol levels were lower in the low BMD group when compared with the normal BMD; however; these differences did not 
reach statistical significance. Stepwise linear regression identified 2 and 5 metabolites associated with BMD (R2=8.58%) and CTx-1 
(R2=15%), respectively. Pathways analysis revealed that these significant metabolites are associated with amino acid pathways such 
as threonine, glutamine, arginine and proline metabolism. Taken together, these findings suggest tentative evidence that there are 
changes in amino acid metabolism in osteoporosis.
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P-233 Metabolic and transcriptomic profiling to investigate clonal evolution of metabolism in MCF7 cells
PRESENTING AUTHOR: Max Colonna, University of Georgia, United States
CO-AUTHORS: Shaying Zhao, Arthur Edison                                                
Shifts in cancer cell metabolism coincide with changes in cell morphology, proliferation, and tumor metastasis. These changes 
are not only driven by genetic mutations, but also by adaptation to the microenvironment of tumor cells, including the availability 
of nutrients. A cell’s ability to adapt its metabolism to changing conditions can drive the clonal evolution of the tumor, potentially 
resulting in more invasive or aggressive cells. This clonal evolution is often observed in the lab, where long term sub-culturing 
leads to development of a phenotypically distinct cell population. Therefore, it is important to understand how different cancer 
cells respond to different environments, both for the integrity of in vitro studies and for more precise prognosis and treatment. To 
investigate this dynamic process, we compared the transcriptomes and metabolomes of a morphologically distinct variant of the 
MCF7 adenocarcinoma cell line, which had been long cultivated in a nutrient-rich medium formulation, against commercially available 
“stock” cells. We then switched the media of each cell line to see if we could induce the other’s transcriptional and metabolic profiles 
over successive passages using RNA-seq and proton NMR metabolomics. We predict that we will observe some plasticity in the 
stock cells’ metabolism, but that the divergent cells have been driven to a “point of no return,” where they become unable to adapt 
to limited nutrients. This has potentially important implications not only for the consideration of cell culture conditions, but also 
understanding how the tumor microenvironment, particularly the availability of nutrients, shapes cancer progression.
P-234 A comparison between male and female metabolomic profiles of hypertensive Black South Africans
PRESENTING AUTHOR: Marianne Venter, Human Metabolomics, North-West University, Potchefstroom, South Africa, South Africa
CO-AUTHORS: Cynthia van Deventer, Jeremie Lindeque, Peet Jansen van Rensburg, Leoné Malan, Francois van der Westhuizen, 
Roan Louw                                          
Introduction: Cardiovascular disease (CVD) is a growing concern in sub-Saharan African populations. Hypertension, a risk factor 
for CVD development, presents with great disparities in incidence between African and Caucasian populations. However, studies 
investigating the underlying mechanisms involved in hypertension development in Africans are scarce. Here we present data from 
the first untargeted metabolomics investigation done on Black South Africans, using a subset of the Sympathetic activity and 
Ambulatory Blood Pressure in Africans (SABPA) cohort. This cohort is exceptionally well phenotyped, including a series of life-style, 
anthropomorphic and biochemical measurements involved in CVD, and is thus very well suited for aiding in the understanding of 
hypertension development, which may lead to better, population specific treatment strategies.  Methods: Male and female Black 
African participants were separately grouped into five quantiles (Q1-Q5) based on 24-hour sympathetic ambulatory blood pressure 
monitoring measurements. Metabolic profiling was done for only the lowest (normotensive) and highest (severely hypertensive) 
quantiles from each gender, using both gas- and liquid chromatography coupled mass spectrometry to capture a wide range of 
metabolites. Statistical analyses included t-tests and principle component analysis, resulting in VIP metabolite selection.  Results: 
Despite comparable differences in males and females between Q1 and Q5 blood pressure measurements, African male participants 
presented with much more pronounced metabolic perturbations, when compared to their female counterparts. While male metabolic 
profiles clearly indicated disturbances in pathways influenced by the NADH/NAD+ ratio, this was not present in females, suggesting 
differences in mechanisms and risk factors involved in hypertension development, between gender groups.
P-235 Standardized Steroid-Profiling for Metabolic Phenotyping Research
PRESENTING AUTHOR: Matthias Scheffler, Biocrates Life Sciences AG, Austria
CO-AUTHORS: Hai Pham Tuan, Matthias Scheffler                                                
Steroid hormone profile analysis (mineralocorticoids, glucocorticoids, sex steroids) is of high interest for metabolic phenotyping and 
allows an improved understanding and role of the individual steroid hormones in metabolomics research. Steroid hormones are i.e. 
important endogenous metabolites in the cholesterol metabolism and are highly relevant for the microbiome and gender research. 
They have two principal biological functions: certain steroids (such as cholesterol) are important components of cell membranes 
which alter membrane fluidity, and many steroids are signalling molecules which activate steroid hormone receptors. UHPLC-MS/MS 
analysis is the technique of choice for multiplexed and quantitative steroid hormone analysis. We will present a standardized, ready-
to-use steroid assay in kit-format intending the quantitative analysis of all 17 key steroids including automated analysis workflow 
and quality controlled data read-out. The steroid metabolites are testosterone, DHT, progesterone, cortisol, estradiol (E2), DHEAS, 
androstenedione, 17-OH, Progesterone, corticosterone, 11-Deoxycortisol, estrone (E1), DHEA, 11-Deoxycorticosterone, aldosterone, 
cortisone, etiocholanolone, androsterone. The UHPLC-MS/MS based assay includes standardized sample preparation in 96-well plate 
format. The sample preparation is performed by a solid phase extraction (SPE) procedure. Between 200 and 500µL serum sample 
volume is needed depending on the triple quadrupole mass spectrometry platform used. 7 minutes run time per sample allows a 
sample throughput of 82 samples in 20 hours. Scientific relevance of steroid hormones and assay performance data including inter-
laboratory comparisons, ring trial and proficiency testing results demonstrating the precision, accuracy, stability, and reproducibility of 
the developed assay for human serum will be presented.
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P-236 Determination of TCA Metabolites by Ion Chromatography HR/AM Mass Spectrometry
PRESENTING AUTHOR: David Peake and Mark Albertson, Thermo Fisher Scientific, United States
CO-AUTHORS: David Peake, Mark Albertson, Shen Hu, Ralf Tautenhahn, Reiko Kiyonami Kiyonami, Jeff Rohrer                                           
Cancer, diabetes, and other metabolomics diseases are known to disrupt metabolomics cycles. [1] However, researching 
metabolomics pathways can be challenging. Many of the analytes are small ionic and structural isomers with the same fragmentation 
pattern, and therefore require chromatographic separation. Standard liquid chromatography methods have limited chromatographic 
resolving power for these types of metabolites. [2] Ion chromatography (IC), designed for the separation of ionic compounds, 
is ideal for the separation of ionic metabolites. Here we demonstrate IC as a complimentary separation technique by providing 
superior resolution and sensitivity of polar metabolites combined with the high resolution and accurate mass measurement (HR/AM) 
capabilities to differentiate isobaric metabolites. The anionic metabolites were separated by anion-exchange chromatography using 
a hydroxide gradient at 380 µL/min, optimized to resolve key phosphate isobars. The IC-MS interface was provided by methanol 
desolvation solvent and an electrolytic device desalting the eluent to water, making the eluent compatible with MS. The method was 
applied to head and neck cancer cell lines provided by UCLA School of Dentistry. Differential analysis was performed using Thermo 
Scientific™ Compound Discoverer™ software. Components of interest (p-value &lt;0.05, fold change &gt;2) were identified using 
high resolution accurate mass, MS/MS and retention time. The experiments showed that the aggressive cancer type cells displayed 
significantly higher levels of TCA metabolites than the less aggressive similar cell type.
P-237 NMR Metabolomics of body fluids as a potential predictive method of therapy outcome in HCC patients
PRESENTING AUTHOR: Patricia Wenk, Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, 
Eberhard Karls University Tuebingen, Germany
CO-AUTHORS: Mohamed Jarboui, Michael Bitzer, Andreas Schmid, Nisar Malek, Bernd Pichler                                            
Hepatocellular carcinoma (HCC) is the second most common cause of cancer deaths worldwide. Late diagnostic and scarce therapy 
options are the main challenging factors in HCC healthcare. Sorafenib, a multikinase-inhibitor, is currently the only approved sytemic 
treatment of advanced HCC. However, therapy with Sorafenib only achieves a modest improvement in overall survival or delayed 
tumor progression. Thus, a systematic assessment method is urgently needed to identify primary or secondary therapy resistance to 
sorafenib. Therefore, we used NMR-based metabolomics to monitor tumor progression in comparison to routine clinical diagnostics. 
Using 1D- and 2D-NMR-based metabolomics, under standardized operating procedures, we analyzed body fluids, namely plasma 
and urine samples of advanced HCC patients (stage3, n=8), prior and following 4 weeks of systemic monotherapy with Sorafenib. 
Quantitative analysis of randomized processed samples of plasma lipoproteins and 25 compounds in urine using supervised 
and unsupervised methods were correlated with treatment outcome as evaluated by physicians according to clinical standards. 
Accordingly, analysis of lipoprotein levels in plasma clearly suggests a correlation between treatment response and cholesterol 
metabolism. Specifically, LDL and HDL particle size tightly correlate with patients’ response status. Furthermore, unsupervised PCA 
analysis and metabolites profiling of urine yielded similar findings as the supervised lipoproteins results. Thus, classification matches 
with the clinicians’ evaluation of Sorafenib treatment outcome. Hereby, NMR-based metabolomics of patients body fluids seem to 
correlate with therapy outcome by metabolomic reprogramming of the tumors non-invasively, and therefore provide a predictive 
classification, to potentially pave the way towards a personalized therapy evaluation of cancer patients.
P-238 Metabolomics and lipidomics as a research and diagnostic tool in inborn errors of metabolism
PRESENTING AUTHOR: Michel van Weeghel, Academic Medical Center, Netherlands
CO-AUTHORS: Katharina Herzog, Mia Pras-Raves, Martin Vervaart, Angela Luyf, Antoine van Kampen, Riekelt Houtkooper, Ronald 
Wanders, Hans Waterham, Frédéric Vaz                                      
Metabolomics and lipidomics are becoming increasingly important as analytical tools for biomarker discovery in research but have 
not frequently been applied to diagnostics. Inborn errors of metabolism are routinely identified by targeted analysis of intermediary 
metabolites. The growing development of high-resolution mass spectrometric techniques, however, opens new avenues to perform 
semi-targeted metabolomics and lipidomics in complex matrices. These matrices include plasma, cells and/or tissues from patients 
who suffer from known or unknown inborn errors of metabolism. In our study, we investigated the metabolome and lipidome profiles 
from a set of 120 plasma samples from patients with 10 known inborn errors of peroxisomal metabolism. We used reversed-phase, 
normal-phase, and hilic chromatography followed by full-scan orbitrap-MS on the Q Exactive plus in positive and negative ionization 
mode and annotated over 200 polar metabolites and over a 1000 lipid species. Furthermore, we identified specific biomarkers for 
the different inborn errors of peroxisomal metabolism and discovered new potential biomarkers. Because this is a semi-targeted 
approach, identities of some of the newly found biomarkers remain to be characterized. The ultimate goal is to use this type of 
metabolomics and lipidomics analyses for first line screening of inborn errors of metabolism.
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P-239 Metabolic profiling of human brain tissue with Alzheimer’s disease by UPLC-LTQ-Orbitrap/MS
PRESENTING AUTHOR: Jeongae Lee, Convergence Research Center for Diagnosis Treatment and Care System of Dementia, Korea 
Institute of Science and Technology, South Korea
CO-AUTHORS: Yoon Hwan Kim, Hoon Ryu, Kyoung Heon Kim, Bong Chul Chung                                             
Alzheimer’s disease (AD) is a multifactorial chronic neurodegenerative disease which triggering progressive cognitive decline and 
memory loss. Even though AD was observed in 1900’s, it has not yet been fully understood. Metabolomics studies could give us a 
new insight of view. In that sense, the aim of this study was to determine significant metabolites and pathways. We have compared 
metabolites in human brain tissue between AD and normal controls with an ultra-high-performance liquid chromatography coupled 
with linear ion trap-orbitrap mass spectrometer. Multivariate data analysis was performed by means of principal component analysis, 
projection to latent structures discriminant analysis and orthogonal projection to latent structures discriminant analysis. The result 
showed clear discrimination between AD and normal control groups. In positive electrospray ionization (ESI) mode, the most 
differential metabolites [a total of 59 (VIP scores &gt; 1, p-value &lt; 0.05) out of 1121 variable ions] included 2-oxoglutarate, 
phenylalanine, tyrosine originating from 2-oxocarboxylic acid metabolism, arginine and proline metabolism. In negative ESI mode, 
the most differential metabolites [a total of 12 (VIP scores &gt; 1, p-value &lt; 0.05) out of 114 variable ions] were cis-aconitate from 
citrate cycle and 2-oxocarboxylic acid metabolism, methylitaconate, 2,3-dimethylmaleate dopaguinone originating from nicotinate and 
nicotinamide metabolism, respectively.
P-240 Application of Quantitative Metabolomics in Disease Biomarker Studies
PRESENTING AUTHOR: Rupasri Mandal, University of Alberta, Canada
CO-AUTHORS: Ray Bahado-Singh, Tom Blydt-Hansen, Guanshi Zhang, Burim Ametaj, David Wishart                                            
Metabolomics has shown significant promise in the discovery of new biomarkers for a number of complex clinical disorders. The 
Metabolomics Innovation Centre (TMIC) has participated in several studies aimed at identifying predictive biomarkers for maternal 
and neonatal health. This work led to the identification of robust serum metabolite biomarkers for first-trimester prediction of early-
onset pre-eclampsia, late-onset pre-eclampsia, Down syndrome and fetal congenital heart defects. Quantitative, multi-platform 
metabolomic analyses of maternal serum showed extensive group differences in the profiles of healthy expectant mothers and 
expectant mothers that later developed or were later shown to have the aforementioned neonatal/perinatal problems. Other studies 
conducted by TMIC have focused on finding diagnostic metabolite biomarkers for T cell–mediated rejection (TCMR) in pediatric 
kidney transplant recipients. Our findings suggest that quantitative urinary metabolomics can serve as a sensitive, specific and 
noninvasive tool for detecting TCMR and that this approach is superior to tissue biopsy and serum creatinine. These data also 
revealed that the biomarker profile exhibits very minimal overlap wiith other allograft injury processes. In veterinary applications, 
TMIC has identified predictive biomarkers for postpartum or periparturient diseases in dairy cattle. Using a multi-platform 
metabolomic approach, we showed that periparturient diseases such as metritis, mastitis, lameness and milk fever, can be predicted 
via serum metabolite profiles up to 6 weeks prior to their development. These biomarker profiles are being further validated and 
it is hoped that they will be translated to inexpensive bed-side or pen-side screening tests using portable devices that are being 
developed by TMIC.
P-241 Metabolomic profiling reveals BDE-47 could induce oxidative stress by inhibiting PPP pathway in MCF-7 cells
PRESENTING AUTHOR: Juntong WEI, Hong Kong Baptist University, Hong Kong
CO-AUTHORS: Li Xiang, Shangfu Li, Chunxue Yang, Zongwei Cai                                             
Polybrominated diphenyl ethers (PBDEs) were widely used as flame retardants for decades and gradually viewed as environmental 
contaminants because of its potential harmness to the organisms. Numerous researches have studied the connection of PBDEs 
to human health but few of them were related to breast carcinoma. In the present study, MCF-7 cells were exposed in vitro with 
different species of PBDEs (BDE-47, BDE-99, BDE-128, BDE-153) to study the influence to breast cells. Results showed that, BDE-
47 was the most toxic one among the studied species and the toxicity to MCF-7 cells was gradually increased when the BDE-47 
concentration exceeded 1 µM in the medium with 1% FBS. The following metabolomic study was conducted by ultra-performance 
liquid chromatography (UPLC) coupled with mass spectrometry (MS). It was found that pyrimidine metabolomic, purine metabolism 
and pentose phosphate pathway (PPP pathway) were significantly downregulated. The downregulation of PPP pathway would result 
to shortage of NADPH. The enzymes involved in reactive oxygen species (ROS) elimination system might be influenced because 
no sufficient NADPH could be used. Since the antioxidases could not clear up the ROS timely, oxidative stress occurred and caused 
damage to cells. Eventually, oxidative stress generated RNA damage and induced accelerating of RNA degradation. The pyrimidine 
metabolism and purine metabolism were downregulated by the degradation eventually. In conclusion, the BDE-47 could induce 
oxidative stress by inhibiting PPP pathway and disorder the whole metabolism of the whole cell subsequently.
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P-242 Metabolomics Characteristics of Buyang Huanwu Decoction in Cerebral Ischemic Stroke Mice
PRESENTING AUTHOR: Wei-Hsiang Hsu, China Medical University, Taiwan
CO-AUTHORS: Yun-Lian Lin, Yuh-Chiang Shen                                                
Background and Purpose?Buyang Huanwu Decoction (BHD), a TCM prescription,   clinically has long been used for neurological 
recovery after stroke. In this study, NMR-based and QTOFMS metabolomics were performed to evaluate the therapeutic effect of 
BHD on the cerebral ischemic/reperfusion (CI/R) injury-induced sub-acute stroke mice. Methods?BHD was prepared as conventional 
method and lyophilyzied. An acute ischemic stroke in mouse model was induced by a middle cerebral ischemic/reperfusion (CI/R) 
injury. Brain tissue and cerebrospinal fluid (CSF) were used for the NMR-based and QTOFMS metabolomics studies. Results?Results 
of NMR data on brain tissue showed that BHD treatment amelioated the anaerobic glycolysis, alleviated the glutamate and GABA 
release from brain to periphery, and attenuated NAA release and taurine level. CSF metabolomics studies by NMR and QTOFMS 
revealed that hypoxanthine, inosine, dihydrouracil, D-threitol, inosine-5’-monophosphate disodium salt (IMP), malic acid, uridine, 
citric acid, AMP, succinate, N-acetylaspartylglutamic acid, phenylalanine, propionyl-L-carnitine, levulinic acid, glycerol 3-phosphate, 
deoxycytidine, 1-methyladenosine, pipecolic acid, cytidine, etc, significantly changed in CI/R-induced stroke. Furthermore, 10 
endogenous metabolites, identified through 1H NMR analysis, were very different between CI/R-induced and sham groups. They 
are acetate, acetone, alanine, creatine, glucose, lactate, myo-inositol, N-nitrosodimethylamine, pyruvate, and succinate which 
demonstrated that metabolic changes in CI/R-induced stroke were also concerned with resultant shifts in energy supply and demand 
after BHD treatment. This finding provides a scientific evidence for the beneficial of BHD in TCM clinical application for ischemic 
stroke.
P-243 Global 1H-NMR Metabolomics of the Human Placenta over 24 hours
PRESENTING AUTHOR: Jacquelyn Walejko, University of Florida, United States
CO-AUTHORS: Anushka Chelliah, Anthony Gregg, Maureen Keller-Wood, Arthur Edison                                             
The current data for optimization of placental specimen collection for metabolomics studies suggest immediate processing of 
specimens. This poses a significant challenge during specimen collection, and the lack of timely processing may result in loss of 
useful metabolic data. We evaluated changes in metabolites of placental tissue at various time-points up to 24 hrs post-delivery. 
Twelve gravid full-term, non-labored patients receiving Caesarian sections were consented for participation in an IRB-approved study 
at UF. Placental specimens were collected at 5 time-points:&lt;5 min, 15 min, 30 min, 1 hr and 24 hrs. Nuclear magnetic resonance 
spectroscopy was conducted on a 600 MHz spectrometer to measure global metabolic profiles of placental samples. Significance of 
metabolites was determined using a Student’s t-test of the area under the metabolite peak(s) of probabilistic quotient normalized 
spectra. While some metabolites (e.g. glucose, fructose, and lactate) were altered in the first 15 min following delivery, a pool 
of 20 was not significantly changed at 30 min. Metabolites significantly increased by 24 hrs included amino acids, ketones, TCA 
cycle intermediates, lactate, and sugars, while glycerophosphocholine, glucose and VLDL were significantly decreased (p&lt;0.05). 
Several amino acids, creatine, and myo-inositol did not significantly change over 24 hrs. Our study challenges the current notion of 
immediate specimen processing, suggesting there may be valuable metabolic data present in tissue up to 30 min post-delivery. To 
date, there is limited data on metabolic transport in the placenta, and the persistence of metabolites may be used to gain information 
on altered metabolism in this tissue.
P-244 Effects of bioactive oligopeptides to human cells – a lipid- and metabolomics approach
PRESENTING AUTHOR: Tobias Demetrowitsch, Christian-Albrechts-University Kiel, Division of Food Technology, Germany
CO-AUTHORS: Julia Jensen-Kroll, Martin Klempt, Ingrid Clawin-Rädecker, Stephan Seifert, Silke Szymczak3, Karin Schwarz               
Effects of bioactive oligopeptides to human cells – a lipid- and metabolomics approach  Introduction:  Within the milk protein 
sequence, several bioactive peptides are encrypted which showed e.g. anti-inflammatory effects. For activation, an enzymatic 
digestion and purification is necessary. The anti-inflammatory bioactivity has been already published. However, the fundamental 
effects to the lipid- and metabolom has not been reported, yet. Therefore, this study aims to observe the changes of the lipid and 
metabolites profile in cells.   Material and Methods:  The peptides were used in an in-trans-approach. The cells were cultivated in 
calf serum and then in human serum. Within the serum cultivation, the treatments were conducted for 48 h. After preparation by 
the SIMPLEX approach, the cell extracts were analyzed by a 7T solariXR FT-ICR-MS (Bruker, Germany). The data validation was 
conducted by the QC protocol (Demetrowitsch et al., 2015).   The data evaluations were conducted by non-targeted and targeted 
methods. For the non-targeted approach, a PCA and a classification algorithm were used to identify specify biomarkers. The 
lipidomics approach was conducted with the LipidXplorer.  Results:   The treatments vs. control showed tight clusters within the PCA 
model. The bucket statistic showed changed metabolite patterns for the high anti-inflammatory treatment. Changed concentration 
were observed for e.g. dityrosine and 6-chlorocatechine. The lipidomics approach provides e.g. highly significant changes for some 
phospholipids, like diacylglycerol (31:7) and phosphatidylinositol (44:3). These findings are in accordance with earlier studies and 
enable us to proceed with this cellular model system for mechanism clarification.
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P-245 Metabolic phenotyping in the mouse model of urinary tract infection shows that 3-hydroxybutyrate in plasma is associated with infection
PRESENTING AUTHOR: Pei Han, King’s College London, United Kingdom
CO-AUTHORS: Yong Huang, Yumin Xie, Wu Yang, Wenying Xiang, Peter Hylands, Cristina Legido-Quigley                                          
Urinary tract infection (UTI)  is one of the most common bacterial infections. Current diagnosis of UTI chiefly relies on its clinical 
presentation, urine dipstick tests and urine culture. Small molecule markers in blood for both infection and recovery would facilitate 
diagnosis and management of UTI.  Mass spectrometry-based fingerprinting of plasma and urine at 3 time points, pre-infection 
(t = -24h), infection (t = 24h) and post 3-day treatment (t = 112h), were acquired in the following four groups: mice which 
were healthy, infected and not treated, infected and treated with ciprofloxacin and infected and treated with Relinqing Granules 
(n=6 per group).  A metabolomics workflow including multivariate analysis and ROC regression was employed to select metabolic 
features that correlated with UTI and its treatment.  Circa 4,000 molecular features were acquired for each sample.  The small acid 
3-hydroxybutyrate was found to be the most discriminatory metabolite for urinary tract infection in plasma, with an area under the 
curve = 0.97 (95% CI: 0.93-1.00, accuracy = 0.91, sensitivity = 0.92 and specificity = 0.91). The level of plasma 3-hydroxybutyrate 
was depleted after infection with a fold change of -22 (q &lt; 0.0001).  Correlation between plasma 3-hydroxybutyrate and urine 
bacterial number in all groups and time points was r = -0.753 (p &lt; 0.0001).  The findings show that plasma 3-hydroxybutyrate 
is depleted  and strongly associated with UTI at both infection and post-treatment stages in a UTI mouse model. Further work is 
envisaged to assess the clinical potential of blood tests to assist UTI management.
P-246 Rapid, Comprehensive and Simultaneous Determination of Inborn Errors of Metabolism using a Validated Untargeted Metabolomics Methodology
PRESENTING AUTHOR: Luke Miller, Metabolon Inc., United States
CO-AUTHORS: Anne Evans, Adam Kennedy, Doug Toal, Don Harvan, John Lennon, Bobby Wiggs, Jacob Wulff, Marcus Miller, Qin 
Sun, Sarah Elsea                                    
In-born errors of metabolism (IEMs) are inherited metabolic disorders. Most IEMs are caused by defects in the enzymes that help 
process nutrients, which result in an accumulation of toxic substances or a deficiency of substances needed for normal body function. 
Making a swift, accurate diagnosis of an IEM is critical in preventing brain damage, organ damage and even death. While there are 
several hundred recognized IEMs, state public health programs only screen for 40 disorders or fewer at birth. Currently, in order to 
accurately diagnose if and which IEM is present requires running an array of different targeted assays, which adds to costs and can 
ultimately only diagnose a limited number of IEMs. Metabolomic profiling gives us an astonishingly rich view of a patient’s metabolic 
disturbances through a single test, suggesting that this technology has the potential to be an efficient, first-line phenotyping tool for 
the diagnosis and monitoring of IEMs. Here we present the use of the Metabolon untargeted metabolomics platform for the analysis 
of a discovery set of 200 pediatric plasma samples which included 21 known IEMs and 70 healthy individuals. The methodology 
correctly identified 20 of the 21 disorders in the panel that can be screened in blood plasma. In the clinic, many different biochemical 
tests would have been required to achieve a similar outcome. Importantly, this methodology accurately identified the affected 
individual patients when compared to a healthy population, demonstrating the power of this methodology for patient screening and 
personalized medicine.
P-247 Lipidomic evaluation of dog hair and skin samples – proof of concept study
PRESENTING AUTHOR: Heike Schwendel, AgResearch Ltd, Grasslands Research Centre, New Zealand
CO-AUTHORS: Emma Bermingham, Nick Cave                                                
Skin and hair consist largely of proteins and lipids. It is thought that lipids affect parameters such as shine and feel, which are viewed 
by dog owners as important measures of coat quality, and by veterinarians as an indicator of dietary sufficiency, overall health, 
and wellbeing. However, to date coat quality is typically assessed by subjective measures which are difficult to replicate. Therefore, 
we aimed to understand whether skin and coat quality could be assessed quantitatively using lipidomics techniques. In order to 
understand the impact of collection method, hair and hair roots, skin swab with a cotton bud, and skin scrubbed with solvent, 
were collected from 3 dogs. Mass spectrometric analysis was carried out on a Q-Exactive Mass Spectrometer and non-targeted 
peak detection was undertaken using the R package XCMS. The data was analysed using the lipid identification software package 
LipidSearchTM. We identified 38 lipids, with 18 lipids in common across all four sample types. The two skin samples had a further 11 
lipids in common, showing a higher number of ceramides and diglycerides compared to the hair samples. Lipid concentration varied 
between sample types, with skin samples showing larger amounts of Sphingolipids, than root and hair samples. Furthermore, skin 
samples show that lipids may be able to discriminate between individual dogs. Sampling method did not significantly affect number 
of lipids for each sample type, therefore enabling the use of methods kinder on the animal. Subsequently, patterns of hair and skin 
lipids need to be correlated with coat quality assessments.
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P-248 Characterization of the fescue toxicosis metabolome in grazing beef cattle and the impact on it of different environmental conditions
PRESENTING AUTHOR: Nikolay Filipov, University of Georgia, United States
CO-AUTHORS: Ryan Mote, Nicholas Hill, Zachary Turner, Zachary Sanders, Douglas Walker, Karan Uppal, Dean Jones                                         
Plant-beneficial endophyte Epichloë coenophiala, infects tall fescue (Lolium arundinaceum), but also produces ergot alkaloids (EA) 
that are causative for fescue toxicosis (FT) in livestock. Multiple signs of FT align with metabolic perturbations and the disease is 
exacerbated by high temperature (T) and humidity (H). In three studies with Angus steers (n=12/study), animals were randomly 
assigned to toxic (E+) or non-toxic treatments (n=6/treatment); one study had sampling dates at different T and H, resulting in 
high or low T-H indices (THIs). Urine, blood, feces, weights and various physiological measurements were collected before and up 
to 28 days post pasture placement. Untargeted high-resolution metabolomics (HRM) was employed to analyze E+ grazing-induced 
plasma and urine metabolome changes and if these changes are influenced by variable THIs. From the data analyzed so far, more 
than 13,000 and close to 21,000 HRM features were detected in the, respectively, urine and plasma of the animals from the first 
study; the most significant effects were observed earlier in the urine and later in the plasma. Multiple EA were detected and their 
urinary and plasma profiles were different. In addition, metabolites indicative of tryptophan and lipid metabolism disruption caused 
by E+ consumption were observed. Some physiological effects of E+ grazing, i.e., increased respiration rates and rectal T were 
THI-independent, but the ear T was affected the most in E+ animals exposed to high THIs, suggesting that the effects of E+ on the 
plasma and urinary metabolomes might be affected by THI status.  
P-249 Evaluating the Cardioprotective Effect and Compatible Principle of Xin-Ke-Shu formulae against Hypoxia/ Reoxygenation Injury in H9c2 Cardiomyocytes with Metabolomic Insights
PRESENTING AUTHOR: Lili Sun, The Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking 
Union Medical College, China
CO-AUTHORS: Hongmei Jia, Liyan Ma, Hongwu Zhang, Zhongmei Zou                                             
To date, no effective clinical therapy is available to treat ischemia/reperfusion (I/R) injury which is the major cause of myocardial 
cell death. Xin-Ke-Shu (XKS) is a traditional Chinese patent medicine used for treating coronary heart diseases. The objective of 
this analysis was to better decipher the possible molecular mechanism and compatible principle that XKS provides cardioprotection 
against I/R injury. Here, a hypoxia/reoxygenation (H/R) model in H9c2 cardiomyocytes was applied,,, to mimic the I/R injuries 
observed in vivo, and a cell metabolomics approach using the ultra performance liquid chromatography coupled with quadrupole 
time-of-flight mass spectrometry (UPLC-Q/TOF MS) was conducted for the first time. The results of multiple evaluation indexes 
demonstrated the significant protective effects of XKS against oxidative stress and apoptosis induced by H/R injury. Multivariate 
statistical analysis showed that the metabolic profile of H/R group clearly deviated from the control group. Thirteen metabolites (C1-
C13) were identified as potential biomarkers associated with H/R-induced injury, which were correlation with the aberrant pathways 
including sphingolipid metabolism, glycerophospholipid metabolism, fatty acid ?-oxidation metabolism and proteolysis. All these 
results indicated that the significant cardioprotective effects of XKS against H/R injury in vitro were probably comprehensive mediated 
by the suppression of oxidative stress, cell apoptosis, membrane disruption, mitochondrial oxidation and proteolysis. Our current data 
also demonstrated that Dan-Shen made crucial contribution to XKS in cardioprotective effects. This study may enable information 
from holistic cell metabolomics to be used for mechanism and compatibility rule elucidation of TCMs.
P-250 Human and tube variability are greater than storage variability in clinical metabolomics
PRESENTING AUTHOR: Charmion Cruickshank-Quinn, University of Colorado Anschutz Medical Campus, United States
CO-AUTHORS: Laura Zheng, Kevin Quinn, Russell Bowler, Richard Reisdorph, Nichole Reisdorph                                            
Background: One major challenge in clinical metabolomics is lack of guidelines for sample collection and handling. Another challenge 
is the pace of the clinical environment that often does not allow for ideal sample collection conditions. These conditions include 
different tube types and the length of time samples sit following collection; both can confound results. Therefore we conducted 
metabolomics analysis of serum and plasma to determine the effect of time and tube type on the metabolome. Methods: Blood, from 
3 individuals, was collected in Tiger, EDTA, and P100 vacutainers. Samples were stored at 4°C for 6 time points (0h, 0.5h, 1h, 2h, 
4h, 24h) prior to centrifugation, aliquotting and storage at -80°C. Metabolomics was performed on plasma and serum using standard 
protocols. ANOVA with multiple testing correction and fold change &gt; 2 compared (1) individuals at the control time point (0h), 
(2) tubes at 0h, and (3) time differences for each tube. T-tests compared each time point against 0h. Results: Individual person 
differences for the EDTA, P100, and Tiger tubes were 946, 1311, and 1205 respectively. Tube differences for individuals 1, 2, and 
3 were, 887, 1069 and 655 respectively. Time differences for the EDTA, P100, and Tiger tubes were 43, 110, and 319 respectively. 
The greatest changes compared to the control time point, occurred at 1h for EDTA, 4h for P100, and 24h for Tiger. Conclusion: Our 
results suggest that subject-to-subject variation and tube-to-tube variation are greater compared to when samples are left on the 
benchtop.
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P-251 Pesticide exposure in early pregnancy associated with fetal growth restriction
PRESENTING AUTHOR: Aude-Claire MORILLON, INFANT Centre / University College Cork, Ireland
CO-AUTHORS: Shirish Yakkundi, Martin Wells, Philip Baker, Louise Kenny                                             
Fetal growth restriction (FGR) is defined as impaired fetal growth compared with the normal growth potential for the fetus. This 
pregnancy complication is estimated to affect 10% of pregnancies and leads to short and long-term complications for the baby. The 
use of pesticides is common practice in agriculture, and exposure during pregnancy has been linked with FGR, birth defects and 
impaired child neurodevelopment. This study assessed exposure to pesticides and their impact on fetal growth. A nested case-
control study used urine samples collected at 20 weeks’ gestation from pregnant women participating in the SCOPE study (www.
scopestudy.net). Cases (n=20) were women with severe FGR (customised birthweight ? 5th centile, n=20) matched by age, body 
mass index and ethnicity to controls (n=20) who had uncomplicated pregnancies. Urine samples (100 µL) were diluted with MQ 
water (200 µL) before analysis. Data were collected for all samples in triplicate in untargeted positive ion mode using UPLC (BEH 
C18 column, 2.1x100 mm, 1.7 µm) coupled with mass spectrometry (Synapt G2-S, Waters), using a data independent analysis 
approach. The label-free data were normalised, processed and database searched using Progenesis QI (Nonlinear dynamics, UK). 
Data were searched against the Human Metabolite Database and pesticide library. Two pesticides (Kresoxim-methyl, Rabenzazol) 
were significantly increased (p &lt;0.01) and 3 (Tolfenpyrad, Carbosulfan, Carbofuran) significantly lowered (p &lt;0.05) in cases 
compared to controls. This study suggests that exposure to commonly used pesticides in early pregnancy may affect in utero growth 
trajectories. Further research is needed to clarify the precise association with FGR.
P-252 MALDI-MS-based High-throughput Metabolite Profiling of Human Body Fluids
PRESENTING AUTHOR: Daisuke Miura, Kyushu University, Japan
CO-AUTHORS: Chihiro Kawano, Akiko Miki, Takanori Ishii, Yoshinori Fujimura, Hiroyuki Wariishi, Mitsuru shindo                                           
Introduction: Metabolite profiling is one of the represent techniques for obtaining information on the relationship between the 
metabolome and factors such as phenotype, quality, or bioactivity. Previously, we have reported that matrix-assisted laser desorption 
ionization-mass spectrometry (MALDI-MS) was useful for highly sensitive and high-throughput metabolite profiling. This technique 
become offline high-throughput MALDI-MS analysis combined with minimal operation of sample preparation. Herein, we applied 
this technique to analyze human serum and urine for high-throughput metabolite profiling and classification of normal, prostate and 
breast cancer specimens.  Preliminary Results: Generally, it is known that there is no perfect MALDI matrix for ionizing all molecules, 
and ionizable molecular coverage of each matrix is limited. To obtain favorable MALDI matrix for detecting low-molecular-weight 
compounds from biofluids, we performed the matrix screening using more than 50 synthesized matrix library and commercially 
available matrix. As a result, 1,5-diaminonaphthalene (1,5-DAN) and synthesized matrix No. 19 (quinolone derivative) were found as 
favorable matrices for detecting several biofluid metabolites. We first investigated optimal sample preparation method (dilution rate 
of specimen, concentration of matrix, solvent of specimen and matrix). Then, we could find the best condition of sample preparation 
for high-throughput metabolite profiling of human biofluid by MALDI-MS. In this experiment, MALDI-MS analysis time is about 30 
second and about 50 metabolite-derived peaks were obtained in a single run. The PCA score plots of obtained MS dataset from 
biofluids showed clear separation of clusters of healthy volunteers and diseases (breast and prostate cancer). Detailed results will be 
discussed in the session.
P-254 Serum metabolomic analysis for understanding estrogen-induced mammary tumorigenic mechanisms in female ACI/Seg rats
PRESENTING AUTHOR: Yoshinori Okamoto, Meijo University, Japan
CO-AUTHORS: Shohei Ogiwara, Kanoko Sakata, Akira Aoki, Koji Ueda, Hideto Jinno                                            
Aim: Estrogen has been reported to be involved in mammary carcinogenesis due to its initiation and promotion effects.  In addition, 
estrogen modulates a broad range of metabolic profiles, potentially leading to mammary tumorigenesis.  In this study, we carried out 
serum metabolomic analysis in female ACI/Seg rats, an estrogen-induced mammary tumor model.  Methods: All animal experiments 
were conducted in compliance with the Animal Experiment Guidelines of Meijo University.  Female ACI/Seg rats (6-week-old; Harlan) 
were subcutaneously implanted with either 17?-estradiol (E2) pellet (2.5 mg E2/17.5 mg cholesterol) or control pellet (20 mg 
cholesterol).  Serum was collected at 22 weeks after pellet insertion.  Serum metabolomic analysis was carried out using QTOF mass 
spectrometer (Triple TOF 6600, AB Sciex) equipped with UHPLC (Shimadzu).  Data were analyzed using open source database (XCMS 
and MS-DIAL).  Results and discussion: All rats that received E2 pellet developed mammary tumor during this experiment, whereas 
no tumor was observed in the control group.  E2 treatment significantly suppressed body weight gain; however, no significant 
difference in food consumption was seen between the two groups.  These results suggest that E2 modulates the metabolic profile 
in ACI/Seg rats, and that these metabolic changes could be associated with mammary tumorigenesis.  Indeed, serum metabolomic 
analysis detected 116 ions that were statistically different (p&lt;0.01) between the groups.  Upon analysis, it was found that some 
of these ions were phosphatidylcholines, lysophosphatidylcholines and sphingomyelins.  Although further experiments are necessary, 
these lipid metabolites could be involved in mammary tumorigenesis in female ACI/Seg rats. 
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P-255 Metabolic alteration in liver tissue following weight change by high fat diet
PRESENTING AUTHOR: MIN-SUN KIM, Korea Basic Science Institute, South Korea
CO-AUTHORS: Geum-Sook Hwang                                                  
Obesity is a health problem that is increasing all over the world. The repeated intentional weight losses followed by weight 
regain is known as yo-yo dieting. Weight change was also found to be associated with an increased disease risk for myocardial 
infarction, stroke, diabetes, and coronary heart disease. Although the potential harmful effects of weight change are recognized, 
the metabolism and the organic dysfunction associated with weight change remain unknown. Thus, the current study evaluated the 
metabolome of liver tissue and identified variations in the levels of significant metabolites in response to weight change. Metabolomic 
profiling of livers from mice was analyzed by 1H-NMR. Subsequently, quantification of important metabolite involved in weight 
change was investigated by GC/MS. Lipid profiling of mice was performed to reveal differences in the levels of specific molecular 
lipid species in the livers of weight change and weight gain phenotypes using UPLC-QTOF/MS. Among aqueous metabolites, alanine, 
glycine, isoleucine, and valine were decreased in weight changed mice compared with weight gain mice. These effect is assumed 
to be connected to upregulation of the gluconeogenesis in liver tissue after HF diet and to get enhanced in weight change mice. In 
lipidomic profiling of liver tissue, Cer and SM were a highly abundant lipids displaying significant changes in weight change vs weight 
gain group. Those sphingolipids play key roles in the regulation of functions of immune cells and might be changed by inflammation. 
Therefore, our finding indicate that obesity-induced hepatic inflammation can be enhanced by weight change.
P-256 Non-Targeted Screening of Extractables and Leachables in E-cigarettes using a Single Platform UPLC-APGC-QTOF-MS
PRESENTING AUTHOR: Steve Wilson, Waters, Australia
CO-AUTHORS: Naren Meruva, Baiba Cabovska, Steven Lai, Dimple Shah, Kari Organtini, Gareth Cleland                                           
Both the GC and LC data was handled on a single data analysis platform. The potential candidate markers were screened against a 
known library of extractables and leachables compounds which was automatically interrogated using mass accurayc, isotopic fit and 
fragment matching. The structural elucidation of unknown contaminants present was performed by using elemental composition, 
database searching and fragment identifications via in-silico fragmentation of a downloaded structure compared to accurate mass 
fragment ion data. In this study, the various components of an e-cigarette (end caps, mouth piece, gauze, heating element and 
flavor formulation) were extracted separately and subjected to non-targeted high resolution screening using both UPLC and APGC 
analysis on a single QTOF-MS platform. Data was acquired using a DIA approach, consisting of alternating high and low collision 
energy states to generate precursor and fragment ions. The data from sample extracts were compared to reagent blank extracts 
to determine the differences and potential extractables. Ensuring these compounds do not pose any toxicological risks to the 
consumer relies on identifying the extractables. The UNIFI Scientific Information System utilises accurate mass precursor and 
fragment information to simplify data review and facilitate the decision-making process. It allows analysts to evaluate complex data 
in a more efficient way and quickly make decisions about the possible identity of known and unknown compounds. This application 
demonstrates how non-targeted screening using LC and GC workflows can be adopted on a single platform for extractable and 
leachable testing in food, cosmetics and pharmaceutical packaging applications.
P-258 Metabolic Markers for the progression of nonalcoholic fatty liver disease in Type 2 diabetes patients
PRESENTING AUTHOR: Tao Wu, Center of Chinese Medical Therapy and Systems Biology, Shanghai University of Traditional 
Chinese Medicine, Shanghai, China, China
CO-AUTHORS: Ming Yang, Hanchen Xu, Lei Wang, Peiyong Zheng, Guang Ji                                            
The report aimed to identify metabolic markers for nonalcoholic fatty liver disease (NAFLD) development in type 2 diabetes 
mellitus (T2DM) patients. Using a targeted ultra performance liquid chromatography (UPLC) coupled with Triple Quadrupole mass 
spectrometry (TQ/MS), we compared serum bile acids levels in T2DM with NAFLD (n = 47) and age-gender matched T2DM without 
NAFLD (n = 47) for the first time. It is interesting that serum bile acid profiles in T2DM with NAFLD are greatly different from 
those without NAFLD, characterized by the significant elevation of TLCA, 3DHCA, GUDCA, CDCA24G, LCA and UDCA, which may be 
potential biomarkers for diagnosis of NAFLD in T2DM, and meanwhile it presents that those increased bile acids may participate the 
formation of NAFLD in T2DM patients. These findings suggest that these newly detected metabolites may participate in the progress 
of NAFLD in T2DM patients.
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P-259 LC-MS based untargeted metabolomics to study biomarkers of aging in rat urine
PRESENTING AUTHOR: ERHAN SIMSEK, Department of Chemistry, NUS, Singapore
CO-AUTHORS: Fong Yau Sam Li                                                  
Aging is a complicated phenomenon involving gradual accumulation of detrimental changes in biological systems resulting 
in significant changes in cellular metabolism. Normal aging process also frequently accompanies numerous diseases such as 
Alzheimer’s, diabetes and kidney disease. It has been proposed that aging process itself may be the underlying cause for these age-
related diseases, and slowing down or reversing it can potentially prevent or cure them. To explore the metabolic changes involved in 
aging process, Sprague Dawley (SD) rats were chosen as model organism. Urine samples from healthy SD rats of 3 and 15 months 
were analyzed using UPLC-QTOF in ESI positive and ESI negative mode. Pooled quality control samples were also analyzed regularly 
throughout the run to check for system stability. After peak picking and statistical analysis, differential metabolites among different 
age groups were chosen and, after performing MS/MS studies, were searched against spectral databases for identification before 
carrying out pathway analysis for biological significance. Along with univariate statistics, multivariate statistical analysis of the data 
using PCA and PLS-DA revealed separation among different age groups. Metabolic features responsible for the separation between 
groups were chosen based on their VIP values and univariate statistics. They were searched against accurate mass metabolite 
libraries of METLIN and Human Matabolome Database (HMDB) for identification. Pathway analysis on the identified features 
revealed a number of pathways that could be implicated in aging process. The study provides new insights into the mechanism and 
biomarkers of aging process.
P-260 Mice Fecal Metabolites Analysis with LC-MS/MS
PRESENTING AUTHOR: Takero Sakai, Shimadzu Corporation, Japan
CO-AUTHORS: Takanari Hattori, Shuichi Kawana, Yoshihiro Hayakawa, Eiichiro Fukusaki, Mitsuharu Matsumoto                                            
Intestinal microbiome plays an important role in health and/or disease because it influences pathological and normal homeostatic 
functions. Low-molecular-weight metabolites produced by intestinal microbiome are absorbed constantly from the intestinal lumen 
and carried to systemic circulation; they play a direct role in health and/or disease. We focused on mice feces and utilized LC-MS/
MS. We evaluated 55 and 97 of metabolites with both ion-pairing method and non-ion-pairing method. In ion-pairing method, 
17 of metabolites were detected in the extract of mice feces (peak area RSD &lt;20%). Main compounds of 17 metabolites were 
amino acids. In non-ion-pairing method, 75 of metabolites were detected in the 10-fold diluted extract of mice feces (peak area 
RSD &lt;20%). Main compounds of 75 metabolites were amino acids and nucleic acid-related substances. As an application to 
fecal metabolomics, feces derived from mice that the age was different (10-week-old and 70-week-old) were analyzed by non-ion-
pairing method. As results of analyses for the extracts of the mice feces, 66 of metabolites were detected. The concentrations of 21 
metabolites (e.g. adenine, aspartic acid, cholic acid, homocysteine, and thymidine) in aged mice (70-week-old) feces were obviously 
lower (p &lt; 0.01) than those in young mice (3-week-old) feces. These differences seem to be caused by both the differences of 
intestinal microbiome and physical senescence. For example, the lower concentration of fecal cholic acid in aged mice depend on 
both the decrease of bacteria that catabolize conjugated bile acids and the reduction of the bile acid secretion by aging.
P-261 Alcohol use caused changes in the metabolite profile of first trimester serum samples of pregnant woman
PRESENTING AUTHOR: Olli Kärkkäinen, University of Eastern Finland, Finland
CO-AUTHORS: Anni Lehikoinen, Marko Lehtonen, Seppo Auriola, Ulrich Tacke, Seppo Heinonen, Kati Hanhineva                                          
Our aim was to evaluate effects of alcohol use to the metabolic profile of women during the first trimester of pregnancy. We used 
serum collected during routine first trimester visit to the hospital from healthy controls (n=55), alcohol users (n=19), drug users 
(n=24) and tobacco smokers (n=40). We measured levels of metabolites with LC-qTOF-MS using HILIC column and positive ESI. 
Significant differences were found between the study groups in the metabolite profiles, such as alcohol and drug-using mothers had 
increased glutamate and decreased glutamine levels, and alcohol-using mothers had decreased serotonin levels when compared 
to the controls. If verified in future studies, these results could help to explain alcohol use caused damage to the fetus as well as 
detection of alcohol use during the first trimester of pregnancy.
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P-262 jMorp: Japanese Multi Omics Reference Panel
PRESENTING AUTHOR: Ikuko Motoike, Tohoku Medical Megabank Organization, Tohoku University, Japan
CO-AUTHORS: Daisuke Saigusa, Seizo Koshiba, Yasutake Katoh, Matsuyuki Shirota, Shu Tadaka, Yuichi Aoki, Kengo Kinoshita, 
Masayuki Yamamoto                                       
It has been shown that biomolecules found in biomaterials whose concentrations vary among individuals reflecting disease risks of 
the subjects are useful and these are called disease biomarkers. Measurement of such biomarkers will provide valuable information 
for disease prevention and early diagnosis. Tohoku Medical Megabank Organization (ToMMo) has completed a multi-omics 
(metabolome and proteome) analysis of 1008 plasma samples that are collected from Japanese residents (male: 433, female: 575) 
who participated in the Tohoku Medical Megabank Project Community-Based Cohort Study. The data have been integrated into the 
database “Japanese Multi Omics Reference Panel (jMorp)” and is publicly available through online [https://jmorp.megabank.tohoku.
ac.jp]. Metabolome data are measured by proton NMR and LC-MS, and proteome data are obtained by nanoLC-MS. In current 
state, we have released distributions of concentrations of 37 metabolites identified by NMR, distributions of peak intensities of 257 
characterized metabolites by LC-MS, and observed frequencies of 256 abundant proteins (proteome data was measured with 501 
plasma samples (male: 190, female: 311)). We are planning to update metabolome data with several thousands sample and add 
results of association studies among these molecules, genome, and individual’s subjective data to our biobank.
P-263
Comprehensive metabolomics-based interpretation of the anti-obesity effects of Dolichos 
lablab (hyacinth bean) or milk thistle (Silybum marianum) administration in high-fat diet-fed 
mice
PRESENTING AUTHOR: Dong Ho Suh, Konkuk University, South Korea
CO-AUTHORS: Eun Sung Jung, Seung-Hyung Kim, Digar Singh, Choong Hwan Lee                                             
Hyacinth bean (Dolichos lablab) is a lesser-known bean that exerts potential anti-obesity effects, but its mechanism and efficacy 
are not well-understood. In this study, we investigated the anti-obesity effects of hyacinth bean compared to milk thistle, which 
have been used for treatment of obesity-related diseases as traditional herbal plant, in high fat-diet (HFD) mice, along with their 
underlying mechanisms. C57BL/6J mice were orally administered hyacinth bean (25 mg/kg/day) or milk thistle (100 mg/kg/day) for 
9 weeks along with HFD. The anti-obesity effects exerted by hyacinth bean and milk thistle on clinical parameters, suppression of 
weight gain and liver steatosis were similar, but with some different. Metabolic pathway analysis revealed that hyacinth bean or milk 
thistle administration mainly attenuated lipid, glucose, and bile acid metabolism-related metabolites changed by HFD, while hyacinth 
bean specifically attenuated most of amino acids derived from pyruvate. These potential biomarkers, such as lipids and amino acids 
showed high correlation with obesity-related blood parameters. From these results, we suggested that lower dose of hyacinth bean 
showed similar anti-obesity effects as milk thistle, confirmed by both clinical and metabolomics analysis.
P-264 Metabolomics Study on Plasma of Alternate Day Fasting and Exercise in Patients with Metabolic Syndrome using UHPLC-QTOF/MS
PRESENTING AUTHOR: Bo Kyung Kim, Kyungpook National University, South Korea
CO-AUTHORS: Mi-Ri Gwon, Min Hee Kwon, Ji-Won Lee, Sook Jin Seong, Young-Ran Yoon                                            
Alternate Day Fasting (ADF; “feed day”, alternated with 25% energy intake “fast day”), is known to be effective for weight loss, 
preventing and improving metabolic diseases. These effects are known to occur in normal weight but the influences of ADF on 
overweight and metabolic syndrome patients remain unclear. Therefore, we aimed to investigate the alterations of endogenous 
metabolites in metabolic syndrome patients after ADF. Thirty-six subjects with metabolic syndrome (BMI 23.1-39.3 kg/m2) were 
randomized into four groups: ADF and exercise (Ex, aerobic and muscle exercise); only ADF; only exercise group; and a control 
group, for 8 weeks. Plasma samples were collected before and after clinical trial and analyzed by an ultra-high performance liquid 
chromatography (UHPLC)-quadrupole time-of-flight (QTOF)/mass spectrometry (MS) and multivariate data analysis. Principal 
component analysis (PCA) and orthogonal projection to latent structures-discriminant analysis (OPLS-DA) score plots showed a 
clear separation between 4 groups. These results suggest that ADF and exercise are effective in the prevention and improvement 
of weight loss and overweight in the metabolic syndrome patients, then to reach solid conclusion in this research, the larger sample 
size and more strict clinical trials are required. Also, this study represents the first UHPLC-QTOF/MS-based metabolomics study to 
evaluate the influence of ADF and exercise on the metabolite alterations in overweight and metabolic syndrome patients. Therefore, 
UHPLC-QTOF/MS-based metabolomics research can be a useful tool for evaluating the effects of dietary and exercise controlling and 
confirming the metabolic syndrome mechanism.
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P-265 Using GC-MS-based metabolite profiling to predict surgical success in otitis media
PRESENTING AUTHOR: Hayley Abbiss, Murdoch University, Australia
CO-AUTHORS: Joel Gummer, Robert Trengove, Andrew Currie, Ruth Thornton                                             
Otitis Media (OM-middle ear infections) are the most common reason a child will visit their GP and be prescribed antibiotics. OM 
is usually associated with the build-up of middle ear fluid (MEF), which is a common cause of conductive hearing loss. In children 
with persistent or recurrent OM, surgical insertion of grommets to allow ventilation of the middle ear is often performed; however, 
in a third of children, disease recurs and repeat surgery is required. The aim of this study was to identify sensitive metabolomic 
biomarkers from MEF and saliva samples associated with surgical success. MEF and saliva samples were collected from 60 study 
participants prior to grommet insertion. Of these, 14 required repeat surgery. To determine the appropriate amount of sample to 
extract and analyse, preliminary analyses were performed on a pooled MEF sample. Serial dilutions of a 50 µL pooled sample were 
prepared giving equivalents of 0.625 – 10 µL of sample. Metabolites were extracted with water and methanol and derivatised for 
GC-q-TOF MS analysis. MS data showed that the MEF samples were rich with features even with the analysis of very small amounts 
of fluid. Chromatographic overloading and detector saturation of some features was evident even in the lowest sample volume; 
however, the response of most features in overloaded and saturated regions was linear up to 5 µL of sample. Samples will be 
extracted and derivatised using the equivalent of 5 µL of sample to uncover whether sensitive biomarkers of surgical success can be 
determined.
P-266 Targeted and non-targeted metabolomics to study developmental neurotoxicity of biocides
PRESENTING AUTHOR: Jonathan Moss, Bruker Pty Ltd (Australia) - Bruker Corporation, Australia
CO-AUTHORS: Pim Leonards, Heiko Neuweger, Jonathan Moss, Sven Meyer, Aiko Barsch                                            
Worldwide, serious concern has arisen about the increased incidence of learning and developmental disorders in children. The 
European DENAMIC project investigated the behavior and cognitive effects of pesticide exposure in mice and rats and studied 
underlying molecular mechanisms of the observed effects using metabolomics. The current paper will focus on a targeted and 
untargeted metabolomics approach using one software package. Mice and rats were exposed to individual pesticides such as 
chlorpyrifos, carbaryl, cypermethrin and endosulfan. Behavior effects were studied once the animals reached adulthood. Metabolomic 
analysis was carried out using brain tissues of mice and rats. Data for targeted and untargeted metabolite analysis was acquired 
by HILIC-QTOF-MS/MS. MetaboScape3.0 software was used for data processing including mass recalibration, multi-pass recursive 
feature extraction with de-isotoping, deconvolution of adducts, and retention time alignment. Identification of known metabolites was 
based on retention time, accurate mass, isotopic pattern information, and MS/MS spectra. A custom made analyte target list of about 
700 metabolites for annotation of known compounds, followed by automatic annotation of unknown peaks was used. Annotated 
compounds, and calculated elemental composition of unknowns, were further evaluated in an interactive list. The list interacts with 
box-whisker, PCA, and volcano plots providing direct information on differences between treatments and pointing to characteristic 
compounds for further investigation. Tentative identification of unknowns with associated MS/MS spectra was conducted by in-silico 
fragmentation based on the MetFrag algorithm. Data analysis time was reduced due to simultaneous and confident assignment of 
known targets and tentative annotation of unknown peaks.
P-267 Metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer: Identification, causes and notions
PRESENTING AUTHOR: Jianghua Feng, Xiamen University, China
CO-AUTHORS: Bohan Zhan, Shi Wen, Heguang Huang                                               
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal tumors. However, the methodological differences between 
orthotopic and subcutaneous xenograft (OX and SX) models will cause confusion in understanding its pathological mechanism and 
clinical relevance. In this study, SX and OX models were established by implanting Panc-1 and BxPC-3 cell strains under skin and 
on the pancreas of mice, respectively. The tumor tissue and serum samples were collected for detection of 1H NMR spectroscopy 
followed by univariate and multivariate statistical analyses. As results, no obvious metabonomic difference was demonstrated in 
serum between the two models, however, the model- and cell strain-specific metabonomic differences were observed in tumor 
tissues. According to the KEGG analysis, ABC transporters, glycerophospholipid metabolism, purine metabolism and central 
carbon metabolism were identified to be the most significant components involved in metabonomic differences. Considering the 
methodological discrepancy in SX and OX models, such differences should be contributed to tumor microenvironment. In general, SX 
are not equivalent to OX models at molecular level. Subcutaneous transplantation displayed its inherent limitations though it offered 
a simple, inexpensive, reproducible and quantifiable advantage. And orthotopic transplantation may be favorable to simulate PDAC in 
patients due to its similar pathogenesis to human pancreatic cancer.
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P-268 Metabolomic profile of exosomes released by FaDu cells exposed to ionizing radiation
PRESENTING AUTHOR: Lukasz Marczak, Institute of Bioorganic Chemistry Polish Academy of Sciences, Poland
CO-AUTHORS: Agata Abramowicz, Anna Wojakowska, Piotr Widlak, Monika Pietrowska                                             
Exosomes are membrane-derived nanovesicles of 30-120 nm in diameter, actively secreted by various types of normal and cancer 
cells. Numerous studies have identified exosomes as a means of intracellular communication. The composition of exosomes differs 
from a cell type to a cell type. More than 41 000 different proteins have been reported as cargo of exosomes and are listed in 
databases like Exocarta (http://www.exocarta.org) and Visclepedia (http://www.microvesicles.org). In addition to proteins, exosomes 
contain lipids, particularly raft-lipids like ceramides, sphingolipids, cholesterol and glycerophospolipids. Beside them, bioactive lipids, 
such as prostaglandins and leukotrienes, and enzymes activated in lipids metabolism, such as phospholipase C are also found in 
exosomes. Although the lipid content in exosomes is extensively studied, changes in lipid profile after ionizing radiation have not yet 
been fully understood. In our study we used FaDu cell line as an experimental model. The FaDu line was established from a punch 
biopsy of an hypopharyngeal tumor. Cells were cultured in a medium with exosome depleted serum (Exo-) and irradiated using 
a therapeutic linear accelerator (Clinac 600) at 2 and 8 Gy/min dose rate. After 24 hours of irradiation the medium was collected 
and exosomes were isolated using a protocol which we developed. Both exosomes and cells were analyzed. For analysis of total 
metabolites, GC/MS techniques were applied, and for lipid profiling shotgun direct analysis Advion Nanomate source and Orbitrap MS 
were used. A. Abramowicz and L. Marczak equally contributed to this work. Project was supported by the National Science Centre, 
Poland, Grant 2013/11/B/NZ7/01512.
P-269 Lipidomics comparing DCD and DBD liver allografts uncovers lysophospholipids elevated in recipients undergoing early allograft dysfunction
PRESENTING AUTHOR: Jin Xu, King’s College London, United Kingdom
CO-AUTHORS: Ana Casas-Ferreira, Cristina Legido-Quigley, Yun Ma, Arundhuti Sen, Min Kim, Petroula Proitsi, Maltina Shkodra, 
Maria Tena, Parthi Srinivasan, Nigel Heaton, Wayel Jassem                                   
Background. Finding specific biomarkers of liver damage in clinical evaluations could increase the pool of available organs for 
transplantation. Lipids are key regulators in cell necrosis and hence this study hypothesised that lipid levels could be altered in organs 
suffering severe ischemia.     Methods. Matched pre- and post-transplant biopsies from donation after circulatory death (DCD, n = 
36, mean warm ischemia time = 21min) and donation after brain death (DBD, n = 76, warm ischemia time = none) were collected. 
Lipidomic discovery and multivariate analysis (MVA) were applied. Afterwards, univariate analysis and clinical associations were 
conducted for selected lipids differentiating between these two groups.     Results. Matched pre- and post-transplant biopsies from 
donation after circulatory death (DCD, n = 36, mean warm ischemia time = 21min) and donation after brain death (DBD, n = 76, 
warm ischemia time = none) were collected. Lipidomic discovery and multivariate analysis (MVA) were applied. Afterwards, univariate 
analysis and clinical associations were conducted for selected lipids differentiating between these two groups.     Conclusions. These 
findings suggest that LysoPC (16:0) and LysoPC (18:0) might have a role in signalling liver tissue damage due to warm ischemia 
before transplantation.
P-270 A new metabolic approach to treat patients with drug resistant epilepsy
PRESENTING AUTHOR: Karin Borges, The University of QLD, Australia
CO-AUTHORS: Jack Germaine, Neha Kaul, Terence O’Brien                                               
Triheptanoin, the triglyceride of heptanoate, is being developed for several congenital metabolic deficiencies to provide energy. 
Heptanoate is metabolised directly into succinyl-CoA and is therefore anaplerotic. Our randomised, double blinded, placebo-controlled 
trial assessed the safety and tolerability of add on oral triheptanoin in patients with drug resistant epilepsy for 12-weeks of treatment. 
Patients were randomised for triheptanoin or “standard” medium chain triglycerides (MCT, triglycerides of octanoate and decanoate) 
to the maximum tolerated dose (maximum 35% of caloric intake). 18 patients were randomised to treatment with triheptanoin 
and 17 to MCT. There were no differences between treatment and MCT in the following parameters: 1) the number of patients 
finishing the full study (10 vs. 11 patients; 56% vs. 65%), 2) the time until withdrawal, 3) the number of adverse events and 4) 
the percentage of prescribed treatment dose taken over the treatment period (85% vs. 98%). Moreover, there were no changes 
between the treatment and placebo group in caloric intake over the treatment period (p=0.32), body weight changes (p=0.93) or 
amount of triheptanoin (0.59 +/- 0.28 g/kg) or MCT (0.72 +/- 0.24 g/kg, p=0.119, rank sum) taken per body weight per day (mean 
+/- SD). The study was not powered to investigate effects on seizure frequency, however five patients on placebo and one patient 
on triheptanoin showed &gt;50% seizure reduction.  In summary, in terms of safety and tolerability there was no difference between 
MCT and triheptanoin treatments when added to a normal diet for adults with treatment resistant epilepsy.
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P-271 Inhibitory effect of Selaginellins from Selaginella tamarscina (Beauv.) Spring against cytochrome P450 isoforms on human liver microsomes.
PRESENTING AUTHOR: Won Cheol Kim, Kyungpook National University, South Korea
CO-AUTHORS: Jae Kyung Heo, Zhexue Wu, Kwang-Hyeon Liu                                               
Selaginella tamariscina (Beauv.) has been used for traditional herbal medicine in not only Korea but also Asia especially in China. 
The ingredients of Selaginella tamariscina (Beauv.) has been also known to have various biological activities including anti-cancer 
activities. In this study, we evaluated the drug-drug interaction potential of four selaginellins obtained from Selaginella tamariscina 
against ten cytochrome P450 isoforms (CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP2J2, and 
CYP3A) in human liver microsomes using cocktail incubation and tandem mass spectrometry. They showed moderate inhibitory 
potential on CYP2C8, CYP2C9 and CYP2J2 enzyme activities (IC50 &lt; 5 ?M), whereas they had weak inhibitory activities against 
CYP2A6 and CYP2E1 enzymes (IC50 &gt; 20 ?M). Among four compounds tested, one compounds showed more weak inhibitory 
potential against 10 P450s than other three compounds. This work was supported by the Bio-Synergy Research Project (NRF-
2014M3A9C4066462) of the Ministry of Science, ICT, and Future Planning through the National Research Foundation of Korea (NRF).
P-272 Metabolic cellular response towards immunotoxic compounds in Jurkat T cells
PRESENTING AUTHOR: Karen Methling, University of Greifswald, Institute of Biochemistry, Germany
CO-AUTHORS: Martina Wurster, Sarah Niehs, Nadin Schultze, Paula Zwicker, Ulrike Lindequist, Beate Haertel, Michael Lalk               
A variety of natural products from microbes, plants, or other sources have been shown to influence the human immune system. 
Immunotoxicity of xenobiotics is up to now mainly investigated by in vivo experiments using laboratory animals.  In this in vitro 
study the metabolic response of Jurkat cells after treatment with immune modulating natural compounds was analyzed using the 
cell line as a model for T cells of the human immune system. The aim was to discover whether investigations of the metabolome 
could contribute to the prediction of immunotoxicity. Data analysis included extracellular metabolome investigations by 1H-NMR 
spectroscopy. Amino acids were analyzed by LC-MS/MS, quantification of nucleotides was done using an ion-pairing HPLC method. 
Polar intracellular metabolites of the central carbon metabolism were investigated by GC-MS methods. Seven immune modulating 
natural products investigated at IC25 and three nontoxic controls were selected. Effects on mean metabolic pathways of Jurkat cells 
were found to be very specific for each compound. Concerning the metabolism of amino acids the level of four amino acids were 
significantly increased after cell treatment with all immune modulating compounds compared to untreated cells and also increased 
compared to cells treated with nontoxic controls.  In summary the metabolomic studies of the Jurkat T cell line were used to identify 
potential metabolic biomarkers for prediction of immunotoxicity.
P-273 Simultaneous Metabolic Profiling in Colorectal Cancer  Using Seemingly Unrelated Regression
PRESENTING AUTHOR: Min Zhang, Purdue University, United States
CO-AUTHORS: Chen Chen, Nagana Gowda, Dabao Zhang, Daniel Raftery                                             
Colorectal cancer (CRC) is one of the most prevalent diseases worldwide and considerable effort has been devoted to identifying 
robust biomarkers to enable prediction, screening and surveillance.     To understand the differences in metabolite levels between 
CRC and polyp patients as well as healthy controls, we employed seemingly unrelated regression (SUR) to model a group of 
metabolites simultaneously while adjusting other clinical covariates including gender, BMI, age, alcohol use, and smoking status. In 
addition, we used ParCorA algorithm to construct metabolite networks in CRC, polyp patients, and healthy controls, respectively, for 
all groups of metabolites both before and after using SUR to account for the effect of confounding variables. Results showed that 
metabolite levels were significantly affected by clinical covariates such as gender, BMI, and smoking status. While several metabolites 
show significant difference between CRC, polyp patients and healthy controls, SUR models also identified a number of significantly 
altered associations for groups of biologically connected metabolites. Furthermore, different metabolite networks constructed in 
CRC, polyp patients and healthy controls are different for several groups of biologically related metabolites before and after SUR 
analysis. Our results provide new insight into addressing the large confounding effects in the metabolomics profiling and shed light 
on establishing reliable noninvasive biomarkers for various types of diseases.
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P-274 Importance of amino acid Citrulline as a metabolomic signature in determining the gut enterocyte status in Celiac disease
PRESENTING AUTHOR: Avinash Lomash, Pediatrics Research & Metabolic Lab, Maulana Azad Medical college & Associated LN 
Hospital,Faculty of Medical Sciences, University of Delhi, India
CO-AUTHORS: Somesh Kumar, Sunil Polipalli, Seema Kapoor                                               
BACKGROUND:Because the endogenous source of amino acid citrulline is small intestine and doesn’t take part in protein,this 
study was designed to evaluate citrulline levels in patients with CD &amp; in their FDR &amp; to establish a correlation between 
histopathological findings &amp;the citrulline levels as metabolomic for villous atrophy METHODS:The procedure adopted for 
measuring citrulline on DBS filter paper was TMS(LC-MSMS)&amp; plasma citrulline was analysed by RP-HPLC.The disease state was 
confirmed by HLA typing RESULTS: Plasma citrulline value in 54 serology positive subjects was 9.0umol/L,in124serology negative 
subjects(FDR)was 24.3umol/L with pvalue of &lt;0.0001.Correlations between biopsy grades of Subjects with their citrulline levels 
were established.For Marsh 3c grade lesions,citrulline levels were 5.6umol/L,for Marsh 3b,levels were 15.0umol/L with p value 0.006.
Understandably the patients with total villous atrophy had a lower citrulline levels even if they were asymptomatic.All the patients 
were on stringent six month follow up on GFD &amp;the value after 6months was 11.53umol/L DISCUSSION:Citrulline may serve as 
a sensitive Non-HLA marker of severity of intestinal damage.It is simple,minimally invasive and promising metabolomic tool which 
suggests the improvement in gut enterocyte mass in patient on GFD from the remotest area of the country by using DBS filter paper.
Evaluating citrulline as a metabolomic and proteomic signature plays a very crucial role in the detection of silent and potential phase 
of the disease in the highest risk group like FDR.This novel finding will give us valuable information on metabolic pathway underlying 
disease pathogenesis,thereby providing us with tools to create novel diagnostics and therapeutics in the future
P-276 Identification of metabolite profiles from germinated soy germ extracts and improvement effects of their female menopause symptoms
PRESENTING AUTHOR: Woo Duck Seo, National Institute of Crop Science, RDA, South Korea
CO-AUTHORS:                                                    
This research was the first to investigate changes in metabolite profiles of germinated soy germ extracts(GSGE). Thirteen isoflavones 
and ten soyasaponins were characterised as aglycone isoflavones (genistein etc.), glycosylated isoflvones (genistin etc.), oleanane 
triterpenoid glycosides (soyasaponins Ab etc.) using ultra performance liquid chromatography quadrupole time-of-flight mass 
spectrometry (UPLC-qTOF-MS) and nuclear magnetic resonance (NMR). Especially, soyasaponin Ab and soyasaponin Bb from 
germinated soy germ were the predominant constituents (40-45 %) with significant differences in cultivars and germinated times. 
Also, we investigated on the prevention of osteoporosis, which are typical disorders of menopausal women. The GSGE was regulated 
which is enriched with soyasaponins osteoblasts via the bone morphogenic protein-2 (BMP-2) stimulated induction of alkaline 
phosphatase (ALP). The osteogenic activity of GSGE was accompanied by synergistic induction of Runx2 as the master transcription 
factors for bone formation. In conclusion, we suggest that anti-osteoporotic activity of GSGE could be because of its osteoblast 
activity, and it could be developed as a potent functional food and pharmacological agent for bone health.   
P-277 Analysis of plasma samples for identification of schizophrenia biomarkers
PRESENTING AUTHOR: Simon Ovenden, DST Group, Australia
CO-AUTHORS: Chad Bousman, Christos Pantelis, Ian Everill                                               
Schizophrenia is a severe mental disorder that affects approximately 1% of the global population.[1-2] There are several common 
symptoms that characterise schizophrenia including delusions and hallucinations, dysfunction and altered cognitive behaviour. It is 
thought that the onset of schizophrenia is caused by either or both of genetic makeup and environmental factors. Several classes 
of metabolites, including lipids and organic and amino acids, have been identified as potential biomarkers for schizophrenia.[1-4] 
As part of an ongoing program looking at identifying biomarkers for mental illness, plasma from a cohort of schizophrenia patients 
was analysed. Plasma samples were prepared for metabolomic and lipidomic sample analysis by both high resolution LC-MS and 1H 
NMR. Putative biomarkers were identified and confirmed through online database searches and additional chemical analysis. This 
presentation will discuss the current results of this ongoing research project, including sample preparation and analysis, multivariate 
statistical analysis results and biomarker identification. [1] Ying Qiao et al. Plasma metabolomics study of first-episode schizophrenia 
treated with olanzapine in female patients. Neuroscience Letters, 2016, 617, 270-276. [2] Y. He et al. Schizophrenia shows a unique 
metabolomics signature in plasma. Translational Psychiatry, 2012, 2, e149. [3] Matej Oreši? et al. Metabolome in schizophrenia and 
other psychotic disorders: a general population-based study. Genome Medicine, 2011, 3:19. [4] Matej Oreši? et al. Phospholipids and 
insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia. Genome Medicine, 2012, 4:1.
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P-278 Metabolomics applied in skeletal muscle impact trauma
PRESENTING AUTHOR: Lian Liu, QUT, Australia
CO-AUTHORS:                                                    
Muscle injury is a prevalent cause of debilitation for workers, athletes, and the public generally at home and in motor vehicle 
accidents.  To date, a number of physical trauma models have been established, including in vivo and in vitro models, which lay a 
foundation of research into skeletal muscle injury. While the general processes associated with skeletal muscle injury have been 
described, some of the more specific factors involved in the recovery processes are identified based on experimental research as 
well.  The project will apply global metabolomics based approaches in in vivo model. Specifically, a rat impact contusion model will 
be utilised to model impact trauma. Dynamic global metabolite profiling using GC-MS/MS will be performed at 6h, 12h, 1, 3, 7 and 
14 days on tissue homogenates to identify factors that are associated with the initial recovery response following injury.  There are 
temporal changes to biochemical pathways and processes during recovery from muscle trauma in vivo, and global metabolomics 
profiling will reveal these changes. Dominant endogenous factors present in injured muscle will activate signalling pathways resulting 
in secretion of cytokines that regulate inflammation and regeneration in skeletal muscle.
P-279 Short-term effect of wasabi rhizome (Wasabia japonica) on metabolic syndrome in high-fructose-diet-fed rats
PRESENTING AUTHOR: Fernanda Thomaz, University of Queensland, Australia
CO-AUTHORS: Sunil Panchal, Lindsay Brown, Leigh Ward, Simon Worrall                                             
The prevalence of metabolic syndrome (MetS), a group of metabolic dysfunctions associated with obesity, has reached over 30% 
worldwide. Plant products such as wasabi rhizome appear to be effective therapeutic agents against obesity and chronic diseases. 
This study aims to investigate the short-term effects of Wasabia japonica rhizome on the metabolic syndrome induced in Wistar rats 
by a high-fructose diet. Methods: Rats were fed either a corn starch (C) or high-fat high-carbohydrate (H) diet for 8 weeks. After 
8 weeks, CW (corn starch plus wasabi; n=12) and HW (high-fat high-carbohydrate plus wasabi; n=12) rats had 5% (w/w) wasabi 
rhizome added to their diet for 8 weeks. Animals had ad libitum access to food and water. Metabolic parameters including body mass 
index (BMI), systolic blood pressure (SBP), together with plasma cholesterol, AST and ALT, and hepatic histology were measured 
after the 16-week protocol. Results: Animals in the CW and HW groups had their BMI reduced by 13% and 17%, along with declines 
in SBP of 3mmHg and 14mmHg, when compared to controls. Plasma ALT and AST of the CW and HW groups were also significantly 
decreased when compared to controls, whereas total cholesterol was lower in the HW, but not in the CW group. Furthermore, hepatic 
histology showed less inflammation in the wasabi-treated groups. Conclusions: This 16-week trial suggests that wasabi exerted 
an ameliorative effect on the studied metabolic parameters, especially on body weight, SBP and inflammatory parameters. Further 
studies are required to investigate the molecular mechanisms underlying our findings.
P-280 Metabolomics facilitated the characterization of functional small molecules towards a diversity of biological innovations
PRESENTING AUTHOR: Haitao Lu, Shanghai Jiao Tong University, China
CO-AUTHORS:                                                    
In vivo small molecules as necessary intermediates are involved in numerous critical metabolic pathways and associated with many 
essential biological functions. In recent years, there is growing evidence to manifest that metabolomics is emerging as a powerful 
tool for facilitating the discovery of functional small molecules which provides novel insights into a diversity of biological concerns 
involving disease diagnosis, therapeutic discovery and toxicology. Yet, metabolomics holds promise in promoting widely biological 
innovations in a real world besides terming biomedical niche, which also yields a wealth of information about food and environmental 
questions concerning safety and toxicology. In this proposed presentation, brief introduction to metabolomics science shall be given 
to highlight its concept, protocol, manipulation and biological application for the first instance, and then a line of typical examples will 
be adopted to demonstrate how metabolomics combining with genetic strategy was employed by my group to facilitate the discovery 
of functional small molecules whose pattern changes can efficiently delineates the complex mechanisms implicated in a diversity of 
biological events via targeting the most affected metabolic pathways, such as disease progression, pathogen virulence and discovery 
and validation of therapeutic targets as well.
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P-281 NMR-based metabolomic analysis for the diagnosis of systemic sclerosis
PRESENTING AUTHOR: Sehyun Oh, Seoul National University, South Korea
CO-AUTHORS: Kyong-Hee Jung                                                  
Systemic sclerosis (SSc) is a complex multi-organ autoimmune disease that is caused by inflammation, vasculopathy and fibrosis. 
Clinical heterogeneity, unpredictable course, high mortality and resistance to treatment make physicians still frustrated. To enhance 
diagnostic ability, new classification criteria of SSc is published by ACR/EULAR in 2015. However, no disease specific biomarker for 
SSc is present yet. Recently, there are unmet needs of useful biomarkers for diagnosis,  evaluation of disease activity and severity 
in SSc. Metabolomics is expected to be a useful tool for the identification of biomarkers and new therapeutic targets. Metabolomic 
analysis has been reported for major rheumatic diseases, such as systemic lupus erythematosus, and rheumatoid arthritis, although 
none yet for SSc.
P-282 Radish Extract Affects the Gut Microbiome in Ovariectomy-induced Mice
PRESENTING AUTHOR: yujin hwang, National Academy of Agricultural Science, RDA, South Korea
CO-AUTHORS: Hana Yi, Min-Jung Shin, Hwan-Hee Jang, Jung-Bong Kim, Jeong-Sook Choe                                            
The radish (Raphanus sativus) is an edible root vegetable of the Brassicaceae family. Radishes are grown and consumed throughout 
the world, being mostly eaten raw as a crunchy salad vegetable. Radishes are rich in ascorbic acid, folic acid, and potassium. They 
are a good source of vitamin B6, riboflavin, magnesium, copper, and calcium. However, little is known about the change of gut 
microbiome by radish. The gut microbiome was analyzed using the 16S rRNA gene sequences. The beta-diversity analyses revealed 
that the overall composition of gut microbiome of mice changed by radish. In addition, Radish changed the gut microbiota structure 
characteristically as a reducing Firmicutes phylum, especially Lactobacillus, and a rising Verrucomicrobia phylum. And we also were 
identified as Akkermansia muciniphila at the species level. The results were concluded that Radish could positively affect gut flora 
structure. However, we have to more study to find the link between the bacterial members and the host metabolism.
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